ANNUAL REPORT
FY 2021 — Annual report
FY 2021PDF · 142 pages5.0 MB
2021 Annual Report
Powered by purpose
Delivering on growth
Building our future
-- 1 of 142 --
1
2021 Annual Report
Dear Shareholders,
Throughout my 34 years at 3M, I have been proud of
the difference we make. Our work is rooted in purpose
– unlocking the value of people, science and ideas to
reimagine what is possible and build what is next.
We use science to strengthen healthcare, empower
consumers, and reshape the future of transportation and
manufacturing. These past two years we have helped lead
the response to COVID-19 and distributed more than
4 billion respirators to protect nurses, doctors and first
responders, while helping accelerate manufacturing of
needed vaccines. At the same time we have stepped up
our efforts in ESG, investing in environmental stewardship
and advancing equity and inclusion in our company and
communities. In combination these efforts demonstrate
the societal value 3M uniquely brings to the world.
Every day the extraordinary people of 3M bring our
purpose to life. It is found in the ingenuity of 3Mers like
Steven Toh, an engineer who pioneered an innovative
rooftop solar project at our factory in Tuas – one of the
largest projects of its kind in all of Singapore. It’s found
in the leadership of L.C. Cartagena, a crew director at
our Aberdeen, South Dakota plant, whose team broke
multiple shift records and produced more than 1 billion
respirators over the last two years. It’s found in the
boldness of Martin Dittmar, an engineer at our plant in
Wuppertal, Germany. Last July, after their community
was devastated by a historic flood, Martin led a crisis
team that jumped into action, shutting down operations
to protect lives – then, incredibly, rebuilding the plant in
a matter of weeks, so they could serve customers with
critical medical products.
There are examples like that across our enterprise. I want
to thank our 95,000 employees – including the 50,000
people in our factories – for living our purpose every day
and for their immense contributions to 3M.
Purpose drives our performance and ensures we meet
the expectations of our stakeholders – which was evident
throughout last year.
1
Strong 2021 driven by market-leading businesses
In an uncertain environment, our 2021 performance
demonstrated the strength and resiliency of the 3M
model. While managing through global supply chain
disruptions, we stayed focused on our customers and
delivered another year of top-line growth greater than
the economies we serve. Companywide we posted 9
percent organic growth, which was broad-based across
our market-leading businesses. We also saw margins of
21 percent, and an 8 percent increase in earnings per
share – or a 14 percent increase on an adjusted basis.
We generated robust free cash flow of $5.9 billion, with
a conversion rate of 99 percent – enabling us to invest
in the business, reduce net debt by $1 billion and return
$5.6 billion to our shareholders through dividends and
share repurchases.
Over the last three years 3M has returned $14 billion to
shareholders, and in February of 2022 we increased our
dividend for the 64th consecutive year.
To hear from Mike and more on where we are making the greatest
impact — visit 3M.com/ESG.
Driven by purpose, delivering performance
This letter refers to non-GAAP measures such as free cash flow and net debt that are not otherwise referenced in the accompanying charts/tables.
See the Financial Condition and Liquidity section of Item 7 of 3M’s 2021 Annual Report on Form 10-K for further details.
-- 2 of 142 --
Advancing commitments to Environmental,
Social and Governance (ESG)
3M is a longtime leader in environmental stewardship
among manufacturers, going back more than 45
years to our groundbreaking Pollution Prevention Pays
program. It is a value that matters deeply to 3Mers, to
our stakeholders, and to me personally. In 2021, we
advanced our leadership with a $1 billion commitment
to achieve carbon neutrality, reduce water use, improve
water quality and reduce our use of plastics. We have
put forward ambitious goals to bend the curve – for
example, a 20% water reduction by 2025 and 50% carbon
reduction by 2030 – while delivering on pledges to make
our factories and communities more sustainable.
We are on track to complete a new water filtration system
in our Cordova, Illinois factory by the end of 2022. In the
past several months, we have committed 125 million
euro to improve water quality at our plant in Zwijndrecht,
Belgium, and in Cottage Grove, Minnesota, we have
closed our incinerator and partnered with a leading
disposal company to manage our waste stream – reducing
energy use by 25% – while committing to invest $165
million to improve water quality and reduce water use.
Beyond our operations, we have a requirement that
every new product improve sustainability. Over the last 5
years 3M innovations helped our customers avoid more
than 75 million tons of emissions – from glass bubbles
that lighten the weight of vehicles, to films that make
homes and electronics more efficient. Going forward,
we will continue to step up our sustainability
commitments, including through new partnerships
like the Water Resilience Coalition and ongoing
support of the United Nations Global Compact.
For society, we are advancing diversity, equity and
inclusion with a pledge to double our representation of
underrepresented groups within 3M. We are executing
multiple programs to make STEM education more
available – including new investments, new scholarship
programs and new partnerships like the United Negro
College Fund, supporting our goal of 5 million STEM
engagements by 2025. Our businesses have also
made commitments – Safety and Industrial is focusing
on access to skilled trades – and we are increasing
transparency through an annual Diversity, Equity and
Inclusion report with details on our progress
and metrics.
For governance, we continue to act with unwavering
integrity and transparency – leading to an 8th straight
recognition by Ethisphere® as one of the World’s Most
Ethical Companies® in 2021.
Increasingly we live in a world where litigation is
impacting many industries and companies, including
3M. For us, the focus is on PFAS – specifically, PFOA
and PFOS – and Combat Arms Version 2. We will
continue to vigorously defend our legal positions based
on science and our values. I encourage you to see our
SEC filings for more details.
2
-- 3 of 142 --
3
2021 Annual Report
Building for long-term growth and value creation
The foundation of 3M’s ability to create unique and
differentiated value is our fundamental strengths. Our
51 technology platforms, advanced manufacturing,
global capabilities and leading brands. At the same
time, we evolve and build on our foundation through
four strategic priorities, which position us for long-term
growth and value creation. Accelerating innovation,
actively managing our portfolio, transforming our
operating model with new digital capabilities, and
investing in our people and culture.
We are innovating faster and differently – implementing
new ways to virtually collaborate with customers
and partners – while investing $3.6 billion in 2021
in the combination of R&D and capital expenditures.
To make the most of long-term opportunities, we are
prioritizing investments in large, fast-growing areas
aligned to global trends like automotive technology,
home improvement, personal safety, health care, and
electronics. In 2021 we saw organic growth in our
automotive electrification platform of 30 percent and
our biopharma business of 26 percent. With people
at home more, we saw organic growth in our home
improvement business of 12 percent last year - on top of
13 percent in 2020 – driven by iconic brands including
our Command damage-free hanging solutions and
Filtrete home filters. To support increasing demand for
Command and Filtrete, we are investing $500 million
to expand our operations in Clinton, Tennessee, adding
nearly 600 manufacturing jobs.
The world is changing rapidly, and we will continue to
capitalize on opportunities across our businesses that
are sizable and significant.
The ongoing reshaping of our portfolio is key to unlocking
value for customers and shareholders. Every day we
challenge ourselves to allocate our resources to the most
attractive opportunities, while identifying acquisitions and
divestitures that shift us to more attractive markets. In
2021 we announced an agreement to divest and combine
our food safety business with Neogen, creating a
global leader that is positioned to capture long-term,
profitable growth.
We are transforming 3M by accelerating our digital
capabilities, and expanding our use of data and analytics
to better serve customers and optimize our supply chain
operations. We have moved more than 60 percent of our
enterprise data capacity to the cloud, while simplifying
business processes, streamlining our operating model and
deploying next-generation cybersecurity tools to protect
our assets.
All of this work is done by people at 3M who are powered
by inclusion, one of our core cultural values, and inspired
by our purpose. This shapes our commitment to a more
diverse and equitable future, and everything we do to help
our people be at their very best. Last year we introduced
new employee work models rooted in flexibility and trust
– called Work Your Way – while making investments to
support 3Mers’ health and well-being.
Our Purpose
Unlock the power of people, ideas, and science
to reimagine what’s possible
-- 4 of 142 --
4
Confident in our future
As I look across 3M, we have four market-leading
business groups aligned to attractive end markets, with
big opportunities in front of them. Together they form an
outstanding portfolio – focused on growing trends, and
leveraging the world-class capabilities of 3M. We also
have a premier leadership team with deep expertise and
diverse experiences from both inside and outside 3M.
We are building a stronger enterprise and I am confident
we will continue to grow our businesses, improve
our operational performance and live our purpose
– delivering for our customers, shareholders and all
stakeholders who have placed their trust in us.
Mike Roman
Chairman and CEO
$40
$35
$30
$25
$20
$15
$10
$5
$0
Sales (billions)
$32.1
2019
$32.2
2020
$35.4
2021
$12
$10
$8
$6
$4
$2
$0
$7.72/$8.79* $9.36/$8.85* $10.12
2019 2020 2021
Earnings per share-diluted
$6.00
$5.50
$5.00
$4.50
$4.00
$3.50
$3.00
$2.50
$2.00
$1.50
$1.00
$0.50
$0.00
$5.76 $5.88 $5.92
Cash dividends paid per share
2019 2020 2021
*Earnings per share-diluted, adjusted for special items (non-GAAP measure). See the Overview section of Item 7 of 3M’s 2021 Annual Report on Form 10-K
for further details.
-- 5 of 142 --
Organic sales growth
business group (year-on-year)
Total sales by business group**
GAAP earnings
per share
+8.0% year-on-year
$10.12
$3.4B
$2.0B
$35.4B 20.8% +1.6% 20.8% -0.5%
$2.2B
$1.6B
19.5% 99%
Dividends Share
Repurchases
+8.8%
Organic sales
year-on-year
$10.12
Adjusted earnings
per share*
+14.0% year-on-year
Return on
invested capital*
Free cash
flow conversion*
Investment in
research and
development
Net sales GAAP operating
income margins
Impact of currency
on worldwide sales
Adjusted operating
income margins*
Impact of acquisitions,
net of divestitures,
on worldwide sales
+9.9% year-on-year -150 basis points
year-on-year
year-on-year -50 basis points
year-on-year
year-on-year
Investment
in capital
expenditures
100% of new products
in development contain
a Sustainability Value
Commitment
Safety &
Industrial
+7.8% +9.0%
Transportation &
Electronics
+8.6%
Health Care
+9.3%
Consumer
*2021 operating cash flow of $7.5B billion. Full financial data and non-GAAP reconciliations of free cash flow conversion and return on invested capital (refer to the Financial
Condition and Liquidity section) and certain amounts adjusted for special items (refer to the Overview section) are included in Item 7 of 3M’s 2021 Annual Report on Form 10-K.
**3M business segment reporting measures include dual credit for certain sales. See 3M’s 2021 Annual Report on Form 10-K for further details.
Safety & Industrial
$12.9B
(36%)
Consumer
$5.9B
(17%)
Health Care
$9.1B
(26%)
Transportation & Electronics
$9.8B
(28%)
5
2021 financial results
2021 Annual Report
-- 6 of 142 --
6
Market-leading businesses
3%
8%
10%
10%
11%
23%
35%
Abrasives
Automotive Aftermarket
Closure & Masking Systems
Electrical Markets
Industrial Adhesives & Tapes
Personal Safety
Roofing Granules
Safety & Industrial
Accelerating safety and industry performance by
serving the industrial, electrical and safety markets.
2021 sales by business
($M) 2021
Sales $12,880
Sales growth 9.8%
Organic sales growth 7.8%
Operating margins 20.9%
2021 performance
10%
12%
18%
19%
41%
Advanced Materials
Automotive & Aerospace
Commercial Solutions
Electronics
Transportation Safety
2021 sales by business
($M) 2021
Sales $9,769
Sales growth 10.6%
Organic sales growth 9.0%
Operating margins 20.6%
2021 performance
Transportation & Electronics
Moving transportation and a connected world forward
by serving automotive and electronic OEM customers.
2021 sales by business
4% 11%
13%
16%
56%
Food Safety
Health Information Systems
Medical Solutions
Oral Care
Separation & Purification Sciences
($M) 2021
Sales $9,050
Sales growth 8.4%
Organic sales growth 8.6%
Operating margins 23.8%
2021 performance
Health Care
Leveraging science and technology to improve the
delivery of health care and patient outcomes.
2%
10% 19%
24%
45%
Consumer Health & Safety Home Care
Home Improvement
Stationery & Office
Other Consumer
2021 sales by business
($M) 2021
Sales $5,856
Sales growth 10.3%
Organic sales growth 9.3%
Operating margins 21.3%
2021 performance
Consumer
Innovating to improve homes, work and life by serving
global consumers.
-- 7 of 142 --
7
(Dollars in millions, except per share amounts)
2021 Annual Report
Financial summary
2021 2020 2019
Operating Results
Net sales $35,355 $32,184 $32,136
Operating income 7,369 7,161 6,174
Net income attributable to 3M 5,921 5,449 4,517
Per share – basic 10.23 9.43 7.83
Per share – diluted 10.12 9.36 7.72
Financial Ratios
Percent of sales
Cost of sales 53.2 % 51.6 % 53.4 %
Selling, general and administrative expense, net of gain
on sale of businesses
20.4 20.3 21.5
Research, development and related expenses 5.6 5.8 5.9
Operating income 20.8 22.3 19.2
Net income attributable to 3M 16.7 16.9 14.1
Additional Information
Cash dividends paid 3,420 3,388 3,316
Per share 5.92 5.88 5.76
Stock price at year-end
Total assets
177.63
47,072
174.79
47,344
176.42
44,659
Long-term debt (excluding current portion) 16,056 17,989 17,518
Capital expenditures
Depreciation and amortization
1,603
1,915
1,501
1,911
1,699
1,593
Research, development and related expenses 1,994 1,878 1,911
Number of employees at year-end
Average shares outstanding – basic (in millions)
95,000
579.0
95,000
577.6
96,000
577.0
Average shares outstanding – diluted (in millions) 585.3 582.2 585.1
-- 8 of 142 --
,% +*++*
*,) + *%/%&$$ ** &%
.4F;<A:GBA
&)$ "
%%,#)'&)+',)*,%++&*+ &%&)7&+
*,) + */%+&
BEG;89<F64?L84E8A787868@58E
B@@<FF<BA9<?8AH@58E
$&$'%0
,H5H9C:"B7CFDCF5H=CB8?4J4E8 " + , AD@CM9F"89BH=:=75H=CB'C
)F=B7=D5@9L97IH=J9C::=79G$8AG8E *G '4H? $<AA8FBG4
-9@9D<CB9BIA69F
,97IF=H=9GF9;=GH9F98DIFGI5BHHC,97H=CB6C:H<97H
+<G?8B9846;6?4FF +E47<A:*L@5B?F %4@8B9846;8K6;4A:8BAJ;<6;E8:<FG8E87
CAACB,HC7? )5F/5@I9 )9F,<5F9 &&& '9K2CF?,HC7?L7<5B;9
&&& <=75;C,HC7?L7<5B;9 "B7
'CH9G8I9 &&& '9K2CF?,HC7?L7<5B;9
'CH9G8I9 &&& '9K2CF?,HC7?L7<5B;9
'CH9G8I9 &&& '9K2CF?,HC7?L7<5B;9
'CH9G8I9 &&& '9K2CF?,HC7?L7<5B;9
'CH9G8I9 &&& '9K2CF?,HC7?L7<5B;9
'CH9-<97CAACBGHC7?C:H<9F9;=GHF5BH=G5@GCHF5898CBH<9,01,K=GGL7<5B;9
,97IF=H=9GF9;=GH9F98DIFGI5BHHCG97H=CB;C:H<97H%BA8
"B8=75H96M7<97?A5F?=:H<9F9;=GHF5BH=G5K9@@ ?BCKBG95GCB98=GGI9F 5G89:=B98=B+I@9C:H<9,97IF=H=9G7H 29G'C
"B8=75H96M7<97?A5F?=:H<9F9;=GHF5BH=GBCHF9EI=F98HC:=@9F9DCFHGDIFGI5BHHC,97H=CBCF,97H=CB8C:H<97H 29G'C
"B8=75H96M7<97?A5F?K<9H<9FH<9F9;=GHF5BH<5G:=@985@@F9DCFHGF9EI=F98HC69:=@986M,97H=CBCF8C:H<9,97IF=H=9GL7<5B;97HC:8IF=B;
H<9DF9798=B;ACBH<GCF:CFGI7<G<CFH9FD9F=C8H<5HH<9F9;=GHF5BHK5GF9EI=F98HC:=@9GI7<F9DCFHG 5B8<5G699BGI6>97HHCGI7<:=@=B;F9EI=F9A9BHG:CF
H<9D5GH85MG 29G'C
"B8=75H96M7<97?A5F?K<9H<9FH<9F9;=GHF5BH<5GGI6A=HH989@97HFCB=75@@M9J9FM"BH9F57H=J95H5=@9F9EI=F98HC69GI6A=HH98DIFGI5BHHC+I@9C:
+9;I@5H=CB, -O C:H<=G7<5DH9F8IF=B;H<9DF9798=B;ACBH<GCF:CFGI7<G<CFH9FD9F=C8H<5HH<9F9;=GHF5BHK5GF9EI=F98HCGI6A=HGI7<:=@9G
29G'C
"B8=75H96M7<97?A5F?K<9H<9FH<9F9;=GHF5BH=G5@5F;95779@9F5H98:=@9F 5B5779@9F5H98:=@9F 5BCB 5779@9F5H98:=@9F 5GA5@@9FF9DCFH=B;7CAD5BM CF5B
9A9F;=B;;FCKH<7CAD5BM ,99H<989:=B=H=CBGC:U@5F;95779@9F5H98:=@9F VU5779@9F5H98:=@9F VUGA5@@9FF9DCFH=B;7CAD5BM V5B8U9A9F;=B;;FCKH<7CAD5BMV
=B+I@96 C:H<9L7<5B;97H
%5F;95779@9F5H98
:=@9F
779@9F5H98
:=@9F
'CB 5779@9F5H98
:=@9F
,A5@@9FF9DCFH=B;
7CAD5BM
A9F;=B;;FCKH<
7CAD5BM
":5B9A9F;=B;;FCKH<7CAD5BM =B8=75H96M7<97?A5F?=:H<9F9;=GHF5BH<5G9@97H98BCHHCIG9H<99LH9B898HF5BG=H=CBD9F=C8:CF7CAD@M=B;K=H<5BMB9KCF
F9J=G98:=B5B7=5@577CIBH=B;GH5B85F8GDFCJ=898DIFGI5BHHC,97H=CB5C:H<9L7<5B;97H
"B8=75H96M7<97?A5F?K<9H<9FH<9F9;=GHF5BH<5G:=@985F9DCFHCB5B85HH9GH5H=CBHC=HGA5B5;9A9BHWG5GG9GGA9BHC:H<99::97H=J9B9GGC:=HG=BH9FB5@7CBHFC@
CJ9F:=B5B7=5@F9DCFH=B;IB89F,97H=CB6C:H<9,5F65B9G(L@9M7H. , 66MH<9F9;=GH9F98DI6@=7577CIBH=B;:=FAH<5HDF9D5F98CF=GGI98=HG
5I8=HF9DCFH 29G'C
"B8=75H96M7<97?A5F?K<9H<9FH<9F9;=GHF5BH=G5G<9@@7CAD5BM5G89:=B98=B+I@96 C:H<97H 29G'C
-<95;;F9;5H9A5F?9HJ5@I9C:JCH=B;GHC7?<9@86MBCB5::=@=5H9GC:H<9F9;=GHF5BH 7CADIH986MF9:9F9B79HCH<97@CG=B;DF=795B8G<5F9GCIHGH5B8=B; K5G
5DDFCL=A5H9@M 6=@@=CB5GC:#5BI5FM 5DDFCL=A5H9@M 6=@@=CB5GC:#IB9 H<9@5GH6IG=B9GG85MC:H<9F9;=GHF5BHWGACGHF979BH@M
7CAD@9H98G97CB8EI5FH9F
,<5F9GC:7CAACBGHC7?CIHGH5B8=B;5H#5BI5FM A=@@=CB
&,$%+* %&)'&)+0))%
)5FHGC:H<9CAD5BMWG89:=B=H=J9DFCLMGH5H9A9BHHC69:=@98DIFGI5BHHC+9;I@5H=CBK=H<=B85MG5:H9F+9;=GHF5BHWG:=G75@M95F 9B8C:979A69F
:CF=HG5BBI5@A99H=B;HC69<9@8CB&5M 5F9=B7CFDCF5H986MF9:9F9B79=BH<=GCFA $=BF9GDCBG9HC)5FH""" "H9AG 5B8
-- 9 of 142 --
2
3M COMPANY
FORM 10-K
For the Year Ended December 31, 2021
Pursuant to Part IV, Item 16, a summary of Form 10-K content follows, including hyperlinked cross-references (in the EDGAR
filing). This allows users to easily locate the corresponding items in Form 10-K, where the disclosure is fully presented. The
summary does not include certain Part III information that will be incorporated by reference from the proxy statement, which
will be filed after this Form 10-K filing.
Beginning
Page
PART I
ITEM 1 Business 3
ITEM 1A Risk Factors 9
ITEM 1B Unresolved Staff Comments 13
ITEM 2 Properties 14
ITEM 3 Legal Proceedings 14
ITEM 4 Mine Safety Disclosures 14
PART II
ITEM 5 Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of 14
Equity Securities
ITEM 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
MD&A is designed to provide a reader of 3M’s financial statements with a narrative from the
perspective of management. 3M’s MD&A is presented in eight sections:
Overview 16
Results of Operations 23
Performance by Business Segment 25
Performance by Geographic Area 30
Critical Accounting Estimates 30
New Accounting Pronouncements 33
Financial Condition and Liquidity 33
Financial Instruments 40
ITEM 7A Quantitative and Qualitative Disclosures About Market Risk 40
ITEM 8 Financial Statements and Supplementary Data 41
Index to Financial Statements 41
Management’s Responsibility for Financial Reporting 41
Management’s Report on Internal Control Over Financial Reporting 42
Report of Independent Registered Public Accounting Firm 43
Consolidated Statement of Income for the years ended December 31, 2021, 2020 and 2019 45
Consolidated Statement of Comprehensive Income for the years ended December 31, 2021, 2020 46
and 2019
Consolidated Balance Sheet at December 31, 2021 and 2020 47
Consolidated Statement of Changes in Equity for the years ended December 31, 2021, 2020 and 48
2019
Consolidated Statement of Cash Flows for the years ended December 31, 2021, 2020 and 2019 49
Notes to Consolidated Financial Statements 50
Note 1. Significant Accounting Policies 50
Note 2. Revenue 59
Note 3. Acquisitions and Divestitures 61
Note 4. Goodwill and Intangible Assets 63
-- 10 of 142 --
3
P
P
3M COMPANY
ANNUAL REPORT ON FORM 10-K
For the Year Ended December 31, 2021
PART I
Item 1. Business.
3M Company was incorporated in 1929 under the laws of the State of Delaware to continue operations begun in 1902. The
Company’s ticker symbol is MMM. As used herein, the term “3M” or “Company” includes 3M Company and its subsidiaries
unless the context indicates otherwise. In this document, for any references to Note 1 through Note 19, refer to the Notes to
Consolidated Financial Statements in Item 8.
Available Information
The SEC maintains a website that contains reports, proxy and information statements, and other information regarding issuers,
including the Company, that file electronically with the SEC. The public can obtain any documents that the Company files with
the SEC at http://www.sec.gov. The Company files annual reports, quarterly reports, proxy statements and other documents
with the Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934 (Exchange Act).
3M also makes available free of charge through its website (http://investors.3M.com) the Company’s Annual Report on
Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and, if applicable, amendments to those reports
filed or furnished pursuant to the Exchange Act as soon as reasonably practicable after the Company electronically files such
material with, or furnishes it to, the SEC.
Note 5. Restructuring Actions 65
Note 6. Supplemental Income Statement Information 68
Note 7. Supplemental Balance Sheet Information 69
Note 8. Supplemental Equity and Comprehensive Income Information 70
Note 9. Supplemental Cash Flow Information 71
Note 10. Income Taxes 71
Note 11. Marketable Securities 75
Note 12. Long-Term Debt and Short-Term Borrowings 75
Note 13. Pension and Postretirement Benefit Plans 79
Note 14. Derivatives 89
Note 15. Fair Value Measurements 94
Note 16. Commitments and Contingencies 97
Note 17. Leases 117
Note 18. Stock-Based Compensation 118
Note 19. Business Segments and Geographic Information 121
ITEM 9 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 125
ITEM 9A Controls and Procedures 125
ITEM 9B Other Information 125
ITEM 9C Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 125
ART III
ITEM 10 Directors, Executive Officers and Corporate Governance 126
ITEM 11 Executive Compensation 126
ITEM 12 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters
126
ITEM 13 Certain Relationships and Related Transactions, and Director Independence 127
ITEM 14 Principal Accounting Fees and Services 127
ART IV
ITEM 15 Exhibits, Financial Statement Schedules 128
ITEM 16 Form 10-K Summary 130
-- 11 of 142 --
General
3M is a diversified technology company with a global presence in the following businesses: Safety and Industrial;
Transportation and Electronics; Health Care; and Consumer. 3M is among the leading manufacturers of products for many of
the markets it serves. Most 3M products involve expertise in product development, manufacturing and marketing, and are
subject to competition from products manufactured and sold by other technologically oriented companies.
Business Segments
3M manages its operations in four business segments. The reportable segments are Safety and Industrial, Transportation and
Electronics, Health Care, and Consumer. 3M’s four business segments bring together common or related 3M technologies,
enhancing the development of innovative products and services and providing for efficient sharing of business resources. Refer
to segment descriptions summarized below (Financial information and other disclosures relating to 3M’s business segments and
operations in major geographic areas are provided in the Notes to Consolidated Financial Statements):
4
-- 12 of 142 --
HF<A8FF*8:@8AG *498GL4A7 A7HFGE<4? +E4AFCBEG4G<BA4A7
?86GEBA<6F 84?G;4E8 BAFH@8E
.B89F@M=B;
8=J=G=CBG
6IG=B9GG9G
$/0/<>9 9>/ 09<
.3=+11</1+>/.
</@/8?/
3809<7+>398
P 6F5G=J9G
P IHCACH=J95:H9FA5F?9H
P @CGIF95B8A5G?=B;GMGH9AG
P @97HF=75@A5F?9HG
P "B8IGHF=5@58<9G=J9G5B8H5D9G
P )9FGCB5@G5:9HM
P +CC:=B;;F5BI@9G
P (H<9FG5:9HM5B8=B8IGHF=5@
P 8J5B798A5H9F=5@G
P IHCACH=J95B859FCGD579
P CAA9F7=5@GC@IH=CBG
P =GD@5MA5H9F=5@G5B8GMGH9AG
P @97HFCB=7GA5H9F=5@GGC@IH=CBG
P -F5BGDCFH5H=CBG5:9HM
P (H<9FHF5BGDCFH5H=CB5B8
9@97HFCB=7G
P FI;89@=J9FM8=J9GH98=B
P CC8G5:9HM
P !95@H<=B:CFA5H=CB
GMGH9AG
P &98=75@GC@IH=CBG
P (F5@75F9
P ,9D5F5H=CB5B8
DIF=:=75H=CBG7=9B79G
P (H<9F<95@H<75F9
P CBGIA9F<95@H<5B8
G5:9HM
P !CA975F9
P !CA9=ADFCJ9A9BH
P ,H5H=CB9FM5B8C::=79
P (H<9F7CBGIA9F
+9DF9G9BH5H=J9
F9J9BI9 ;9B9F5H=B;
57H=J=H=9G DFC8I7HG
CFG9FJ=79G
P "B8IGHF=5@56F5G=J9G5B8:=B=G<=B;
:CFA9H5@KCF?=B;5DD@=75H=CBG
P IHC6C8MF9D5=FGC@IH=CBG
P @CGIF9GMGH9AG:CFD9FGCB5@
<M;=9B9DFC8I7HG A5G?=B; 5B8
D57?5;=B;A5H9F=5@G
P @97HF=75@DFC8I7HG5B8A5H9F=5@G
:CF7CBGHFI7H=CB5B8
A5=BH9B5B79 DCK9F8=GHF=6IH=CB
5B89@97HF=75@CF=;=B5@9EI=DA9BH
A5BI:57HIF9FG(&G
P ,HFI7HIF5@58<9G=J9G5B8H5D9G
P +9GD=F5HCFM <95F=B; 9M95B8:5@@
DFCH97H=CBGC@IH=CBG
P '5HIF5@5B87C@CF 7C5H98A=B9F5@
;F5BI@9G:CFG<=B;@9G
P 8J5B79879F5A=7GC@IH=CBG
P HH57<A9BHH5D9G :=@AG GCIB8
5B8H9AD9F5HIF9A5B5;9A9BH
:CFHF5BGDCFH5H=CBJ9<=7@9G
P )F9A=IA@5F;9:CFA5H;F5D<=7
:=@AG:CF58J9FH=G=B;5B8:@99H
G=;B5;9
P %=;<HA5B5;9A9BH:=@AG5B8
9@97HFCB=7G5GG9A6@MGC@IH=CBG
P )57?5;=B;5B8=BH9F7CBB97H=CB
GC@IH=CBG
P +9:@97H=J9G=;B5;9:CF
<=;<K5M 5B8J9<=7@9G5:9HM
P CC8G5:9HM=B8=75HCF
GC@IH=CBG
P !95@H<75F9DFC798IF9
7C8=B;5B8
F9=A6IFG9A9BHGC:HK5F9
P ,?=B KCIB875F9 5B8
=B:97H=CBDF9J9BH=CB
DFC8I7HG5B8GC@IH=CBG
P 9BH=GHFM5B8CFH<C8CBH=5
GC@IH=CBG
P =@HF5H=CB5B8DIF=:=75H=CB
GMGH9AG
P CBGIA9F65B85;9G
6F579G GIDDCFHG5B8
7CBGIA9FF9GD=F5HCFG
P @95B=B;DFC8I7HG:CF
H<9<CA9
P +9H5=@56F5G=J9G D5=BH
5779GGCF=9G 75F75F9
"2DFC8I7HG D=7HIF9
<5B;=B;5B87CBGIA9F
5=FEI5@=HMGC@IH=CBG
P ,H5H=CB9FMDFC8I7HG
,CA9G95GCB5@=HM=AD57HG
H<=G6IG=B9GGG9;A9BH
F9@5H98HC657? HC G7<CC@
;9B9F5@@M=BH<9H<=F8
EI5FH9FC:957<M95F
L5AD@96F5B8G
C::9F=B;G
P &RI6=HFCBR""56F5G=J9G
P ,7CH7< F=H9R6F5G=J9G
P ,7CH7<-9A:@9L/=BM@-5D9G
,7CH7<?CH9C5H=B;G MB5H9@
@C75HCFG ,7CH7<75GHF9G=BG
P C@@=G=CBF9D5=F5B8D5=BHGDF5M
DFC8I7HG
P +97@CG56@9:5GH9B9FGH5D9G5B8
@569@A5H9F=5@G:CF8IF56@9;CC8G
P @97HF=75@=B:F5GHFI7HIF9DFC8I7HG
A98=IAJC@H5;9756@95779GGCF=9G
5B8=BGI@5H=CBH5D9G
P &R/!RCB8=B;H5D9G
,7CH7<QA5G?=B; D57?5;=B;5B8
:=@5A9BHH5D9G
P =GDCG56@9F9GD=F5HCFG5B8:5@@
DFCH97H=CBDFC8I7HG
P ,7CH7<;5F8R)FCH97HCF:CF
G<=B;@9G
P &R'9LH9@R9F5A=7:=69FG
5B8H9LH=@9G
P -<=BGI@5H9R7CIGH=7
"BGI@5H=CBDFC8I7HG5B8
5IHCACH=J97CADCB9BHG
P &R'CJ97RB;=B99F98
@I=8G
P &R,7CH7<@=H9R;F5D<=7
:=@AG &R,7CH7<75@R5B8
&RCBHFC@H57R
CAA9F7=5@;F5D<=7G
P @97HFCB=78=GD@5M
9B<5B79A9BH:=@AG5B8
CDH=75@@M7@95F58<9G=J9G
P @97HFCB=7=BH9F7CBB97H
DFC8I7HG
P &R=5ACB8 F589R
F9:@97H=J9G<99H=B;:CF
HF5BGDCFH5H=CBG5:9HM
P &R)9HF=:=@AR5B8
&R@@9F;9B-9GH=B;
P &RB7CAD5GGR
A98=75@7C8=B;GMGH9AG
P &R-9;589FAR
KCIB88F9GG=B;G
/ Q-<9F5DM
,MGH9AG5B88=GDCG56@9
F9GD=F5HCFG=BH<9<95@H<
75F97<5BB9@
P &R=@H9?R5B8&R
+9@M1R89BH5@:=@=B;
A5H9F=5@G5B879A9BHG
&R@5F=HMR5@=;B9FG
P =CD<5FA55B8CH<9F
:=@HF5H=CBGMGH9AG 65;G
75DGI@9G5B87CADCB9BHG
P R .-.+(R
5B8'9L75F9RD9FGCB5@
<95@H<75F9DFC8I7HG
P ,7CH7< F=H9R7@95B=B;
GIDD@=9G GDCB;9G
6FIG<9G 5B8G7CIF=B;
D58G,7CH7<;5F8R
DFC8I7HG
P ,7CH7<QH5D9G5B8
CH<9FDFC8I7HG
=@HF9H9R:=@H9FG5B8
CAA5B8R58<9G=J9
DFC8I7HG
P )CGH =HQDFC8I7HG
+9DF9G9BH5H=J9
A5F?9HHF9B8GCF
CDDCFHIB=H=9G
P CBB97H98G5:9HM
P ,HFI7HIF5@6CB8=B;
P ,IF:579:=B=G<=B;
P +9GD=F5HCFMDFCH97H=CB
P I=@8=B;7CADCB9BHG
P IHCA5H=CB5B8FC6CH=7G
P F=8AC89FB=N5H=CB
P IHCACH=J99@97HF=:=75H=CB
P ,IGH5=B56@9D57?5;=B;
P IHCACH=J99@97HF=:=75H=CB
P ,9A=7CB8I7HCF:56F=75H=CB5B8
5GG9A6@M
P 5H579BH9FH<9FA5@
A5B5;9A9BH
P 8J5B798KCIB875F9
P )CDI@5H=CB<95@H<7@=B=75@
75F9=ADFCJ9A9BH
D@5H:CFA
P "B7F95G98:CC8G5:9HM
P =CD<5FA5=B8IGHFM
9LD5BG=CB
P IGHCACFH<C8CBH=7G
P =FEI5@=HM
P CBB97H98:=@H9FG5B8
CH<9FDFC8I7HG
<FGE<5HG<BA
&DFC8I7HG5F9GC@8H<FCI;<BIA9FCIG8=GHF=6IH=CB7<5BB9@G =B7@I8=B;8=F97H@MHCIG9FG5B8H<FCI;<BIA9FCIG9 7CAA9F79
5B8HF58=H=CB5@K<C@9G5@9FG F9H5=@9FG >C669FG 8=GHF=6IHCFG5B8895@9FG=B5K=89J5F=9HMC:HF589G=BA5BM7CIBHF=9G5FCIB8H<9
KCF@8 &5B5;9A9BH69@=9J9GH<97CB:=89B79C:K<C@9G5@9FG F9H5=@9FG >C669FG 8=GHF=6IHCFG5B8895@9FG=B&5B8=HGDFC8I7HGT
57CB:=89B7989J9@CD98H<FCI;<@CB;5GGC7=5H=CBK=H<G?=@@98A5F?9H=B;5B8G5@9GF9DF9G9BH5H=J9GT<5G7CBHF=6IH98
G=;B=:=75BH@MHC&WGDCG=H=CB=BH<9A5F?9HD@5795B8HC=HG;FCKH<
-- 13 of 142 --
Resources
Human Capital
On December 31, 2021, the Company employed approximately 95,000 people (full-time equivalents), with approximately
38,000 employed in the United States and 57,000 employed internationally. The ability to recruit, retain, develop, protect, and
fairly compensate its global workforce are enablers of 3M’s success. This includes four general categories of focus: Health and
Safety; Development; Diversity, Equity and Inclusion; and Compensation and Benefits.
Health and Safety
3M is committed to the safety, health, and well-being of its employees. The Company continuously evaluates opportunities to
raise safety and health standards, visiting sites to identify and manage environmental health and safety risks; evaluating
compliance with regulatory requirements and 3M policy; and maintaining a global security operation for the protection of
facilities and people on 3M sites. 3M also promotes a culture of health and well-being through disease prevention programs, on-
site clinical services, employee assistance programs, and comprehensive health care benefits.
Development
Developing employees contributes to growing 3M’s business. 3M maintains talent and succession planning processes, including
regular review by the Company’s chief executive officer (CEO) and reporting up through the Board of Directors. The Company
has a suite of high-potential leadership development programs which brings a consistent approach to leadership development.
3M also has development programs for managers and supervisors and provides learning opportunities for all employees, in
addition to regular coaching and support from their supervisor. With the Company’s global online employee learning platform,
employees are able to access unique, just-in-time development resources in over 15 languages to support their career aspirations
and advance their skills.
Diversity, Equity and Inclusion
A diverse, global workforce and inclusive culture that provides fair and equitable opportunities helps 3M remain competitive,
advance its innovation culture, and serve customers. 3M focuses on attracting and advancing top talent and has publicly
committed to advance global diversity in management across all dimensions, with additional specific goals to continue
advancing pay equity and to increase the Company’s diversity with underrepresented groups. 3M supports these values with an
internal CEO Inclusion Council, a forum led by senior management to advance diversity, equity, and inclusion initiatives. The
Company also plans to invest $50 million over 2020 to 2025 to address racial opportunity gaps through workforce development
initiatives in the communities in which its employees live and 3M business operates.
Compensation and Benefits
3M has a trust-based approach to work that empowers employees to work where and when they can best achieve their goals,
which supports attraction and retention of talent around the globe. In addition to a professional and flexible work environment
that promotes innovation, well-being, and rewards performance, 3M’s total compensation for employees includes a variety of
components that support sustainable employment and the ability to build a strong financial future, including competitive
market-based pay and comprehensive benefits. In addition to earning a base salary, eligible employees are compensated for
their contributions to the Company’s goals with both short-term cash incentives and long-term equity-based incentives.
Through its global pay philosophy, principles and consistent implementation, 3M is committed to providing fair and equitable
pay for employees. Eligible full-time employees in the United States also have access to medical, dental, and vision plans;
savings and retirement plans; a 3M employee stock purchase plan; and other resources. Some of these benefits can also be
available to regular part-time employees who work at least 20 hours a week. Programs and benefits differ internationally for a
variety of reasons, such as local legal requirements, market practices, and negotiations with works councils, trade unions, and
other employee representative bodies.
Raw Materials
In 2021, the coronavirus (COVID-19) pandemic caused imbalances within global supply markets. As markets re-opened and
demand increased following COVID lockdowns, the Company experienced raw material price inflation and constrained supply.
Multiple weather, logistics and other disruptive events worsened global supply chain imbalances and contributed to higher
costs.
6
-- 14 of 142 --
The Company continued to deploy productivity projects to minimize the impact of raw material inflation and market supply
challenges, including input management, reformulations, and multi-sourcing activities. Overall, on a consolidated basis, 3M
experienced net raw material price inflation in 2021. To help manage disruption to its manufacturing operations, 3M deploys
careful management of existing raw material inventories, strategic relationships with key suppliers, as well as qualification of
additional supply sources. It is difficult to predict future shortages of raw materials or the impact any such shortages would
have. 3M manages spend category price risks through negotiated supply contracts and price protection agreements. In addition,
3M evaluates suppliers’ conformance with environmental and social compliance requirements.
Patents, Trademarks and Licenses
The Company’s products are sold around the world under various trademarks. The Company also owns, or holds licenses to
use, numerous U.S. and foreign patents. The Company’s research and development activities generate a steady stream of
inventions that are covered by new patents or trade secrets. Patents applicable to specific products extend for varying periods
according to the date of patent application filing or patent grant and the legal term of patents in the various countries where
patent protection is obtained. The actual protection afforded by a patent, which can vary from country to country, depends upon
the type of patent, the scope of its coverage and the availability of legal remedies in the country.
The Company believes that its trademarks, patents, and trade secrets provide an important competitive advantage in many of its
businesses. In general, no single patent or group of related patents is in itself essential to the Company as a whole or to any of
the Company’s business segments.
Government Regulation and Environmental Law Compliance
The Company’s business operations are subject to various governmental regulations in the U.S. and internationally, including,
among others, those related to product liability, antitrust, intellectual property, environmental, tax, the U.S. Foreign Corrupt
Practices Act and other anti-bribery laws, U.S. trade sanctions, regulations of the U.S. Food and Drug Administration (FDA)
and similar foreign agencies, U.S. federal healthcare program-related laws and regulations, such as the False Claims Act, anti-
kickback laws and the Sunshine Act.
3M’s manufacturing operations are affected by national, state and local environmental laws and regulations around the world.
The Company places consistent emphasis on environmental responsibility. 3M has made, and plans to continue making,
necessary expenditures for compliance with applicable laws and regulations. 3M is also involved in remediation actions relating
to environmental matters from past operations at certain sites (refer to “Environmental Matters and Litigation” in Note 16,
Commitments and Contingencies).
Environmental expenditures relating to existing conditions caused by past operations that do not contribute to current or future
revenues are expensed. Reserves for liabilities for anticipated remediation costs are recorded on an undiscounted basis when
they are probable and reasonably estimable, generally no later than the completion of feasibility studies, the Company’s
commitment to a plan of action, or approval by regulatory agencies. Environmental expenditures for capital projects that
contribute to current or future operations generally are capitalized and depreciated over their estimated useful lives.
In 2021, 3M expended approximately $157 million on capital projects for environmental purposes as defined below. Capital
projects for environmental purposes include waste reduction and pollution control programs such as, water usage reduction and
water quality improvement equipment, scrubbers, containment structures, solvent recovery units and thermal oxidizers. Capital
expenditures for similar projects are presently expected to approach approximately $668 million for 2022 and 2023 in
aggregate.
Although an estimate of certain nearer-term capital expenditures is provided above, 3M cannot predict with certainty whether
future costs of compliance with government regulations (including environmental regulations) will have a material effect on its
capital expenditures, earnings or competitive position.
Information about our Executive Officers
Following is a list of the executive officers of 3M, and their age, present position, the year elected to their present position and
other positions they have held during the past five years. No family relationships exist among any of the executive officers
named, nor is there any undisclosed arrangement or understanding pursuant to which any person was selected as an officer.
This information is presented in the table below as of the date of the 10-K filing (February 9, 2022).
7
-- 15 of 142 --
&=7<59@ +CA5B <5=FA5BC:H<9C5F85B8
<=9:L97IH=J9(::=79F <=9:L97IH=J9(::=79F
<=9:(D9F5H=B;(::=79F5B8L97IH=J9/=79)F9G=89BH
L97IH=J9/=79)F9G=89BH "B8IGHF=5@IG=B9GG FCID
#C<B) 5BCJ9HN L97IH=J9/=79)F9G=89BH
<=9:-97<BC@C;M(::=79F
5B8BJ=FCBA9BH5@
+9GDCBG=6=@=HM
,9B=CF/=79)F9G=89BH <=9:-97<BC@C;M(::=79F5B8BJ=FCBA9BH5@
+9GDCBG=6=@=HM
,9B=CF/=79)F9G=89BH "BBCJ5H=CB5B8,H9K5F8G<=D5B8<=9:
-97<BC@C;M(::=79F
,9B=CF/=79)F9G=89BHC:+9G95F7<5B89J9@CDA9BH5B8<=9:
-97<BC@C;M(::=79F
$5F=B5<5J9N ,9B=CF/=79)F9G=89BH5B8
<=9:,HF5H9;M(::=79F ,9B=CF/=79)F9G=89BH IGHCA9F(D9F5H=CBG
@C65@IG=B9GG=F97HCF !CA9"ADFCJ9A9BHIG=B9GG
3C9=7?GCB L97IH=J9/=79)F9G=89BH
5B8<=9:!IA5B
+9GCIF79G(::=79F
,9B=CF/=79)F9G=89BH -5@9BH %95FB=B;5B8"BG=;<HG
/=79)F9G=89BH (F;5B=N5H=CB::97H=J9B9GG5B8-5@9BH !IA5B
+9GCIF79G
/=79)F9G=89BH (F;5B=N5H=CB::97H=J9B9GG !IA5B+9GCIF79G
/=79)F9G=89BH @C65@!IA5B+9GCIF79GIG=B9GG(D9F5H=CBG
!IA5B+9GCIF79G
!+=F97HCF CBGIA9FIG=B9GG FCID
)9H9F =66CBG FCID)F9G=89BH BH9FDF=G9
(D9F5H=CBG <=9:L97IH=J9(::=79F -=F9<I6
L97IH=J9/=79)F9G=89BH @C65@9J9@CDA9BH5B8)FC8I7H,IDD@M
,( &5HH9@ "B7
F=7 !5AA9G L97IH=J9/=79)F9G=89BH
<=9:CIBHFM CJ9FB5B79
5B8,9FJ=79G(::=79F
,9B=CF/=79)F9G=89BH &5BI:57HIF=B;,IDD@M<5=B
,9B=CF/=79)F9G=89BH IG=B9GG-F5BG:CFA5H=CB"B:CFA5H=CB
-97<BC@C;M
/=79)F9G=89BH CFDCF5H9CBHFC@@9F5B8<=9:77CIBH=B;(::=79F
G<=G<$ $<5B8DIF FCID)F9G=89BH
-F5BGDCFH5H=CB
@97HFCB=7G
L97IH=J9/=79)F9G=89BH -F5BGDCFH5H=CB@97HFCB=7IG=B9GG
FCID
L97IH=J9/=79)F9G=89BH @97HFCB=7GB9F;MIG=B9GG FCID
,9B=CF/=79)F9G=89BH +9G95F7<5B89J9@CDA9BH 5B8<=9:
-97<BC@C;M(::=79F
#9::F9M+ %5J9FG FCID)F9G=89BH CBGIA9F
IG=B9GG FCID
L97IH=J9/=79)F9G=89BH CBGIA9FIG=B9GG FCID
/=79)F9G=89BH5B8 9B9F5@&5B5;9F IHCACH=J95B89FCGD579
,C@IH=CBG=J=G=CB
/=79)F9G=89BH5B8 9B9F5@&5B5;9F CBGHFI7H=CB5B8!CA9
"ADFCJ9A9BH=J=G=CB
&5F?&IFD<M L97IH=J9/=79)F9G=89BH
<=9:"B:CFA5H=CB5B8
=;=H5@(::=79F
<=9:"B:CFA5H=CB(::=79F 66CHH%56CF5HCF=9G
@C65@<=9:"B:CFA5H=CB(::=79F5B8/=79)F9G=89BH -, 66CHH
%56CF5HCF=9G
&98=75@9J=79G<=9:"B:CFA5H=CB(::=79F5B8=J=G=CB5@/)
66CHH%56CF5HCF=9G
&CB=G<)5HC@5K5@5 L97IH=J9/=79)F9G=89BH
<=9:=B5B7=5@5B8
-F5BG:CFA5H=CB(::=79F
,9B=CF/=79)F9G=89BH5B8<=9:=B5B7=5@(::=79F
<=9:=B5B7=5@(::=79F !95@H<5F95B8/=79)F9G=89BH (D9F5H=CB5@
-F5BG:CFA5H=CB 9B9F5@@97HF=7
<=9:=B5B7=5@(::=79F !95@H<5F9 9B9F5@@97HF=7
&C>89<)CI@ FCID)F9G=89BH !95@H<
5F9IG=B9GG FCID L97IH=J9/=79)F9G=89BH !95@H<5F9IG=B9GG FCID
L97IH=J9/=79)F9G=89BH ,5:9HM5B8 F5D<=7GIG=B9GG FCID
)F9G=89BH5B8 9B9F5@&5B5;9F &5B585
$9J=B! +<C89G L97IH=J9/=79)F9G=89BH
<=9:%9;5@::5=FG(::=79F ,9B=CF/=79)F9G=89BH5B89DIHM 9B9F5@CIBG9@
/=79)F9G=89BH5B89DIHM 9B9F5@CIBG9@
)F9G=89BH5B8<=9:"BH9@@97HI5@)FCD9FHMCIBG9@ (::=79C:
"BH9@@97HI5@)FCD9FHMCIBG9@5B8&"BBCJ5H=J9)FCD9FH=9G
&=7<59@ /5@9 FCID)F9G=89BH ,5:9HM
"B8IGHF=5@IG=B9GG FCID L97IH=J9/=79)F9G=89BH ,5:9HM"B8IGHF=5@IG=B9GG FCID
L97IH=J9/=79)F9G=89BH !95@H<5F9IG=B9GG FCID
%4@8 :8 'E8F8AG'BF<G<BA
084E
?86G87
GB
'E8F8AG
'BF<G<BA &G;8E'BF<G<BAF8?77HE<A:
-- 16 of 142 --
Cautionary Note Concerning Factors That May Affect Future Results
This Annual Report on Form 10-K, including “Management’s Discussion and Analysis of Financial Condition and Results of
Operations” in Item 7, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act
of 1995. The Company may also make forward-looking statements in other reports filed with the Securities and Exchange
Commission, in materials delivered to shareholders and in press releases. In addition, the Company’s representatives may from
time to time make oral forward-looking statements.
Forward-looking statements relate to future events and typically address the Company’s expected future business and financial
performance. Words such as “plan,” “expect,” “aim,” “believe,” “project,” “target,” “anticipate,” “intend,” “estimate,” “will,”
“should,” “could,” “forecast” and other words and terms of similar meaning, typically identify such forward-looking
statements. In particular, these include, among others, statements relating to:
• worldwide economic, political, regulatory, international trade, capital markets and other external conditions, such as
interest rates, financial conditions of our suppliers and customers, trade restrictions such as tariffs in addition to
retaliatory counter measures, inflation, and natural and other disasters or climate change affecting the operations of the
Company or our suppliers and customers,
• risks related to public health crises such as the global pandemic associated with the coronavirus (COVID-19),
• liabilities related to certain fluorochemicals and the outcome of contingencies,
• the Company’s strategy for growth, future revenues, earnings, cash flow, uses of cash and other measures of financial
performance, and market position,
• competitive conditions and customer preferences,
• foreign currency exchange rates and fluctuations in those rates,
• new business opportunities, product development, and future performance or results of current or anticipated products,
• fluctuations in the costs and availability of purchased components, compounds, raw materials and energy,
• Information technology systems including ERP system roll-out and implementations,
• Security breaches and other disruptions to information technology infrastructure,
• the scope, nature or impact of acquisition, strategic alliance and divestiture activities,
• operational execution, including inability to generate productivity improvements as estimated,
• future levels of indebtedness, common stock repurchases and capital spending,
• future availability of and access to credit markets,
• pension and postretirement obligation assumptions and future contributions,
• asset impairments,
• tax liabilities and effects of changes in tax rates, laws or regulations, and
• legal and regulatory proceedings, legal compliance risks (including third-party risks) with regards to environmental,
product liability and other laws and regulations in the United States and other countries in which we operate.
The Company assumes no obligation to update or revise any forward-looking statements.
Forward-looking statements are based on certain assumptions and expectations of future events and trends that are subject to
risks and uncertainties. Actual future results and trends may differ materially from historical results or those reflected in any
such forward-looking statements depending on a variety of factors. Important information as to these factors can be found in
this document, including, among others, “Management’s Discussion and Analysis of Financial Condition and Results of
Operations” under the headings of “Overview,” “Financial Condition and Liquidity,” and annually in “Critical Accounting
Estimates.” Discussion of these factors is incorporated by reference from Part I, Item 1A, “Risk Factors,” of this document, and
should be considered an integral part of Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and
Results of Operations.” For additional information concerning factors that may cause actual results to vary materially from
those stated in the forward-looking statements, see our reports on Form 10-K, 10-Q and 8-K filed with the SEC from time to
time.
Item 1A. Risk Factors
Provided below is a cautionary discussion of what we believe to be the most important risk factors applicable to the Company.
Discussion of these factors is incorporated by reference into and considered an integral part of Part I, Item 2, “Management’s
Discussion and Analysis of Financial Conditions and Results of Operations.”
9
-- 17 of 142 --
Risks Related to the Global Economy and Public Health Crises
* The Company’s results are impacted by the effects of, and changes in, worldwide economic, political, regulatory,
international trade and other external conditions.
The Company operates in more than 70 countries and derives approximately 60 percent of its revenues from outside the United
States, and, accordingly, the Company’s business is subject to global competition and geopolitical risks that are beyond its
control, such as disruptions in financial markets, economic downturns, government actions impacting international trade
agreements, imposing trade restrictions such as tariffs, and retaliatory counter measures, inflation, government deficit reduction
and other austerity measures in specific countries or regions, or in the various industries in which the Company operates; social,
political or labor conditions in specific countries or regions; or adverse changes in the availability and cost of capital, interest
rates, or exchange control, ability to expatriate earnings and other regulations in the jurisdictions in which the Company
operates. Climate change, as well as related environmental and social regulations, may negatively impact the Company or its
customers and suppliers, in terms of availability and cost of natural resources, sources and supply of energy, product demand
and manufacturing, and the health and well-being of individuals and communities in which we operate.
* The Company is subject to risks related to public health crises such as the global pandemic associated with the coronavirus
(COVID-19).
3M, as a global company, is impacted by public health crises such as the global pandemic associated with COVID-19. The
outbreak has significantly increased economic and demand uncertainty. In addition, public and private sector policies and
initiatives to reduce the transmission of COVID-19, such as the imposition of travel restrictions, the adoption of remote
working, and government-ordered vaccine mandates, have impacted and will continue to impact 3M’s operations. In these
challenging and dynamic circumstances, 3M continues to work to protect its employees and the public, maintain business
continuity and sustain its operations, including ensuring the safety and protection of approximately 50,000 people who work in
our plants and distribution centers across the world, many of whom support the manufacturing and delivery of products that are
critical in response to the global pandemic. COVID-19 has impacted 3M’s supply chains relative to global demand for products
like respirators, surgical masks and commercial cleaning solutions. Within individual regions and countries around the world,
3M is working with governments, distributors and others to prioritize supplies to the most critical customer and public health
needs. In addition, trade barriers, export restrictions and other similar measures imposed by national governments also
negatively impact the supplies of personal protection equipment including those made by 3M going into the most needed areas.
COVID-19 has also affected the ability of suppliers and vendors to provide products and services to 3M. Some of these
COVID-related factors have increased demand for certain 3M products, while others have decreased demand from certain end
markets or could make it more difficult for 3M to serve customers. 3M has received reports of price gouging, counterfeiting and
other illegal or fraudulent activities involving its N95 respirators, has taken legal action in several states and continues to work
with state, federal and international law enforcement to protect the public and 3M against those who seek to exploit 3M’s brand
and reputation and defraud others. Furthermore, COVID-19 has impacted and may further impact the broader economies of
affected countries, including negatively impacting economic growth, the proper functioning of financial and capital markets,
foreign currency exchange rates, and interest rates. For example, COVID-19 has led to disruption and volatility in the global
capital markets, which increases the cost of capital and could adversely impact access to capital. With increasing vaccinations
and as economies start to reopen in certain parts of the world, workplace safety, for the Company and others, will increasingly
become a focus of concern. As part of the return to work process at the Company, the Company could face additional privacy
and data security risks in various countries related to the collection of data regarding employees and contractors with respect to
COVID-19 testing, temperature checks, contact tracing, and vaccination status. As the pandemic evolves, demand for personal
protection products such as disposable respirators may decline from prior levels. Due to the speed and scope with which the
COVID situation is developing and evolving and the uncertainty of its duration and the timing of recovery, 3M is not able at
this time to predict the extent to which the COVID-19 pandemic may have a material effect on its consolidated results of
operations or financial condition.
* Foreign currency exchange rates and fluctuations in those rates may affect the Company’s ability to realize projected growth
rates in its sales and earnings.
Because the Company’s financial statements are denominated in U.S. dollars and approximately 60 percent of the Company’s
revenues are derived from outside the United States, the Company’s results of operations and its ability to realize projected
growth rates in sales and earnings could be adversely affected if the U.S. dollar strengthens significantly against foreign
currencies.
10
-- 18 of 142 --
Risks Related to Legal and Regulatory Proceedings
* The Company faces liabilities related to certain fluorochemicals, which could adversely impact our results.
As previously reported, the Company has been voluntarily cooperating with various local, state, federal (primarily the U.S.
Environmental Protection Agency (EPA)), and international agencies in their review of the environmental and health effects of
a broad group of perfluoroalkyl and polyfluoroalkyl substances produced by the Company, collectively known as “PFAS.” The
PFAS group contains several categories and classes of durable chemicals and materials with properties that include oil, water,
temperature, chemical and fire resistance, as well as electrical insulating properties. The strength of the carbon-fluorine bond
also means that these compounds do not easily degrade. These characteristics have made PFAS critical to the manufacture of
electronic devices such as cell phones, tablets and semi-conductors. They are also used to help prevent infections in products
like surgical gowns and drapes. Commercial aircraft and low-emissions vehicles also rely on PFAS technology. PFAS
compounds are currently manufactured by various companies, including 3M, and are used in everyday products. As science and
technology evolve and advance, and in response to evolving knowledge and the understanding that PFAS compounds had the
potential to build up over time, 3M announced in 2000 that we would voluntarily phase out production of perfluorooctanoate
(PFOA) and perfluorooctane sulfonate (PFOS) globally as a precautionary measure. We phased out of materials used to
produce certain repellants and surfactant products, with most of these activities in the U.S. completed by the end of 2002.
Phased out products included Aqueous Film Forming Foam (AFFF) and coatings for food packaging, for example. 3M
currently is defending lawsuits concerning various PFAS-related products and chemistries, and is subject to unasserted and
asserted claims and governmental regulatory proceedings and inquiries related to the production and use of PFAS in a variety of
jurisdictions, as discussed in Note 16, “Commitments and Contingencies,” within the Notes to Consolidated Financial
Statements. An adverse outcome in any one or more of these matters could be material to our financial results. For example, we
recorded a pre-tax charge of $897 million, inclusive of legal fees and other related obligations, in the first quarter of 2018 with
respect to the settlement of a matter brought by the State of Minnesota involving the presence of PFAS in the groundwater,
surface water, fish or other aquatic life, and sediments in the state. Governmental inquiries or lawsuits involving PFAS could
lead to our incurring liability for damages or other costs, civil or criminal proceedings, the imposition of fines and penalties, or
other remedies, as well as restrictions on or added costs for our business operations going forward, including in the form of
restrictions on discharges at our manufacturing facilities, suspension of their operations, switching costs in seeking alternative
sources of supply, potential customer damage claims due to supply disruptions or otherwise.
* The Company’s future results may be affected by various asserted and unasserted legal and regulatory proceedings and legal
compliance risks, including those involving product liability, antitrust, intellectual property, environmental, tax, the U.S.
Foreign Corrupt Practices Act and other anti-bribery laws, U.S. trade sanctions compliance, regulations of the U.S. Food and
Drug Administration (FDA) and similar foreign agencies, U.S. federal healthcare program-related laws and regulations
including the False Claims Act, anti-kickback laws, the Sunshine Act, or other matters. Legal compliance risks also include
third-party risks where the Company’s suppliers, vendors or channel partners have business practices that are inconsistent
with 3M’s Supplier Responsibility Code, 3M performance requirements or with legal requirements.
The outcome of these legal proceedings may differ from the Company’s expectations because the outcomes of litigation,
including regulatory matters, are often difficult to reliably predict. Although the Company maintains general liability insurance,
the amount of liability that may result from certain of these risks may not always be covered by, or could exceed, the applicable
insurance coverage. Various factors or developments can lead the Company to change current estimates of liabilities and related
insurance receivables where applicable, or make such estimates for matters previously not susceptible of reasonable estimates,
such as a significant judicial ruling or judgment, a significant settlement, significant regulatory developments or changes in
applicable law. A future adverse ruling, settlement or unfavorable development could result in future charges that could have a
material adverse effect on the Company’s results of operations or cash flows in any particular period. In addition, negative
publicity related to product liability, environmental, health and safety or other matters referenced above involving the Company
may negatively impact the Company’s reputation. For a more detailed discussion of the legal proceedings involving the
Company and the associated accounting estimates, see the discussion in Note 16, “Commitments and Contingencies,” within
the Notes to Consolidated Financial Statements.
Risks Related to Our Products and Customer Preferences
* The Company’s results are affected by competitive conditions and customer preferences.
Demand for the Company’s products, which impacts revenue and profit margins, is affected by (i) the development and timing
of the introduction of competitive products; (ii) the Company’s response to downward pricing to stay competitive; (iii) changes
in customer order patterns, such as changes in the levels of inventory maintained by customers and the timing of customer
purchases which may be affected by announced price changes, changes in the Company’s incentive programs, or the customer’s
11
-- 19 of 142 --
ability to achieve incentive goals; (iv) changes in customers’ preferences for our products, including the success of products
offered by our competitors, and changes in customer designs for their products that can affect the demand for some of the
Company’s products; and (v) changes in the business environment related to disruptive technologies, such as artificial
intelligence, block-chain, expanded analytics and other enhanced learnings from increasing volume of available data.
* The Company’s growth objectives are largely dependent on the timing and market acceptance of its new product offerings,
including its ability to continually renew its pipeline of new products and to bring those products to market.
This ability is subject to difficulties or delays in product development, such as the inability to identify viable new products,
obtain adequate intellectual property protection, or gain market acceptance of new products. There are no guarantees that new
products will prove to be commercially successful.
* The Company’s future results are subject to vulnerability with respect to materials and fluctuations in the costs and
availability of purchased components, compounds, raw materials, energy, and labor due to shortages, increased demand and
wages, logistics, supply chain interruptions, manufacturing site disruptions, natural disasters and other disruptive factors.
The Company depends on various components, compounds, raw materials, and energy (including oil and natural gas and their
derivatives) supplied by others for the manufacturing of its products. Supplier relationships have been and could be interrupted
in the future due to supplier material shortage, climate impacts, natural and other disasters and other disruptive events, or be
terminated. Any sustained interruption in the Company’s receipt of adequate supplies, supply chain disruptions impacting the
distribution of products, or disruption to key manufacturing sites’ operations due to natural and other disasters or events, such
as government actions relating to discharge or emission permits or other legal or regulatory requirements, could have a material
adverse effect on the Company. In addition, while the Company has a process to minimize volatility in component and material
pricing, no assurance can be given that the Company will be able to successfully manage price fluctuations or that future price
fluctuations or shortages will not have a material adverse effect on the Company.
Risks Related to Our Business
* The Company employs information technology systems to support its business, including ongoing phased implementation of
an enterprise resource planning (ERP) system as part of business transformation on a worldwide basis over the next several
years. Security breaches and other disruptions to the Company’s information technology infrastructure could interfere with the
Company’s operations, compromise information belonging to the Company or its customers, suppliers, and employees,
exposing the Company to liability which could adversely impact the Company’s business and reputation.
In the ordinary course of business, the Company relies on centralized and local information technology networks and systems,
some of which are provided, hosted or managed by vendors and other third parties, to process, transmit and store electronic
information, and to manage or support a variety of businesses. Additionally, the Company collects and stores certain data,
including proprietary business information, and has access to confidential or personal information in certain of our businesses
that is subject to privacy and cybersecurity laws, regulations and customer-imposed controls. Despite our cybersecurity and
business continuity measures (including employee and third-party training, monitoring of networks and systems, patching,
maintenance, and backup of systems and data), the Company’s information technology networks and infrastructure are still
potentially vulnerable to the security risks of our vendors and third-party service providers, security breaches, damage,
disruptions or shutdowns due to attacks by threat actors including nation-state actors, computer viruses, hardware, software, and
system vulnerabilities, ransomware, service or cloud provider disruptions or security breaches, employee error or malfeasance,
power outages, telecommunication or utility failures, systems failures, natural disasters or other catastrophic events. The
Company’s adoption of remote working, initially driven by the pandemic, may also introduce additional threats or disruptions
to our information technology networks and infrastructure. Despite our cybersecurity measures, it is possible for security
vulnerabilities to remain undetected for an extended time period, up to and including several years. While we have experienced,
and expect to continue to experience, threats and disruptions to the Company’s information technology infrastructure, none of
them to date has had a material impact to the Company. Any such threats or disruptions could result in legal claims or
proceedings, disclosures to regulators, liability or penalties under privacy laws, interference with the Company’s operations,
and damage to the Company’s reputation, which could adversely affect the Company’s business. Although the Company
maintains insurance coverage for various cybersecurity and business continuity risks, there can be no guarantee that all costs or
losses incurred will be fully insured.
12
-- 20 of 142 --
* Acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and
other evolving business strategies, and possible organizational restructuring could affect future results.
The Company monitors its business portfolio and organizational structure and has made and may continue to make acquisitions,
strategic alliances, divestitures and changes to its organizational structure. With respect to acquisitions, including, for example,
the acquisition of Acelity, Inc. and its KCI subsidiaries (a leading global medical technology company), future results will be
affected by the Company’s ability to integrate acquired businesses quickly and obtain the anticipated synergies.
* The Company’s future results may be affected by its operational execution, including scenarios where the Company generates
fewer productivity improvements than estimated.
The Company’s financial results depend on the successful execution of its business operating plans. The Company utilizes
various tools, such as Lean Six Sigma, and engages in ongoing global business transformation. Business transformation is
defined as changes in processes and internal/external service delivery across 3M to move to more efficient business models to
improve operational efficiency and productivity, while allowing 3M to serve customers with greater speed and efficiency. This
is enabled by the ongoing multi-year phased implementation of an ERP system. There can be no assurance that all of the
projected productivity improvements will be realized. In addition, the ability to adapt to business model and other changes and
agility to respond to customer needs and service expectations are important, which, if not done successfully, could negatively
impact the Company’s ability to win new business and enhance revenue and 3M’s brand. Operational challenges, including
those related to customer service, pace of change and productivity improvements, could have a material adverse effect on the
Company’s business, financial conditions and results of operations.
Risks Related to Financial and Capital Markets and Tax Matters
* The Company's defined benefit pension and postretirement plans are subject to financial market risks that could adversely
impact our results.
The performance of financial markets and discount rates impact the Company's funding obligations under its defined benefit
plans. Significant changes in market interest rates, decreases in the fair value of plan assets and investment losses on plan
assets, and legislative or regulatory changes relating to defined benefit plan funding may increase the Company's funding
obligations and adversely impact its results of operations and cash flows.
* Change in the Company’s credit ratings could increase cost of funding.
The Company’s credit ratings are important to 3M’s cost of capital. The major rating agencies routinely evaluate the
Company’s credit profile and assign debt ratings to 3M. This evaluation is based on a number of factors, which include
financial strength, business and financial risk, as well as transparency with rating agencies and timeliness of financial reporting.
3M currently has an A1 credit rating with a negative outlook from Moody’s Investors Service and an A+ credit rating with a
negative outlook from Standard & Poor’s. The Company’s credit ratings have served to lower 3M’s borrowing costs and
facilitate access to a variety of lenders. The addition of further leverage to the Company’s capital structure could impact 3M’s
credit ratings in the future. Failure to maintain strong investment grade ratings would adversely affect the Company’s cost of
funding and could adversely affect liquidity and access to capital markets.
* Changes in tax rates, laws or regulations could adversely impact our financial results.
The Company’s business is subject to tax-related external conditions, such as tax rates, tax laws and regulations, changing
political environments in the U.S. and foreign jurisdictions that impact tax examination, assessment and enforcement
approaches. In addition, changes in tax laws including further regulatory developments arising from U.S. tax reform legislation
and/or regulations around the world could result in a tax expense or benefit recorded to the Company’s Consolidated Statement
of Earnings. In connection with the Base Erosion and Profit Shifting (BEPS) Integrated Framework provided by Organization
for Economic Cooperation and Development (OECD), determination of multi-jurisdictional taxation rights and the rate of tax
applicable to certain types of income may be subject to potential change. Due to uncertainty of the regulation changes and other
tax-related factors stated above, it is currently not possible to assess the ultimate impact of these actions on our financial
statements.
Item 1B. Unresolved Staff Comments.
None.
13
-- 21 of 142 --
Item 2. Properties.
In the U.S., 3M’s general offices, corporate research laboratories, and certain division laboratories are located in St. Paul,
Minnesota. The Company operates 61 manufacturing facilities in 29 states. Internationally, the Company operates 89
manufacturing and converting facilities in 30 countries.
3M owns the majority of its physical properties. 3M’s physical facilities are highly suitable for the purposes for which they
were designed. Because 3M is a global enterprise characterized by substantial inter-segment cooperation, properties are often
used by multiple business segments.
Item 3. Legal Proceedings.
Discussion of legal matters is incorporated by reference from Part II, Item 8, Note 16, “Commitments and Contingencies,” of
this document, and should be considered an integral part of Part I, Item 3, “Legal Proceedings.”
Item 4. Mine Safety Disclosures.
Pursuant to Section 1503 of the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Act”), the Company is
required to disclose, in connection with the mines it operates, information concerning mine safety violations or other regulatory
matters in its periodic reports filed with the SEC. For the year 2021, the information concerning mine safety violations or other
regulatory matters required by Section 1503(a) of the Act is included in Exhibit 95 to this annual report.
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities.
Equity compensation plans’ information is incorporated by reference from Part III, Item 12, “Security Ownership of Certain
Beneficial Owners and Management and Related Stockholder Matters,” of this document, and should be considered an integral
part of Item 5. At January 31, 2022, there were 65,295 shareholders of record. 3M’s stock ticker symbol is MMM and is listed
on the New York Stock Exchange, Inc. (NYSE), the Chicago Stock Exchange, Inc., and the SWX Swiss Exchange. Cash
dividends declared and paid totaled $1.48 and $1.47 per share for each quarter in 2021 and 2020, respectively. 3M typically
declares and pays dividends in the same quarter.
Issuer Purchases of Equity Securities
Repurchases of 3M common stock are made to support the Company’s stock-based employee compensation plans and for other
corporate purposes. In November 2018, 3M’s Board of Directors replaced the Company’s February 2016 repurchase program
with a new repurchase program. This new program authorizes the repurchase of up to $10 billion of 3M’s outstanding common
stock, with no pre-established end date.
14
-- 22 of 142 --
FFH8E'HE6;4F8FB9DH<GL*86HE<G<8F
E8:<FG8E87CHEFH4AGGB*86G<BAB9G;8K6;4A:86G
'8E<B7
+BG4?%H@58EB9
*;4E8F'HE6;4F87
I8E4:8'E<68
'4<7C8E
*;4E8
+BG4?%H@58EB9
*;4E8F'HE6;4F87
4F'4EGB9'H5?<6?L
AABHA687'?4AF
BE'EB:E4@F
$4K<@H@
CCEBK<@4G8
B??4E-4?H8B9
*;4E8FG;4G$4L
08G8'HE6;4F87
HA78EG;8'?4AF
BE'EB:E4@F
$<??<BAF
#5BI5FM T
96FI5FM
&5F7<
#5BI5FM &5F7<
DF=@
&5M
#IB9
DF=@ #IB9
#I@M
I;IGH
,9DH9A69F
#I@M ,9DH9A69F
(7HC69F
'CJ9A69F
979A69F
(7HC69F 979A69F
#5BI5FM 979A69F
444444444444444444444444444444444444444444444444444
-<9HCH5@BIA69FC:G<5F9GDIF7<5G98=B7@I89G=G<5F9GDIF7<5G98IB89FH<9C5F8WG5IH<CF=N5H=CBG89G7F=69856CJ9 5B8
==G<5F9GDIF7<5G98=B7CBB97H=CBK=H<H<99L9F7=G9C:GHC7?CDH=CBG
-<9HCH5@BIA69FC:G<5F9GDIF7<5G985GD5FHC:DI6@=7@M5BBCIB798D@5BGCFDFC;F5AG=B7@I89GG<5F9GDIF7<5G98IB89FH<9
C5F8WG5IH<CF=N5H=CBG89G7F=69856CJ9
G8@ 1)8F8EI872
-- 23 of 142 --
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is designed to provide a
reader of 3M’s financial statements with a narrative from the perspective of management. 3M’s MD&A is presented in eight
sections:
• Overview
• Results of Operations
• Performance by Business Segment
• Performance by Geographic Area
• Critical Accounting Estimates
• New Accounting Pronouncements
• Financial Condition and Liquidity
• Financial Instruments
Forward-looking statements in Item 7 may involve risks and uncertainties that could cause results to differ materially from
those projected (refer to the section entitled “Cautionary Note Concerning Factors That May Affect Future Results” in Item 1
and the risk factors provided in Item 1A for discussion of these risks and uncertainties).
Additional information about results of operations and financial condition for 2020 and 2019 can be found in “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” sections in the Company’s Annual Report on Form
10-K for the year ended December 31, 2020.
OVERVIEW
3M is a diversified global manufacturer, technology innovator and marketer of a wide variety of products and services.
Effective in the first quarter of 2021, 3M made the following changes. Information provided herein reflects the impact of these
changes for all periods presented.
• Change in accounting principle for net periodic pension and postretirement plan cost. See detailed discussion in Note
1.
• Change in measure of segment operating performance used by 3M’s chief operating decision maker—impacting 3M’s
disclosed measure of segment profit/loss (business segment operating income). See additional information in Note 19.
• Change in alignment of certain products within 3M’s Consumer business segment—creating the Consumer Health and
Safety Division. See additional information in Note 19.
3M manages its operations in four operating business segments: Safety and Industrial; Transportation and Electronics; Health
Care; and Consumer. From a geographic perspective, any references to EMEA refer to Europe, Middle East and Africa on a
combined basis. References are made to organic sales (which include both organic volume impacts and selling price impacts)
that is defined as the change in net sales, absent the separate impacts on sales from foreign currency translation and
acquisitions, net of divestitures. Acquisition and divestiture sales change impacts, if any, are measured separately for the first
twelve months post-transaction. 3M believes this information is useful to investors and management in understanding ongoing
operations and in analysis of ongoing operating trends.
Consideration of COVID-19:
3M is impacted by the global pandemic and related effects associated with the coronavirus (COVID-19). Risk factors with
respect to COVID-19 can be found in Item 1A “Risk Factors” in this document. Given the diversity of 3M’s businesses, some
of the factors relative to COVID-19 have increased the demand for 3M products, while others have decreased demand or made
it more difficult for 3M to serve customers.
Overall, 3M experienced broad-based organic growth across business segments and all geographies in 2021 despite global
supply challenges. 3M’s total sales increased 9.9% for the full year 2021 when compared to 2020. Organic sales increased 8.8%
for the full year 2021 when compared to 2020. In 2021, COVID-related respirator sales negatively impacted year-on-year
organic sales growth by approximately 0.2% as they grew at a slower rate than the rest of the Company. Given the diversity of
3M's businesses, the impact of COVID-19 varied across the Company. In 2020, 3M experienced strong sales in personal safety,
as well as in other areas such as home improvement, general cleaning, semiconductor, data center, and biopharma filtration
while businesses aligned to general industrial applications with strength in abrasives and industrial adhesives and tapes. At the
same time, weakness in several end markets, while improving, contributed in part to sales declines in a number of 3M's
businesses such as oral care, automotive and aerospace, advanced materials, commercial solutions, stationery and office,
16
-- 24 of 142 --
automotive aftermarket. Refer to the Performance by Business Segment section later in MD&A for additional discussion of
sales by segment.
3M’s operating income margins decreased 1.5 percentage points year-on-year for the year ending December 31, 2021.
Factoring out the impact on operating income of special items as described in the Certain amounts adjusted for special items -
(non-GAAP measures) section below, operating income margins decreased 0.5 percentage points to 20.8 percent for the year
ending December 31, 2021 when compared to 2020. Various COVID-19 implications contributed in part to these results.
Overall, the impact of the COVID-19 pandemic on 3M’s consolidated results of operations was primarily driven by factors
related to changes in demand for products and disruption in global supply chains. While it is not feasible to identify or quantify
all the other direct and indirect implications on 3M’s results of operations, below are factors that 3M believes have also affected
its 2021 results when compared to 2020:
Factors contributing to charges or other impacts:
• Increased raw materials and logistics costs from ongoing COVID-19 related global supply chain challenges further
magnified by extreme weather events, such as February 2021 winter storm Uri in the United States.
• Cost management in discretionary spending in areas such as travel, professional services, and advertising/
merchandising resulting in lower spending in 2020.
• Government-sponsored COVID-response stimulus and relief initiatives in 2020, including certain employee retention
benefits under the Coronavirus Aid, Relief and Economic Security (CARES) Act in the United States.
• Lower incentive compensation and self-insured medical visit/insurance expense in 2020.
Factors providing benefits or other impacts:
• Continued productivity efforts, including year-on-year savings from restructuring actions taken in 2020 and 2021.
• Period expenses of unabsorbed manufacturing costs and increased expected credit losses on customer receivables in
2020.
• Restructuring actions addressing structural enterprise costs and operations in certain end markets as a result of the
COVID-19 pandemic and related economic impact resulting in a 2020 charge of $58 million.
• Committed financial support in 2020 to various COVID-relief and medical research initiatives.
• Charge of $22 million in 2020 related to equity securities as discussed in the “Assets and Liabilities that are Measured
at Fair Value on a Nonrecurring Basis” section of Note 15 that use the measurement alternative described therein in
addition to an immaterial pre-tax charge related to impairment of certain indefinite lived tradenames.
Refer to the Financial Condition and Liquidity section below for more information on the Company’s liquidity position.
Due to the speed with which the COVID-19 situation is developing and evolving and the uncertainty of its duration and the
timing of recovery, 3M is not able at this time to predict the extent to which the COVID-19 pandemic may have a material
effect on its consolidated results of operations or financial condition.
17
-- 25 of 142 --
8-:)<16/16+75-5):/16)6,-):616/;8-:;0):-)<<:1*=<)*4-<7 +75576;0):-074,-:;B,14=<-,
-<9:C@@CK=B;H56@9DFCJ=89GH<9=B7F95G9897F95G9=BCD9F5H=B;=B7CA9A5F;=BG5B88=@IH9895FB=B;GD9FG<5F9:CF
7CAD5F98HCH<9G5A9D9F=C8@5GHM95F =B588=H=CBHC7CAD5F98HC G5DD@=756@9 79FH5=B=H9AG=BH<9H56@9F9:@97H
GD97=:=7=B7CA9H5LF5H9G5GGC7=5H98H<9F9K=H<
'8E68AGB9A8GF4?8F 4EA<A:FC8E7<?HG87F;4E8
084E8A787868@58E
,5A9D9F=C8@5GHM95F
,=;B=:=75BH@=H=;5H=CB F9@5H987<5F;9G 69B9:=HG N
5=B @CGGCBG5@9C:6IG=B9GG9G
=J9GH=HIF9 F9@5H98F9GHFI7HIF=B;57H=CBG T T
%CGGCB897CBGC@=85H=CBC:/9B9NI9@5BGI6G=8=5FM % ' N
,5A9D9F=C8@5GHM95F 9L7@I8=B;GD97=5@=H9AG
"B7F95G9 897F95G98I9HC
(F;5B=7;FCKH< DFC8I7H=J=HM5B8CH<9F T
,9@@=B;DF=795B8F5KA5H9F=5@=AD57H
7EI=G=H=CBG 8=J9GH=HIF9G N
CF9=;B9L7<5B;9=AD57HG N
(H<9F9LD9BG9=B7CA9 B9H % '
"B7CA9H5LF5H9 % '
,<5F9GC:7CAACBGHC7?CIHGH5B8=B; % '
IFF9BHD9F=C8 9L7@I8=B;GD97=5@=H9AG
,=;B=:=75BH@=H=;5H=CB F9@5H987<5F;9G 69B9:=HG N T N
5=B @CGGCBG5@9C:6IG=B9GG9G N N
=J9GH=HIF9 F9@5H98F9GHFI7HIF=B;57H=CBG N N
IFF9BHD9F=C8
-<9CAD5BMF9:9FGHCJ5F=CIGU58>IGH98V5ACIBHGCFA95GIF9GCB5BU58>IGH9865G=GV -<9G99L7@I89GD97=5@=H9AG -<9G9
BCB )A95GIF9G5F9:IFH<9F89G7F=6985B8F97CB7=@98HCH<9ACGH8=F97H@M7CAD5F56@9 ):=B5B7=5@A95GIF9G=BH<9
/<>+38+79?8>=+.4?=>/.09<=:/-3+63>/7=898"7/+=?</=G97H=CB69@CK
8=G7IGG=CBF9@5H98HCH<97CADCB9BHGC:M95F CB M95F7<5B;9G=BCD9F5H=B;=B7CA9A5F;=B5B895FB=B;GD9F8=@IH98G<5F9
:C@@CKG
!<1+83-1<9A>2 :<9.?->3@3>C+8.9>2/<
P "B CF;5B=7JC@IA9;FCKH<5B8CB;C=B;7CGHA5B5;9A9BHC::G9H6MA5BI:57HIF=B;<958K=B8G:FCA;@C65@GIDD@M
7<5=B7<5@@9B;9G =B7F95G987CAD9BG5H=CB 69B9:=H7CGHG 5B8=B7F95G98@=H=;5H=CB F9@5H987CGHG=B7F95G98CD9F5H=B;
=B7CA9A5F;=BG5B895FB=B;GD9F8=@IH98G<5F9M95F CB M95F -<9:C@@CK=B;5@GC=AD57H98F9GI@HGCFDFCJ=89588=H=CB5@
=B:CFA5H=CB
P 69B9:=HC:A=@@=CBDF9 H5L D9FG<5F95:H9FH5L:FCA5:5JCF56@9F5N=@=5B,IDF9A9CIFH
897=G=CBH<5H7CB7@I898CBH<9=AD57HC:GH5H9J5@I9 58898H5LK<9B89H9FA=B=B;F5N=@WG:989F5@G5@9G 65G98
GC7=5@H5LT9GG9BH=5@@M@CK9F=B;H<9GC7=5@H5LH<5H&G<CI@8<5J9D5=8=BDF=CFD9F=C8G
P 9FH5=B7<5B;9G=B@9;5@F9G9FJ97<5F;9GM95F CJ9F M95F &F9;I@5F@MF9J=9KG5B8ID85H9G=HG5GGC7=5H98
@=56=@=H=9G5B8=G=BJC@J98=BJ5F=CIGHF=5@G5B889:9BG9DF9D5F5H=CB5G8=G7IGG98=B'CH9
P &7CBH=BI98DF=CF=H=N5H=CBC:=BJ9GHA9BHG=B;FCKH<5B8GIGH5=B56=@=HM
P 69B9:=H:FCAF9GHFI7HIF=B;57H=CBGH5?9B=B5B8DCG=H=J9 B9;5H=J9=AD57HC:M95F CJ9F M95F7<5B;9
=BBCB 8=J9GH=HIF9 F9@5H98F9GHFI7HIF=B;7<5F;9G B9HC:58>IGHA9BHG :CFF9GD97H=J9D9F=C8G 'CH9DFCJ=89G
588=H=CB5@=B:CFA5H=CBF9@5H=J9HCF9GHFI7HIF=B;57H=CBG
P %CK9FM95F CB M95FB9H;5=BGF9@5H98HC79FH5=BDFCD9FHMG5@9G
P (/" =AD57HGF97C;B=N98CB79FH5=B5GG9HG=B
P "B @CK9FCF;5B=7JC@IA9;FCKH<5G5F9GI@HC:G=;B=:=75BH(/" F9@5H98=AD57HG =B588=H=CBHC(/"
F9@5H98B9H:57HCFG89G7F=698=BH<9DF9798=B;(J9FJ=9KTCBG=89F5H=CBC:(/" G97H=CB 897F95G986CH<
95FB=B;GD9F8=@IH98G<5F95B8CD9F5H=B;=B7CA9A5F;=BM95F CB M95F &5@GC9LD9F=9B798M95F CJ9F M95F=B7F95G98
7CGHG5G5F9GI@HC:H<9F9;I@5FF9J=9KC:=HGF9GD=F5HCFA5G?@=56=@=H=9G5B879FH5=B:C@@CK CB5779@9F5H9889DF97=5H=CB
-- 26 of 142 --
following some of the restructuring in 2019 and 2020. Partially offsetting these increased costs were year-on-year net
gains related to certain property sales (in 2020 within Safety and Industrial and in 2019 within Corporate and
Unallocated), lower non divestiture-related restructuring charges year-on-year, in addition to benefits recognized in
2020 related to the restructuring and other actions taken in 2019 (and the adjustments thereto in 2020) along with
continued cost management and productivity efforts.
• On a combined basis, higher defined benefit pension and postretirement service cost increased expense year-on-year
for both 2021 and 2020.
Selling price and raw material impact:
• In 2021, 3M experienced higher raw material, logistics, and outsourced manufacturing costs from strong end-market
demand and ongoing COVID-19 and related global supply chain challenges that were further magnified by extreme
weather events, such as February 2021 winter storm Uri in the U.S. These factors were partially offset by higher
selling prices in 2021.
• In 2020, higher selling prices in addition to lower raw material cost impacts benefited operating income margins year-
on-year
Acquisitions/divestitures:
• Divestiture impacts in 2021 and 2020 are primarily comprised of the lost income from the divestiture of the
Company’s drug delivery business (sale completed in May 2020).
• Acquisition impacts, which are measured for the first twelve months post-transaction, relate to the acquisitions of
M*Modal (first quarter 2019), and Acelity (fourth quarter 2019). The net impacts related to these acquisitions included
income from operations, more than offset by transaction and integration costs. Financing costs related to these
acquisitions is also included.
Foreign exchange impacts:
• Foreign currency impacts (net of hedging) increased operating income by approximately $103 million and decreased
operating income by approximately $62 million (or an increase in pre-tax earnings of approximately $119 million and
a decrease in pre-tax earnings of approximately $57 million) year-on-year for 2021 and 2020, respectively. These
estimates include: (a) the effects of year-on-year changes in exchange rates on translating current period functional
currency profits into U.S. dollars and on current period non-functional currency denominated purchases or transfers of
goods between 3M operations, and (b) year-on-year changes in transaction gains and losses, including derivative
instruments designed to reduce foreign currency exchange rate risks. Prior to 2021, for (a) 3M used prior year
functional currency profits and non-functional currency purchase/transfer information as the base in determining these
amounts. Comparative prior period amounts have been updated to reflect this updated methodology.
Other expense (income), net:
• Higher income related to non-service cost components of pension and postretirement expense decreased expense year-
on-year for both 2021 and 2020.
• Interest expense (net of interest income) decreased in 2021 compared to the same periods year-on-year. 2021 interest
expense also included an early debt extinguishment pre-tax charge in the first quarter of 2021.
• Interest expense (net of interest income) increased in 2020, as a result of higher U.S. average debt balances and lower
year-on-year interest income driven by lower average interest rates on cash balances. 2020 interest expense also
included an early debt extinguishment charge in conjunction with the repayment of notes in December 2020.
Income tax rate:
• Certain items above reflect specific income tax rates associated therewith. Overall, the effective tax rates for 2021,
2020, and 2019 were 17.8 percent, 19.7 percent, and 19.7 percent, respectively. These reflect a decrease of 1.9
percentage points from 2020 to 2021 and a flat comparison from 2019 to 2020.
• On an adjusted basis (as discussed below), the effective tax rates for 2021, 2020, and 2019 were 17.8 percent, 20.3
percent, and 20.2 percent, respectively. These reflect a decrease of 2.5 percentage points from 2020 to 2021 and an
increase of 0.1 percentage points from 2019 to 2020.
• The primary factors that decreased the Company's effective tax rate in 2021 were geographical income mix and
favorable adjustments in 2021 related to impacts of U.S. international tax provisions. Refer to Note 10 for additional
details.
Shares of common stock outstanding:
• Higher shares outstanding decreased earnings per share per diluted share for 2021, while lower shares outstanding
increased earnings per share diluted share for 2020.
19
-- 27 of 142 --
Certain amounts adjusted for special items - (non-GAAP measures):
In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides non-GAAP measures that
adjust for the impacts of special items. For the periods presented, special items include the items described below. Operating
income (measure of segment operating performance), income before taxes, net income, earnings per share, and the effective tax
rate are all measures for which 3M provides the reported GAAP measure and a measure adjusted for special items. The adjusted
measures are not in accordance with, nor are they a substitute for, GAAP measures. The Company considers these non-GAAP
measures in evaluating and managing the Company’s operations. The Company believes that discussion of results adjusted for
these items is meaningful to investors as it provides a useful analysis of ongoing underlying operating trends. The determination
of these items may not be comparable to similarly titled measures used by other companies. Special items include:
Significant litigation-related charges/benefits:
• In 2020, 3M recorded a net pre-tax charge of $17 million ($13 million after tax) related to PFAS (certain
perfluorinated compounds) matters. The charge was more than offset by a reduction in tax expense of $52 million
related to resolution of tax treatment with authorities regarding the previously disclosed 2018 agreement reached with
the State of Minnesota that resolved the Natural Resources Damages lawsuit. These items, in aggregate, resulted in a
$39 million after tax benefit.
• In 2019, the Company recorded significant litigation-related charges of $762 million ($590 million after tax) related to
PFAS matters ($449 million pre-tax) and coal mine dust respirator mask lawsuits ($313 million pre-tax). These
charges are further discussed in Note 16.
Gain/loss on sale of businesses:
• In 2020, 3M recorded a pre-tax gain of $2 million ($1 million loss after tax) related to the sale of its advanced ballistic-
protection business and recognition of certain contingent consideration and a pre-tax gain of $387 million ($304
million after tax) related to the sale of its drug delivery business. Refer to Note 3 for further details.
• In the first quarter of 2019, 3M recorded a gain related to the sale of certain oral care technology comprising a business
in addition to reflecting an earnout on a previous divestiture, which together resulted in a net gain of $8 million ($7
million after tax). In the second quarter of 2019, as a result of a “held for sale” tax benefit related to the legal entities
associated with the pending divestiture of the Company’s gas and flame detection business, 3M recorded an after-tax
gain of $43 million. In the third quarter of 2019, 3M recorded a gain related to the divestiture of the Company’s gas
and flame detection business and an immaterial impact as a result of measuring a disposal group at the lower of its
carrying amount or fair value less cost to sell, which in aggregate resulted in a pre-tax gain of $106 million ($79
million after tax).
Divestiture-related restructuring actions:
• In 2020, following the divestiture of substantially all of the drug delivery business (see Note 3) management approved
and committed to undertake certain restructuring actions addressing corporate functional costs and manufacturing
footprint across 3M in relation to the magnitude of amounts previously allocated/burdened to the divested business. As
a result, 3M recorded a pre-tax charge of $55 million ($46 million after tax) and made a subsequent immaterial
adjustment thereto. Refer to Note 5 for further details.
Loss on deconsolidation of Venezuelan subsidiary:
• In 2019, 3M recorded a pre-tax charge of $162 million related to the deconsolidation of the Company’s Venezuelan
subsidiary as further discussed in Note 1.
20
-- 28 of 142 --
B??4EF<A@<??<BAF 8K68CGC8EF;4E8
4@BHAGF
&C8E4G<A:
A6B@8
&C8E4G<A:
A6B@8
$4E:<A
A6B@8
89BE8
+4K8F
'EBI<F<BA
9BE
A6B@8
+4K8F
9986G<I8
+4K
)4G8
%8G A6B@8
GGE<5HG45?8
GB$
4EA<A:F
'8E
<?HG87
*;4E8
4EA<A:F
C8E
7<?HG87
F;4E8
C8E68AG
6;4A:8
295F9B898979A69F
)
8>IGHA9BHG:CFGD97=5@=H9AG
,=;B=:=75BH@=H=;5H=CB F9@5H98
7<5F;9G 69B9:=HG
5=B @CGGCBG5@9C:6IG=B9GG9G
%CGGCB897CBGC@=85H=CBC:
/9B9NI9@5BGI6G=8=5FM T T
295F9B898979A69F
58>IGH985ACIBHGBCB )
A95GIF9G
295F9B898979A69F
)
8>IGHA9BHG:CFGD97=5@=H9AG
,=;B=:=75BH@=H=;5H=CB F9@5H98
7<5F;9G 69B9:=HG
5=B @CGGCBG5@9C:6IG=B9GG9G
=J9GH=HIF9 F9@5H98F9GHFI7HIF=B;
57H=CBG
295F9B898979A69F
58>IGH985ACIBHGBCB )
A95GIF9G
295F9B898979A69F
)
8>IGHA9BHG:CFGD97=5@=H9AG
'CB9
295F9B898979A69F
58>IGH985ACIBHGBCB )
A95GIF9G
(-): ;)4-;)6,78-:)<16/16+75-*A*=;16-;;;-/5-6<
-<9:C@@CK=B;H56@9G7CBH5=BG5@9G5B8CD9F5H=B;=B7CA9F9GI@HG6M6IG=B9GGG9;A9BH:CFH<9M95FG9B898979A69F
5B8 +9:9FHCH<9G97H=CB9BH=H@98)9F:CFA5B796MIG=B9GG,9;A9BH@5H9F=B&:CF588=H=CB5@8=G7IGG=CB7CB79FB=B;
J9FGIGF9GI@HG =B7@I8=B;CFDCF5H95B8.B5@@C75H98 +9:9FHC'CH9:CF588=H=CB5@=B:CFA5H=CBCB6IG=B9GG
G9;A9BHG =B7@I8=B;@=A=B5H=CBC:I5@F98=H
IF
6;4A:8
B??4EF<A@<??<BAF %8G
*4?8F B9
+BG4? &C8E
A6B@8 %8G
*4?8F B9
+BG4? &C8E
A6B@8 %8G
*4?8F &C8E
A6B@8
HF<A8FF*8:@8AGF
,5:9HM5B8"B8IGHF=5@
-F5BGDCFH5H=CB5B8@97HFCB=7G
!95@H<5F9
CBGIA9F
CFDCF5H95B8.B5@@C75H98 N T
@=A=B5H=CBC:I5@F98=H
-CH5@CAD5BM
-- 29 of 142 --
084E8A787868@58E
.BE?7J<78*4?8F;4A:85LHF<A8FF*8:@8AG &E:4A<6F4?8F 6DH<F<G<BAF <I8FG<GHE8F +E4AF?4G<BA +BG4?F4?8F6;4A:8
,5:9HM5B8"B8IGHF=5@ T T
-F5BGDCFH5H=CB5B8@97HFCB=7G T T
!95@H<5F9 T
CBGIA9F T T
-CH5@CAD5BM T
(-): ;)4-;:-;=4<;*A/-7/:)801+):-)
)9F79BH7<5B;9=B:CFA5H=CB7CAD5F9GH<9M95F9B898979A69F K=H<H<9G5A9D9F=C8@5GHM95F IB@9GGCH<9FK=G9
=B8=75H98
084E8A787868@58E
@8E<64F F<4
'46<9<6
HEBC8
$<77?84FG
9E<64 &G;8E
,A4??B64G87 .BE?7J<78
'9HG5@9GA=@@=CBG
C:KCF@8K=89G5@9G N
CADCB9BHGC:B9HG5@9G7<5B;9
(F;5B=7G5@9G
7EI=G=H=CBG N N N N
=J9GH=HIF9G N
-F5BG@5H=CB
-CH5@G5@9G7<5B;9
88=H=CB5@=B:CFA5H=CB69MCB8K<5H=G=B7@I898=BH<9DF9798=B;H56@9=G5G:C@@CKG
P "BH<9A9F=75G;9C;F5D<=75F95 . , HCH5@G5@9G=B7F95G98D9F79BHK<=7<=B7@I898=B7F95G98CF;5B=7G5@9GC:
D9F79BH -CH5@G5@9G=B&9L=7C=B7F95G98D9F79BHK<=7<=B7@I898=B7F95G98CF;5B=7G5@9GC:D9F79BH "B5B585
HCH5@G5@9G=B7F95G98D9F79BHK<=7<=B7@I898=B7F95G98CF;5B=7G5@9GC:D9F79BH "BF5N=@ HCH5@G5@9G=B7F95G98
D9F79BHK<=7<=B7@I898=B7F95G98CF;5B=7G5@9GC:D9F79BH
P "BH<9G=5)57=:=7;9C;F5D<=75F95 <=B5HCH5@G5@9G=B7F95G98D9F79BHK<=7<=B7@I898=B7F95G98CF;5B=7G5@9GC:
D9F79BH "B#5D5B HCH5@G5@9GK9F9:@5HK<=7<=B7@I898=B7F95G98CF;5B=7G5@9GC:D9F79BH
(-): ;)4-;:-;=4<;*A/-7/:)801+):-)
)9F79BH7<5B;9=B:CFA5H=CB7CAD5F9GH<9:I@@M95FK=H<H<9:I@@M95F IB@9GGCH<9FK=G9=B8=75H98
084E8A787868@58E
@8E<64F
F<4
'46<9<6
HEBC8
$<77?84FG
9E<64
&G;8E
,A4??B64G87 .BE?7J<78
'9HG5@9GA=@@=CBG
C:KCF@8K=89G5@9G T
CADCB9BHGC:B9HG5@9G7<5B;9
(F;5B=7G5@9G
7EI=G=H=CBG
=J9GH=HIF9G
-F5BG@5H=CB
-CH5@G5@9G7<5B;9
88=H=CB5@=B:CFA5H=CB69MCB8K<5H=G=B7@I898=BH<9DF9798=B;H56@9=G5G:C@@CKG
P "BH<9A9F=75G;9C;F5D<=75F95 . , HCH5@G5@9G=B7F95G98D9F79BHK<=7<=B7@I898=B7F95G98CF;5B=7G5@9GC:
D9F79BH -CH5@G5@9G897F95G98D9F79BH=B&9L=7CK<=7<=B7@I898897F95G98CF;5B=7G5@9GC:D9F79BH "B5B585
-- 30 of 142 --
total sales decreased 1 percent which included decreased organic sales of 4 percent. In Brazil, total sales decreased 17
percent which included increased organic sales of 7 percent.
• In the Asia Pacific geographic area, China total sales increased 4 percent which included increased organic sales of 3
percent. In Japan, total sales decreased 3 percent which included decreased organic sales of 7 percent.
Managing currency risks:
The weaker U.S. dollar had a positive impact on sales in full year 2021 compared to the same period last year. Net of the
Company’s hedging strategy, foreign currency positively impacted earnings for full year 2021 compared to the same period last
year. 3M utilizes a number of tools to manage currency risk related to earnings including natural hedges such as pricing,
productivity, hard currency, hard currency-indexed billings, and localizing source of supply. 3M also uses financial hedges to
mitigate currency risk. In the case of more liquid currencies, 3M hedges a portion of its aggregate exposure, using a 12, 24 or
36 month horizon, depending on the currency in question. For less liquid currencies, financial hedging is frequently more
expensive with more limitations on tenor. Thus, this risk is largely managed via local operational actions using natural hedging
tools as discussed above. In either case, 3M’s hedging approach is designed to mitigate a portion of foreign currency risk and
reduce volatility, ultimately allowing time for 3M’s businesses to respond to changes in the marketplace.
Financial condition:
Refer to the section entitled “Financial Condition and Liquidity” later in MD&A for a discussion of items impacting cash flows.
In November 2018, 3M’s Board of Directors replaced the Company’s February 2016 repurchase program with a new
repurchase program. This new program authorizes the repurchase of up to $10 billion of 3M’s outstanding common stock, with
no pre-established end date. In 2021, the Company purchased $2.2 billion of its own stock and $0.4 billion in 2020. As of
December 31, 2021, approximately $5.6 billion remained available under the authorization. In February 2022, 3M’s Board of
Directors declared a first-quarter 2022 dividend of $1.49 per share, an increase of 1 percent. This marked the 64th consecutive
year of dividend increases for 3M.
Raw materials:
Refer to the section entitled “Raw materials” in Item 1 for discussion of 3M's sources and availability of raw materials in 2021.
Pension and postretirement defined benefit/contribution plans:
On a worldwide basis, 3M’s pension and postretirement plans were 93 percent funded at year-end 2021. The primary U.S.
qualified pension plan, which is approximately 67 percent of the worldwide pension obligation, was 97 percent funded and the
international pension plans were 101 percent funded. The U.S. non-qualified pension plan is not funded due to tax
considerations and other factors. Asset returns in 2021 for the primary U.S. qualified pension plan were 6.7%, as 3M
strategically invests in both growth assets and fixed income matching assets to manage its funded status. For the primary U.S.
qualified pension plan, the expected long-term rate of return on an annualized basis for 2022 is 6.00%. The primary U.S.
qualified pension plan year-end 2021 discount rate was 2.89%, up 0.34 percentage points from the year-end 2020 discount rate
of 2.55%. The increase in U.S. discount rates resulted in an decreased valuation of the projected benefit obligation (PBO). The
primary U.S. qualified pension plan’s funded status increased 5 percentage point in 2021 due to the lower PBO resulting from
the discount rate increase. Additional detail and discussion of international plan asset returns and discount rates is provided in
Note 13 (Pension and Postretirement Benefit Plans).
3M expects to contribute approximately $100 million to $200 million of cash to its global defined benefit pension and
postretirement plans in 2022. The Company does not have a required minimum cash pension contribution obligation for its U.S.
plans in 2022. 3M expects global defined benefit pension and postretirement expense in 2022 to decrease by approximately $20
million pre-tax when compared to 2021. Refer to “Critical Accounting Estimates” within MD&A and Note 13 (Pension and
Postretirement Benefit Plans) for additional information concerning 3M’s pension and post-retirement plans.
RESULTS OF OPERATIONS
Net Sales:
Refer to the preceding “Overview” section and the “Performance by Business Segment” section later in MD&A for additional
discussion of sales change.
23
-- 31 of 142 --
8-:)<16/@8-6;-;
'8E68AGB9A8GF4?8F I8EFHF
CGHC:G5@9G
,9@@=B; ;9B9F5@5B858A=B=GHF5H=J99LD9BG9G,
+9G95F7< 89J9@CDA9BH5B8F9@5H989LD9BG9G+
5=BCBG5@9C:6IG=B9GG9G N
(D9F5H=B;=B7CA9A5F;=B
)9BG=CB5B8DCGHF9H=F9A9BHG9FJ=797CGH9LD9BG9=GF97CF898=B7CGHC:G5@9G , 5B8+ +9:9FHC'CH9)9BG=CB5B8
)CGHF9H=F9A9BH)@5BG:CFH<9G9FJ=797CGH7CADCB9BHGC:B9HD9F=C8=769B9:=H7CGHG
-<9CAD5BM=G7CBH=BI=B;H<9CB;C=B;89D@CMA9BHC:5B9BH9FDF=G9F9GCIF79D@5BB=B;+)GMGH9ACB5KCF@8K=8965G=G
K=H<H<9G9=BJ9GHA9BHG=AD57H=B;7CGHC:G5@9G , 5B8+
7;<7.#)4-;
CGHC:G5@9G=B7@I89GA5BI:57HIF=B; 9B;=B99F=B;5B8:F9=;<H7CGHG
CGHC:G5@9G A95GIF985G5D9F79BHC:G5@9G =B7F95G98=BK<9B7CAD5F98HC8I9HC<=;<9FF5KA5H9F=5@ @C;=GH=7G
5B8CIHGCIF798A5BI:57HIF=B;7CGHGA5BI:57HIF=B;DFC8I7H=J=HM=AD57HG:FCA;@C65@GIDD@M7<5=B7<5@@9B;9G=B7F95G98
7CAD9BG5H=CB5B869B9:=H7CGHG=B7F95G9858>IGHA9BHGHCCH<9F9BJ=FCBA9BH5@@=56=@=H=9G5B8=B7F95G98=BJ9GHA9BHG=B;FCKH<
DFC8I7H=J=HM5B8GIGH5=B56=@=HM CGHC:G5@9GK5G5@GC=AD57H986MM95F CJ9F M95F7<5B;9G=BF9GHFI7HIF=B;7<5F;9G B9HC:
F9GHFI7HIF=B;69B9:=HG 295F CJ9F M95F7CGH=B7F95G9GK9F9D5FH=5@@MC::G9H6M@CK9F(/" F9@5H98B9H=AD57HGH5?9B=B
J9FGIG@5GHM95F =B7@I8=B;D9F=C89LD9BG9GC:IB56GCF698A5BI:57HIF=B;7CGHGH5?9B=B
#-4416/-6-:)4)6,,5161;<:)<1>-@8-6;-;
, A95GIF985G5D9F79BHC:G5@9G 897F95G98=BK<9B7CAD5F98HC , K5G=AD57H986M=B7F95G98
@=H=;5H=CB F9@5H987CGHG 7CAD9BG5H=CB5B869B9:=H7CGHG 5B8GD9B8=B;CB?9M;FCKH<=B=H=5H=J9G , K5G5@GC=AD57H986M
M95F CJ9F M95F7<5B;9G=BF9GHFI7HIF=B;7<5F;9G B9HC:F9GHFI7HIF=B;69B9:=HG CGH=B7F95G9GK9F9D5FH=5@@MC::G9H6MH<9=AD57H
C:H<9:5JCF56@9897=G=CBC:H<9F5N=@=5B,IDF9A9CIFH=BH<9G97CB8EI5FH9FC:F9;5F8=B;H<975@7I@5H=CBC:D5GHGC7=5@
H5L9G5B8CB;C=B;;9B9F5@&7CGHA5B5;9A9BH )F=CFM95F5@GC=B7@I8985BIA69FC:(/" F9@5H98B9H=AD57HG5G89G7F=698
=BH<9!@/<@3/A98=3./<+>39890!( G97H=CB56CJ9
"-;-):+0->-4785-6<)6,"-4)<-,@8-6;-;
+ A95GIF985G5D9F79BHC:G5@9G 897F95G98=BK<9B7CAD5F98HC &7CBH=BI98HC=BJ9GH=B=HG?9M=B=H=5H=J9G
=B7@I8=B;+5=A985H8=GFIDH=J9=BBCJ5H=CBDFC;F5AGK=H<H<9DCH9BH=5@HC7F95H99BH=F9@MB9KA5F?9HG5B88=GFIDH9L=GH=B;
A5F?9HG
)1676#)4-7.=;16-;;-;
IF=B; H<9CAD5BMF97CF8985DF9 H5L;5=BC:A=@@=CBA=@@=CB@CGG5:H9FH5LF9@5H98HCH<9G5@9C:=HG58J5B798
65@@=GH=7 DFCH97H=CB6IG=B9GG5B8F97C;B=H=CBC:79FH5=B7CBH=B;9BH7CBG=89F5H=CB 88=H=CB5@@M =B H<9CAD5BMF97CF8985
DF9 H5L;5=BC:A=@@=CB5:H9FH5LF9@5H98HCH<9G5@9C:GI6GH5BH=5@@M5@@C:=HG8FI;89@=J9FM6IG=B9GG
<0-:@8-6;-6+75--<
,99'CH9:CF589H5=@986F95?CIHC:H<=G@=B9=H9A
"BH9F9GH9LD9BG9B9HC:=BH9F9GH=B7CA9897F95G988IF=B;5B8=B7F95G988IF=B; -<9897F95G9=BK5G8I9HC
@CK9F. , 5J9F5;9896H65@5B79G5B8H<9=AD57HC:=BH9F9GHF5H9GK5DGD@57988IF=B;H<9M95F =BH9F9GH9LD9BG95@GC
=B7@I8985B95F@M896H9LH=B;I=G<A9BHDF9 H5L7<5F;9=BH<9:=FGHEI5FH9FC: -<9=B7F95G9=BK5G8I9HC<=;<9F. ,
5J9F5;9896H65@5B79G5B8@CK9FM95F CB M95F=BH9F9GH=B7CA98F=J9B6M@CK9F5J9F5;9=BH9F9GHF5H9GCB75G<65@5B79G
=BH9F9GH9LD9BG95@GC=B7@I8985B95F@M896H9LH=B;I=G<A9BH7<5F;9=B7CB>IB7H=CBK=H<H<9F9D5MA9BHC:BCH9G=B979A69F
-- 32 of 142 --
-<9BCB G9FJ=79D9BG=CB5B8DCGHF9H=F9A9BHB9H69B9:=H=B7F95G98A=@@=CB5B8A=@@=CB=B5B8
F9GD97H=J9@M -<9<=;<9FM95F CB M95F69B9:=H=BK5GDF=A5F=@M8I9HC897F95G989LD9BG9:FCA@CK9F8=G7CIBHF5H9G
5DD@=756@9HC +9:9FHC'CH9:CF588=H=CB5@89H5=@G
!:7>1;176.7:6+75-$)@-;
'8E68AGB9CE8 G4K<A6B@8
::97H=J9H5LF5H9
57HCFGH<5H=AD57H98H<9H5LF5H9G69HK99BM95FG5F9:IFH<9F8=G7IGG98=BH<9(J9FJ=9KG97H=CB56CJ95B8=B'CH9
-<9H5LF5H975BJ5FM:FCAEI5FH9FHCEI5FH9F8I9HC8=G7F9H9=H9AG GI7<5GH<9G9HH@9A9BHC:=B7CA9H5L5I8=HG 7<5B;9G=BH5L
@5KG 5B89AD@CM99G<5F9 65G98D5MA9BH577CIBH=B;5GK9@@5GF97IFF=B;:57HCFG GI7<5GH<9;9C;F5D<=7A=LC:=B7CA969:CF9
H5L9G
+9:9FHC'CH9:CF:IFH<9F8=G7IGG=CBC:=B7CA9H5L9G
6+75-7;;.:75%6+76;741,)<-,#=*;1,1):1-;-<7.$)@-;
$<??<BAF
"B7CA9@CGG:FCAIB7CBGC@=85H98GI6G=8=5F=9G B9HC:H5L9G
"B7CA9@CGG:FCAIB7CBGC@=85H98GI6G=8=5F=9G B9HC:H5L9G =G5HHF=6IH56@9HCH<9CAD5BMWG577CIBH=B;IB89FH<99EI=HM
A9H<C8:CFCKB9FG<=D=BH9F9GHG=B79FH5=B9BH=H=9GGI7<5G$=B89J5:C@@CK=B;&G8=J9GH=HIF9C:H<98FI;89@=J9FM6IG=B9GG=B
-<6+75-7;;<<:1*=<)*4-<776+76<:74416/6<-:-;<
$<??<BAF
'9H=B7CA9@CGG5HHF=6IH56@9HCBCB7CBHFC@@=B;=BH9F9GH
'9H=B7CA9@CGG5HHF=6IH56@9HCBCB7CBHFC@@=B;=BH9F9GHF9DF9G9BHGH<99@=A=B5H=CBC:H<9=B7CA9CF@CGG5HHF=6IH56@9HCBCB &
CKB9FG<=D=BH9F9GHG=B&7CBGC@=85H989BH=H=9G -<9DF=A5FMBCB7CBHFC@@=B;=BH9F9GHF9@5H9GHC&"B8=5%=A=H98 C:K<=7<&WG
9::97H=J9CKB9FG<=D=GD9F79BH
')&)$%0,* %***$%+
"H9A IG=B9GG,9;A9BHG DFCJ=89G5BCJ9FJ=9KC:&WG6IG=B9GGG9;A9BHG "B588=H=CB 8=G7@CGIF9GF9@5H=B;HC&WG6IG=B9GG
G9;A9BHG5F9DFCJ=898=B'CH9 ::97H=J9=BH<9:=FGHEI5FH9FC: H<9A95GIF9C:G9;A9BHCD9F5H=B;D9F:CFA5B79IG986M
&WG7<=9:CD9F5H=B;897=G=CBA5?9F(&7<5B;985B8 5G5F9GI@H &WG8=G7@CG98A95GIF9C:G9;A9BHDFC:=H @CGG
6IG=B9GGG9;A9BHCD9F5H=B;=B7CA9K5GID85H98:CF5@@7CAD5F5H=J9D9F=C8GDF9G9BH98 -<97<5B;9HC6IG=B9GGG9;A9BH
CD9F5H=B;=B7CA95@=;BGK=H<H<9ID85H9HC<CKH<9(&5GG9GG9GD9F:CFA5B795B85@@C75H9GF9GCIF79G:CFH<9CAD5BMWG
6IG=B9GGG9;A9BHGG99'CH9:CF588=H=CB5@89H5=@G
"B:CFA5H=CBDFCJ=898<9F9=BF9:@97HGH<9=AD57HC:H<9G97<5B;9G:CF5@@D9F=C8GDF9G9BH98 &A5B5;9G=HGCD9F5H=CBG=B:CIF
6IG=B9GGG9;A9BHG -<9F9DCFH56@9G9;A9BHG5F9,5:9HM5B8"B8IGHF=5@-F5BGDCFH5H=CB5B8@97HFCB=7G!95@H<5F95B8
CBGIA9F
7:87:)<-)6,%6)447+)<-,
"B588=H=CBHCH<9G9:CIF6IG=B9GGG9;A9BHG &5GG=;BG79FH5=B7CGHGHCUCFDCF5H95B8.B5@@C75H98 VK<=7<=GDF9G9BH98
G9D5F5H9@M=BH<9DF9798=B;6IG=B9GGG9;A9BHGH56@95B8=B'CH9 CFDCF5H95B8.B5@@C75H98CD9F5H=B;=B7CA9=B7@I89G
UGD97=5@=H9AGV5B8UCH<9F7CFDCF5H99LD9BG9 B9HV ,D97=5@=H9AG=B7@I89G=;B=:=75BH@=H=;5H=CB F9@5H987<5F;9G 69B9:=HG ;5=B @CGG
CBG5@9C:6IG=B9GG9G 5B88=J9GH=HIF9 F9@5H98F9GHFI7HIF=B;7CGHG (H<9F7CFDCF5H99LD9BG9 B9H=B7@I89G=H9AGGI7<5GB9H7CGHG
F9@5H98HC@=A=H98IB5@@C75H987CFDCF5H9GH5::5B879BHF5@@MA5B5;98A5H9F=5@F9GCIF7979BH9FGC:9LD9FH=G97CGHG 79FH5=B
@=H=;5H=CB5B89BJ=FCBA9BH5@9LD9BG9G@5F;9@MF9@5H98HC@9;57MDFC8I7HG 6IG=B9GG9GBCH5@@C75H98HC6IG=B9GGG9;A9BHG
7CFDCF5H9D<=@5BH<FCD=757H=J=HM 5B8CH<9FB9H7CGHGH<5H&A5M7<CCG9BCHHC5@@C75H98=F97H@MHC=HG6IG=B9GGG9;A9BHG (H<9F
-- 33 of 142 --
7CFDCF5H99LD9BG9 B9H5@GC=B7@I89G7CGHG5B8=B7CA9:FCA7CBHF57HA5BI:57HIF=B; HF5BG=H=CBG9FJ=79G5B8CH<9F5FF5B;9A9BHG
K=H<H<957EI=F9FC:H<9CAAIB=75H=CB&5F?9HG=J=G=CB:C@@CK=B;=HG8=J9GH=HIF9H<FCI;<5B8H<957EI=F9FC:H<9
:CFA9FFI;9@=J9FM6IG=B9GG:C@@CK=B;=HG8=J9GH=HIF9 "H9AG7@5GG=:=985GF9J9BI9:FCAH<=G57H=J=HM5F9=B7@I898=B
CFDCF5H95B8.B5@@C75H98B9HG5@9G 975IG9CFDCF5H95B8.B5@@C75H98=B7@I89G5J5F=9HMC:A=G79@@5B9CIG=H9AG =H=GGI6>97H
HC:@I7HI5H=CBCB5EI5FH9F@M5B85BBI5@65G=G
CFDCF5H95B8.B5@@C75H98B9HCD9F5H=B;@CGG=B7F95G98=BK<9B7CAD5F98HCDF=A5F=@MF9@5H98HCH<9DF9 H5L;5=BC:
A=@@=CB=B7@I898=BGD97=5@=H9AG=B5G5F9GI@HC:&G8=J9GH=HIF9C:=HG8FI;89@=J9FM6IG=B9GGG99'CH9:CF
588=H=CB5@89H5=@G
%:/-3+6>/7=
+9:9FHCH<9/<>+38+79?8>=+.4?=>/.09<=:/-3+63>/7=898"7/+=?</=G97H=CB5B8'CH9:CF588=H=CB5@89H5=@GCBH<9
=AD57HC:G=;B=:=75BH@=H=;5H=CB F9@5H987<5F;9G 69B9:=HG ;5=B @CGGCBG5@9C:6IG=B9GG9G 5B88=J9GH=HIF9 F9@5H98F9GHFI7HIF=B;
57H=CBGH<5H5F9F9:@97H98=BCFDCF5H95B8.B5@@C75H98
!>2/<9<:9<+>/B:/8=/ />
(H<9F7CFDCF5H9CD9F5H=B;9LD9BG9G897F95G98=BK<9B7CAD5F98HC -<9897F95G9K5GDF=A5F=@M8I9HC5
A=@@=CBDF9 H5L69B9:=H:FCAH<9=AD57HC:H<9:5JCF56@9897=G=CBC:H<9F5N=@=5B,IDF9A9CIFH=BH<9G97CB8EI5FH9FC:
F9;5F8=B;H<975@7I@5H=CBC:D5GHGC7=5@H5L9G 7CBH=BI98@CK9FCJ9F5@@7CFDCF5H9GH5::GD9B8=B;5B8:=FGHEI5FH9F7<5F;9G
F9@5H98HC9EI=HMG97IF=H=9G5G8=G7IGG98=BH<9UGG9HG5B8%=56=@=H=9GH<5H5F9&95GIF985H5=F/5@I9CB5'CBF97IFF=B;5G=GV
G97H=CBC:'CH9 D5FH=5@@MC::G9H6M=B7F95G98@9;5@5B8F9G9FJ958>IGHA9BH7CGHG
8-:)<16/=;16-;;#-/5-6<;
"B:CFA5H=CBF9@5H98HC&WG6IG=B9GGG9;A9BHG=GDF9G9BH98=BH<9H56@9GH<5H:C@@CKK=H<588=H=CB5@7CBH9LH=BH<9
7CFF9GDCB8=B;B5FF5H=J969@CKH<9H56@9G
-<9:C@@CK=B;8=G7IGG9GHCH5@M95FF9GI@HG:CF7CAD5F98HC5B87CAD5F98HC:CF957<6IG=B9GGG9;A9BH
#).-<A)6,6,=;<:1)4=;16-;; 7.+76;741,)<-,;)4-;
,5@9GA=@@=CBG
,5@9G7<5B;95B5@MG=G
(F;5B=7G5@9G
=J9GH=HIF9G N
-F5BG@5H=CB
-CH5@G5@9G7<5B;9
IG=B9GGG9;A9BHCD9F5H=B;=B7CA9A=@@=CBG
)9F79BH7<5B;9
)9F79BHC:G5@9G
(-): :-;=4<;
,5@9G=B,5:9HM5B8"B8IGHF=5@K9F9ID D9F79BH=B. , 8C@@5FG
(B5BCF;5B=7G5@9G65G=G
P ,5@9G=B7F95G98=B56F5G=J9G =B8IGHF=5@58<9G=J9G5B8H5D9G 5IHCACH=J95:H9FA5F?9H 9@97HF=75@A5F?9HG FCC:=B;
;F5BI@9G 5B87@CGIF95B8A5G?=B;GMGH9AG5B8897F95G98=BD9FGCB5@G5:9HMM95F CB M95F
P FCKH<K5G8F=J9B6M=ADFCJ=B;;9B9F5@=B8IGHF=5@A5BI:57HIF=B;57H=J=HM5B8CH<9F9B8 A5F?9H89A5B8D5FH=5@@M
C::G9H6MDF=CF M95FGHFCB;D5B89A=7 F9@5H98F9GD=F5HCFA5G?89A5B8
-- 34 of 142 --
IG=B9GGG9;A9BHCD9F5H=B;=B7CA9A5F;=BG897F95G98M95F CB M95F8I9HC=B7F95G9G=BF5KA5H9F=5@G @C;=GH=7G5B8@=H=;5H=CB
F9@5H987CGHG@CK9F;5=BCBG5@9C:DFCD9FH=9G5B8A5BI:57HIF=B;DFC8I7H=J=HM=AD57HGH<5HK9F9D5FH=5@@MC::G9H6MG5@9G;FCKH<
@9J9F5;9 @CK9FM95F CB M95FF9GD=F5HCFA5G?F9G9FJ9=B7F95G9G 5B869B9:=HG:FCAF9GHFI7HIF=B;57H=CBG5B8@CK9FF9@5H98
7<5F;9G
(-): :-;=4<;
,5@9G=B,5:9HM5B8"B8IGHF=5@K9F9ID D9F79BH=B. , 8C@@5FG
(B5BCF;5B=7G5@9G65G=G
P ,5@9G=B7F95G98=BD9FGCB5@G5:9HM5B8FCC:=B;;F5BI@9G K<=@9=B8IGHF=5@58<9G=J9G5B8H5D9G 9@97HF=75@A5F?9HG
7@CGIF95B8A5G?=B;GMGH9AG 5IHCACH=J95:H9FA5F?9H 5B856F5G=J9GG5@9G897F95G98M95F CB M95F
P ,HFCB;;FCKH<F9@5H98HCIBDF97989BH9889A5B8:CFF9GD=F5HCFG5G5F9GI@HC:H<9(/" D5B89A=7K5GD5FH=5@@M
C::G9H6MGC:HB9GGH<5H=AD57H98G5@9G;FCKH<57FCGGACGHC:H<9CAD5BMWG;9B9F5@=B8IGHF=5@ F9@5H98DCFH:C@=C
=J9GH=HIF9G
P 8=J9GH=HIF9GH<5H=AD57H98F9GI@HGF9@5H9HCH<9I;IGHG5@9C:H<9;5G5B8:@5A989H97H=CB6IG=B9GG
IG=B9GGG9;A9BHCD9F5H=B;=B7CA9A5F;=BG=B7F95G98 M95F CB M95FDF=A5F=@MF9@5H98HCGHFCB;DFC8I7H=J=HM 7CBH=BI98
7CGH8=G7=D@=B95B869B9:=HG:FCA79FH5=BDFCD9FHMG5@9 F9GHFI7HIF=B;5B8CH<9F57H=CBG
$:)6;87:<)<176)6,4-+<:761+;=;16-;; 7.+76;741,)<-,;)4-;
,5@9GA=@@=CBG
,5@9G7<5B;95B5@MG=G
(F;5B=7G5@9G
=J9GH=HIF9G N
-F5BG@5H=CB
-CH5@G5@9G7<5B;9
IG=B9GGG9;A9BHCD9F5H=B;=B7CA9A=@@=CBG
)9F79BH7<5B;9
)9F79BHC:G5@9G
(-): :-;=4<;
,5@9G=B-F5BGDCFH5H=CB5B8@97HFCB=7GK9F9ID D9F79BH=B. , 8C@@5FG
(B5BCF;5B=7G5@9G65G=G
P ,5@9G=B7F95G98=B58J5B798A5H9F=5@G 7CAA9F7=5@GC@IH=CBG 5IHCACH=J95B859FCGD579 9@97HFCB=7G5B8HF5BGDCFH5H=CB
G5:9HM
P ,5@9G=B7F95G98=B5IHCACH=J95B859FCGD579:FCA=ADFCJ=B;5IHCACH=J9 9B8A5F?9H57H=J=HM5B8=B7F95G9G=B75F5B8
@=;<HHFI7?6I=@8G D5FH=5@@MC::G9H6M=AD57HG:FCAG9A=7CB8I7HCFGIDD@M7<5=B7CBGHF5=BHG
P ,5@9G=B7F95G98=B9@97HFCB=7G8I9HCGHFCB;89A5B8=B85H579BH9F G9A=7CB8I7HCF =BH9F7CBB97H5B87CBGIA9F
9@97HFCB=7GA5F?9HG D5FH=5@@MC::G9H6M=AD57HG:FCAG9A=7CB8I7HCFGIDD@M7<5=B7CBGHF5=BHG
P ,5@9G=B7F95G98=B7CAA9F7=5@GC@IH=CBG 58J5B798A5H9F=5@G5B8HF5BGDCFH5H=CBG5:9HM8I9HC=B7F95G9858J9FH=G=B;
GD9B85B8F9HIFBHCKCF?D@579HF9B8G
IG=B9GGG9;A9BHCD9F5H=B;=B7CA9A5F;=BG=B7F95G98M95F CB M95F8I9HCG5@9G;FCKH<@9J9F5;9 69B9:=HG:FCAF9GHFI7HIF=B;
57H=CBG5B8@CK9FF9@5H987<5F;9G 5B8(/"=AD57HGF97C;B=N98CB79FH5=B5GG9HG=BH<5HK9F9D5FH=5@@MC::G9H6M
=B7F95G9G=BF5KA5H9F=5@G5B8@C;=GH=77CGHG A5BI:57HIF=B;DFC8I7H=J=HM=AD57HG 5B8=B7F95G987CAD9BG5H=CB5B869B9:=H7CGHG
-- 35 of 142 --
(-): :-;=4<;
,5@9G=B-F5BGDCFH5H=CB5B8@97HFCB=7GK9F98CKB D9F79BH=B. , 8C@@5FG
(B5BCF;5B=7G5@9G65G=G
P ,5@9G=B7F95G98=B9@97HFCB=7G K<=@9G5@9G897F95G98=BHF5BGDCFH5H=CBG5:9HM 58J5B798A5H9F=5@G 7CAA9F7=5@GC@IH=CBG
5B85IHCACH=J95B859FCGD579
P @97HFCB=7G F9@5H98;FCKH<K5G@986M89A5B8:CFG9A=7CB8I7HCF 85H579BH9F 5B8:57HCFM5IHCA5H=CB9B8 A5F?9HG
5B8K5GD5FH=5@@MC::G9H6MGC:HB9GG=BH<97CBGIA9F9@97HFCB=7G9B8 A5F?9H
P IHCACH=J95B859FCGD579K5GDF=A5F=@M=AD57H986MH<9897@=B9=B;@C65@75F5B8@=;<HHFI7?6I=@8G CAA9F7=5@
GC@IH=CBG5B8HF5BGDCFH5H=CBG5:9HMK9F9=AD57H986MGC:H 9B8A5F?9HGGI7<5G<CGD=H5@=HM 58J9FH=G=B;5B8<=;<K5M
=B:F5GHFI7HIF98I9HCGC7=5@8=GH5B7=B;5B8KCF? :FCA <CA9DFCHC7C@G5G5F9GI@HC:(/"
=J9GH=HIF9G
P "B#5BI5FM &7CAD@9H98H<9G5@9C:=HG58J5B79865@@=GH=7 DFCH97H=CB6IG=B9GG +9:9FHC'CH9:CF89H5=@G
IG=B9GGG9;A9BHCD9F5H=B;=B7CA9A5F;=BG897F95G98 DF=A5F=@MF9@5H98HC@CK9FG5@9G5B8F98I798DFC8I7H=J=HM=B?9M
9B8 A5F?9HG8I9HC(/" F9@5H98=AD57HG D5FH=5@@MC::G9H6M7CBH=BI987CGH8=G7=D@=B95B869B9:=HG:FCA
F9GHFI7HIF=B;57H=CBG
-)4<0):-=;16-;; 7.+76;741,)<-,;)4-;
,5@9GA=@@=CBG
,5@9G7<5B;95B5@MG=G
(F;5B=7G5@9G
7EI=G=H=CBG N
=J9GH=HIF9G
-F5BG@5H=CB
-CH5@G5@9G7<5B;9
IG=B9GGG9;A9BHCD9F5H=B;=B7CA9A=@@=CBG
)9F79BH7<5B;9
)9F79BHC:G5@9G
(-): :-;=4<;
,5@9G=B!95@H<5F9K9F9ID D9F79BH=B. , 8C@@5FG
(B5BCF;5B=7G5@9G65G=G
P ,5@9G=B7F95G98=BCF5@75F9 G9D5F5H=CB5B8DIF=:=75H=CB :CC8G5:9HM <95@H<=B:CFA5H=CBGMGH9AG5B8A98=75@GC@IH=CBG
P ,5@9G=B7F95G98=BCF5@75F98F=J9B6M<=;<9FM95F CB M95F89BH5@DFC798IF9G5B8=BG9D5F5H=CB5B8DIF=:=75H=CB:FCA
7CBH=BI98<=;<89A5B8:CF6=CD<5FA5:=@HF5H=CBGC@IH=CBG:CF(/" F9@5H98J577=B95B8H<9F5D9IH=789J9@CDA9BH5B8
A5BI:57HIF=B;
P ,5@9G=B7F95G98=BA98=75@GC@IH=CBG:FCAF=G=B;9@97H=J9DFC798IF9JC@IA9G=BH<9:=FGHG=LACBH<GC:5B8GHFCB;
F9GD=F5HCF89A5B8=BH<9:=FGHEI5FH9FC:
P ,5@9G=B7F95G98=B<95@H<=B:CFA5H=CBGMGH9AG8I9HC=ADFCJ=B;<CGD=H5@=B:CFA5H=CBH97<BC@C;M=BJ9GHA9BHG
=J9GH=HIF9G
P "B&5M &7CAD@9H98H<9G5@9C:GI6GH5BH=5@@M5@@C:=HG8FI;89@=J9FM6IG=B9GG
IG=B9GGG9;A9BHCD9F5H=B;=B7CA9A5F;=BG=B7F95G98M95F CB M95F8I9HCG5@9G;FCKH<@9J9F5;95B869B9:=HG:FCA
F9GHFI7HIF=B;57H=CBG5B8@CK9FF9@5H987<5F;9GH<5HK9F9D5FH=5@@MC::G9H6MGIDD@M7<5=B8=GFIDH=CBG =B7F95G9G=BF5KA5H9F=5@G
-- 36 of 142 --
5B8@C;=GH=7G7CGHG 895@ F9@5H987CGHG5GGC7=5H98K=H<H<95BBCIB7988=J9GH=HIF9C:H<9:CC8G5:9HM6IG=B9GGG99'CH9
A5BI:57HIF=B;DFC8I7H=J=HM=AD57HG =B7F95G987CAD9BG5H=CB5B869B9:=H7CGHG 5B8=B7F95G98=BJ9GHA9BHG=B;FCKH<
(-): :-;=4<;
,5@9G=B!95@H<5F9K9F9ID D9F79BH=B. , 8C@@5FG
(B5BCF;5B=7G5@9G65G=G
P ,5@9G=B7F95G98=BA98=75@GC@IH=CBG G9D5F5H=CB5B8DIF=:=75H=CB 5B8:CC8G5:9HM K<=@9G5@9G897F95G98=B<95@H<
=B:CFA5H=CBGMGH9AG5B8CF5@75F9
P "B7F95G9G=B<95@H<75F9JC@IA9G69B9:=H986CH<A98=75@GC@IH=CBG5B8CF5@75F95:H9FG=;B=:=75BH8=GFIDH=CBG=BH<9
G97CB8EI5FH9F K=H<GHFCB;D5B89A=7 F9@5H9889A5B8:CF8=GDCG56@9F9GD=F5HCFGF9GI@H=B;=B=B7F95G98G5@9G:CFA98=75@
GC@IH=CBG K<=@9CF5@75F9G5@9G897F95G98M95F CB M95F "B588=H=CB <95@H<=B:CFA5H=CBGMGH9AG897F95G988I9HC
<CGD=H5@GF9A5=B=B;75IH=CIGF9@5H=J9HCH<9=F=B:CFA5H=CBH97<BC@C;M=BJ9GHA9BHG
7EI=G=H=CBG
P "B96FI5FM &57EI=F98&&C85@ 5@958=B;<95@H<75F9H97<BC@C;MDFCJ=89FC:7@CI8 65G98 7CBJ9FG5H=CB5@
5FH=:=7=5@=BH9@@=;9B79 DCK9F98GMGH9AGH<5H<9@DD<MG=7=5BG9::=7=9BH@M75DHIF95B8=ADFCJ9H<9D5H=9BHB5FF5H=J9
P "B(7HC69F &7CAD@9H98H<957EI=G=H=CBC:79@=HM"B7 5B8=HG$"GI6G=8=5F=9G 5@958=B;;@C65@A98=75@
H97<BC@C;M7CAD5BM:C7IG98CB58J5B798KCIB875F95B8GD97=5@HMGIF;=75@5DD@=75H=CBG
=J9GH=HIF9G
P "BH<9:=FGHEI5FH9FC: H<9CAD5BMGC@879FH5=BCF5@75F9H97<BC@C;M7CADF=G=B;56IG=B9GG
P "B&5M &7CAD@9H98H<9G5@9C:GI6GH5BH=5@@M5@@C:=HG8FI;89@=J9FM6IG=B9GG
IG=B9GGG9;A9BHCD9F5H=B;=B7CA9A5F;=BG897F95G98 M95F CB M95F 8F=J9B6M=AD57HGF9@5H98HCH<979@=HM57EI=G=H=CB
=B588=H=CBHCG=;B=:=75BHG5@9G897@=B9G=BCF5@75F98IF=B;H<9G97CB8EI5FH9FC: D5FH=5@@MC::G9H6M7CBH=BI987CGH
8=G7=D@=B95B869B9:=HG:FCAF9GHFI7HIF=B;5B8CH<9F7CGHG
76;=5-:=;16-;; 7.+76;741,)<-,;)4-;
,5@9GA=@@=CBG
,5@9G7<5B;95B5@MG=G
(F;5B=7G5@9G
-F5BG@5H=CB
-CH5@G5@9G7<5B;9
IG=B9GGG9;A9BHCD9F5H=B;=B7CA9A=@@=CBG
)9F79BH7<5B;9
)9F79BHC:G5@9G
(-): :-;=4<;
,5@9G=BCBGIA9FK9F9ID D9F79BH=B. , 8C@@5FG
(B5BCF;5B=7G5@9G65G=G
P ,5@9G=B7F95G98=BGH5H=CB9FM5B8C::=79 <CA9=ADFCJ9A9BH 7CBGIA9F<95@H<5B8G5:9HM 5B8<CA975F9
P ,5@9G=B7F95G98=B<CA9=ADFCJ9A9BH8F=J9B6M7CBH=BI98GHF9B;H<=BH<9A5F?9HK=H<GHFCB;89A5B8:CFCAA5B8 -&
58<9G=J9G =@HF9H9-&
5=FEI5@=HMGC@IH=CBG &9;I=5FG -&
5IHC75F95B8,7CH7<@I9-&
D5=BH9FWGH5D9
P ,5@9G=B7F95G98=BGH5H=CB9FM5B8C::=79:FCACB;C=B;GHF9B;H<=B89A5B8:CFD57?5;=B;5B8G<=DD=B;DFC8I7HG )CGH
=HQ GC@IH=CBG5B8,7CH7<Q
6F5B8C::=79H5D9G5GH<96IG=B9GG@5DG@5GHM95FWG(/" F9@5H987CAD5F=GCBG
IG=B9GGG9;A9BHCD9F5H=B;=B7CA9A5F;=BG897F95G98M95F CB M95F5G5F9GI@HC:=B7F95G9G=BF5KA5H9F=5@G @C;=GH=7G 5B8
CIHGCIF798<5F8;CC8GA5BI:57HIF=B;7CGHG A5BI:57HIF=B;DFC8I7H=J=HM=AD57HG 5B8=B7F95G987CAD9BG5H=CB5B869B9:=H7CGHG
H<5HACF9H<5BC::G9H@9J9F5;9:FCAG5@9G;FCKH<5B869B9:=HG:FCAF9GHFI7HIF=B;57H=CBG5B8@CK9FF9@5H987<5F;9G
-- 37 of 142 --
(-): :-;=4<;
,5@9G=BCBGIA9FK9F9ID D9F79BH=B. , 8C@@5FG
(B5BCF;5B=7G5@9G65G=G
P ,5@9G=B7F95G98=B<CA9=ADFCJ9A9BH5B8<CA975F9 K<=@97CBGIA9F<95@H<5B8G5:9HM5B8GH5H=CB9FM5B8C::=79
897F95G98
P ,H5H=CB9FM5B8C::=79897@=B98M95F CB M95F5G5F9GI@HC:A5BM6IG=B9GGC::=79G5B8G7<CC@GF9A5=B=B;D5FH=5@@MCF
:I@@M7@CG988I9HCH<9D5B89A=7
P ,5@9GG<CK987CBH=BI98GHF9B;H<=BH<9CAD5BMWGCAA5B8 R =@HF9H9R ,7CH7<@I9R ,7CH7<F=H9R 5B8
&9;I=5FGR6F5B8G
IG=B9GGG9;A9BHCD9F5H=B;=B7CA9A5F;=BG=B7F95G98 M95F CB M95F5G5F9GI@HC:GHFCB;CF;5B=7G5@9G;FCKH<5B8
7CBH=BI987CGH8=G7=D@=B9
')&)$%0&)' )
0<=@9&A5B5;9G=HG6IG=B9GG9G;@C65@@M5B869@=9J9G=HG6IG=B9GGG9;A9BHF9GI@HG5F9H<9ACGHF9@9J5BHA95GIF9C:
D9F:CFA5B79 H<9CAD5BM5@GCIH=@=N9G;9C;F5D<=75F9585H55G5G97CB85FMD9F:CFA5B79A95GIF9 LDCFHG5@9G5F9;9B9F5@@M
F9DCFH98K=H<=BH<9;9C;F5D<=75F95K<9F9H<9:=B5@G5@9GHC&7IGHCA9FG5F9A589 DCFH=CBC:H<9DFC8I7HGCF7CADCB9BHG
GC@86M&WGCD9F5H=CBGHC=HG7IGHCA9FG5F99LDCFH986MH<9G97IGHCA9FGHC8=::9F9BH;9C;F5D<=75F95G G7IGHCA9FGACJ9
H<9=FCD9F5H=CBG:FCACB9;9C;F5D<=75F95HC5BCH<9F &WGF9GI@HGK=@@:C@@CK -<IG B9HG5@9G=B5D5FH=7I@5F;9C;F5D<=75F95
5F9BCH=B8=75H=J9C:9B8 IG9F7CBGIADH=CB=BH<5H;9C;F5D<=75F95 =B5B7=5@=B:CFA5H=CBF9@5H98HC&CD9F5H=CBG=BJ5F=CIG
;9C;F5D<=75F95G=GDFCJ=898=B'CH95B8'CH9
+9:9FHCH<9U(J9FJ=9KVG97H=CB:CF5GIAA5FMC:B9HG5@9G6M;9C;F5D<=75F955B86IG=B9GGG9;A9BH
8B:E4C;<6E84*HCC?8@8AG4? A9BE@4G<BA
@C?BL88F4FB9868@58E 4C<G4?*C8A7<A:
'EBC8EGL '?4AG4A7DH<C@8AG
A8G4FB9868@58E
$<??<BAF 8K68CG@C?BL88F
A9F=75G
G=5)57=:=7
IFCD9 &=88@95GH5B8:F=75
-CH5@CAD5BM
5847A5-6<
AD@CMA9BHF9A5=B987CBG=GH9BH=BK<9B7CAD5F98HC -<956CJ9H56@9=B7@I89GH<9=AD57HC:57EI=G=H=CBG B9HC:
8=J9GH=HIF9G5B8CH<9F57H=CBG
)81<)4#8-6,16/-<!:78-:<A!4)6<)6,9=185-6<
"BJ9GHA9BHG=BDFCD9FHM D@5BH5B89EI=DA9BH9B56@9;FCKH<57FCGGA5BM8=J9FG9A5F?9HG <9@D=B;HCA99HDFC8I7H89A5B85B8
=B7F95G=B;A5BI:57HIF=B;9::=7=9B7M &=G=B7F95G=B;=HG=BJ9GHA9BH=BA5BI:57HIF=B;5B8GCIF7=B;75D56=@=HM=BCF89FHCACF9
7@CG9@M5@=;B=HGDFC8I7H75D56=@=HMK=H<=HGG5@9G=BA5>CF;9C;F5D<=75F95G=BCF89FHC69GHG9FJ9=HG7IGHCA9FGH<FCI;<CIHH<9
KCF@8K=H<DFCDF=9H5FM 5IHCA5H98 9::=7=9BH G5:95B8GIGH5=B56@9DFC79GG9G 5D=H5@GD9B8=B;=G8=G7IGG98=BACF989H5=@@5H9F=B
&=BH<9G97H=CB9BH=H@98U5G<@CKG:FCA"BJ9GH=B;7H=J=H=9G V
) + #&,%+ %*+ $+*
"B:CFA5H=CBF9;5F8=B;G=;B=:=75BH577CIBH=B;DC@=7=9G=G=B7@I898=B'CH9HCH<97CBGC@=85H98:=B5B7=5@GH5H9A9BHG GGH5H98=B
'CH9 H<9DF9D5F5H=CBC::=B5B7=5@GH5H9A9BHG=B7CB:CFA=HMK=H<. , ;9B9F5@@M5779DH98577CIBH=B;DF=B7=D@9GF9EI=F9G
A5B5;9A9BHHCA5?979FH5=B9GH=A5H9G5B85GGIADH=CBG ,I7<9GH=A5H9G5B85GGIADH=CBG5F9GI6>97HHC=B<9F9BHIB79FH5=BH=9G
K<=7<A5MF9GI@H=B57HI5@5ACIBHG8=::9F=B;:FCAH<9G99GH=A5H9G
-- 38 of 142 --
-<9CAD5BM7CBG=89FGH<9=H9AG69@CKHC697F=H=75@577CIBH=B;9GH=A5H9G F=H=75@577CIBH=B;9GH=A5H9G5F9H<CG99GH=A5H9G
A589=B577CF85B79K=H<;9B9F5@@M5779DH98577CIBH=B;DF=B7=D@9GH<5H=BJC@J95G=;B=:=75BH@9J9@C:9GH=A5H=CBIB79FH5=BHM5B8
<5J9<58CF5F9F95GCB56@M@=?9@MHC<5J95A5H9F=5@=AD57HCBH<9:=B5B7=5@7CB8=H=CBCFF9GI@HGC:CD9F5H=CBGC:H<9CAD5BM
,9B=CFA5B5;9A9BH<5G8=G7IGG98H<989J9@CDA9BH G9@97H=CB5B88=G7@CGIF9C:=HG7F=H=75@577CIBH=B;9GH=A5H9GK=H<H<9I8=H
CAA=HH99C:&WGC5F8C:=F97HCFG
-/)4!:7+--,16/;
GG9GGA9BHGC:@5KGI=HG5B87@5=AG75B=BJC@J95G9F=9GC:7CAD@9L>I8;A9BHG56CIH:IHIF99J9BHG H<9CIH7CA9GC:K<=7<5F9
=B<9F9BH@MIB79FH5=B 5B875BF9@M<95J=@MCB9GH=A5H9G5B85GGIADH=CBG -<9CAD5BM577FI9G5B9GH=A5H98@=56=@=HM:CF@9;5@
DFC7998=B;7@5=AGH<5H5F96CH<DFC656@95B8F95GCB56@M9GH=A56@9=B577CF85B79K=H<77CIBH=B;,H5B85F8C8=:=75H=CB,
98>381/8-3/= )@95G9F9:9FHCH<9G97H=CB9BH=H@98U)FC79GG:CF=G7@CGIF95B8+97CF8=B;C:%=56=@=H=9G+9@5H98HC%9;5@
)FC7998=B;GV7CBH5=B98=BU%9;5@)FC7998=B;GV=B'CH9:CF588=H=CB5@=B:CFA5H=CB56CIHGI7<9GH=A5H9G
!-6;176)6,!7;<:-<1:-5-6< *41/)<176;
-<9CAD5BM5DD@=9G79FH5=B9GH=A5H9G:CFH<98=G7CIBHF5H9G5B89LD97H98F9HIFBCBD@5B5GG9HG=B89H9FA=B=B;=HG89:=B98
69B9:=HD9BG=CB5B8DCGHF9H=F9A9BHC6@=;5H=CBG5B8F9@5H98B9HD9F=C8=769B9:=H7CGHG -<969@CK:IFH<9F89G7F=69GH<9G9
9GH=A5H9G 'CH9DFCJ=89GH<9K9=;<H985J9F5;9GC:H<9G95GGIADH=CBG5GC:5DD@=756@985H9G5B8:CFF9GD97H=J9D9F=C8G5B8
588=H=CB5@=B:CFA5H=CBCB<CKH<9F5H9GK9F989H9FA=B98
3=-9?8><+>/
-<989:=B9869B9:=HD9BG=CB5B8DCGHF9H=F9A9BHC6@=;5H=CBF9DF9G9BHGH<9DF9G9BHJ5@I9C:H<969B9:=HGH<5H9AD@CM99G5F9
9BH=H@98HC=BH<9:IHIF9:CFG9FJ=79G5@F958MF9B89F985GC:H<9A95GIF9A9BH85H9 -<9CAD5BMA95GIF9GH<9DF9G9BHJ5@I9C:
H<9G9:IHIF969B9:=HG6MDFC>97H=B;69B9:=HD5MA9BH75G<:@CKG:CF957<:IHIF9D9F=C85B88=G7CIBH=B;H<9G975G<:@CKG657?HC
H<9979A69FA95GIF9A9BH85H9 IG=B;H<9M=9@8GC:5DCFH:C@=CC:<=;<EI5@=HM :=L98 =B7CA9896H=BGHFIA9BHGH<5HKCI@8
DFC8I7975G<:@CKGGI::=7=9BH=BH=A=B;5B85ACIBHHCG9HH@9DFC>97H98:IHIF969B9:=HG ,9FJ=797CGH5B8=BH9F9GH7CGH5F9
A95GIF98G9D5F5H9@MIG=B;H<9GDCHM=9@87IFJ95DDFC57<5DD@=98HC957<7CFF9GDCB8=B;C6@=;5H=CB ,9FJ=797CGHG5F989H9FA=B98
65G98CB8IF5H=CB GD97=:=7GDCHF5H9G5DD@=98HCH<9G9FJ=797CGH75G<:@CKG -<9=BH9F9GH7CGH75@7I@5H=CB=G89H9FA=B986M
5DD@M=B;8IF5H=CB GD97=:=7GDCHF5H9GHCH<9M95F 6M M95FDFC>97H9869B9:=HD5MA9BHG -<9GDCHM=9@87IFJ95DDFC57<8C9GBCH
5::97HH<9A95GIF9A9BHC:H<9HCH5@69B9:=HC6@=;5H=CBG5GH<97<5B;9=BG9FJ=795B8=BH9F9GH7CGHGC::G9HH<957HI5F=5@;5=BG5B8
@CGG9GF97CF898=BCH<9F7CADF9<9BG=J9=B7CA9 <5B;9G=B9LD97H9869B9:=HD5MA9BH5B8G9FJ=797CGH75G<:@CKG 5GK9@@5G
CB;C=B;7<5B;9G=BA5F?9H57H=J=HM5B8M=9@8G 75IG9H<9G9F5H9GHC69GI6>97HHCIB79FH5=BHM
.G=B;H<=GA9H<C8C@C;M H<9CAD5BM89H9FA=B988=G7CIBHF5H9G:CF=HGD@5BG5G:C@@CK
, * (H4?<9<87'8AF<BA
AG8EA4G<BA4?'8AF<BA
J8<:;G874I8E4:8
, * 'BFGE8G<E8@8AG
$87<64?
868@58E #<45<?<GL
9B9:=HC6@=;5H=CB
%8G'8E<B7<68A89<GBFGB@CBA8AGF
,9FJ=797CGH
"BH9F9GH7CGH
B:/->/.</>?<898:6+8+==/>=
-<99LD97H98F9HIFBCBD@5B5GG9HG:CFH<9DF=A5FM. , EI5@=:=98D9BG=CBD@5B=G65G98CBGHF5H9;=75GG9H5@@C75H=CBC:H<9D@5B
@CB; H9FA75D=H5@A5F?9HF9HIFB9LD97H5H=CBG 5B89LD97H98D9F:CFA5B79:FCA57H=J9=BJ9GHA9BHA5B5;9A9BH CFH<9DF=A5FM
. , EI5@=:=98D9BG=CBD@5B H<99LD97H98@CB; H9FAF5H9C:F9HIFBCB5B5BBI5@=N9865G=G:CF=G 5897F95G9:FCA
=B +9HIFBCB5GG9HG5GGIADH=CBG:CF=BH9FB5H=CB5@D9BG=CB5B8CH<9FDCGH F9H=F9A9BH69B9:=HD@5BG5F975@7I@5H98CB
5D@5B 6M D@5B65G=GIG=B;D@5B5GG9H5@@C75H=CBG5B89LD97H98@CB; H9FAF5H9C:F9HIFB5GGIADH=CBG -<9K9=;<H985J9F5;9
9LD97H98F9HIFB:CFH<9=BH9FB5H=CB5@D9BG=CBD@5BG=G :CF7CAD5F98HC :CF <5B;9G=B5GG9H5@@C75H=CB
5B8A5F?9HD9F:CFA5B79CJ9FH=A9 5ACB;CH<9F:57HCFG 75IG9H<9G99GH=A5H9GHC69GI6>97HHCIB79FH5=BHM
CFH<9M95F9B898979A69F H<9CAD5BMF97C;B=N987CBGC@=85H9889:=B9869B9:=HDF9 H5LD9BG=CB5B8
DCGHF9H=F9A9BHG9FJ=797CGH9LD9BG9C:A=@@=CB5B8569B9:=HC:A=@@=CBF9@5H98HC5@@BCB G9FJ=79D9BG=CB5B8
DCGHF9H=F9A9BHB9H69B9:=H7CGHG5:H9FG9HH@9A9BHG 7IFH5=@A9BHG GD97=5@H9FA=B5H=CB69B9:=HG5B8CH<9F:CF5HCH5@7CBGC@=85H98
89:=B9869B9:=HDF9 H5LD9BG=CB5B8DCGHF9H=F9A9BH9LD9BG9C:A=@@=CB 8CKB:FCAA=@@=CB=B
-- 39 of 142 --
"B 89:=B9869B9:=HD9BG=CB5B8DCGHF9H=F9A9BHG9FJ=797CGH9LD9BG9=G5BH=7=D5H98HCHCH5@5DDFCL=A5H9@MA=@@=CB
K<=@9BCB G9FJ=79D9BG=CB5B8DCGHF9H=F9A9BHB9H69B9:=H7CGHG=G5BH=7=D5H98HC69569B9:=HC:5DDFCL=A5H9@MA=@@=CB :CF5
HCH5@7CBGC@=85H9889:=B9869B9:=HDF9 H5LD9BG=CB5B8DCGHF9H=F9A9BH9LD9BG9C:A=@@=CB 5897F95G9C:5DDFCL=A5H9@M
A=@@=CB7CAD5F98HC
-<9H56@969@CKGIAA5F=N9GH<9=AD57HCBD9BG=CB9LD9BG9:CFH<9. , 5B8=BH9FB5H=CB5@D9BG=CBD@5BGC:5
D9F79BH5;9DC=BH=B7F95G9 897F95G9=BH<99LD97H98@CB; H9FAF5H9C:F9HIFBCBD@5B5GG9HG5B88=G7CIBHF5H95GGIADH=CBGIG98HC
A95GIF9D@5B@=56=@=H=9G5B8B9HD9F=C8=769B9:=H7CGH -<9H56@95GGIA9G5@@CH<9F:57HCFG5F9<9@87CBGH5BH =B7@I8=B;H<9
G@CD9C:H<98=G7CIBHF5H9M=9@87IFJ9G
A6E84F886E84F8<A%8G'8E<B7<68A89<GBFG
<F6BHAG)4G8 KC86G87)8GHEABA
FF8GF
$<??<BAF
. , D9BG=CBD@5BG
"BH9FB5H=CB5@D9BG=CBD@5BG
77,?144)6,-:<)1676/1>-,;;-<;
-<9CAD5BMA5?9G79FH5=B9GH=A5H9G5B8>I8;A9BHG=BF9@5H=CBHC;CC8K=@@5B879FH5=B@CB; @=J985GG9HG -<CG9=B7@I89
7CBG=89F5H=CBGA589=BH<9J5@I5H=CBC:79FH5=B57EI=F98=89BH=:=56@989:=B=H9 @=J985B8=B89:=B=H9 @=J985GG9HG5G5F9GI@HC:
6IG=B9GG7CA6=B5H=CBG5GK9@@5G7CBG=89F5H=CBG=B=AD5=FA9BH5GG9GGA9BHGC:;CC8K=@@
-;?3=3>39890-/<>+383./8>303+,6/./0383>/63@/.+8.38./0383>/63@/.+==/>=
"B7CB>IB7H=CBK=H<5B57EI=G=H=CBC:56IG=B9GG H<9CAD5BMF97CF8G=89BH=:=56@989:=B=H9 @=J985B8=B89:=B=H9 @=J98=BH5B;=6@9
5GG9HG57EI=F985HH<9=FF9GD97H=J9:5=FJ5@I9G5GC:H<985H9C:57EI=G=H=CB -<97CFF9GDCB8=B;:5=FJ5@I99GH=A5H9G:CFH<9G9
5GG9HG57EI=F98=B7@I89DFC>97H98:IHIF975G<:@CKG 5GGC7=5H988=G7CIBHF5H9GIG98HC75@7I@5H9DF9G9BHJ5@I9 5GG9H@=:97M7@9G
FCM5@HMF5H9G 5B87IGHCA9FF9H9BH=CBF5H9G -<9:5=FJ5@I975@7I@5H98:CF=B89:=B=H9 @=J98=BH5B;=6@95GG9HGGI7<5G79FH5=B
HF589B5A9G =B588=H=CBHC=BH5B;=6@95GG9HGH<5H5F989:=B=H9 @=J98GI7<5GD5H9BHG 7IGHCA9FF9@5H=CBG<=DG HF589B5A9G5B8CH<9F
H97<BC@C;M 65G985GG9HGA5M7<5B;98IF=B;H<9:=B5@=N5H=CBC:H<9DIF7<5G9DF=795@@C75H=CB 8I9HCH<9G=;B=:=75BH9GH=A5H9G
IG98=B89H9FA=B=B;H<9=F:5=FJ5@I9 G5F9GI@H H<9CAD5BMA5MA5?958>IGHA9BHGHCH<9DFCJ=G=CB5@5ACIBHGF97CF898:CF
79FH5=B=H9AG5GD5FHC:H<9DIF7<5G9DF=795@@C75H=CBGI6G9EI9BHHCH<957EI=G=H=CB BCHHC9L7998CB9M95F5:H9FH<957EI=G=H=CB
85H9 IBH=@H<9DIF7<5G9577CIBH=B;5@@C75H=CB=G:=B5@=N98 <5B;9G=B:57HCFGH<5HA5M=AD57HDFC>97H98:IHIF975G<:@CKG
8=G7CIBHF5H9G 7IGHCA9FDF9:9F9B79G 5B8CH<9F9GH=A5H9G56CJ9 5GK9@@5GIB89F@M=B;A5F?9H5B8CJ9F5@@97CBCA=77CB8=H=CBG
5ACB;CH<9F=H9AG 75IG9H<9G99GH=A5H9GHC69GI6>97HHCIB79FH5=BHM
==/==7/8>=90199.A366
GC:979A69F &;CC8K=@@HCH5@985DDFCL=A5H9@M 6=@@=CB CC8K=@@=GH9GH98:CF=AD5=FA9BH5BBI5@@M=BH<9
:CIFH<EI5FH9FC:957<M95F 5G:IFH<9F8=G7IGG9869@CK 5B8=GH9GH9869HK99B5BBI5@H9GHG=:5B9J9BHC77IFGCF7=F7IAGH5B79G
7<5B;9H<5HKCI@8=B8=75H9H<975FFM=B;5ACIBHA5M69=AD5=F98 "::IHIF9BCB 75G<5GG9H=AD5=FA9BH7<5F;9G5F9H5?9B &
KCI@89LD97HH<5HCB@M5DCFH=CBC:H<9;CC8K=@@KCI@869=AD5=F98
"AD5=FA9BHH9GH=B;:CF;CC8K=@@=G8CB95H5F9DCFH=B;IB=H@9J9@ K=H<5@@;CC8K=@@5GG=;B98HC5F9DCFH=B;IB=H +9DCFH=B;IB=HG
5F9CB9@9J9@69@CKH<96IG=B9GGG9;A9BH@9J9@ 6IH5F9F9EI=F98HC697CA6=B98K<9BF9DCFH=B;IB=HGK=H<=BH<9G5A9G9;A9BH
<5J9G=A=@5F97CBCA=77<5F57H9F=GH=7G H& F9DCFH=B;IB=HG7CFF9GDCB8HC58=J=G=CB &8=8BCH7CA6=B95BMC:=HGF9DCFH=B;
IB=HG:CF=AD5=FA9BHH9GH=B; B=AD5=FA9BH@CGGKCI@869F97C;B=N98K<9BH<975FFM=B;5ACIBHC:H<9F9DCFH=B;IB=HWGB9H
5GG9HG9L7998GH<99GH=A5H98:5=FJ5@I9C:H<9F9DCFH=B;IB=H 5B8H<9@CGGKCI@89EI5@H<5H8=::9F9B79 -<99GH=A5H98:5=FJ5@I9C:
5F9DCFH=B;IB=H=G89H9FA=B9865G98CB5A5F?9H5DDFC57<IG=B;7CAD5F56@97CAD5BM=B:CFA5H=CBGI7<5G"-95FB=B;G
69:CF9=BH9F9GH H5L9G 89DF97=5H=CB5B85ACFH=N5H=CBAI@H=D@9G &5@GCD9F:CFAG58=G7CIBH9875G<:@CK5B5@MG=G:CF79FH5=B
F9DCFH=B;IB=HGK<9F9H<9A5F?9H5DDFC57<=B8=75H9G588=H=CB5@F9J=9K=GK5FF5BH98 0<9F95DD@=756@9 H<98=G7CIBH9875G<:@CK
5B5@MG=GIG9GDFC>97H9875G<:@CKGH<5H5F965G98CBG5@9G;FCKH<5B8H9FA=B5@J5@I95GGIADH=CBG 5ACB;CH<9F:57HCFG <5B;9G
=BF9DCFH=B;IB=H95FB=B;G 7CAD5F56@97CAD5BM=B:CFA5H=CB 5B89LD97H98:IHIF975G<:@CKG 5GK9@@5GIB89F@M=B;A5F?9H5B8
CJ9F5@@97CBCA=77CB8=H=CBG 5ACB;CH<9F:57HCFG A5?9H<9G99GH=A5H9GGI6>97HHCIB79FH5=BHM
G89G7F=698=B'CH9 9::97H=J9=BH<9:=FGHEI5FH9FC: H<9CAD5BM7<5B;98=HG6IG=B9GGG9;A9BHF9DCFH=B; CF
7<5B;9GH<5HF9GI@H98=BF9DCFH=B;IB=H7<5B;9G H<9CAD5BM5DD@=98H<9F9@5H=J9:5=FJ5@I9A9H<C8HC89H9FA=B9H<9=AD57HCB
;CC8K=@@C:H<95GGC7=5H98F9DCFH=B;IB=HG H<9F9GI@HGC:K<=7<K9F9=AA5H9F=5@ "B7CB>IB7H=CBK=H<H<97<5B;9=BG9;A9BH
F9DCFH=B; &7CAD@9H985B5GG9GGA9BH=B8=75H=B;BCF9GI@H=B;;CC8K=@@=AD5=FA9BH9L=GH98 -<98=G7IGG=CBH<5H:C@@CKGF9@5H9G
-- 40 of 142 --
to the separate fourth quarter 2021 annual impairment test and is in the context of the reporting unit structure that existed at that
time.
Based on the annual test in the fourth quarter of 2021, no goodwill impairment was indicated for any of the reporting units. As
of October 1, 2021, 3M had 22 primary reporting units, with ten reporting units accounting for approximately 94 percent of the
goodwill. These ten reporting units were comprised of the following divisions: Advanced Materials, Display Materials and
Systems, Electronics Materials Solutions, Health Information Systems, Industrial Adhesives and Tapes, Medical Solutions, Oral
Care, Personal Safety, Separation and Purification Sciences, and Transportation Safety.
3M is a highly integrated enterprise, where businesses share technology and leverage common fundamental strengths and
capabilities, thus many of 3M’s businesses could not easily be sold on a stand-alone basis. 3M’s focus on research and
development has resulted in a portion of 3M’s value being comprised of internally developed businesses.
3M will continue to monitor its reporting units and asset groups in 2022 for any triggering events or other indicators of
impairment.
Uncertainty in Income Tax Positions:
The extent of 3M’s operations involves dealing with uncertainties and judgments in the application of complex tax regulations
in a multitude of jurisdictions. The final taxes paid are dependent upon many factors, including negotiations with taxing
authorities in various jurisdictions and resolution of disputes arising from federal, state, and international tax audits. The
Company recognizes potential liabilities and records tax liabilities for anticipated tax audit issues in the United States and other
tax jurisdictions based on its estimate of whether, and the extent to which, additional taxes will be due. The Company follows
guidance provided by ASC 740, Income Taxes, a subset of which relates to uncertainty in income taxes, to record these
liabilities (refer to Note 10 for additional information). The Company adjusts these reserves in light of changing facts and
circumstances; however, due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment
that is materially different from the Company’s current estimate of the tax liabilities. If the Company’s estimate of tax liabilities
proves to be less than the ultimate assessment, an additional charge to expense would result. If payment of these amounts
ultimately proves to be less than the recorded amounts, the reversal of the liabilities would result in tax benefits being
recognized in the period when the Company determines the liabilities are no longer necessary.
NEW ACCOUNTING PRONOUNCEMENTS
Information regarding new accounting pronouncements is included in Note 1 to the Consolidated Financial Statements.
FINANCIAL CONDITION AND LIQUIDITY
The strength and stability of 3M’s business model and strong free cash flow capability, together with proven capital markets
access, provides financial flexibility and enables the Company to invest through business cycles. Investing in 3M’s business to
drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This
includes research and development, capital expenditures, and commercialization capability. The Company also continues to
actively manage its portfolio through acquisitions and divestitures to maximize value for shareholders. 3M expects to continue
returning cash to shareholders through dividends and share repurchases. To fund cash needs in the United States, the Company
relies on ongoing cash flow from U.S. operations, access to capital markets and repatriation of the earnings of its foreign
affiliates that are not considered to be permanently reinvested. For those international earnings still considered to be reinvested
indefinitely, the Company currently has no plans or intentions to repatriate these funds for U.S. operations. See Note 10 for
further information on earnings considered to be reinvested indefinitely.
3M maintains a strong liquidity profile. The company's primary short-term liquidity needs are met through cash on hand and
U.S. commercial paper issuances. 3M believes it will have continuous access to the commercial paper market. 3M’s
commercial paper program permits the Company to have a maximum of $5 billion outstanding with a maximum maturity of
397 days from date of issuance. At December 31, 2021, there was no commercial paper issued and outstanding.
Total Debt:
The strength of 3M’s credit profile and significant ongoing cash flows provide 3M proven access to capital markets.
Additionally, the Company’s debt maturity profile is staggered to help ensure refinancing needs in any given year are
reasonable in proportion to the total portfolio. 3M currently has an A1 credit rating with a negative outlook from Moody’s
Investors Service and an A+ credit rating with negative outlook from Standard and Poor’s.
33
-- 41 of 142 --
-<9CAD5BMWGHCH5@896HK5G@CK9F5H979A69F K<9B7CAD5F98HC979A69F 97F95G9G=B896H5F9
:IFH<9F89G7F=698=B'CH95B8K9F9@5F;9@M8I9HCH<9&5F7<95F@MF989ADH=CBJ=5A5?9 K<C@975@@C::9FGC:
A=@@=CB=B896H5B8H<9'CJ9A69FF9D5MA9BHC:A=@@=CB9IFCG5;;F9;5H9DF=B7=D5@5ACIBHC:IFC6CB8GH<5HA5HIF98
CF8=G7IGG=CBC:F9D5MA9BHGC:5B8DFC7998G:FCA896HF9:9FHCH<9:C@@CK=B;U5G<@CKG:FCA=B5B7=B;7H=J=H=9GVG97H=CB
G8=G7IGG98=B'CH9 8IF=B;H<9G97CB85B8H<=F8EI5FH9FGC: &9BH9F98=BHC=BH9F9GHF5H9GK5DGH<5H7CBJ9FH98D5FHC:
H<9CAD5BMWG 6=@@=CB5B8A=@@=CBDF=B7=D5@5ACIBHC::=L98F5H9BCH9G8I95B8 F9GD97H=J9@M =BHC:@C5H=B;
F5H9896H:CFH<9DCFH=CBC:H<9=FH9FAGH<FCI;<A=8
"B#I@M H<9.B=H98$=B;8CAWG=B5B7=5@CB8I7HIH<CF=HM5BBCIB798H<5H=HKCI@8BC@CB;9FF9EI=F965B?GHCGI6A=H
F5H9G:CFH<9%CB8CB"BH9F5B?(::9F98+5H9U%"(+V5:H9F "B'CJ9A69F H<9"9B7<A5F?8A=B=GHF5H=CB
" %"(+WG58A=B=GHF5HCF DFCDCG989LH9B8=B;H<9DI6@=75H=CBC:.,%"(+H<FCI;<#IB9 ,I6G9EI9BH@M =B&5F7<
C: "GH5H98=HK=@@795G9DI6@=75H=CBC:79FH5=B%"(+F5H9G5:H9F979A69F .,%"(+F5H9GH<5H8CBCH
795G9CB979A69F K=@@7CBH=BI9HC69DI6@=G<98H<FCI;<#IB9 -<9CAD5BM<5GF9J=9K98=HG896H
G97IF=H=9G 65B?:57=@=H=9G 5B889F=J5H=J9=BGHFIA9BHGH<5HIH=@=N9%"(+5GH<9F9:9F9B79F5H95B8H<9G95;F99A9BHG7CBH5=B
F9@9J5BH:5@@657?@5B;I5;9 -<9CAD5BMWG5B5@MG=GC:=HGCH<9F7CAA9F7=5@7CBHF57HG:CIB8H<5HGI7<7CBHF57HG 5G5;9B9F5@
DF57H=79 8CBCHF9:9F9B79%"(+ &K=@@7CBH=BI9=HG5GG9GGA9BH5B8ACB=HCFF9;I@5HCFM89J9@CDA9BHG8IF=B;H<9HF5BG=H=CB
D9F=C8
::97H=J996FI5FM H<9CAD5BMID85H98=HGUK9@@ ?BCKBG95GCB98=GGI9FV0$,"G<9@:F9;=GHF5H=CBGH5H9A9BH
K<=7<F9;=GH9FG5B=B89H9FA=B5H95ACIBHC:896HCF9EI=HMG97IF=H=9G:CF:IHIF9=GGI5B795B8G5@9 -<=GF9D@5798&WGDF9J=CIG
G<9@:F9;=GHF5H=CB85H9896FI5FM "B&5M =B7CBB97H=CBK=H<H<90$,"G<9@: &9BH9F98=BHC5B5A9B8985B8
F9GH5H988=GHF=6IH=CB5;F99A9BHF9@5H=B;HCH<9:IHIF9=GGI5B795B8G5@9:FCAH=A9HCH=A9C:H<9CAD5BMWGA98=IA H9FA
BCH9GDFC;F5A,9F=9G IDHCH<95;;F9;5H9DF=B7=D5@5ACIBHC:6=@@=CB K<=7<K5G5B=B7F95G9:FCAH<9DF9J=CIG
5;;F9;5H9DF=B7=D5@5ACIBHIDHC6=@@=CBC:H<9G5A9,9F=9G
GC:979A69F H<9HCH5@5ACIBHC:896H=GGI985GD5FHC:H<9A98=IA H9FABCH9GDFC;F5A,9F=9G =B7@IG=J9C:
896H=GGI98=B96FI5FM5B8DF=CFM95FG=G5DDFCL=A5H9@M 6=@@=CBIH=@=N=B;H<9:CF9=;B9L7<5B;9F5H9G5DD@=756@95H
H<9H=A9C:=GGI5B79:CFH<99IFC89BCA=B5H98896H 88=H=CB5@@M H<9I;IGH5B8&5F7<896HK5G=GGI98IB89FH<9
0$,"G<9@:F9;=GHF5H=CB 6IHBCH5GD5FHC:H<9A98=IA H9FABCH9GDFC;F5A,9F=9G "B:CFA5H=CBK=H<F9GD97HHC@CB; H9FA
896H=GGI5B79G5B8A5HIF=H=9G:CFH<9D9F=C8GDF9G9BH985B87F98=H:57=@=H=9G=G=B7@I898=B'CH9
);0);09=1>)4-6<;)6,):3-<)*4-#-+=:1<1-;
H979A69F &<58 6=@@=CBC:75G< 75G<9EI=J5@9BHG5B8A5F?9H56@9G97IF=H=9G C:K<=7<5DDFCL=A5H9@M
6=@@=CBK5G<9@86MH<9CAD5BMWG:CF9=;BGI6G=8=5F=9G5B85DDFCL=A5H9@M 6=@@=CBK5G<9@86MH<9.B=H98,H5H9G
-<9G965@5B79G5F9=BJ9GH98=B65B?=BGHFIA9BHG5B8CH<9F<=;< EI5@=HM:=L98=B7CA9G97IF=H=9G H979A69F &<58
6=@@=CBC:75G< 75G<9EI=J5@9BHG5B8A5F?9H56@9G97IF=H=9G C:K<=7<5DDFCL=A5H9@M 6=@@=CBK5G<9@86MH<9
CAD5BMWG:CF9=;BGI6G=8=5F=9G5B85DDFCL=A5H9@M 6=@@=CBK5G<9@86MH<9.B=H98,H5H9G -<9897F95G9:FCA979A69F
F9GI@H98:FCA<=;<9FG<5F9F9DIF7<5G9GC:HF95GIFMGHC7? H<9&5F7<95F@MF989ADH=CBJ=5A5?9 K<C@975@@C::9FGC:
A=@@=CB=B896H 5B8H<9'CJ9A69FF9D5MA9BHC:A=@@=CB9IFCG5;;F9;5H9DF=B7=D5@5ACIBH D5FH=5@@MC::G9H6M
GHFCB;75G<:@CK:FCACD9F5H=CBG
-<-*<676!5-);=:-
'9H896H=GBCH89:=B98IB89F. , )5B8A5MBCH697CADIH98H<9G5A95GG=A=@5F@MH=H@98A95GIF9GIG986MCH<9F
7CAD5B=9G -<9CAD5BM89:=B9GB9H896H5GHCH5@896H@9GGH<9HCH5@C:75G< 75G<9EI=J5@9BHG5B87IFF9BH5B8@CB; H9FA
A5F?9H56@9G97IF=H=9G &69@=9J9GB9H896H=GA95B=B;:I@HC=BJ9GHCFG5G&7CBG=89FGB9H896H5B8=HG7CADCB9BHGHC69
=ADCFH5BH=B8=75HCFGC:@=EI=8=HM5B8:=B5B7=5@DCG=H=CB -<9:C@@CK=B;H56@9DFCJ=89GB9H896H5GC:979A69F 5B8
868@58E
;4A:8 $<??<BAF
-CH5@896H
%9GG5G< 75G<9EI=J5@9BHG5B8A5F?9H56@9G97IF=H=9G
'9H896HBCB )A95GIF9
+9:9FHCH<9DF9798=B;U-CH5@96HV5B8U5G< 5G<EI=J5@9BHG5B8&5F?9H56@9,97IF=H=9GVG97H=CBG:CF588=H=CB5@89H5=@G
-- 42 of 142 --
)4)6+-#0--<
&WGGHFCB;65@5B79G<99H5B8@=EI=8=HMDFCJ=89H<9CAD5BMK=H<G=;B=:=75BH:@9L=6=@=HMHC:IB8=HGBIA9FCIGCDDCFHIB=H=9G
;C=B;:CFK5F8 -<9CAD5BMK=@@7CBH=BI9HC=BJ9GH=B=HGCD9F5H=CBGHC8F=J9;FCKH< =B7@I8=B;7CBH=BI5@F9J=9KC:57EI=G=H=CB
CDDCFHIB=H=9G
-<9CAD5BMIG9GKCF?=B;75D=H5@A95GIF9GH<5HD@5799AD<5G=G5B8:C7IGCB79FH5=BKCF?=B;75D=H5@5GG9HG GI7<5G577CIBHG
F979=J56@95B8=BJ9BHCFM57H=J=HM
'7:316/)81<)4676!5-);=:-
868@58E
;4A:8 $<??<BAF
IFF9BH5GG9HG
%9GGIFF9BH@=56=@=H=9G
0CF?=B;75D=H5@BCB )A95GIF9
/5F=CIG5GG9HG5B8@=56=@=H=9G =B7@I8=B;75G<5B8G<CFH H9FA896H 75B:@I7HI5H9G=;B=:=75BH@M:FCAACBH<HCACBH<89D9B8=B;CB
G<CFH H9FA@=EI=8=HMB998G 0CF?=B;75D=H5@=GBCH89:=B98IB89F. , ;9B9F5@@M5779DH98577CIBH=B;DF=B7=D@9G5B8A5MBCH69
7CADIH98H<9G5A95GG=A=@5F@MH=H@98A95GIF9GIG986MCH<9F7CAD5B=9G -<9CAD5BM89:=B9GKCF?=B;75D=H5@5G7IFF9BH
5GG9HGA=BIG7IFF9BH@=56=@=H=9G &69@=9J9GKCF?=B;75D=H5@=GA95B=B;:I@HC=BJ9GHCFG5G5A95GIF9C:CD9F5H=CB5@9::=7=9B7M
5B8G<CFH H9FA:=B5B7=5@<95@H<
0CF?=B;75D=H5@897F95G98 6=@@=CB7CAD5F98K=H<979A69F 5@5B797<5B;9G=B7IFF9BH5GG9HG=B7F95G98KCF?=B;
75D=H5@ 8F=J9B6M=B7F95G9G=B=BJ9BHCFM D5FH=5@@MC::G9H6M897F95G9G=BA5F?9H56@9G97IF=H=9G 7IFF9BH 5@5B797<5B;9G=B
7IFF9BH@=56=@=H=9G897F95G98KCF?=B;75D=H5@ DF=A5F=@M8I9HC=B7F95G9G=BG<CFH H9FA6CFFCK=B;5B8H<97IFF9BHDCFH=CBC:@CB;
H9FA896H5B8577CIBHGD5M56@9
"BJ9BHCFM=B7F95G98:FCA979A69F DF=A5F=@M5G5F9GI@HC:=B7F95G98IB89F@M=B;CD9F5H=B;57H=J=HMF9@5H98HC
=B7F95G98G5@9GD5FH=5@@MC::G9H6M:CF9=;B7IFF9B7MHF5BG@5H=CB=AD57HG K<=@9A5F?9H56@9G97IF=H=9G 7IFF9BH897F95G98:FCA
@CK9F=BJ9GHA9BHG=B7CAA9F7=5@D5D9F5B8. , HF95GIFMG97IF=H=9G IFF9BHDCFH=CBC:@CB; H9FA896H=B7F95G9865G98CB
IB89F@M=B;896HA5HIF=H=9GK<=@9577CIBHGD5M56@95@GC=B7F95G985G5F9GI@HC:=B7F95G98CD9F5H=B;57H=J=HM:FCAH<5HC:@5H9
D5FH=5@@MC::G9H6M:CF9=;B7IFF9B7MHF5BG@5H=CB=AD57HG
"-<=:6766>-;<-,)81<)4676!5-);=:-
+9HIFBCB"BJ9GH985D=H5@+("=GBCH89:=B98IB89F. , ;9B9F5@@M5779DH98577CIBH=B;DF=B7=D@9G -<9F9:CF9 +("G<CI@8
BCH697CBG=89F985GI6GH=HIH9:CFCH<9FA95GIF9GDF9D5F98=B577CF85B79K=H<. , )5B8A5MBCH697CAD5F56@9HC
G=A=@5F@MH=H@98A95GIF9GIG986MCH<9F7CAD5B=9G -<9CAD5BM89:=B9G+("5G58>IGH98B9H=B7CA9B9H=B7CA9=B7@I8=B;
BCB 7CBHFC@@=B;=BH9F9GHD@IG5:H9F H5L=BH9F9GH9LD9BG98=J=8986M5J9F5;9=BJ9GH9875D=H5@9EI=HMD@IG896H -<9CAD5BM
69@=9J9G+("=GA95B=B;:I@HC=BJ9GHCFG5G=H:C7IG9GCBG<5F9<C@89FJ5@I97F95H=CB -<975@7I@5H=CB=GDFCJ=898=BH<969@CK
H56@9
-<9=B7F95G9=B+("K5G8F=J9B6MH<9=B7F95G98CD9F5H=B;=B7CA95B8H<9<=;<9FBCB G9FJ=79D9BG=CB5B8DCGHF9H=F9A9BHB9H
69B9:=HM95F CB M95F
-- 43 of 142 --
084EF8A787868@58E$<??<BAF
)8GHEABA AI8FG874C<G4?ABA '@84FHE8
'9H=B7CA9=B7@I8=B;BCB 7CBHFC@@=B;=BH9F9GH
"BH9F9GH9LD9BG95:H9F H5L
8>IGH98B9H=B7CA9+9HIFB
J9F5;9G<5F9<C@89FG9EI=HM=B7@I8=B;BCB 7CBHFC@@=B;=BH9F9GH
J9F5;9G<CFH H9FA5B8@CB; H9FA896H
J9F5;9=BJ9GH9875D=H5@
+9HIFBCB=BJ9GH9875D=H5@BCB )A95GIF9
::97H=J9=B7CA9H5LF5H9IG98:CF=BH9F9GH9LD9BG9
5@7I@5H=CBC:5J9F5;99EI=HM=B7@I89GBCB 7CBHFC@@=B;=BH9F9GH
B8=B;HCH5@9EI=HM5GC:
&5F7<
#IB9
,9DH9A69F
979A69F
J9F5;9HCH5@9EI=HM
5@7I@5H=CBC:5J9F5;9896H
B8=B;G<CFH H9FA5B8@CB; H9FA896H5GC:
&5F7<
#IB9
,9DH9A69F
979A69F
J9F5;9G<CFH H9FA5B8@CB; H9FA896H
);047?;
5G<:@CKG:FCACD9F5H=B; =BJ9GH=B;5B8:=B5B7=B;57H=J=H=9G5F9DFCJ=898=BH<9H56@9GH<5H:C@@CK "B8=J=8I5@5ACIBHG=BH<9
CBGC@=85H98,H5H9A9BHC:5G<@CKG9L7@I89H<99::97HGC:57EI=G=H=CBG 8=J9GH=HIF9G5B89L7<5B;9F5H9=AD57HGCB75G<5B8
75G<9EI=J5@9BHG K<=7<5F9DF9G9BH98G9D5F5H9@M=BH<975G<:@CKG -<IG H<95ACIBHGDF9G9BH98=BH<9:C@@CK=B;CD9F5H=B;
=BJ9GH=B;5B8:=B5B7=B;57H=J=H=9GH56@9GF9:@97H7<5B;9G=B65@5B79G:FCAD9F=C8HCD9F=C858>IGH98:CFH<9G99::97HG
-- 44 of 142 --
);047?;.:75 8-:)<16/+<1>1<1-;
084EFA787868@58E $<??<BAF
'9H=B7CA9=B7@I8=B;BCB7CBHFC@@=B;=BH9F9GH
9DF97=5H=CB5B85ACFH=N5H=CB
CAD5BMD9BG=CB5B8DCGHF9H=F9A9BH7CBHF=6IH=CBG
CAD5BMD9BG=CB5B8DCGHF9H=F9A9BH9LD9BG9
,HC7? 65G987CAD9BG5H=CB9LD9BG9
5=BCBG5@9C:6IG=B9GG9G N
"B7CA9H5L9G89:9FF985B8577FI98=B7CA9H5L9G
77CIBHGF979=J56@9
"BJ9BHCF=9G
77CIBHGD5M56@9
(H<9FTB9H
'9H75G<DFCJ=8986MCD9F5H=B;57H=J=H=9G
5G<:@CKG:FCACD9F5H=B;57H=J=H=9G75B:@I7HI5H9G=;B=:=75BH@M:FCAD9F=C8HCD9F=C8 5GD9BG=CB:IB8=B;897=G=CBG H5LH=A=B;
8=::9F9B79G5B8CH<9F=H9AG75BG=;B=:=75BH@M=AD57H75G<:@CKG
"B 75G<:@CKGDFCJ=8986MCD9F5H=B;57H=J=H=9G897F95G987CAD5F98HCH<9G5A9D9F=C8@5GHM95F K=H<H<=G897F95G9
DF=A5F=@M8I9HCKCF?=B;75D=H5@7<5B;9G -<97CA6=B5H=CBC:577CIBHGF979=J56@9 =BJ9BHCF=9G5B8577CIBHGD5M56@9897F95G98
CD9F5H=B;75G<:@CK6MA=@@=CB=B 7CAD5F98HC5BCD9F5H=B;75G<:@CK=ADFCJ9A9BHC:A=@@=CB=B
88=H=CB5@8=G7IGG=CBCBKCF?=B;75D=H5@7<5B;9G=GDFCJ=89895F@=9F=BH<9U=B5B7=5@CB8=H=CB5B8%=EI=8=HMVG97H=CB
);047?;.:756>-;<16/+<1>1<1-;
084EF8A787868@58E $<??<BAF
)IF7<5G9GC:DFCD9FHM D@5BH5B89EI=DA9BH))
)FC7998G:FCAG5@9C:))5B8CH<9F5GG9HG
7EI=G=H=CBG B9HC:75G<57EI=F98 N
)IF7<5G9G5B8DFC7998G:FCAA5HIF=H=9G5B8G5@9C:A5F?9H56@9G97IF=H=9G5B8=BJ9GHA9BHG B9H
)FC7998G:FCAG5@9C:6IG=B9GG9G B9HC:75G<GC@8 N
(H<9FTB9H
'9H75G<DFCJ=8986MIG98=B=BJ9GH=B;57H=J=H=9G
"BJ9GHA9BHG=BDFCD9FHM D@5BH5B89EI=DA9BH9B56@9;FCKH<57FCGGA5BM8=J9FG9A5F?9HG <9@D=B;HCA99HDFC8I7H89A5B85B8
=B7F95G=B;A5BI:57HIF=B;9::=7=9B7M "B &F98I798CJ9F5@@GD9B8=B;=B@=;<HC:IB79FH5=BHMF9;5F8=B;(/" 6IH
7CBH=BI98HC=BJ9GH=B9LD5B8=B;H<9CAD5BMWG56=@=HMHC=B7F95G9DFC8I7H=CBC:F9GD=F5HCFMDFC8I7HGHCA99HKCF@8K=89
89A5B8 -<9CAD5BM9LD97HG=B7F95G9875D=H5@GD9B8=B;=B5G&7CBH=BI9GHC=BJ9GH=B;FCKH< DFC8I7H=J=HM5B8
GIGH5=B56=@=HM
&F97CF8G75D=H5@ F9@5H98;CJ9FBA9BH;F5BHG95FB985GF98I7H=CBGHCH<97CGHC:DFCD9FHM D@5BH5B89EI=DA9BH5B85GGC7=5H98
IBD5=8@=56=@=H=9G5B8;F5BHDFC7998GF979=J56@95F97CBG=89F98BCB 75G<7<5B;9G=BGI7<65@5B79G:CFDIFDCG9GC:DF9D5F5H=CBC:
GH5H9A9BHC:75G<:@CKG
&=BJ9GHG=BF9B9K5@5B8A5=BH9B5B79DFC;F5AG K<=7<D9FH5=BHC7CGHF98I7H=CB 7M7@9H=A9 A5=BH5=B=B;5B8F9B9K=B;
7IFF9BH75D57=HM 9@=A=B5H=B;DC@@IH=CB 5B87CAD@=5B79 CGHGF9@5H98HCA5=BH9B5B79 CF8=B5FMF9D5=FG 5B879FH5=BCH<9F=H9AG
5F99LD9BG98 &5@GC=BJ9GHG=B;FCKH< K<=7<588GHC75D57=HM 8F=J9B6MB9KDFC8I7HG 6CH<H<FCI;<9LD5BG=CBC:7IFF9BH
:57=@=H=9G5B8B9K:57=@=H=9G =B5@@M &5@GC=BJ9GHG=BCH<9F=B=H=5H=J9G GI7<5G=B:CFA5H=CBH97<BC@C;M"- @56CF5HCFM
:57=@=H=9G 5B857CBH=BI98:C7IGCB=BJ9GHA9BHG=BGIGH5=B56=@=HM
+9:9FHC'CH9:CF=B:CFA5H=CBCB57EI=G=H=CBG5B88=J9GH=HIF9G -<9CAD5BM=G57H=J9@M7CBG=89F=B;588=H=CB5@57EI=G=H=CBG
=BJ9GHA9BHG5B8GHF5H9;=75@@=5B79G 5B8:FCAH=A9HCH=A9A5M5@GC8=J9GH79FH5=B6IG=B9GG9G 7EI=G=H=CBG B9HC:75G<57EI=F98
-- 45 of 142 --
=BDF=A5F=@MF9@5H9HCH<9D5MA9BHA589:CF7CBH=B;9BH7CBG=89F5H=CB=BF9;5F8GHCH<979@=HM57EI=G=H=CB )FC7998G:FCA
G5@9C:6IG=B9GG9G=BDF=A5F=@MF9@5H9HCH<9G5@9GC:H<9CAD5BMWG58J5B79865@@=GH=7 DFCH97H=CB6IG=B9GG5B8=HG8FI;
89@=J9FM6IG=B9GG
)IF7<5G9GC:A5F?9H56@9G97IF=H=9G5B8=BJ9GHA9BHG5B8DFC7998G:FCAA5HIF=H=9G5B8G5@9C:A5F?9H56@9G97IF=H=9G5B8
=BJ9GHA9BHG5F9DF=A5F=@M5HHF=6IH56@9HC79FH=:=75H9GC:89DCG=H H=A989DCG=HG 7CAA9F7=5@D5D9F 5B8CH<9FG97IF=H=9G K<=7<5F9
7@5GG=:=985G5J5=@56@9 :CF G5@9 "BH<9G9=B7@I898H<9A5HIF=HMC:H<9<9@8 HC A5HIF=HM896HG97IF=HMH<5HK5GDIF7<5G98HC
G5H=G:MH<9F989ADH=CBC:H<9-<=F8%=9B'CH9GK<=7<A5HIF98=B&5M +9:9FHC'CH9:CFACF989H5=@G56CIH&WG
8=J9FG=:=98A5F?9H56@9G97IF=H=9GDCFH:C@=C
);047?;.:7516)6+16/+<1>1<1-;
084EF8A787868@58E $<??<BAF
<5B;9=BG<CFH H9FA896HTB9H
+9D5MA9BHC:896HA5HIF=H=9G;F95H9FH<5B85MG
)FC7998G:FCA896HA5HIF=H=9G;F95H9FH<5B85MG
-CH5@75G<7<5B;9=B896H
)IF7<5G9GC:HF95GIFMGHC7?
)FC7998G:FCA=GGI5B79GC:HF95GIFMGHC7?DIFGI5BHHCGHC7?CDH=CB5B869B9:=HD@5BG
=J=89B8GD5=8HCGHC7?<C@89FG
(H<9FTB9H
'9H75G<IG98=B:=B5B7=B;57H=J=H=9G
/,>->3@3>C
97F95G9G=B896HK9F9@5F;9@M8I9HCH<9&5F7<95F@MF989ADH=CBC:A=@@=CB=B896HA5HIF=B;=BJ=5A5?9
K<C@975@@C::9FG5B8H<9'CJ9A69FF9D5MA9BHC:A=@@=CB9IFCG5;;F9;5H9DF=B7=D5@5ACIBHC:IFC6CB8GH<5H
A5HIF98 -<9CAD5BM<58BC7CAA9F7=5@D5D9FCIHGH5B8=B;5H979A69F 5B8979A69F '9H7CAA9F7=5@
D5D9F=GGI5B79G=B588=H=CBHCF9D5MA9BHG5B86CFFCK=B;G6M=BH9FB5H=CB5@GI6G=8=5F=9G5F9@5F;9@MF9:@97H98=BU<5B;9=B
G<CFH H9FA896HSB9HV=BH<9DF9798=B;H56@9 &WGDF=A5FMG<CFH H9FA@=EI=8=HMB998G5F9A9HH<FCI;<75G<CB<5B85B8. ,
7CAA9F7=5@D5D9F=GGI5B79G +9:9FHC'CH9:CFACF989H5=@F9;5F8=B;896H
/,>->3@3>C
97F95G9G=B896HF9@5H98HCH<9F9D5MA9BHC:896HDF=A5F=@M7CBG=GH=B;C:H<95;;F9;5H9A=@@=CBDF=B7=D5@5ACIBHC:-<=F8
%=9B'CH9G5B8H<9A=@@=CB9IFCG5B8A=@@=CB5;;F9;5H9DF=B7=D5@5ACIBHC::@C5H=B; F5H9A98=IA H9FABCH9GH<5H
A5HIF98=B&5M5B8I;IGH F9GD97H=J9@M IF=B;H<9H<=F8EI5FH9FC: H<9CAD5BMD5=8H<9CIHGH5B8=B;
65@5B79GCBH<9=F#5D5B9G9M9B5B89IFC7F98=H:57=@=H=9G "B588=H=CB 6=@@=CB5;;F9;5H9DF=B7=D5@5ACIBHC:BCH9GA5HIF=B;
=B,9DH9A69FK9F9F9D5=8=B979A69FJ=5A5?9 K<C@9 75@@C::9FG "B7F95G9G=B896HK9F9F9@5H98HCH<9&5F7<
=GGI5B79C: 6=@@=CB=BF9;=GH9F98BCH9G (IHGH5B8=B;7CAA9F7=5@D5D9F897F95G98A=@@=CB:FCA979A69F HC
979A69F
$/:?<-2+=/=9097798%>9-5
+9DIF7<5G9GC:7CAACBGHC7?5F9A589HCGIDDCFHH<9CAD5BMWGGHC7? 65G989AD@CM997CAD9BG5H=CBD@5BG5B8:CFCH<9F
7CFDCF5H9DIFDCG9G "B H<9CAD5BMDIF7<5G98 6=@@=CBC:=HGCKBGHC7? &F9DIF7<5G98G<5F9G 5:H9F<5J=B;
GIGD9B898F9DIF7<5G9GK=H<CH<9FF9DIF7<5G957H=J=HM@=A=H98HC&GGHC7?7CAD9BG5H=CBD@5BG=BH<9:=FGHEI5FH9FC:
CFACF9=B:CFA5H=CB F9:9FHCH<9H56@9H=H@98U"GGI9F)IF7<5G9GC:EI=HM,97IF=H=9GV=B)5FH"" "H9A -<9CAD5BM8C9GBCH
IH=@=N989F=J5H=J9=BGHFIA9BHG@=B?98HCH<9CAD5BMWGGHC7?
3@3./8.="+3.>9%2+</296./<=
&<5GD5=88=J=89B8GG=B79 "B96FI5FM &WGC5F8C:=F97HCFG897@5F985:=FGH EI5FH9F8=J=89B8C:
D9FG<5F9 5B=B7F95G9C:D9F79BH -<=G=G9EI=J5@9BHHC5B5BBI5@8=J=89B8C: D9FG<5F95B8A5F?98H<9H<7CBG97IH=J9
M95FC:8=J=89B8=B7F95G9G
-- 46 of 142 --
(H<9F75G<:@CKG:FCA:=B5B7=B;57H=J=H=9GA5M=B7@I89J5F=CIGCH<9F=H9AG GI7<5G75G<D5=85GGC7=5H98K=H<79FH5=B89F=J5H=J9
=BGHFIA9BHG 8=GHF=6IH=CBGHCCFG5@9GC:BCB7CBHFC@@=B;=BH9F9GHG 7<5B;9G=B75G<CJ9F8F5:H65@5B79G 5B8DF=B7=D5@D5MA9BHG:CF
:=B5B79@95G9G
:--);047?676!5-);=:-
F9975G<:@CK5B8:F9975G<:@CK7CBJ9FG=CB5F9BCH89:=B98IB89F. , ;9B9F5@@M5779DH98577CIBH=B;DF=B7=D@9G )
-<9F9:CF9 H<9MG<CI@8BCH697CBG=89F985GI6GH=HIH9:CF=B7CA9CF75G<:@CK85H5DF9D5F98=B577CF85B79K=H<. , )5B8
A5MBCH697CAD5F56@9HCG=A=@5F@MH=H@98A95GIF9GIG986MCH<9F7CAD5B=9G -<9CAD5BM89:=B9G:F9975G<:@CK5GB9H75G<
DFCJ=8986MCD9F5H=B;57H=J=H=9G@9GGDIF7<5G9GC:DFCD9FHM D@5BH5B89EI=DA9BH "HG<CI@8BCH69=B:9FF98H<5HH<99BH=F9:F99
75G<:@CK5ACIBH=G5J5=@56@9:CF8=G7F9H=CB5FM9LD9B8=HIF9G -<9CAD5BM89:=B9G:F9975G<:@CK7CBJ9FG=CB5G:F9975G<:@CK
8=J=8986MB9H=B7CA95HHF=6IH56@9HC& -<9CAD5BM69@=9J9G:F9975G<:@CK5B8:F9975G<:@CK7CBJ9FG=CB5F9A95B=B;:I@
HC=BJ9GHCFG5GH<9M5F9IG9:I@A95GIF9GC:D9F:CFA5B795B8H<9CAD5BMIG9GH<9G9A95GIF9G5G5B=B8=75H=CBC:H<9GHF9B;H<
C:H<97CAD5BM5B8=HG56=@=HMHC;9B9F5H975G< F9975G<:@CK5B8:F9975G<:@CK7CBJ9FG=CBJ5FM57FCGGEI5FH9FGH<FCI;<CIH
H<9M95F 9@CK:=B85F975DC::F9975G<:@CK5B8:F9975G<:@CK7CBJ9FG=CB
+9:9FHCH<9DF9798=B;U5G<@CKG:FCA(D9F5H=B;7H=J=H=9GV5B8U5G<@CKG:FCA"BJ9GH=B;7H=J=H=9GVG97H=CBG:CF
8=G7IGG=CBC:=H9AGH<5H=AD57H98H<9CD9F5H=B;75G<:@CK5B8DIF7<5G9GC:))7CADCB9BHGC:H<975@7I@5H=CBC::F9975G<
:@CK +9:9FHCH<9DF9798=B;U+9GI@HGC:(D9F5H=CBGVG97H=CB:CF8=G7IGG=CBC:=H9AGH<5H=AD57H98H<9B9H=B7CA95HHF=6IH56@9HC
&7CADCB9BHC:H<975@7I@5H=CBC::F9975G<:@CK7CBJ9FG=CB
F9975G<:@CK7CBJ9FG=CB897F95G98=B7CAD5F98HC5GB9H=B7CA95HHF=6IH56@9HC&=B7F95G98K<=@9:F9975G<:@CK
897F95G98
084EF8A787868@58E $<??<BAF
$4=BE'4F;?BJ4G8:BE<8F
'9H75G<DFCJ=8986MIG98=BCD9F5H=B;57H=J=H=9G
'9H75G<DFCJ=8986MIG98=B=BJ9GH=B;57H=J=H=9G
'9H75G<DFCJ=8986MIG98=B:=B5B7=B;57H=J=H=9G
E884F;?BJABA '@84FHE8
'9H75G<DFCJ=8986MIG98=BCD9F5H=B;57H=J=H=9G
)IF7<5G9GC:DFCD9FHM D@5BH5B89EI=DA9BH
F9975G<:@CK
'9H=B7CA95HHF=6IH56@9HC&
F9975G<:@CK7CBJ9FG=CB
)<-:1)4);0"-9=1:-5-6<.:7567?676<:)+<=)4)6, <0-: *41/)<176;
&WGA5H9F=5@75G<F9EI=F9A9BHG:FCA?BCKB7CBHF57HI5@5B8CH<9FC6@=;5H=CBGDF=A5F=@MF9@5H9HC:C@@CK=B; :CFK<=7<
=B:CFA5H=CBCB6CH<5G<CFH H9FA5B8@CB; H9FA65G=G=GDFCJ=898=BH<9=B8=75H98BCH9GHCH<97CBGC@=85H98:=B5B7=5@GH5H9A9BHG
P -5LC6@=;5H=CBGT+9:9FHC'CH9
P 96HT+9:9FHC'CH9 IHIF975G<D5MA9BHG:CF=BH9F9GHCB@CB; H9FA896H=G5DDFCL=A5H9@M6=@@=CB
P CAA=HA9BHG5B87CBH=B;9B7=9GT+9:9FHC'CH9
P (D9F5H=B;5B8:=B5B79@95G9GT+9:9FHC'CH9
&DIF7<5G9GH<9A5>CF=HMC:=HGA5H9F=5@G5B8G9FJ=79G5GB99898 K=H<BCIB7CB8=H=CB5@7CAA=HA9BHG "B@=A=H98
7=F7IAGH5B79G =BH<9BCFA5@7CIFG9C:6IG=B9GG &9BH9FG=BHCIB7CB8=H=CB5@DIF7<5G9C6@=;5H=CBGK=H<J5F=CIGJ9B8CFGH<5H
A5MH5?9H<9:CFAC: :CF9L5AD@9 H5?9CFD5M7CBHF57HG=BK<=7<&;I5F5BH99GD5MA9BHHC9BGIF95J5=@56=@=HMHC&C:
79FH5=BA5H9F=5@GCFG9FJ=79GCFHC9BGIF9CB;C=B;9::CFHGCB75D=H5@DFC>97HG -<9CAD5BM9LD97HGHCF979=J9IB89F@M=B;
A5H9F=5@GCFG9FJ=79G:CFH<9G9DIF7<5G9C6@=;5H=CBG -CH<99LH9BHH<9@=A=H985ACIBHC:H<9G9DIF7<5G9C6@=;5H=CBG:@I7HI5H9G =H
@5F;9@MHF9B8GK=H<BCFA5@ 7CIFG97<5B;9G=BF9;I@5FCD9F5H=B;57H=J=H=9G 88=H=CB5@@M 7CBHF57HI5@75D=H5@7CAA=HA9BHG
F9DF9G9BH5GA5@@D5FHC:H<9CAD5BMWG9LD97H9875D=H5@GD9B8=B;
-- 47 of 142 --
FINANCIAL INSTRUMENTS
The Company enters into foreign exchange forward contracts, options and swaps to hedge against the effect of exchange rate
fluctuations on cash flows denominated in foreign currencies and to offset, in part, the impacts of changes in value of various
non-functional currency denominated items including certain intercompany financing balances. The Company manages interest
rate risks using a mix of fixed and floating rate debt. To help manage borrowing costs, the Company may enter into interest rate
swaps. Under these arrangements, the Company agrees to exchange, at specified intervals, the difference between fixed and
floating interest amounts calculated by reference to an agreed-upon notional principal amount. The Company manages
commodity price risks through negotiated supply contracts and price protection agreements.
Refer to Item 7A, “Quantitative and Qualitative Disclosures About Market Risk”, for further discussion of foreign exchange
rates risk, interest rates risk, commodity prices risk and value at risk analysis.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
In the context of Item 7A, 3M is exposed to market risk due to the risk of loss arising from adverse changes in foreign currency
exchange rates, interest rates and commodity prices. Changes in those factors could impact the Company’s results of operations
and financial condition. Senior management provides oversight for risk management and derivative activities, determines
certain of the Company’s financial risk policies and objectives, and provides guidelines for derivative instrument utilization.
Senior management also establishes certain associated procedures relative to control and valuation, risk analysis, counterparty
credit approval, and ongoing monitoring and reporting.
The Company is exposed to credit loss in the event of nonperformance by counterparties in interest rate swaps, currency swaps,
and forward and option contracts. However, the Company’s risk is limited to the fair value of the instruments. The Company
actively monitors its exposure to credit risk through the use of credit approvals and credit limits, and by selecting major
international banks and financial institutions as counterparties. The Company does not anticipate nonperformance by any of
these counterparties.
Foreign Exchange Rates Risk:
Foreign currency exchange rates and fluctuations in those rates may affect the Company’s net investment in foreign subsidiaries
and may cause fluctuations in cash flows related to foreign denominated transactions. 3M is also exposed to the translation of
foreign currency earnings to the U.S. dollar. The Company enters into foreign exchange forward and option contracts to hedge
against the effect of exchange rate fluctuations on cash flows denominated in foreign currencies. These transactions are
designated as cash flow hedges. 3M may de-designate these cash flow hedge relationships in advance of the occurrence of the
forecasted transaction. The maximum length of time over which 3M hedges its exposure to the variability in future cash flows
of the forecasted transactions is 36 months. In addition, 3M enters into foreign currency contracts that are not designated in
hedging relationships to offset, in part, the impacts of changes in value of various non-functional currency denominated items
including certain intercompany financing balances. As circumstances warrant, the Company also uses foreign currency forward
contracts and foreign currency denominated debt as hedging instruments to hedge portions of the Company’s net investments in
foreign operations. The dollar equivalent gross notional amount of the Company’s foreign exchange forward and option
contracts designated as either cash flow hedges or net investment hedges was $2.6 billion at December 31, 2021. The dollar
equivalent gross notional amount of the Company’s foreign exchange forward and option contracts not designated as hedging
instruments was $3.7 billion at December 31, 2021. In addition, as of December 31, 2021, the Company had €2.9 billion in
principal amount of foreign currency denominated debt designated as non-derivative hedging instruments in certain net
investment hedges as discussed in Note 14 in the “Net Investment Hedges” section.
Interest Rates Risk:
The Company may be impacted by interest rate volatility with respect to existing debt and future debt issuances. 3M manages
interest rate risk and expense using a mix of fixed and floating rate debt. In addition, the Company may enter into interest rate
swaps that are designated and qualify as fair value hedges. Under these arrangements, the Company agrees to exchange, at
specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon
notional principal amount. The dollar equivalent (based on inception date foreign currency exchange rates) gross notional
amount of the Company’s interest rate swaps at December 31, 2021 was $800 million. Additional details about 3M’s long-term
debt can be found in Note 12, including references to information regarding derivatives and/or hedging instruments, further
discussed in Note 14, associated with the Company’s long-term debt.
40
-- 48 of 142 --
CAAC8=HM)F=79G+=G?
-<9CAD5BMA5B5;9G7CAAC8=HMDF=79F=G?GH<FCI;<B9;CH=5H98GIDD@M7CBHF57HG5B8DF=79DFCH97H=CB5;F99A9BHG -<9F9@5H98
A5F? HC A5F?9H;5=BCF@CGGCBEI5@=:M=B;<98;9GK5G=B7@I898=BCH<9F7CADF9<9BG=J9=B7CA9HCH<99LH9BH9::97H=J9 5B8
F97@5GG=:=98=BHC7CGHC:G5@9G=BH<9D9F=C88IF=B;K<=7<H<9<98;98HF5BG57H=CB5::97H9895FB=B;G
/5@I9H+=G?
-<9J5@I95HF=G?5B5@MG=G=GD9F:CFA985BBI5@@MHC5GG9GGH<9CAD5BMWGG9BG=H=J=HMHC7<5B;9G=B7IFF9B7MF5H9G =BH9F9GHF5H9G
5B87CAAC8=HMDF=79G &CBH95F@CG=AI@5H=CBH97<B=EI9K5GIG98HCH9GHH<9=AD57HCB5:H9F H5L95FB=B;GF9@5H98HC896H
=BGHFIA9BHG =BH9F9GHF5H989F=J5H=J9G5B8IB89F@M=B;:CF9=;B9L7<5B;95B87CAAC8=HM9LDCGIF9GCIHGH5B8=B;5H979A69F
-<9AC89@H<=F8 D5FHM65B?85H5G9HIG985D9F79BH7CB:=89B79@9J9@CJ9F5 ACBH<H=A9<CF=NCB -<=GAC89@8C9G
BCHDIFDCFHHCF9DF9G9BHK<5H57HI5@@MK=@@699LD9F=9B7986MH<9CAD5BM "B H<9AC89@K5G9LD5B898HC7CJ9F5@@C:
&WG7IFF9B7=9G5B8<98;=B;57H=J=HMJ9FGIGDF9J=CIG@M=B7@I8=B;&WGB=B9DF=A5FM7IFF9B7=9G9L7@I8=B;<98;9G )F=CFD9F=C8
5ACIBHG<5J9699BID85H98HCF9:@97HH<97IFF9BHD9F=C8WGF9J=G98A9H<C8C@C;M -<9:C@@CK=B;H56@9GIAA5F=N9GH<9DCGG=6@9
58J9FG95B8DCG=H=J9=AD57HGHC5:H9F H5L95FB=B;GF9@5H98HCH<9G99LDCGIF9G
7I8EF8<@C46GBA49G8E G4K84EA<A:F 'BF<G<I8<@C46GBA49G8E G4K84EA<A:F
$<??<BAF
CF9=;B9L7<5B;9F5H9G
"BH9F9GHF5H9G
CAAC8=HMDF=79G
B5B5@MG=GC:H<9;@C65@9LDCGIF9GF9@5H98HCDIF7<5G987CADCB9BHG5B8A5H9F=5@G=GD9F:CFA985H957<M95F 9B8 CB9
D9F79BHDF=797<5B;9KCI@8F9GI@H=B5DF9 H5L7CGHCFG5J=B;GC:5DDFCL=A5H9@MA=@@=CBD9FM95F -<9;@C65@9B9F;M
9LDCGIF9=GGI7<H<5H5H9BD9F79BHDF=797<5B;9KCI@8F9GI@H=B5DF9 H5L7CGHCFG5J=B;GC:5DDFCL=A5H9@MA=@@=CBD9FM95F
@C65@9B9F;M9LDCGIF9=B7@I89G9B9F;M7CGHGIG98=B&DFC8I7H=CB5B8CH<9F:57=@=H=9G DF=A5F=@M9@97HF=7=HM5B8B5HIF5@;5G
G8@ <A4A6<4?*G4G8@8AGF4A7*HCC?8@8AG4EL4G4
+9DCFHC:"B89D9B89BH+9;=GH9F98)I6@=777CIBH=B;=FA)("
CBGC@=85H98=B5B7=5@,H5H9A9BHG
A78KGB<A4A6<4?*G4G8@8AGF
7CAD@9H9GIAA5FMC:CFA $7CBH9BH =B7@I8=B;H<9=B89LHC:=B5B7=5@GH5H9A9BHG =G:CIB85HH<969;=BB=B;C:H<=G
8C7IA9BH
$4A4:8@8AGOF)8FCBAF<5<?<GL9BE<A4A6<4?)8CBEG<A:
&5B5;9A9BH=GF9GDCBG=6@9:CFH<9=BH9;F=HM5B8C6>97H=J=HMC:H<9:=B5B7=5@=B:CFA5H=CB=B7@I898=BH<=GF9DCFH -<9:=B5B7=5@
GH5H9A9BHG<5J9699BDF9D5F98=B577CF85B79K=H<577CIBH=B;DF=B7=D@9G;9B9F5@@M5779DH98=BH<9.B=H98,H5H9GC:A9F=75
0<9F9B979GG5FM H<9:=B5B7=5@GH5H9A9BHGF9:@97H9GH=A5H9G65G98CBA5B5;9A9BHWG>I8;A9BH
&5B5;9A9BH<5G9GH56@=G<985B8A5=BH5=BG5GMGH9AC:=BH9FB5@7CBHFC@CJ9F:=B5B7=5@F9DCFH=B;:CFH<9CAD5BM5B8=HG
GI6G=8=5F=9G -<=GGMGH9A5B8=HG9GH56@=G<98577CIBH=B;DFC798IF9G5B8F9@5H987CBHFC@G5F989G=;B98HCDFCJ=89F95GCB56@9
5GGIF5B79H<5H5GG9HG5F9G5:9;I5F898 H<5HH<96CC?G5B8F97CF8GDFCD9F@MF9:@97H5@@HF5BG57H=CBG H<5HDC@=7=9G5B8DFC798IF9G
5F9=AD@9A9BH986MEI5@=:=98D9FGCBB9@ 5B8H<5HDI6@=G<98:=B5B7=5@GH5H9A9BHG5F9DFCD9F@MDF9D5F985B8:5=F@MDF9G9BH98 -<9
CAD5BMWGGMGH9AC:=BH9FB5@7CBHFC@CJ9F:=B5B7=5@F9DCFH=B;=GGIDDCFH986MK=89@M7CAAIB=75H98KF=HH9BDC@=7=9G =B7@I8=B;
6IG=B9GG7CB8I7HDC@=7=9G K<=7<5F989G=;B98HCF9EI=F95@@9AD@CM99GHCA5=BH5=B<=;<9H<=75@GH5B85F8G=BH<97CB8I7HC:
CAD5BM5::5=FG "BH9FB5@5I8=HCFG7CBH=BI5@@MF9J=9KH<9577CIBH=B;5B87CBHFC@GMGH9A
&CAD5BM
-- 49 of 142 --
Management’s Report on Internal Control Over Financial Reporting
Management is responsible for establishing and maintaining an adequate system of internal control over financial reporting.
Management conducted an assessment of the Company’s internal control over financial reporting based on the framework
established by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control — Integrated
Framework (2013). Based on the assessment, management concluded that, as of December 31, 2021, the Company’s internal
control over financial reporting is effective.
The Company’s internal control over financial reporting as of December 31, 2021 has been audited by PricewaterhouseCoopers
LLP, an independent registered public accounting firm, as stated in their report which is included herein, which expresses an
unqualified opinion on the effectiveness of the Company’s internal control over financial reporting as of December 31, 2021.
3M Company
42
-- 50 of 142 --
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders of 3M Company
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheet of 3M Company and its subsidiaries (the “Company”) as of
December 31, 2021 and 2020, and the related consolidated statements of income, of comprehensive income, of changes in
equity and of cash flows for each of the three years in the period ended December 31, 2021, including the related notes
(collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over
financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013)
issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial
position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the
three years in the period ended December 31, 2021 in conformity with accounting principles generally accepted in the United
States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over
financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013)
issued by the COSO.
Changes in Accounting Principles
As discussed in Notes 1 and 8 to the consolidated financial statements, the Company changed the manner in which it accounts
for net periodic pension and postretirement plan cost in 2021 and the manner in which it accounts for leases in 2019,
respectively.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal
control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included
in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express
opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting
based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement,
whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material
respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement
of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks.
Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated
financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by
management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal
control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the
risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based
on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the
circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures
that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and
dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance with authorizations of management and directors of the
company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or
disposition of the company’s assets that could have a material effect on the financial statements.
43
-- 51 of 142 --
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial
statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or
disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or
complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated
financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate
opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Legal Proceedings
As described in Note 16 to the consolidated financial statements, management records liabilities for legal proceedings in those
instances where it can reasonably estimate the amount of the loss and when loss is probable. Where the reasonable estimate of
the probable loss is a range, management records as an accrual in its financial statements the most likely estimate of the loss, or
the low end of the range if there is no one best estimate. Management either discloses the amount of a possible loss or range of
loss in excess of established accruals if estimable, or states that such an estimate cannot be made. Management discloses
significant legal proceedings even where liability is not probable or the amount of the liability is not estimable, or both, if
management believes there is at least a reasonable possibility that a loss may be incurred.
The principal considerations for our determination that performing procedures relating to legal proceedings is a critical audit
matter are the significant judgment by management when assessing the likelihood of a loss being incurred and when estimating
the loss or range of loss for each claim, which in turn led to significant auditor judgment, subjectivity, and effort in performing
procedures and evaluating management’s assessment of the liabilities and disclosures associated with legal proceedings.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall
opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to
management’s evaluation of the liability related to legal proceedings, including controls over determining the likelihood of a
loss and whether the amount of loss can be reasonably estimated, as well as financial statement disclosures. These procedures
also included, among others, obtaining and evaluating the letters of audit inquiry with internal and external legal counsel,
evaluating the reasonableness of management’s assessment regarding whether an unfavorable outcome is reasonably possible or
probable and reasonably estimable, and evaluating the sufficiency of the Company’s disclosures related to legal proceedings.
/s/ PricewaterhouseCoopers LLP
Minneapolis, Minnesota
February 9, 2022
We have served as the Company’s auditor since 1975.
44
-- 52 of 142 --
$B@C4AL4A7*H5F<7<4E<8F
BAFB?<74G87*G4G8@8AGB9 A6B@8
084EF8A787868@58E
$<??<BAF 8K68CGC8EF;4E84@BHAGF
'9HG5@9G
(D9F5H=B;9LD9BG9G
CGHC:G5@9G
,9@@=B; ;9B9F5@5B858A=B=GHF5H=J99LD9BG9G
+9G95F7< 89J9@CDA9BH5B8F9@5H989LD9BG9G
5=BCBG5@9C:6IG=B9GG9G N
-CH5@CD9F5H=B;9LD9BG9G
(D9F5H=B;=B7CA9
(H<9F9LD9BG9=B7CA9 B9H
"B7CA969:CF9=B7CA9H5L9G
)FCJ=G=CB:CF=B7CA9H5L9G
"B7CA9C:7CBGC@=85H98;FCID
"B7CA9@CGG:FCAIB7CBGC@=85H98GI6G=8=5F=9G B9HC:H5L9G T
'9H=B7CA9=B7@I8=B;BCB7CBHFC@@=B;=BH9F9GH
%9GG'9H=B7CA9@CGG5HHF=6IH56@9HCBCB7CBHFC@@=B;=BH9F9GH
'9H=B7CA95HHF=6IH56@9HC&
09=;<H985J9F5;9&7CAACBG<5F9GCIHGH5B8=B;T65G=7
5FB=B;GD9FG<5F95HHF=6IH56@9HC&7CAACBG<5F9<C@89FGT65G=7
09=;<H985J9F5;9&7CAACBG<5F9GCIHGH5B8=B;T8=@IH98
5FB=B;GD9FG<5F95HHF=6IH56@9HC&7CAACBG<5F9<C@89FGT8=@IH98
-<9577CAD5BM=B;'CH9GHCCBGC@=85H98=B5B7=5@,H5H9A9BHG5F95B=BH9;F5@D5FHC:H<=GGH5H9A9BH
-- 53 of 142 --
$B@C4AL4A7*H5F<7<4E<8F
BAFB?<74G87*G4G8@8AGB9B@CE8;8AF<I8 A6B@8
084EF8A787868@58E
$<??<BAF
'9H=B7CA9=B7@I8=B;BCB7CBHFC@@=B;=BH9F9GH
(H<9F7CADF9<9BG=J9=B7CA9@CGG B9HC:H5L
IAI@5H=J9HF5BG@5H=CB58>IGHA9BH
9:=B9869B9:=HD9BG=CB5B8DCGHF9H=F9A9BHD@5BG58>IGHA9BH
5G<:@CK<98;=B;=BGHFIA9BHG
-CH5@CH<9F7CADF9<9BG=J9=B7CA9@CGG B9HC:H5L
CADF9<9BG=J9=B7CA9@CGG=B7@I8=B;BCB7CBHFC@@=B;=BH9F9GH
CADF9<9BG=J9=B7CA9@CGG5HHF=6IH56@9HCBCB7CBHFC@@=B;=BH9F9GH
CADF9<9BG=J9=B7CA9@CGG5HHF=6IH56@9HC&
-<9577CAD5BM=B;'CH9GHCCBGC@=85H98=B5B7=5@,H5H9A9BHG5F95B=BH9;F5@D5FHC:H<=GGH5H9A9BH
-- 54 of 142 --
$B@C4AL4A7*H5F<7<4E<8F
BAFB?<74G874?4A68*;88G
G868@58E
B??4EF<A@<??<BAF 8K68CGC8EF;4E84@BHAG
FF8GF
IFF9BH5GG9HG
5G<5B875G<9EI=J5@9BHG
&5F?9H56@9G97IF=H=9GT7IFF9BH
77CIBHGF979=J56@9TB9HC:5@@CK5B79GC:5B8
"BJ9BHCF=9G
=B=G<98;CC8G
0CF?=BDFC79GG
+5KA5H9F=5@G5B8GIDD@=9G
-CH5@=BJ9BHCF=9G
)F9D5=8G
(H<9F7IFF9BH5GG9HG
-CH5@7IFF9BH5GG9HG
)FCD9FHM D@5BH5B89EI=DA9BH
%9GG77IAI@5H9889DF97=5H=CB
)FCD9FHM D@5BH5B89EI=DA9BHTB9H
(D9F5H=B;@95G9F=;<HC:IG95GG9HG
CC8K=@@
"BH5B;=6@95GG9HGTB9H
(H<9F5GG9HG
-CH5@5GG9HG
#<45<?<G<8F
IFF9BH@=56=@=H=9G
,<CFH H9FA6CFFCK=B;G5B87IFF9BHDCFH=CBC:@CB; H9FA896H
77CIBHGD5M56@9
77FI98D5MFC@@
77FI98=B7CA9H5L9G
(D9F5H=B;@95G9@=56=@=H=9GT7IFF9BH
(H<9F7IFF9BH@=56=@=H=9G
-CH5@7IFF9BH@=56=@=H=9G
%CB; H9FA896H
)9BG=CB5B8DCGHF9H=F9A9BH69B9:=HG
(D9F5H=B;@95G9@=56=@=H=9G
(H<9F@=56=@=H=9G
-CH5@@=56=@=H=9G
CAA=HA9BHG5B87CBH=B;9B7=9G'CH9
DH<GL
&CAD5BMG<5F9<C@89FGW9EI=HM
CAACBGHC7?D5FJ5@I9 D5FJ5@I9 G<5F9G=GGI98
,<5F9GCIHGH5B8=B; 979A69F
,<5F9GCIHGH5B8=B; 979A69F
88=H=CB5@D5=8 =B75D=H5@
+9H5=B9895FB=B;G
-F95GIFMGHC7? 5H7CGH
77IAI@5H98CH<9F7CADF9<9BG=J9=B7CA9@CGG
-CH5@&CAD5BMG<5F9<C@89FGW9EI=HM
'CB7CBHFC@@=B;=BH9F9GH
-CH5@9EI=HM
-CH5@@=56=@=H=9G5B89EI=HM
-<9577CAD5BM=B;'CH9GHCCBGC@=85H98=B5B7=5@,H5H9A9BHG5F95B=BH9;F5@D5FHC:H<=GGH5H9A9BH
-- 55 of 142 --
$B@C4AL4A7*H5F<7<4E<8F
BAFB?<74G87*G4G8@8AGB9;4A:8F<ADH<GL
084EF8A787868@58E
$B@C4AL*;4E8;B?78EF
B??4EF<A@<??<BAF 8K68CGC8EF;4E84@BHAGF +BG4?
B@@BA
*GB6>4A7
77<G<BA4?
'4<7 <A
4C<G4? )8G4<A87
4EA<A:F +E84FHEL
*GB6>
66H@H?4G87
&G;8E
B@CE8;8AF<I8
A6B@8#BFF
%BA
6BAGEB??<A:
AG8E8FG
4?4A684G868@58E
"AD57HC:58CDH=CBC:,.'C T
"AD57HC:58CDH=CBC:,.'C
'9H=B7CA9
(H<9F7CADF9<9BG=J9=B7CA9@CGG B9HC:H5L
IAI@5H=J9HF5BG@5H=CB58>IGHA9BH
9:=B9869B9:=HD9BG=CB5B8DCGH F9H=F9A9BHD@5BG
58>IGHA9BH T
5G<:@CK<98;=B;=BGHFIA9BHG IBF95@=N98;5=B@CGG T
-CH5@CH<9F7CADF9<9BG=J9=B7CA9@CGG B9HC:H5L
=J=89B8G897@5F98 D9FG<5F9 'CH9
,HC7? 65G987CAD9BG5H=CB
+957EI=F98GHC7?
"GGI5B79GDIFGI5BHHCGHC7?CDH=CBG5B869B9:=HD@5BG
4?4A684G868@58E
'9H=B7CA9
(H<9F7CADF9<9BG=J9=B7CA9@CGG B9HC:H5L
IAI@5H=J9HF5BG@5H=CB58>IGHA9BH
9:=B9869B9:=HD9BG=CB5B8DCGH F9H=F9A9BHD@5BG
58>IGHA9BH T
5G<:@CK<98;=B;=BGHFIA9BHG IBF95@=N98;5=B@CGG T
-CH5@CH<9F7CADF9<9BG=J9=B7CA9@CGG B9HC:H5L
=J=89B8G897@5F98 D9FG<5F9 'CH9
)IF7<5G9C:BCB 7CBHFC@@=B;=BH9F9GH
,HC7? 65G987CAD9BG5H=CB
+957EI=F98GHC7?
"GGI5B79GDIFGI5BHHCGHC7?CDH=CBG5B869B9:=HD@5BG
4?4A684G868@58E
'9H=B7CA9
(H<9F7CADF9<9BG=J9=B7CA9@CGG B9HC:H5L
IAI@5H=J9HF5BG@5H=CB58>IGHA9BH
9:=B9869B9:=HD9BG=CB5B8DCGH F9H=F9A9BHD@5BG
58>IGHA9BH N
5G<:@CK<98;=B;=BGHFIA9BHG IBF95@=N98;5=B@CGG N
-CH5@CH<9F7CADF9<9BG=J9=B7CA9@CGG B9HC:H5L
=J=89B8G897@5F98 D9FG<5F9 'CH9
,HC7? 65G987CAD9BG5H=CB
+957EI=F98GHC7?
"GGI5B79GDIFGI5BHHCGHC7?CDH=CBG5B869B9:=HD@5BG
4?4A684G868@58E
*HCC?8@8AG4?F;4E8<A9BE@4G<BA
+E84FHELFGB6>
9;=BB=B;65@5B79
+957EI=F98GHC7?
"GGI5B79GDIFGI5BHHCGHC7?CDH=CBG5B869B9:=HD@5BG
B8=B;65@5B79
-<9577CAD5BM=B;'CH9GHCCBGC@=85H98=B5B7=5@,H5H9A9BHG5F95B=BH9;F5@D5FHC:H<=GGH5H9A9BH
-- 56 of 142 --
$B@C4AL4A7*H5F<7<4E<8F
BAFB?<74G87*G4G8@8AGB94F;?BJF
084EF8A787868@58E
$<??<BAF
4F;?BJF9EB@&C8E4G<A:6G<I<G<8F
'9H=B7CA9=B7@I8=B;BCB7CBHFC@@=B;=BH9F9GH
8>IGHA9BHGHCF97CB7=@9B9H=B7CA9=B7@I8=B;BCB7CBHFC@@=B;=BH9F9GHHCB9H
75G<DFCJ=8986MCD9F5H=B;57H=J=H=9G
9DF97=5H=CB5B85ACFH=N5H=CB
CAD5BMD9BG=CB5B8DCGHF9H=F9A9BH7CBHF=6IH=CBG
CAD5BMD9BG=CB5B8DCGHF9H=F9A9BH9LD9BG9
,HC7? 65G987CAD9BG5H=CB9LD9BG9
5=BCBG5@9C:6IG=B9GG9G N
9:9FF98=B7CA9H5L9G
%CGGCB897CBGC@=85H=CBC:/9B9NI9@5BGI6G=8=5FM N T
<5B;9G=B5GG9HG5B8@=56=@=H=9G
77CIBHGF979=J56@9
"BJ9BHCF=9G
77CIBHGD5M56@9
77FI98=B7CA9H5L9G7IFF9BH5B8@CB; H9FA
(H<9FTB9H
'9H75G<DFCJ=8986MIG98=BCD9F5H=B;57H=J=H=9G
4F;?BJF9EB@ AI8FG<A:6G<I<G<8F
)IF7<5G9GC:DFCD9FHM D@5BH5B89EI=DA9BH))
)FC7998G:FCAG5@9C:))5B8CH<9F5GG9HG
7EI=G=H=CBG B9HC:75G<57EI=F98 N
)IF7<5G9GC:A5F?9H56@9G97IF=H=9G5B8=BJ9GHA9BHG
)FC7998G:FCAA5HIF=H=9G5B8G5@9C:A5F?9H56@9G97IF=H=9G5B8=BJ9GHA9BHG
)FC7998G:FCAG5@9C:6IG=B9GG9G B9HC:75G<GC@8 N
(H<9FTB9H
'9H75G<DFCJ=8986MIG98=B=BJ9GH=B;57H=J=H=9G
4F;?BJF9EB@<A4A6<A:6G<I<G<8F
<5B;9=BG<CFH H9FA896HTB9H
+9D5MA9BHC:896HA5HIF=H=9G;F95H9FH<5B85MG
)FC7998G:FCA896HA5HIF=H=9G;F95H9FH<5B85MG
)IF7<5G9GC:HF95GIFMGHC7?
)FC7998G:FCA=GGI5B79C:HF95GIFMGHC7?DIFGI5BHHCGHC7?CDH=CB5B869B9:=H
D@5BG
=J=89B8GD5=8HCG<5F9<C@89FG
(H<9FTB9H
'9H75G<DFCJ=8986MIG98=B:=B5B7=B;57H=J=H=9G
::97HC:9L7<5B;9F5H97<5B;9GCB75G<5B875G<9EI=J5@9BHG
'9H=B7F95G9897F95G9=B75G<5B875G<9EI=J5@9BHG
5G<5B875G<9EI=J5@9BHG5H69;=BB=B;C:M95F
5G<5B875G<9EI=J5@9BHG5H9B8C:D9F=C8
-<9577CAD5BM=B;'CH9GHCCBGC@=85H98=B5B7=5@,H5H9A9BHG5F95B=BH9;F5@D5FHC:H<=GGH5H9A9BH
-- 57 of 142 --
Notes to Consolidated Financial Statements
NOTE 1. Significant Accounting Policies
Consolidation: 3M is a diversified global manufacturer, technology innovator and marketer of a wide variety of products. All
applicable subsidiaries are consolidated. All intercompany transactions are eliminated. As used herein, the term “3M” or
“Company” refers to 3M Company and subsidiaries unless the context indicates otherwise.
Basis of presentation: Certain amounts in the prior years’ consolidated financial statements have been reclassified to conform to
the current year presentation.
Effective in the first quarter of 2021, 3M made the following changes. Information provided herein reflects the impact of these
changes for all periods presented.
• Change in accounting principle for net periodic pension and postretirement plan cost. See below for additional
information.
• Change in measure of segment operating performance used by 3M’s chief operating decision maker—impacting 3M’s
disclosed measure of segment profit/loss (business segment operating income). See additional information in Note 19.
• Change in alignment of certain products within 3M’s Consumer business segment—creating the Consumer Health and
Safety Division. See additional information in Note 19.
Foreign currency translation: Local currencies generally are considered the functional currencies outside the United States with
the exception of 3M’s subsidiaries in Argentina, the economy of which was considered highly inflationary beginning in 2018,
and accordingly, the financial statements of these subsidiaries are remeasured as if their functional currency is that of their
parent. Assets and liabilities for operations in local-currency environments are translated at month-end exchange rates of the
period reported. Income and expense items are translated at average monthly currency exchange rates in effect during the
period. Cumulative translation adjustments are recorded as a component of accumulated other comprehensive income (loss) in
shareholders’ equity.
3M had a consolidating subsidiary in Venezuela, the financial statements of which were remeasured as if its functional currency
were that of its parent because Venezuela’s economic environment is considered highly inflationary. The operating income of
this subsidiary was immaterial as a percent of 3M’s consolidated operating income for the periods presented. In light of
circumstances, including the country’s unstable environment and heightened unrest leading to sustained lack of demand, and
expectation that these circumstances will continue for the foreseeable future, during May 2019, 3M concluded it no longer met
the criteria of control in order to continue consolidating its Venezuelan operations. As a result, as of May 31, 2019, the
Company began reflecting its interest in the Venezuelan subsidiary as an equity investment that does not have a readily
determinable fair value. This resulted in a pre-tax charge of $162 million within other expense (income) in the second quarter of
2019. The charge primarily relates to $144 million of foreign currency translation losses associated with foreign currency
movements before Venezuela was accounted for as a highly inflationary economy and pension elements previously included in
accumulated other comprehensive loss along with write-down of intercompany receivable and investment balances associated
with this subsidiary. Beginning May 31, 2019, 3M’s consolidated balance sheets and statements of operations no longer include
the Venezuelan entity’s operations other than an immaterial equity investment and associated loss or income thereon largely
only to the extent, that 3M provides support or materials and receives funding or dividends.
Use of estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the
disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and
expenses during the reporting period. The Company considered the coronavirus (COVID-19) related impacts on its estimates,
as appropriate, within its consolidated financial statements and there may be changes to those estimates in future periods. 3M
believes that the accounting estimates are appropriate after giving consideration to the increased uncertainties surrounding the
severity and duration of the COVID-19 pandemic. Such estimates and assumptions are subject to inherent uncertainties which
may result in actual amounts differing from these estimates.
Cash and cash equivalents: Cash and cash equivalents consist of cash and temporary investments with maturities of three
months or less when acquired.
Marketable securities: Marketable securities include available-for-sale debt securities and are recorded at fair value. Cost of
securities sold use the first in, first out (FIFO) method. The classification of marketable securities as current or non-current is
based on the availability for use in current operations. 3M reviews impairments associated with its marketable securities in
accordance with the measurement guidance provided by ASC 320, Investments-Debt Securities and ASC 326-30, Available-
50
-- 58 of 142 --
for-Sale Debt Securities, when determining whether a decline in fair value below the amortized cost basis has resulted from a
credit loss or other factors. An impairment relating to credit losses is recorded through an allowance for credit losses. The
allowance is limited by the amount that the fair value is less than the amortized cost basis. A change in the allowance for credit
losses is recorded into earnings in the period of the change. Any impairment that has not been recorded through an allowance
for credit losses is recorded through accumulated other comprehensive income as a component of shareholders’ equity. The
factors considered in determining whether a credit loss exists can include the extent to which fair value is less than the
amortized cost basis, changes in the credit quality of the underlying loan obligors, credit ratings actions, as well as other factors.
When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt
security with the amortized cost basis of the security to determine what allowance amount, if any, should be recorded. Amounts
are reclassified out of accumulated other comprehensive income and into earnings upon sale or a change in the portions of
impairment related to credit losses and not related to credit losses.
Investments: All equity securities that do not result in consolidation and are not accounted for under the equity method are
measured at fair value with changes therein reflected in net income. 3M utilizes the measurement alternative for equity
investments that do not have readily determinable fair values and measures these investments at cost less impairment plus or
minus observable price changes in orderly transactions. The balance of these securities is disclosed in Note 7.
Other assets: Other assets include deferred income taxes, product and other insurance receivables, the cash surrender value of
life insurance policies, medical equipment in rental arrangements utilized primarily by hospitals and other medical clinics,
prepaid pension and postretirement and other long-term assets. Investments in life insurance policies are reported at the amount
that could be realized under contract at the balance sheet date, with any changes in cash surrender value or contract value during
the period accounted for as an adjustment of premiums paid. Cash outflows and inflows associated with life insurance activity
are included in “Purchases of marketable securities and investments” and “Proceeds from maturities and sale of marketable
securities and investments,” respectively.
Inventories: Inventories are stated at the lower of cost or net realizable value (NRV), which is defined as estimated selling
prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Cost is
determined on a first-in, first-out basis.
Property, plant and equipment: Property, plant and equipment, including capitalized interest and internal direct engineering
costs, are recorded at cost. Depreciation of property, plant and equipment generally is computed using the straight-line method
based on the estimated useful lives of the assets. The estimated useful lives of buildings and improvements primarily range
from ten to forty years, with the majority in the range of twenty to forty years. The estimated useful lives of machinery and
equipment primarily range from three to fifteen years, with the majority in the range of five to ten years. Fully depreciated
assets other than capitalized internally developed software are retained in property, plant and equipment and accumulated
depreciation accounts until disposal. Upon disposal, assets and related accumulated depreciation are removed from the accounts
and the net amount, less proceeds from disposal, is charged or credited to operations. Property, plant and equipment amounts
are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset (asset
group) may not be recoverable. An impairment loss would be recognized when the carrying amount of an asset exceeds the
estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition. The amount
of the impairment loss recorded is calculated by the excess of the asset’s carrying value over its fair value. Fair value is
generally determined using a discounted cash flow analysis. 3M records capital-related government grants earned as reductions
to the cost of property, plant and equipment; and associated unpaid liabilities and grant proceeds receivable are considered non-
cash changes in such balances for purposes of preparation of statement of cash flows.
Conditional asset retirement obligations: A liability is initially recorded at fair value for an asset retirement obligation
associated with the retirement of tangible long-lived assets in the period in which it is incurred if a reasonable estimate of fair
value can be made. Conditional asset retirement obligations exist for certain long-term assets of the Company. The obligation is
initially measured at fair value using expected present value techniques. Over time the liabilities are accreted for the change in
their present value and the initial capitalized costs are depreciated over the remaining useful lives of the related assets. The asset
retirement obligation liability was $176 million and $145 million at December 31, 2021 and 2020, respectively.
Goodwill: Goodwill is the excess of cost of an acquired entity over the amounts assigned to assets acquired and liabilities
assumed in a business combination. Goodwill is not amortized. Goodwill is tested for impairment annually in the fourth quarter
of each year, and is tested for impairment between annual tests if an event occurs or circumstances change that would indicate
the carrying amount may be impaired. Impairment testing for goodwill is done at a reporting unit level, with all goodwill
assigned to a reporting unit. Reporting units are one level below the business segment level, but are required to be combined
when reporting units within the same segment have similar economic characteristics. 3M did not combine any of its reporting
units for impairment testing. The impairment loss is measured as the amount by which the carrying value of the reporting unit’s
51
-- 59 of 142 --
net assets exceeds its estimated fair value, not to exceed the carrying value of the reporting unit’s goodwill. The estimated fair
value of a reporting unit is determined based on a market approach using comparable company information such as EBITDA
(earnings before interest, taxes, depreciation and amortization) multiples. Companies have the option to first assess qualitative
factors to determine whether the fair value of a reporting unit is not “more likely than not” less than its carrying amount, which
is commonly referred to as “Step 0”. 3M has chosen not to apply Step 0 for its annual goodwill assessments.
Intangible assets: Intangible asset types include customer related, patents, other technology-based, tradenames and other
intangible assets acquired from an independent party. Intangible assets with a definite life are amortized over a period ranging
from five years to twenty years on a systematic and rational basis (generally straight line) that is representative of the asset’s
use. The estimated useful lives vary by category, with customer-related largely between ten to twenty years, patents largely
between seven to thirteen years, other technology-based largely between six to twenty years, definite lived tradenames largely
between six and twenty years, and other intangibles largely between five to eight years. Intangible assets are removed from their
respective gross asset and accumulated amortization accounts when they are no longer in use. Refer to Note 4 for additional
details on the gross amount and accumulated amortization of the Company’s intangible assets. Costs related to internally
developed intangible assets, such as patents, are expensed as incurred, within “Research, development and related expenses.”
Intangible assets with a definite life are tested for impairment whenever events or circumstances indicate that the carrying
amount of an asset (asset group) may not be recoverable. An impairment loss is recognized when the carrying amount exceeds
the estimated undiscounted cash flows from the asset’s or asset group’s ongoing use and eventual disposition. If an impairment
is identified, the amount of the impairment loss recorded is calculated by the excess of the asset’s carrying value over its fair
value. Fair value is generally determined using a discounted cash flow analysis.
Intangible assets with an indefinite life, namely certain tradenames, are not amortized. Indefinite-lived intangible assets are
tested for impairment annually, and are tested for impairment between annual tests if an event occurs or circumstances change
that would indicate that the carrying amount may be impaired. An impairment loss would be recognized when the fair value is
less than the carrying value of the indefinite-lived intangible asset.
Restructuring actions: Restructuring actions generally include significant actions involving employee-related severance
charges, contract termination costs, and impairment or accelerated depreciation/amortization of assets associated with such
actions. Employee-related severance charges are largely based upon distributed employment policies and substantive severance
plans. These charges are reflected in the quarter when the actions are probable and the amounts are estimable, which typically is
when management approves the associated actions. Severance amounts for which affected employees in certain circumstances
are required to render service in order to receive benefits at their termination dates were measured at the date such benefits were
communicated to the applicable employees and recognized as expense over the employees’ remaining service periods. Contract
termination and other charges primarily reflect costs to terminate a contract before the end of its term (measured at fair value at
the time the Company provided notice to the counterparty) or costs that will continue to be incurred under the contract for its
remaining term without economic benefit to the Company.
Revenue (sales) recognition: The Company sells a wide range of products to a diversified base of customers around the world
and has no material concentration of credit risk or significant payment terms extended to customers. The vast majority of 3M’s
customer arrangements contain a single performance obligation to transfer manufactured goods as the promise to transfer the
individual goods is not separately identifiable from other promises in the contracts and, therefore, not distinct. However, to a
limited extent 3M also enters into customer arrangements that involve intellectual property out-licensing, multiple performance
obligations (such as equipment, installation and service), software with coterminous post-contract support, services and non-
standard terms and conditions.
The Company recognizes revenue in light of the guidance of Accounting Standards Codification (ASC) 606, Revenue from
Contracts with Customers. Revenue is recognized when control of goods has transferred to customers. For the majority of the
Company’s customer arrangements, control transfers to customers at a point-in-time when goods/services have been delivered
as that is generally when legal title, physical possession and risks and rewards of goods/services transfer to the customer. In
limited arrangements, control transfers over time as the customer simultaneously receives and consumes the benefits as 3M
completes the performance obligation(s).
Revenue is recognized at the transaction price which the Company expects to be entitled. When determining the transaction
price, 3M estimates variable consideration applying the portfolio approach practical expedient under ASC 606. The main
sources of variable consideration for 3M are customer rebates, trade promotion funds, and cash discounts. These sales
incentives are recorded as a reduction to revenue at the time of the initial sale using the most-likely amount estimation method.
The most-likely amount method is based on the single most likely outcome from a range of possible consideration outcomes.
The range of possible consideration outcomes are primarily derived from the following inputs: sales terms, historical
52
-- 60 of 142 --
experience, trend analysis, and projected market conditions in the various markets served. Because 3M serves numerous
markets, the sales incentive programs offered vary across businesses, but the most common incentive relates to amounts paid or
credited to customers for achieving defined volume levels or growth objectives. There are no material instances where variable
consideration is constrained and not recorded at the initial time of sale. Free goods are accounted for as an expense and
recorded in cost of sales. Product returns are recorded as a reduction to revenue based on anticipated sales returns that occur in
the normal course of business. 3M primarily has assurance-type warranties that do not result in separate performance
obligations. Sales, use, value-added, and other excise taxes are not recognized in revenue. The Company has elected to present
revenue net of sales taxes and other similar taxes.
For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each
performance obligation using 3M’s best estimate of the standalone selling price of each distinct good or service in the contract.
The Company did not recognize any material revenue in the current reporting period for performance obligations that were fully
satisfied in previous periods.
The Company does not have material unfulfilled performance obligation balances for contracts with an original length greater
than one year in any years presented. Additionally, the Company does not have material costs related to obtaining a contract
with amortization periods greater than one year for any year presented.
3M applies ASC 606 utilizing the following allowable exemptions or practical expedients:
• Exemption to not disclose the unfulfilled performance obligation balance for contracts with an original length of one
year or less.
• Practical expedient relative to costs of obtaining a contract by expensing sales commissions when incurred because the
amortization period would have been one year or less.
• Portfolio approach practical expedient relative to estimation of variable consideration.
• “Right to invoice” practical expedient based on 3M’s right to invoice the customer at an amount that reasonably
represents the value to the customer of 3M’s performance completed to date.
• Election to present revenue net of sales taxes and other similar taxes.
• Sales-based royalty exemption permitting future intellectual property out-licensing royalty payments to be excluded
from the otherwise required remaining performance obligations disclosure
The Company recognizes revenue from the rental of durable medical devices in accordance with the guidance of ASC 842,
Leases. The Company recognizes rental revenue based on the length of time a device is used by the patient/organization, (i) at
the contracted rental rate for contracted customers and (ii) generally, retail price for non-contracted customers. The leases are
short-term in nature, generally providing for daily or monthly pricing, and are all classified as operating leases.
Accounts receivable and allowances: Trade accounts receivable are recorded at the invoiced amount and do not bear interest.
The Company maintains allowances for bad debts, cash discounts, and various other items. The allowances for bad debts and
cash discounts are based on the best estimate of the amount of expected credit losses in existing accounts receivable and
anticipated cash discounts. The Company determines the allowances based on historical write-off experience by industry and
regional economic data, current expectations of future credit losses, and historical cash discounts. The Company reviews the
allowances monthly. The allowances for bad debts as well as the provision for credit losses, write-off activity and recoveries for
the periods presented are not material. The Company does not have any significant off-balance-sheet credit exposure related to
its customers. The Company has long-term customer receivables that do not have significant credit risk, and the origination
dates of which are typically not older than five years. These long-term receivables are subject to an allowance methodology
similar to other receivables.
Advertising and merchandising: These costs are charged to operations in the period incurred, and totaled $327 million in 2021,
$278 million in 2020 and $348 million in 2019.
Research, development and related expenses: These costs are charged to operations in the period incurred and are shown on a
separate line of the Consolidated Statement of Income. Research, development and related expenses totaled $1.994 billion in
2021, $1.878 billion in 2020 and $1.911 billion in 2019. Research and development expenses, covering basic scientific research
and the application of scientific advances in the development of new and improved products and their uses, totaled $1.243
billion in 2021, $1.146 billion in 2020 and $1.253 billion in 2019. Related expenses primarily include technical support;
internally developed patent costs, which include costs and fees incurred to prepare, file, secure and maintain patents;
amortization of externally acquired patents and externally acquired in-process research and development; and gains/losses
associated with certain corporate approved investments in R&D-related ventures.
53
-- 61 of 142 --
8>/<8+6?=/=90>A+</-<9CAD5BM75D=H5@=N9G8=F97H7CGHGC:G9FJ=79GIG98=BH<989J9@CDA9BHC: 5B89LH9FB5@GC:HK5F9
57EI=F98:CFIG95G =BH9FB5@ IG9GC:HK5F9 ACIBHG75D=H5@=N985F95ACFH=N98CJ9F5D9F=C8C:H<F99HCG9J9BM95FG ;9B9F5@@MCB
5GHF5=;<H @=B965G=G IB@9GG5BCH<9FGMGH9A5H=75B8F5H=CB5@65G=G=GACF9F9DF9G9BH5H=J9C:H<9GC:HK5F9WGIG9 ACIBHG5F9
F9DCFH985G57CADCB9BHC:9=H<9FA57<=B9FM5B89EI=DA9BHCF:=B5B79@95G9GK=H<=BDFCD9FHM D@5BH5B89EI=DA9BH I@@M
89DF97=5H98=BH9FB5@ IG9GC:HK5F95GG9HG5F9F9ACJ98:FCADFCD9FHM D@5BH5B89EI=DA9BH5B8577IAI@5H9889DF97=5H=CB
577CIBHG
8@3<987/8>+6BJ=FCBA9BH5@9LD9B8=HIF9GF9@5H=B;HC9L=GH=B;7CB8=H=CBG75IG986MD5GHCD9F5H=CBGH<5H8CBCH7CBHF=6IH9HC
7IFF9BHCF:IHIF9F9J9BI9G5F99LD9BG98 +9G9FJ9G:CF@=56=@=H=9GF9@5H98HC5BH=7=D5H98F9A98=5H=CB7CGHG5F9F97CF898CB5B
IB8=G7CIBH9865G=GK<9BH<9M5F9DFC656@95B8F95GCB56@M9GH=A56@9 ;9B9F5@@MBC@5H9FH<5BH<97CAD@9H=CBC::95G=6=@=HM
GHI8=9G H<9CAD5BMWG7CAA=HA9BHHC5D@5BC:57H=CB CF5DDFCJ5@6MF9;I@5HCFM5;9B7=9G BJ=FCBA9BH5@9LD9B8=HIF9G:CF
75D=H5@DFC>97HGH<5H7CBHF=6IH9HC7IFF9BHCF:IHIF9CD9F5H=CBG;9B9F5@@M5F975D=H5@=N985B889DF97=5H98CJ9FH<9=F9GH=A5H98
IG9:I@@=J9G
8-97/>+B/=-<9DFCJ=G=CB:CF=B7CA9H5L9G=G89H9FA=B98IG=B;H<95GG9H5B8@=56=@=HM5DDFC57< .B89FH<=G5DDFC57<
89:9FF98=B7CA9H5L9GF9DF9G9BHH<99LD97H98:IHIF9H5L7CBG9EI9B79GC:H9ADCF5FM8=::9F9B79G69HK99BH<975FFM=B;5ACIBHG
5B8H5L65G=GC:5GG9HG5B8@=56=@=H=9G -<9CAD5BMF97CF8G5J5@I5H=CB5@@CK5B79HCF98I79=HG89:9FF98H5L5GG9HGK<9B
IB79FH5=BHMF9;5F8=B;H<9=FF95@=N56=@=HM9L=GHG GC:979A69F 5B8 H<9CAD5BM<58J5@I5H=CB5@@CK5B79GC:
A=@@=CB5B8A=@@=CBCB=HG89:9FF98H5L5GG9HG F9GD97H=J9@M -<9CAD5BMF97C;B=N9G5B8A95GIF9G=HGIB79FH5=BH5L
DCG=H=CBG65G98CBH<9FI@9GIB89F, 8-97/&+B/=
+<8381=:/<=2+</-<98=::9F9B79=BH<9K9=;<H985J9F5;9&G<5F9GCIHGH5B8=B;:CF75@7I@5H=B;65G=75B88=@IH9895FB=B;G
D9FG<5F95HHF=6IH56@9HC&7CAACBG<5F9<C@89FG=GH<9F9GI@HC:H<98=@IH=CB5GGC7=5H98K=H<H<9CAD5BMWGGHC7? 65G98
7CAD9BG5H=CBD@5BG 9FH5=BCDH=CBGCIHGH5B8=B;IB89FH<9G9GHC7? 65G987CAD9BG5H=CBD@5BG8IF=B;H<9M95FG 5B8
K9F9BCH=B7@I898=BH<97CADIH5H=CBC:8=@IH9895FB=B;GD9FG<5F95HHF=6IH56@9HC&7CAACBG<5F9<C@89FG6975IG9H<9M
KCI@8<5J9<585B5BH= 8=@IH=J99::97H A=@@=CB5J9F5;9CDH=CBG:CF A=@@=CB5J9F5;9CDH=CBG:CF 5B8
A=@@=CB5J9F5;9CDH=CBG:CF -<97CADIH5H=CBG:CF65G=75B88=@IH9895FB=B;GD9FG<5F9:CFH<9M95FG9B898979A69F
:C@@CK
4EA<A:F'8E*;4E8B@CHG4G<BAF
@BHAGF<A@<??<BAF 8K68CGC8EF;4E84@BHAGF
'IA9F5HCF
'9H=B7CA95HHF=6IH56@9HC&
9BCA=B5HCF
9BCA=B5HCF:CFK9=;<H985J9F5;9&7CAACBG<5F9GCIHGH5B8=B;S65G=7
=@IH=CB5GGC7=5H98K=H<H<9CAD5BMWGGHC7? 65G987CAD9BG5H=CBD@5BG
9BCA=B5HCF:CFK9=;<H985J9F5;9&7CAACBG<5F9GCIHGH5B8=B;S8=@IH98
5FB=B;GD9FG<5F95HHF=6IH56@9HC&7CAACBG<5F9<C@89FGS65G=7
5FB=B;GD9FG<5F95HHF=6IH56@9HC&7CAACBG<5F9<C@89FGS8=@IH98
%>9-5,+=/.-97:/8=+>398-<9CAD5BMF97C;B=N9G7CAD9BG5H=CB9LD9BG9:CF=HGGHC7? 65G987CAD9BG5H=CBDFC;F5AG K<=7<
=B7@I89GHC7?CDH=CBG F9GHF=7H98GHC7? F9GHF=7H98GHC7?IB=HG+,.G D9F:CFA5B79G<5F9G 5B8H<9 9B9F5@AD@CM99GW,HC7?
)IF7<5G9)@5B ,)) .B89F5DD@=756@9577CIBH=B;GH5B85F8G H<9:5=FJ5@I9C:G<5F9 65G987CAD9BG5H=CB=G89H9FA=B985HH<9
;F5BH85H95B8H<9F97C;B=H=CBC:H<9F9@5H989LD9BG9=GF97CF898CJ9FH<9D9F=C8=BK<=7<H<9G<5F9 65G987CAD9BG5H=CBJ9GHG
!CK9J9F K=H<F9GD97HHC=B7CA9H5L9G H<9F9@5H98898I7H=CB:FCAH5L9GD5M56@9=G65G98CBH<95K5F8WG=BHF=BG=7J5@I95HH<9
H=A9C:9L9F7=G9:CF5BCDH=CBCFCBH<9:5=FJ5@I9IDCBJ9GH=B;C:H<95K5F8:CF+,.G K<=7<75B699=H<9F;F95H9F7F95H=B;
5B9L79GGH5L69B9:=HCF@9GG7F95H=B;5H5L89:=7=9B7MH<5BH<989:9FF98H5L69B9:=HF97C;B=N985G7CAD9BG5H=CB7CGH=G
F97C;B=N98=BH<9:=B5B7=5@GH5H9A9BHG -<9G99L79GGH5L69B9:=HG 89:=7=9B7=9G5F9F97C;B=N985G=B7CA9H5L69B9:=H 9LD9BG9=B
H<9GH5H9A9BHC:=B7CA95B8 K=H<=BH<9GH5H9A9BHC:75G<:@CKG 5F97@5GG=:=98=BCD9F5H=B;57H=J=H=9G=BH<9G5A9A5BB9F5G
CH<9F75G<:@CKGF9@5H98HC=B7CA9H5L9G -<99LH9BHC:9L79GGH5L69B9:=HG 89:=7=9B7=9G=GGI6>97HHCJ5F=5H=CB=B&GHC7?DF=79
5B8H=A=B; 9LH9BHC:+,.J9GH=B;G5B89AD@CM99GHC7?CDH=CB9L9F7=G9G
97:</2/8=3@/38-97/-CH5@7CADF9<9BG=J9=B7CA95B8H<97CADCB9BHGC:577IAI@5H98CH<9F7CADF9<9BG=J9=B7CA9@CGG
5F9DF9G9BH98=BH<9CBGC@=85H98,H5H9A9BHC:CADF9<9BG=J9"B7CA95B8H<9CBGC@=85H98,H5H9A9BHC:<5B;9G=BEI=HM
-- 62 of 142 --
Accumulated other comprehensive income (loss) is composed of foreign currency translation effects (including hedges of net
investments in international companies), defined benefit pension and postretirement plan adjustments, unrealized gains and
losses on available-for-sale debt securities, and unrealized gains and losses on cash flow hedging instruments. The Company
uses the portfolio approach for releasing income tax effects from accumulated other comprehensive income.
Derivatives and hedging activities: All derivative instruments within the scope of ASC 815, Derivatives and Hedging, are
recorded on the balance sheet at fair value. The Company uses interest rate swaps, currency swaps, and foreign currency
forward and option contracts to manage risks generally associated with foreign exchange rate, interest rate and commodity
market volatility. All hedging instruments that qualify for hedge accounting are designated and effective as hedges, in
accordance with U.S. generally accepted accounting principles. If the underlying hedged transaction ceases to exist, all changes
in fair value of the related derivatives that have not been settled are recognized in current earnings. Instruments that do not
qualify for hedge accounting are marked to market with changes recognized in current earnings. Cash flows from derivative
instruments are classified in the statement of cash flows in the same category as the cash flows from the items subject to
designated hedge or undesignated (economic) hedge relationships. The Company does not hold or issue derivative financial
instruments for trading purposes and is not a party to leveraged derivatives.
Credit risk: The Company is exposed to credit loss in the event of nonperformance by counterparties in interest rate swaps,
currency swaps, and forward and option contracts. However, the Company’s risk is limited to the fair value of the instruments.
The Company actively monitors its exposure to credit risk through the use of credit approvals and credit limits, and by selecting
major international banks and financial institutions as counterparties. 3M enters into master netting arrangements with
counterparties when possible to mitigate credit risk in derivative transactions. A master netting arrangement may allow each
counterparty to net settle amounts owed between a 3M entity and the counterparty as a result of multiple, separate derivative
transactions. The Company does not anticipate nonperformance by any of these counterparties. 3M has elected to present the
fair value of derivative assets and liabilities within the Company’s consolidated balance sheet on a gross basis even when
derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation.
Fair value measurements: 3M follows ASC 820, Fair Value Measurements and Disclosures, with respect to assets and
liabilities that are measured at fair value on a recurring basis and nonrecurring basis. Under the standard, fair value is defined as
the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants as of the measurement date. The standard also establishes a hierarchy for inputs used in measuring
fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most
observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or
liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs
that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability
developed based upon the best information available in the circumstances. The hierarchy is broken down into three levels.
Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs include quoted
prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that
are not active, and inputs (other than quoted prices) that are observable for the asset or liability, either directly or indirectly.
Level 3 inputs are unobservable inputs for the asset or liability. Categorization within the valuation hierarchy is based upon the
lowest level of input that is significant to the fair value measurement.
Acquisitions: The Company accounts for business acquisitions in accordance with ASC 805, Business Combinations. This
standard requires the acquiring entity in a business combination to recognize all (and only) the assets acquired and liabilities
assumed in the transaction and establishes the acquisition-date fair value as the measurement objective for all assets acquired
and liabilities assumed in a business combination. Certain provisions of this standard prescribe, among other things, the
determination of acquisition-date fair value of consideration paid in a business combination (including contingent
consideration) and the exclusion of transaction and acquisition-related restructuring costs from acquisition accounting. In
addition to business combinations, 3M periodically acquires certain tangible and/or intangible assets and purchases interests in
certain enterprises that do not otherwise qualify for accounting as business combinations. These transactions are largely
reflected as additional asset purchase and investment activity.
Leases: 3M determines if an arrangement is a lease upon inception. A contract is or contains a lease if the contract conveys the
right to control the use of an identified asset for a period of time in exchange for consideration. The right to control the use of
an asset includes the right to obtain substantially all of the economic benefits of the underlying asset and the right to direct how
and for what purpose the asset is used. 3M determines certain service agreements that contain the right to use an underlying
asset are not leases because 3M does not control how and for what purpose the identified asset is used. Examples of such
agreements include master supply agreements, product processing agreements, warehouse and distribution services agreements,
power purchase agreements, and transportation purchase agreements.
55
-- 63 of 142 --
Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease
payments over the lease term. The discount rate used to calculate present value is 3M’s incremental borrowing rate or, if
available, the rate implicit in the lease. 3M determines the incremental borrowing rate for leases using a portfolio approach
based primarily on the lease term and the economic environment of the applicable country or region.
As a lessee, the Company leases distribution centers, office space, land, and equipment. Certain 3M lease agreements include
rental payments adjusted annually based on changes in an inflation index. 3M’s leases do not contain material residual value
guarantees or material restrictive covenants. Lease expense is recognized on a straight-line basis over the lease term.
Certain leases include one or more options to renew, with terms that can extend the lease term up to five years. 3M includes
options to renew the lease as part of the right of use lease asset and liability when it is reasonably certain the Company will
exercise the option. In addition, certain leases contain fair value purchase and termination options with an associated penalty. In
general, 3M is not reasonably certain to exercise such options.
For the measurement and classification of its lease agreements, 3M groups lease and non-lease components into a single lease
component for all underlying asset classes. Variable lease payments primarily include payments for non-lease components,
such as maintenance costs, payments for leased assets used beyond their noncancellable lease term as adjusted for contractual
options to terminate or renew, additional payments related to a subsequent adjustment in an inflation index, and payments for
non-components such as sales tax. Certain 3M leases contain immaterial variable lease payments based on number of units
produced.
Change in Accounting Principle for Determining Net Periodic Pension and Postretirement Plan Cost
In the first quarter of 2021, 3M changed the method it uses to calculate the market-related value of fixed income securities
included in its pension and other postretirement plan assets. The market-related value is used to determine the expected return
on plan assets and the amortization of net unamortized actuarial gains or losses expense components of net periodic benefit
cost. The Company previously used the calculated value approach for all plan assets, deferring over three years the impact on
these amounts of asset gains or losses that differed from expected returns. 3M changed to the fair value approach for calculating
market-related value for the fixed income class of plan assets, which does not involve deferring the impact of excess plan asset
gains or losses in the determination of these two components of net periodic benefit cost. 3M considers the use of the fair value
approach preferable to the calculated value approach as it results in a more current reflection of impacts of changes in value of
these plan assets in the determination of net periodic benefit cost. Additionally, given the plans’ liability-driven investment
strategy whereby the changes in value of the fixed income plan assets should offset changes in the value of the plans’ liabilities,
this approach more closely aligns the expected return on plan assets expense component with the value reflected in the plans’
funded status. This change was applied retrospectively to all periods presented within 3M’s financial statements. The change
did not impact consolidated operating income or net cash provided by operating activities but did impact the previously
reported portion of pension and postretirement net periodic benefit cost (benefit) that was included within non-operating other
expense (income) along with related consolidated income items such as net income and earnings per share. Other impacts
included related changes to previously reported consolidated other comprehensive income, retained earnings, accumulated other
comprehensive income (loss), and associated line items within the determination of net cash provided by operating activities.
For classes of plan assets other than fixed income investments, the Company continues to use the calculated value approach to
determine their market-related value.
56
-- 64 of 142 --
-<958CDH=CBC:H<=G7<5B;9=AD57H98DF9J=CIG@MF9DCFH985ACIBHG=B7@I898<9F9=B5G=B8=75H98=BH<9H56@9G69@CK
BAFB?<74G87*G4G8@8AGB9 A6B@8
084E8A787868@58E
$<??<BAF 8K68CGC8EF;4E84@BHAGF
,A78E'E<BE
$8G;B7 F7=HFG87
,A78E'E<BE
$8G;B7 F7=HFG87
(H<9F9LD9BG9=B7CA9 B9H
"B7CA969:CF9=B7CA9H5L9G
)FCJ=G=CB:CF=B7CA9H5L9G
"B7CA9C:7CBGC@=85H98;FCID
'9H=B7CA9=B7@I8=B;BCB7CBHFC@@=B;=BH9F9GH
'9H=B7CA95HHF=6IH56@9HC&
5FB=B;GD9FG<5F95HHF=6IH56@9HC&7CAACB
G<5F9<C@89FGT65G=7
5FB=B;GD9FG<5F95HHF=6IH56@9HC&7CAACB
G<5F9<C@89FGT8=@IH98
BAFB?<74G87*G4G8@8AGB9B@CE8;8AF<I8 A6B@8
084E8A787868@58E
$<??<BAF
,A78E'E<BE
$8G;B7 F7=HFG87
,A78E'E<BE
$8G;B7 F7=HFG87
'9H=B7CA9=B7@I8=B;BCB7CBHFC@@=B;=BH9F9GH
(H<9F7CADF9<9BG=J9=B7CA9@CGG B9HC:H5L
9:=B9869B9:=HD9BG=CB5B8DCGHF9H=F9A9BHD@5BG
58>IGHA9BH
-CH5@CH<9F7CADF9<9BG=J9=B7CA9@CGG B9HC:H5L
CADF9<9BG=J9=B7CA9@CGG=B7@I8=B;BCB7CBHFC@@=B;
=BH9F9GH
CADF9<9BG=J9=B7CA9@CGG5HHF=6IH56@9HC&
BAFB?<74G874?4A68*;88G
FB9868@58E
$<??<BAF
,A78E'E<BE
$8G;B7 F7=HFG87
+9H5=B9895FB=B;G
77IAI@5H98CH<9F7CADF9<9BG=J9=B7CA9@CGG
BAFB?<74G87*G4G8@8AGB94F;?BJF
084E8A787868@58E
$<??<BAF
,A78E'E<BE
$8G;B7 F7=HFG87
,A78E'E<BE
$8G;B7 F7=HFG87
'9H=B7CA9=B7@I8=B;BCB7CBHFC@@=B;=BH9F9GH
CAD5BMD9BG=CB5B8DCGHF9H=F9A9BH9LD9BG9
(H<9FTB9H
-<97IAI@5H=J958>IGHA9BH5GC:#5BI5FM H<969;=BB=B;C:H<995F@=9GHD9F=C8DF9G9BH98=BH<97CBGC@=85H98:=B5B7=5@
GH5H9A9BHG=B7@I898<9F9=B K5G5A=@@=CBF98I7H=CBHC957<C:F9H5=B9895FB=B;G5B8577IAI@5H98CH<9F7CADF9<9BG=J9@CGG
-- 65 of 142 --
$/6+>/."+<>C->3@3>C
&8C9GBCH<5J95BMA5H9F=5@F9@5H98D5FHM57H=J=HM
%8J66BHAG<A:'EBABHA68@8AGF
-<9H56@9G69@CKDFCJ=89GIAA5F=9GC:B9K577CIBH=B;DFCBCIB79A9BHG58CDH986M&8IF=B;5B8C:DFCBCIB79A9BHG
=GGI98 6IHBCHM9H58CDH986MH<9CAD5BM
*G4A74E7F7BCG87HE<A:
*G4A74E7 )8?8I4AG8F6E<CG<BA 9986G<I84G89BE$ @C46G4A7&G;8E$4GG8EF
,.'C
%37:630C381>2/--9?8>381
09<8-97/&+B/=&9:3-
@=A=B5H9G79FH5=B9L=GH=B;9L79DH=CBG
F9@5H98HCH<9;9B9F5@5DDFC57<=B,
F9@5H=B;HC:F5B7<=G9H5L9G
F98I7=B;7CAD@9L=HM=BH<9=BH9F=A
D9F=C8577CIBH=B;:CFM95F HC 85H9@CGG
@=A=H5H=CBG5B87<5B;9G=BH5L@5KG
5B87@5F=:M=B;H<9577CIBH=B;:CF
HF5BG57H=CBGCIHG=89C:6IG=B9GG
7CA6=B5H=CBH<5HF9GI@H=B5GH9D ID=B
H<9H5L65G=GC:;CC8K=@@
#5BI5FM 8CDH=CBC:H<=G,.8=8BCH
<5J95A5H9F=5@=AD57HCB&WG
7CBGC@=85H98F9GI@HGC:CD9F5H=CBG
5B8:=B5B7=5@7CB8=H=CB
,.'C
6+<30C381>2/8>/<+->398=
,/>A//8&9:3-
8@/=>7/8>=F;?3>C
%/-?<3>3/=&9:3-
8@/=>7/8>=F;?3>C/>29.
+8.938>(/8>?</=+8.
&9:3- /<3@+>3@/=+8.
/.1381
@5F=:=9GK<9B577CIBH=B;:CF79FH5=B
9EI=HMG97IF=H=9G 5CAD5BMG<CI@8
7CBG=89FC6G9FJ56@9HF5BG57H=CBG
69:CF95DD@M=B;CFIDCB8=G7CBH=BI=B;
H<99EI=HMA9H<C8C:577CIBH=B;:CF
H<9DIFDCG9GC:5DD@M=B;H<9
A95GIF9A9BH5@H9FB5H=J9
"B8=75H9GK<9B89H9FA=B=B;H<9
577CIBH=B;:CF79FH5=B89F=J5H=J9G 5
CAD5BMG<CI@8BCH7CBG=89F=:H<9
IB89F@M=B;G97IF=H=9GKCI@869
577CIBH98:CFIB89FH<99EI=HMA9H<C8
CF:5=FJ5@I9CDH=CB
#5BI5FM 8CDH=CBC:H<=G,.8=8BCH
<5J95A5H9F=5@=AD57HCB&WG
7CBGC@=85H98F9GI@HGC:CD9F5H=CBG
5B8:=B5B7=5@7CB8=H=CB
,.'C
$/0/</8-/$+>/$/09<7
&9:3-+-363>+>39890
>2/00/->=90$/0/</8-/$+>/
$/09<798
38+8-3+6$/:9<>3815B8
,.'C
$/0/</8-/$+>/$/09<7
&9:3-%-9:/
)FCJ=89GH9ADCF5FMCDH=CB5@
9LD98=9BHG5B89L79DH=CBGHC9L=GH=B;
;I=85B79CB7CBHF57HAC8=:=75H=CBG
5B8<98;9577CIBH=B;HC:57=@=H5H9H<9
A5F?9HHF5BG=H=CB:FCA9L=GH=B;
F9:9F9B79F5H9G GI7<5G%"(+K<=7<
=G69=B;D<5G98CIH69;=BB=B;5HH<9
9B8C: HC5@H9FB5H9F9:9F9B79
F5H9G GI7<5G,(+
::97H=J9IDCB
,.=GGI5B79G=B
&K=@@5DD@MH<=G;I=85B79HC
5DD@=756@97CBHF57HG5B8
=BGHFIA9BHGK<9B =:H<9M5F9
AC8=:=98 +9J=9KC:F9@9J5BH
5FF5B;9A9BHG7CB7@I898H<5H
=AD@=75H=CBGC:H<9G9,.G
KCI@8BCH<5J95A5H9F=5@=AD57H
CB&WG7CBGC@=85H98F9GI@HGC:
CD9F5H=CBG5B8:=B5B7=5@
7CB8=H=CB
-- 66 of 142 --
*G4A74E7F FFH874A7%BG08G7BCG87
*G4A74E7 )8?8I4AG8F6E<CG<BA 9986G<I84G89BE$ @C46G4A7&G;8E$4GG8EF
,.'C ?=38/==
97,38+>398=&9:3-
--9?8>38109<98><+->
==/>=+8.98><+->
3+,363>3/=0<9798><+->=
A3>2?=>97/<=
"GGI98=B(7HC69F +9EI=F9G
57EI=F=B;9BH=H=9GHC5DD@M,HC
F97C;B=N95B8A95GIF97CBHF57H5GG9HG
5B8@=56=@=H=9G57EI=F98H<FCI;<5
6IG=B9GG7CA6=B5H=CB
#5BI5FM -<=G;I=85B79=G5DD@=756@9HC5@@
6IG=B9GG7CA6=B5H=CBGC77IFF=B;
5:H9FH<99::97H=J985H9
,.'C
9@/<87/8>==3=>+8-/
&9:3- 3=-69=?</=,C
?=38/==8>3>3/=+,9?>
9@/<87/8>==3=>+8-/
"GGI98=B'CJ9A69F +9EI=F9G
8=G7@CGIF9G56CIH79FH5=BHMD9GC:
;CJ9FBA9BH5GG=GH5B79F979=J98 -<9
8=G7@CGIF9G=B7@I89=B:CFA5H=CB56CIH
H<9B5HIF9C:H<9HF5BG57H=CBG5B8
F9@5H98577CIBH=B;DC@=7MIG98HC
577CIBH:CFH<9A H<9@=B9=H9AGCBH<9
65@5B79G<99H5B8=B7CA9GH5H9A9BH
5::97H986MH<9HF5BG57H=CBG5B8H<9
5ACIBHG5DD@=756@9HC957<:=B5B7=5@
GH5H9A9BH=H9A 5B8H<9G=;B=:=75BH
H9FAG5B87CB8=H=CBGC:H<9
HF5BG57H=CB
#5BI5FM GH<=G,.F9@5H9GHC
8=G7@CGIF9GCB@M H<9F9K=@@69BC
=AD57HHC&WG7CBGC@=85H98
F9GI@HGC:CD9F5H=CBG5B8
:=B5B7=5@7CB8=H=CB
%&+ )8I8AH8
98><+->+6+8-/=
9:9FF98F9J9BI9DF=A5F=@MF9@5H9GHCF9J9BI9H<5H=GF97C;B=N98CJ9FH=A9:CFCB9 M95FGC:HK5F9@=79BG97CBHF57HG +9:9FHC'CH9
:CF89:9FF98F9J9BI965@5B79G5H979A69F 5B8 DDFCL=A5H9@MA=@@=CBC:H<9979A69F
65@5B79K5GF97C;B=N985GF9J9BI98IF=B;H<9M95F9B898979A69F K<=@95DDFCL=A5H9@MA=@@=CBC:H<9
979A69F 65@5B79K5GF97C;B=N985GF9J9BI98IF=B;H<9M95F9B898979A69F
!:/<+>381/+=/$/@/8?/
'9HG5@9G=B7@I89GF9BH5@F9J9BI9:FCA8IF56@9A98=75@89J=79G5GD5FHC:CD9F5H=B;@95G95FF5B;9A9BHGF9DCFH98K=H<=BH<9
&98=75@,C@IH=CBG=J=G=CB K<=7<K5GA=@@=CB5B8A=@@=CB:CFH<9M95F9B898979A69F 5B8
979A69F F9GD97H=J9@M DD@=756@9F9BH5@F9J9BI9:CFH<9M95F9B898979A69F K5GBCHA5H9F=5@
-- 67 of 142 --
3=+11</1+>/.</@/8?/3809<7+>398
-<9CAD5BMJ=9KGH<9:C@@CK=B;8=G5;;F9;5H988=G7@CGIF9G5GIG9:I@HCIB89FGH5B8=B;H<97CADCG=H=CBC:F9J9BI9F97C;B=N98
8IF=B;H<9F9GD97H=J9F9DCFH=B;D9F=C8G
084E8A787868@58E
%8G*4?8F$<??<BAF
6F5G=J9G
IHCACH=J9:H9FA5F?9H
@CGIF95B8&5G?=B;,MGH9AG
@97HF=75@&5F?9HG
"B8IGHF=5@8<9G=J9G5B8-5D9G
)9FGCB5@,5:9HM
+CC:=B; F5BI@9G
(H<9F,5:9HM5B8"B8IGHF=5@
-CH5@,5:9HM5B8"B8IGHF=5@IG=B9GG,9;A9BH
8J5B798&5H9F=5@G
IHCACH=J95B89FCGD579
CAA9F7=5@,C@IH=CBG
@97HFCB=7G
-F5BGDCFH5H=CB,5:9HM
(H<9F-F5BGDCFH5H=CB5B8@97HFCB=7G
-CH5@-F5BGDCFH5H=CB5B8@97HFCB=7GIG=B9GG,9;A9BH
FI;9@=J9FM N
CC8,5:9HM
!95@H<"B:CFA5H=CB,MGH9AG
&98=75@,C@IH=CBG
(F5@5F9
,9D5F5H=CB5B8)IF=:=75H=CB,7=9B79G
(H<9F!95@H<5F9
-CH5@!95@H<5F9IG=B9GG FCID
CBGIA9F!95@H<5B8,5:9HM
!CA95F9
!CA9"ADFCJ9A9BH
,H5H=CB9FM5B8(::=79
(H<9FCBGIA9F
-CH5@CBGIA9FIG=B9GG FCID
CFDCF5H95B8.B5@@C75H98
@=A=B5H=CBC:I5@F98=H
-CH5@CAD5BM
084E8A787868@58E
%8G*4?8F$<??<BAF
A9F=75G
G=5)57=:=7
IFCD9 &=88@95GH5B8:F=75
(H<9F.B5@@C75H98
0CF@8K=89
-- 68 of 142 --
Americas included United States net sales to customers of $15.0 billion, $13.9 billion and $13.2 billion in 2021, 2020 and 2019,
respectively. Asia Pacific included China/Hong Kong net sales to customers of $4.0 billion, $3.5 billion and $3.3 billion in
2021, 2020 and 2019, respectively.
NOTE 3. Acquisitions and Divestitures
Acquisitions:
3M makes acquisitions of certain businesses from time to time that are aligned with its strategic intent with respect to, among
other factors, growth markets and adjacent product lines or technologies. Goodwill resulting from business combinations is
largely attributable to the existing workforce of the acquired businesses and synergies expected to arise after 3M’s acquisition
of these businesses.
2021 acquisitions:
There were no acquisitions that closed during the year ended December 31, 2021.
2020 acquisitions:
There were no acquisitions that closed during the year ended December 31, 2020.
2019 acquisitions:
In February 2019, 3M completed the acquisition of the technology business of M*Modal for $0.7 billion of cash, net of cash
acquired, and assumption of $0.3 billion of M*Modal’s debt. Based in Pittsburgh, Pennsylvania, M*Modal is a leading
healthcare technology provider of cloud-based, conversational artificial intelligence-powered systems that help physicians
efficiently capture and improve the patient narrative. The allocation of purchase consideration related to M*Modal was
completed in the fourth quarter of 2019. Net sales and operating loss (inclusive of transaction and integration costs) of this
business included in 3M’s consolidated results of operations in 2019 were approximately $300 million and $25 million,
respectively. M*Modal is reported within the Company’s Health Care business.
In October 2019, the Company completed the acquisition of all of the ownership interests of Acelity Inc. and its KCI
subsidiaries. Acelity is a leading global medical technology company focused on advanced wound care and specialty surgical
applications marketed under the KCI brand. In the first quarter of 2020, the Company paid certain considerations previously
accrued under the terms of related agreements. Adjustments in 2020 to the purchase price allocation were approximately $34
million and related to identification and valuation of certain acquired assets and liabilities. The change to provisional amounts
did not result in material impacts to results of operations in 2020 or any portion related to earlier quarters in the measurement
period. The allocation of purchase consideration related to Acelity was completed in the third quarter of 2020. Net sales and
operating loss (inclusive of transaction and integration costs) of this business included in 3M’s consolidated results of
operations in the fourth quarter of 2019 were approximately $350 million and $45 million, respectively. Acelity is reported
within the Company’s Health Care business.
61
-- 69 of 142 --
)FC:CFA5=B:CFA5H=CBF9@5H98HCH<9G957EI=G=H=CBG<5GBCH699B=B7@I8985GH<9=AD57HCBH<9CAD5BMWG7CBGC@=85H98F9GI@HG
C:CD9F5H=CBGK5GBCH7CBG=89F98A5H9F=5@ -<9:C@@CK=B;H56@9G<CKGH<9=AD57HCBH<97CBGC@=85H9865@5B79G<99HC:H<9
DIF7<5G9DF=795@@C75H=CBGF9@5H98HCH<957EI=G=H=CBG5B85GG=;B98:=B=H9 @=J985GG9HK9=;<H985J9F5;9@=J9G
6DH<F<G<BA6G<I<GL
$<??<BAF
FF8G#<45<?<GL $$B74? 68?<GL +BG4?
<A<G8 #<I87
AG4A:<5?8 FF8G
.8<:;G87
I8E4:8#<I8F
084EF
77CIBHGF979=J56@9
"BJ9BHCFM T
(H<9F7IFF9BH5GG9HG
)FCD9FHM D@5BH 5B89EI=DA9BH
)IF7<5G98:=B=H9 @=J98=BH5B;=6@95GG9HG
IGHCA9FF9@5H98=BH5B;=6@95GG9HG
(H<9FH97<BC@C;M 65G98=BH5B;=6@95GG9HG
9:=B=H9 @=J98HF589B5A9G
)IF7<5G98;CC8K=@@
(H<9F5GG9HG
77CIBHGD5M56@95B8CH<9F@=56=@=H=9G
"BH9F9GH695F=B;896H
9:9FF98H5L5GG9H @=56=@=HM5B8577FI98=B7CA9H5L9G
'9H5GG9HG57EI=F98
,IDD@9A9BH5@=B:CFA5H=CB
5G<D5=8
%9GG5G<57EI=F98
5G<D5=8 B9HC:75G<57EI=F98
CBG=89F5H=CBD5M56@9 T
5G<D5=85B87CBG=89F5H=CBD5M56@9 B9HC:75G<57EI=F98
)IF7<5G98=89BH=:=56@9:=B=H9 @=J98=BH5B;=6@95GG9HGF9@5H98HC57EI=G=H=CBGK<=7<7@CG98=BHCH5@98 6=@@=CB -<9
5GGC7=5H98:=B=H9 @=J98=BH5B;=6@95GG9HG57EI=F98K=@@695ACFH=N98CB5GMGH9A5H=75B8F5H=CB5@65G=G;9B9F5@@MGHF5=;<H@=B9
CJ9F5K9=;<H98 5J9F5;9@=:9C:M95FG@=J9GF5B;=B;:FCAHCM95FG
<I8FG<GHE8F
&A5M8=J9GH79FH5=B6IG=B9GG9G:FCAH=A9HCH=A965G98IDCBF9J=9KC:H<9CAD5BMWGDCFH:C@=C7CBG=89F=B; 5ACB;CH<9F
=H9AG :57HCFGF9@5H=J9HCH<99LH9BHC:GHF5H9;=75B8H97<BC@C;=75@5@=;BA9BH5B8CDH=A=N5H=CBC:75D=H5@89D@CMA9BH =B588=H=CB
HC7CBG=89F=B;=:G9@@=B;H<96IG=B9GG9GF9GI@HG=BH<9;F95H9GHJ5@I97F95H=CB:CFH<9CAD5BM5B8:CFG<5F9<C@89FG G8=G7IGG98
=B'CH9IG=B9GG,9;A9BHG ;5=BG @CGG9GCBG5@9C:6IG=B9GG9G5F9F9:@97H98=BCFDCF5H95B8.B5@@C75H98
.3@/=>3>?</=+8.+889?8-/..3@/=>3>?</=
-<9F9K9F9BC8=J9GH=HIF9GH<5H7@CG988IF=B;H<9M95F9B898979A69F
"B979A69F &9BH9F98=BHC56=B8=B;C::9FHCG9@@=HG:@CCFDFC8I7HG6IG=B9GG=B09GH9FBIFCD9 D5FHC:H<9CBGIA9F
6IG=B9GG -<=G6IG=B9GG<5G5BBI5@G5@9GC:@9GGH<5BA=@@=CB -<9HF5BG57H=CB=G9LD97H98HC7@CG9=BH<9:=FGHEI5FH9FC:
GI6>97HHC7IGHCA5FM7@CG=B;7CB8=H=CBG5B8F9;I@5HCFMF9EI=F9A9BHG &9LD97HG5B=AA5H9F=5@DF9 H5L;5=B5G5F9GI@HC:
H<=G8=J9GH=HIF9
"B979A69F &9BH9F98=BHC5;F99A9BHGK=H<'( 'CFDCF5H=CBDIFGI5BHHCK<=7<&K=@@G9D5F5H9=HGCC8,5:9HM
=J=G=CB6IG=B9GGD5FHC:H<9!95@H<5F96IG=B9GG5B87CA6=B9=HK=H<'( '=B5HF5BG57H=CBH<5H=G=BH9B898HC69H5L
-- 70 of 142 --
efficient to 3M and its shareholders for U.S. federal income tax purposes. Under the terms of the agreements, which involve a
tax-free Reverse Morris Trust, the Food Safety business will be spun-off or split-off to 3M shareholders and simultaneously
merged with NEOGEN. Existing NEOGEN shareholders will continue to own approximately 49.9% of the combined company
and 3M shareholders will receive approximately 50.1% of the combined company. In connection with the transaction, the Food
Safety business will incur new debt and fund to 3M consideration valued at approximately $1 billion, subject to closing and
other adjustments. The transaction is expected to close by the end of the third quarter of 2022, subject to approval by NEOGEN
shareholders, receipt of required regulatory approvals and the satisfaction of other customary closing conditions. Net sales
information relative to the Food Safety Division is included in Note 2. Due to factors such as the potential nature of the
transaction and underlying approvals, the Food Safety business is not considered held for sale as of December 31, 2021.
2020 divestitures:
In January 2020, 3M completed the sale of its advanced ballistic-protection business, formerly part of the Transportation and
Electronics business, to Avon Rubber p.l.c for $86 million in cash and recognized certain contingent consideration from the
outcome of pending tenders. Further contingent consideration of less than $25 million may be recognized depending on
outcomes in the future. The business, with annual sales of approximately $85 million, consists of ballistic helmets, body armor,
flat armor and related helmet-attachment products serving government and law enforcement. 3M reflected immaterial impacts
in the third quarter of 2019 as a result of measuring this disposal group at the lower of its carrying amount or fair value less cost
to sell and in the first quarter 2020 related to completion of the divestiture and recognition of contingent consideration.
In May 2020, 3M completed the sale of substantially all of its drug delivery business, formerly part of the Health Care business,
to an affiliate of Altaris Capital Partners, LLC for $617 million in consideration including $487 million of cash, approximately
$70 million in the form of an interest-bearing security, and approximately $60 million in the form of a 17 percent
noncontrolling interest in the new company, Kindeva Drug Delivery (Kindeva). Non-cash consideration was valued at time of
initial recognition on an income-based approach using relevant estimated future cash flows and applicable market interest rates
while considering impacts of restrictions related to transferability. The divested business had annual sales of approximately
$380 million. 3M retained its transdermal drug delivery components business. 3M reflected a pre-tax gain of $387 million as a
result of the divestiture. The Company reflects its ownership interest in Kindeva using the equity method of accounting
incorporating the recording of 3M’s share of earnings/losses on a lag-basis based on availability of Kindeva financial
statements. As a result, income/loss from this unconsolidated subsidiary began to be reflected in 3M’s financial statements in
the third quarter of 2020. Kindeva and 3M entered into certain limited-term agreements related to post-divestiture transition and
supply services.
In the third quarter of 2020, 3M completed the sale of a small dermatology products business, formerly part of the Health Care
business, for immaterial proceeds that approximated the business’s book value.
2019 divestitures:
During the first quarter of 2019, the Company sold certain oral care technology comprising a business and reflected an earnout
on a previous divestiture resulting in an aggregate immaterial gain.
In August 2019, 3M closed on the sale of its gas and flame detection business, a leader in fixed and portable gas and flame
detection, to Teledyne Technologies Incorporated. 3M’s gas and flame business was part of the overall October 2017
acquisition of underlying legal entities and associated assets of Scott Safety. This business has annual sales of approximately
$120 million. The transaction resulted in a pre-tax gain of $112 million.
Operating income and held for sale amounts
The aggregate operating income of these businesses, including the announced divestitures, was approximately $120 million,
$160 million and $160 million in 2021, 2020 and 2019, respectively. The amounts of major assets and liabilities associated with
disposal groups classified as held-for-sale as of December 31, 2021 were not material.
NOTE 4. Goodwill and Intangible Assets
Goodwill
There was no goodwill recorded from acquisitions during 2021 and 2020. The acquisition activity in the following table also
includes the net impact of adjustments to the preliminary allocation of purchase price within the one year measurement-period
following prior acquisitions, which decreased goodwill by $34 million during 2020. The amounts in the “Translation and other”
63
-- 71 of 142 --
7C@IAB=BH<9:C@@CK=B;H56@9DF=A5F=@MF9@5H9HC7<5B;9G=B:CF9=;B7IFF9B7M9L7<5B;9F5H9G -<9;CC8K=@@65@5B796M6IG=B9GG
G9;A9BH:C@@CKG
$<??<BAF *498GL4A7
A7HFGE<4?
+E4AFCBEG4G<BA
4A7
?86GEBA<6F 84?G;4E8 BAFH@8E +BG4?
B@C4AL
5@5B795GC:979A69F
7EI=G=H=CB57H=J=HM T T T
=J9GH=HIF957H=J=HM T T
-F5BG@5H=CB5B8CH<9F
5@5B795GC:979A69F
-F5BG@5H=CB5B8CH<9F
5@5B795GC:979A69F
77CIBH=B;GH5B85F8GF9EI=F9H<5H;CC8K=@@69H9GH98:CF=AD5=FA9BH5BBI5@@M5B869HK99B5BBI5@H9GHG=B79FH5=B7=F7IAGH5B79G
GI7<5G57<5B;9=BF9DCFH=B;IB=HGCFH<9H9GH=B;C:F97CJ9F56=@=HMC:5G=;B=:=75BH5GG9H;FCIDK=H<=B5F9DCFH=B;IB=H H&
F9DCFH=B;IB=HG7CFF9GDCB8HC58=J=G=CB
G89G7F=698=B'CH9 9::97H=J9=BH<9:=FGHEI5FH9FC: H<9CAD5BM7<5B;98=HG6IG=B9GGG9;A9BHF9DCFH=B; CF5BM
DFC8I7H7<5B;9GH<5HF9GI@H98=BF9DCFH=B;IB=H7<5B;9G H<9CAD5BM5DD@=98H<9F9@5H=J9:5=FJ5@I9A9H<C8HC89H9FA=B9H<9
=AD57HCB;CC8K=@@C:H<95GGC7=5H98F9DCFH=B;IB=HG H<9F9GI@HGC:K<=7<K9F9=AA5H9F=5@ CC8K=@@65@5B79GF9DCFH9856CJ9
F9:@97HH<9G96IG=B9GGG9;A9BHF9DCFH=B;7<5B;9G=BH<995F@=9GHD9F=C8DF9G9BH98 -<9CAD5BM5@GC7CAD@9H98=HG5BBI5@
;CC8K=@@=AD5=FA9BHH9GH=BH<9:CIFH<EI5FH9FC::CF5@@F9DCFH=B;IB=HG5B889H9FA=B98H<5HBC=AD5=FA9BH9L=GH98 "B
588=H=CB H<9CAD5BM<58BC=AD5=FA9BHGC:;CC8K=@@=B CF7IAI@5H=J9@M
6DH<E87 AG4A:<5?8FF8GF
-<975FFM=B;5ACIBH5B8577IAI@5H985ACFH=N5H=CBC:57EI=F98:=B=H9 @=J98=BH5B;=6@95GG9HG =B588=H=CBHCH<965@5B79C:BCB
5ACFH=N56@9=BH5B;=6@95GG9HG 5GC:979A69F :C@@CK
$<??<BAF
IGHCA9FF9@5H98=BH5B;=6@95GG9HG
)5H9BHG
(H<9FH97<BC@C;M 65G98=BH5B;=6@95GG9HG
9:=B=H9 @=J98HF589B5A9G
(H<9F5ACFH=N56@9=BH5B;=6@95GG9HG
-CH5@;FCGG75FFM=B;5ACIBH
77IAI@5H985ACFH=N5H=CBT7IGHCA9FF9@5H98
77IAI@5H985ACFH=N5H=CBTD5H9BHG
77IAI@5H985ACFH=N5H=CBTCH<9FH97<BC@C;M 65G98
77IAI@5H985ACFH=N5H=CBT89:=B=H9 @=J98HF589B5A9G
77IAI@5H985ACFH=N5H=CBTCH<9F
-CH5@577IAI@5H985ACFH=N5H=CB
-CH5@:=B=H9 @=J98=BH5B;=6@95GG9HGTB9H
'CB 5ACFH=N56@9=BH5B;=6@95GG9HGDF=A5F=@MHF589B5A9G
-CH5@=BH5B;=6@95GG9HGTB9H
9FH5=BHF589B5A9G57EI=F986M&5F9BCH5ACFH=N986975IG9H<9M<5J9699B=B9L=GH9B79:CFCJ9FM95FG <5J95<=GHCFMC:
@958=B; A5F?9HG<5F9DCG=H=CBG <5J9699B5B85F9=BH9B898HC697CBH=BICIG@MF9B9K98 5B8H<95GGC7=5H98DFC8I7HGC:K<=7<
5F99LD97H98HC;9B9F5H975G<:@CKG:CF&:CF5B=B89:=B=H9D9F=C8C:H=A9 G8=G7IGG98=B'CH9 &F9:@97H985B
=AA5H9F=5@7<5F;9F9@5H98HC=AD5=FA9BHC:79FH5=B=B89:=B=H9 @=J985GG9HG=BH<9:=FGHEI5FH9FC:
-- 72 of 142 --
ACFH=N5H=CB9LD9BG9:CFH<9M95FG9B898979A69F:C@@CKG
$<??<BAF
ACFH=N5H=CB9LD9BG9
LD97H985ACFH=N5H=CB9LD9BG9:CF57EI=F985ACFH=N56@9=BH5B;=6@95GG9HGF97CF8985GC:979A69F :C@@CKG
$<??<BAF 9G8E
ACFH=N5H=CB9LD9BG9
-<9DF9798=B;9LD97H985ACFH=N5H=CB9LD9BG9=G5B9GH=A5H9 7HI5@5ACIBHGC:5ACFH=N5H=CB9LD9BG9A5M8=::9F:FCA
9GH=A5H985ACIBHG8I9HC588=H=CB5@=BH5B;=6@95GG9H57EI=G=H=CBG 7<5B;9G=B:CF9=;B7IFF9B7M9L7<5B;9F5H9G =AD5=FA9BHC:
=BH5B;=6@95GG9HG 5779@9F5H985ACFH=N5H=CBC:=BH5B;=6@95GG9HG5B8CH<9F9J9BHG &9LD9BG9GH<97CGHG=B7IFF98HCF9B9KCF
9LH9B8H<9H9FAC:=BH5B;=6@95GG9HG
%&+ )8FGEH6GHE<A:6G<BAF
)6, "-;<:=+<=:16/+<176;
!:/<+>398+6 +<5/>381+:+,363>C$/=><?->?<381
"B@5H9 &5BBCIB798=HKCI@8IB89FH5?979FH5=B57H=CBGHC:IFH<9F9B<5B79=HGCD9F5H=CBG5B8A5F?9H=B;75D56=@=H=9GHC
H5?958J5BH5;9C:79FH5=B;@C65@A5F?9HHF9B8GK<=@989 DF=CF=H=N=B;=BJ9GHA9BHG=BG@CK9F ;FCKH<9B8A5F?9HG IF=B;H<9
:CIFH<EI5FH9FC: A5B5;9A9BH5DDFCJ985B87CAA=HH98HCIB89FH5?95GGC7=5H98F9GHFI7HIF=B;57H=CBG=AD57H=B;
5DDFCL=A5H9@M DCG=H=CBGF9GI@H=B;=B5DF9 H5L7<5F;9C:A=@@=CB "B A5B5;9A9BH5DDFCJ985B87CAA=HH98HC
IB89FH5?9588=H=CB5@57H=CBGIB89FH<=G=B=H=5H=J9F9GI@H=B;=B5DF9 H5L7<5F;9C:A=@@=CB +9A5=B=B;57H=J=H=9GF9@5H98HC
H<9F9GHFI7HIF=B;57H=CBG5DDFCJ985B87CAA=HH98IB89FH<=G=B=H=5H=J95F99LD97H98HC69@5F;9@M7CAD@9H98H<FCI;<H<9H<=F8
EI5FH9FC: &9LD97HGHC7CAA=HHC:IFH<9F57H=CBGIB89FH<=G=B=H=5H=J9H<FCI;<95F@M -<=G5;;F9;5H9=B=H=5H=J9
69;IB=B5B87CBH=BI=B;H<FCI;<95F@M =G9LD97H98HC=AD57H5DDFCL=A5H9@M DCG=H=CBGKCF@8K=89K=H<5B
9LD97H98DF9 H5L7<5F;95DDFC57<=B;A=@@=CBCJ9FH<5HD9F=C8 -<9F9@5H98F9GHFI7HIF=B;7<5F;9GK9F9F97CF898=BH<9
=B7CA9GH5H9A9BH5G:C@@CKG
$<??<BAF
CGHC:G5@9G
,9@@=B; ;9B9F5@5B858A=B=GHF5H=J99LD9BG9G
+9G95F7< 89J9@CDA9BH5B8F9@5H989LD9BG9G
-CH5@CD9F5H=B;=B7CA9=AD57H
-<96IG=B9GGG9;A9BHCD9F5H=B;=B7CA9=AD57HC:H<9G9F9GHFI7HIF=B;7<5F;9G=GGIAA5F=N985G:C@@CKG
$<??<BAF @C?BL88
)8?4G87 @C?BL88
)8?4G87 FF8G )8?4G87
4A7&G;8E +BG4?
,5:9HM5B8"B8IGHF=5@
-F5BGDCFH5H=CB5B8@97HFCB=7G
!95@H<5F9
CBGIA9F
CFDCF5H95B8.B5@@C75H98
-CH5@(D9F5H=B;LD9BG9
-- 73 of 142 --
+9GHFI7HIF=B;57H=CBG =B7@I8=B;75G<5B8BCB 75G<=AD57HG :C@@CK
$<??<BAF @C?BL88
)8?4G87 FF8G )8?4G87
4A7&G;8E +BG4?
LD9BG9=B7IFF98=BH<9:CIFH<EI5FH9FC:
'CB 75G<7<5B;9G T
77FI98F9GHFI7HIF=B;57H=CB65@5B79G5GC:979A69F T
"B7F9A9BH5@9LD9BG9=B7IFF98=B N
5G<)5MA9BHG N
8>IGHA9BHG N
77FI98F9GHFI7HIF=B;57H=CB65@5B79G5GC:979A69F N
3@/=>3>?</$/6+>/.$/=><?->?<381
IF=B;H<9G97CB8EI5FH9FC: :C@@CK=B;H<98=J9GH=HIF9C:GI6GH5BH=5@@M5@@C:H<98FI;89@=J9FM6IG=B9GGG99'CH9
A5B5;9A9BH5DDFCJ985B87CAA=HH98HCIB89FH5?979FH5=BF9GHFI7HIF=B;57H=CBG588F9GG=B;7CFDCF5H9:IB7H=CB5@7CGHG5B8
A5BI:57HIF=B;:CCHDF=BH57FCGG&=BF9@5H=CBHCH<9A5;B=HI89C:5ACIBHGDF9J=CIG@M5@@C75H98 6IF89B98HCH<98=J9GH98
6IG=B9GG -<9G957H=CBG5::97H985DDFCL=A5H9@M DCG=H=CBGKCF@8K=895B8F9GI@H98=B5G97CB8EI5FH9FDF9 H5L7<5F;9
C:A=@@=CB K=H<=BCFDCF5H95B8.B5@@C75H98 -<98=J9GH=HIF9 F9@5H98F9GHFI7HIF=B;57H=CBGK9F9F97CF898=BH<9=B7CA9
GH5H9A9BH5G:C@@CKG
$<??<BAF
CGHC:G5@9G
,9@@=B; ;9B9F5@5B858A=B=GHF5H=J99LD9BG9G
+9G95F7< 89J9@CDA9BH5B8F9@5H989LD9BG9G
-CH5@CD9F5H=B;=B7CA9=AD57H
=J9GH=HIF9 F9@5H98F9GHFI7HIF=B;57H=CBG =B7@I8=B;75G<5B8BCB 75G<=AD57HG :C@@CK
$<??<BAF
@C?BL88
)8?4G87
FF8G )8?4G87
4A7&G;8E +BG4?
LD9BG9=B7IFF98=BH<9G97CB8EI5FH9FC:
'CB 75G<7<5B;9G T
5G<D5MA9BHG T
8>IGHA9BHG T
77FI98F9GHFI7HIF=B;57H=CB65@5B795GC:979A69F
5G<)5MA9BHG N
8>IGHA9BHG N
77FI98F9GHFI7HIF=B;57H=CB65@5B795GC:#IB9
+9A5=B=B;57H=J=H=9GF9@5H98HCH<=G8=J9GH=HIF9 F9@5H98F9GHFI7HIF=B;K9F9@5F;9@M7CAD@9H98=BH<9H<=F8EI5FH9FC:
!>2/<$/=><?->?<381
88=H=CB5@@M =BH<9G97CB8EI5FH9FC: A5B5;9A9BH5DDFCJ985B87CAA=HH98HCIB89FH5?979FH5=BF9GHFI7HIF=B;57H=CBG
588F9GG=B;GHFI7HIF5@9BH9FDF=G97CGHG5B8CD9F5H=CBG=B79FH5=B9B8A5F?9HG5G5F9GI@HC:H<9(/" D5B89A=75B8F9@5H98
-- 74 of 142 --
97CBCA=7=AD57HG -<9G957H=CBG5::97H985DDFCL=A5H9@MDCG=H=CBGKCF@8K=895B8F9GI@H98=B5G97CB8EI5FH9FDF9 H5L
7<5F;9C:A=@@=CB -<9F9GHFI7HIF=B;7<5F;9GK9F9F97CF898=BH<9=B7CA9GH5H9A9BH5G:C@@CKG
&=@@=CBG
CGHC:G5@9G
,9@@=B; ;9B9F5@5B858A=B=GHF5H=J99LD9BG9G
+9G95F7< 89J9@CDA9BH5B8F9@5H989LD9BG9G
-CH5@CD9F5H=B;=B7CA9=AD57H
-<96IG=B9GGG9;A9BHCD9F5H=B;=B7CA9=AD57HC:H<9G9F9GHFI7HIF=B;7<5F;9G=GGIAA5F=N985G:C@@CKG
$<??<BAF @C?BL88
)8?4G87 FF8G )8?4G87
4A7&G;8E +BG4?
,5:9HM5B8"B8IGHF=5@ T
-F5BGDCFH5H=CB5B8@97HFCB=7G T
!95@H<5F9 T
CBGIA9F T
CFDCF5H95B8.B5@@C75H98 T
-CH5@(D9F5H=B;LD9BG9
+9GHFI7HIF=B;57H=CBG =B7@I8=B;75G<5B8BCB 75G<=AD57HG :C@@CK
$<??<BAF
@C?BL88
)8?4G87 FF8G )8?4G87 +BG4?
LD9BG9=B7IFF98=BH<9G97CB8EI5FH9FC:
'CB 75G<7<5B;9G T
5G<D5MA9BHG T
8>IGHA9BHG T
77FI98F9GHFI7HIF=B;57H=CB65@5B79G5GC:979A69F T
5G<)5MA9BHG N
8>IGHA9BHG N
77FI98F9GHFI7HIF=B;57H=CB65@5B79G5GC:&5F7< N
+9A5=B=B;57H=J=H=9GF9@5H98HCH<=GF9GHFI7HIF=B;K9F9@5F;9@M7CAD@9H98=BH<9G97CB8EI5FH9FC:
"-;<:=+<=:16/+<176;
IF=B;H<9G97CB8EI5FH9FC: =B@=;<HC:G@CK9FH<5B9LD97H98G5@9G A5B5;9A9BH5DDFCJ985B87CAA=HH98HC
IB89FH5?979FH5=BF9GHFI7HIF=B;57H=CBG -<9G957H=CBG=AD57H985DDFCL=A5H9@M DCG=H=CBGKCF@8K=89 =B7@I8=B;5HHF=H=CB
-<9CAD5BMF97CF898G97CB8EI5FH9FDF9 H5L7<5F;9GC:A=@@=CB 88=H=CB5@@M 8IF=B;H<9:CIFH<EI5FH9FC: HC
F95@=;B&WGCF;5B=N5H=CB5@GHFI7HIF95B8CD9F5H=B;AC89@HC=ADFCJ9;FCKH<5B8CD9F5H=CB5@9::=7=9B7M A5B5;9A9BH5DDFCJ98
5B87CAA=HH98HCIB89FH5?979FH5=BF9GHFI7HIF=B;57H=CBG -<9G957H=CBG=AD57H985DDFCL=A5H9@M DCG=H=CBGKCF@8K=89
-<9CAD5BMF97CF898:CIFH<EI5FH9FDF9 H5L7<5F;9GC:A=@@=CB -<9G9F9GHFI7HIF=B;7<5F;9GK9F9F97CF898=BH<9
=B7CA9GH5H9A9BH5G:C@@CKG
$<??<BAF
CGHC:G5@9G
,9@@=B; ;9B9F5@5B858A=B=GHF5H=J99LD9BG9G
+9G95F7< 89J9@CDA9BH5B8F9@5H989LD9BG9G
-CH5@CD9F5H=B;=B7CA9=AD57H
(H<9F9LD9BG9=B7CA9 B9H
-CH5@=B7CA969:CF9=B7CA9H5L9G=AD57H
-- 75 of 142 --
-<9G97CB8EI5FH9F57H=CBG=B7@I8985JC@IBH5FM95F@MF9H=F9A9BH=B79BH=J9=B=H=5@7<5F;9:IFH<9F8=G7IGG98=B'CH9
H<97<5F;9:CFK<=7<=G=B7@I898=BCH<9F9LD9BG9=B7CA9 B9H56CJ9
-<9CD9F5H=B;=B7CA9=AD57HC:H<9G9F9GHFI7HIF=B;7<5F;9G5F9GIAA5F=N986M6IG=B9GGG9;A9BH5G:C@@CKG
$<??<BAF @C?BL88
)8?4G87 FF8G )8?4G87 +BG4?
,5:9HM5B8"B8IGHF=5@ T
-F5BGDCFH5H=CB5B8@97HFCB=7G T
!95@H<5F9 T
CBGIA9F T
CFDCF5H95B8.B5@@C75H98
-CH5@(D9F5H=B;LD9BG9
+9GHFI7HIF=B;57H=CBG =B7@I8=B;75G<5B8BCB 75G<=AD57HG :C@@CK
$<??<BAF @C?BL88
)8?4G87 FF8G )8?4G87 +BG4?
LD9BG9=B7IFF98=BH<9G97CB8EI5FH9F5B8:CIFH<EI5FH9FC:
'CB 75G<7<5B;9G
5G<D5MA9BHG T
8>IGHA9BHG T
77FI98F9GHFI7HIF=B;57H=CB65@5B79G5GC:979A69F T
5G<)5MA9BHG T
8>IGHA9BHG T
77FI98F9GHFI7HIF=B;57H=CB65@5B79G5GC:979A69F T
8>IGHA9BHG=BH<9H56@956CJ9F9:@97H7<5B;9G=B9GH=A5H9G:FCA:57HCFGGI7<5G588=H=CB5@B5HIF5@5HHF=H=CB5B8F989D@CMA9BH5G
(/" 89@5M98H<9GH5FHC:D@5B9L97IH=CB5B8ID85H9C:7CGHG5GGC7=5H98K=H<H<9A=LC:=AD57H98FC@9G +9A5=B=B;
57H=J=H=9GF9@5H98HCH<=GF9GHFI7HIF=B;K9F9@5F;9@M7CAD@9H98H<FCI;<95F@M
%&+ *HCC?8@8AG4? A6B@8*G4G8@8AG A9BE@4G<BA
(H<9F9LD9BG9=B7CA9 B9H7CBG=GHGC:H<9:C@@CK=B;
$<??<BAF
"BH9F9GH9LD9BG9
"BH9F9GH=B7CA9
)9BG=CB5B8DCGHF9H=F9A9BHB9HD9F=C8=769B9:=H7CGH69B9:=H
%CGGCB897CBGC@=85H=CBC:/9B9NI9@5BGI6G=8=5FM N T
-CH5@
"BH9F9GH9LD9BG9=B7@I89G95F@M896H9LH=B;I=G<A9BHDF9 H5L7<5F;9GC:5DDFCL=A5H9@MA=@@=CB5B8A=@@=CB=B5B8
F9GD97H=J9@M
)9BG=CB5B8DCGHF9H=F9A9BHB9HD9F=C8=769B9:=H7CGHG89G7F=698=BH<9H56@956CJ9=B7@I895@@7CADCB9BHGC:89:=B9869B9:=H
D@5BB9HD9F=C8=769B9:=H7CGHG9L79DHG9FJ=797CGH K<=7<=GF9DCFH98=BJ5F=CIGCD9F5H=B;9LD9BG9@=B9G )9BG=CB5B8
DCGHF9H=F9A9BHB9HD9F=C8=769B9:=H7CGHG:CF=B7@I8985G97CB8EI5FH9F7<5F;9F9@5H98HCH<9JC@IBH5FM95F@MF9H=F9A9BH
=B79BH=J9DFC;F5A5BBCIB798=B&5M=B588=H=CBHC. , BCB EI5@=:=98D9BG=CBD@5BG9HH@9A9BH7<5F;9GC:A=@@=CB
F97C;B=N98=BH<9:CIFH<EI5FH9FC: +9:9FHC'CH9:CF588=H=CB5@89H5=@GCBH<9JC@IBH5FM95F@MF9H=F9A9BH=B79BH=J9
DFC;F5A=B588=H=CBHCH<97CADCB9BHGC:D9BG=CB5B8DCGHF9H=F9A9BHB9HD9F=C8=769B9:=H7CGHG
-- 76 of 142 --
"B H<9CAD5BM=B7IFF9857<5F;9C:A=@@=CBF9@5H98HCH<9897CBGC@=85H=CBC:=HG/9B9NI9@5BGI6G=8=5FM +9:9FHC
'CH9:CF588=H=CB5@89H5=@G
%&+ *HCC?8@8AG4?4?4A68*;88G A9BE@4G<BA
88=H=CB5@GIDD@9A9BH5@65@5B79G<99H=B:CFA5H=CB=GDFCJ=898=BH<9H56@9H<5H:C@@CKG
$<??<BAF
&G;8E6HEE8AG4FF8GF
9F=J5H=J95GG9HG 7IFF9BH
"BGIF5B79F9@5H98F979=J56@9G DF9D5=89LD9BG9G5B8CH<9F
(H<9F
-CH5@CH<9F7IFF9BH5GG9HG
'EBC8EGL C?4AG4A78DH<C@8AG 4G6BFG
%5B8
I=@8=B;G5B8@95G9<C@8=ADFCJ9A9BHG
&57<=B9FM5B89EI=DA9BH
CBGHFI7H=CB=BDFC;F9GG
FCGGDFCD9FHM D@5BH5B89EI=DA9BH
77IAI@5H9889DF97=5H=CB
)FCD9FHM D@5BH5B89EI=DA9BH B9H
&G;8E4FF8GF
9:9FF98=B7CA9H5L9G
)F9D5=8D9BG=CB5B8DCGHF9H=F9A9BH
"BGIF5B79F9@5H98F979=J56@9G5B8CH<9F
5G<GIFF9B89FJ5@I9C:@=:9=BGIF5B79DC@=7=9G
EI=HMA9H<C8=BJ9GHA9BHG
EI=HM5B8CH<9F=BJ9GHA9BHG
(H<9F
-CH5@CH<9F5GG9HG
&G;8E6HEE8AG?<45<?<G<8F
77FI98F965H9G
9:9FF98F9J9BI9
9F=J5H=J9@=56=@=H=9G
AD@CM9969B9:=HG5B8K=H<<C@8=B;G
CBH=B;9BH@=56=@=HM7@5=AG5B8CH<9F
)FCD9FHM G5@9G F9@5H985B8CH<9FH5L9G
)9BG=CB5B8DCGHF9H=F9A9BH69B9:=HG
(H<9F
-CH5@CH<9F7IFF9BH@=56=@=H=9G
&G;8E?<45<?<G<8F
%CB;H9FA=B7CA9H5L9GD5M56@9
AD@CM9969B9:=HG
CBH=B;9BH@=56=@=HM7@5=AG5B8CH<9F
=B5B79@95G9C6@=;5H=CBG
9:9FF98=B7CA9H5L9G
(H<9F
-CH5@CH<9F@=56=@=H=9G
-- 77 of 142 --
%&+ *HCC?8@8AG4?DH<GL4A7B@CE8;8AF<I8 A6B@8 A9BE@4G<BA
CAACBGHC7? D5FJ5@I9D9FG<5F9C:6=@@=CBG<5F9G=G5IH<CF=N98 K=H< G<5F9G=GGI985GC:979A69F
5B8 )F9:9FF98GHC7? K=H<CIHD5FJ5@I9 C:A=@@=CBG<5F9G=G5IH<CF=N986IHIB=GGI98
5G<8=J=89B8G897@5F985B8D5=8HCH5@98 5B8 D9FG<5F9:CF957<EI5FH9F=B 5B8
F9GD97H=J9@M K<=7<F9GI@H98=BHCH5@M95F897@5F985B8D5=88=J=89B8GC: 5B8 D9FG<5F9 F9GD97H=J9@M
"B7CBB97H=CBK=H<&WG#5BI5FM 58CDH=CBC:,.'C +97@5GG=:=75H=CBC:9FH5=B-5L::97HG:FCA
77IAI@5H98(H<9FCADF9<9BG=J9"B7CA9 5B8,.'C %95G9G H<9CAD5BMF97CF8985B=B7F95G9=BF9H5=B98
95FB=B;GC:5DDFCL=A5H9@M 6=@@=CBK=H<C::G9HH=B;=B7F95G9HC577IAI@5H98CH<9F7CADF9<9BG=J9@CGG:CFH<9G5A95ACIBH
5B8A=@@=CB F9GD97H=J9@M
;4A:8F<A66H@H?4G87&G;8EB@CE8;8AF<I8 A6B@8#BFFGGE<5HG45?8GB$5LB@CBA8AG
$<??<BAF
H@H?4G<I8
+E4AF?4G<BA
7=HFG@8AG
89<A878A89<G
'8AF<BA4A7
'BFGE8G<E8@8AG
'?4AF
7=HFG@8AG
4F;?BJ
87:<A:
AFGEH@8AGF
,AE84?<M87
4<A#BFF
+BG4?
66H@H?4G87
&G;8E
B@CE8;8AF<I8
A6B@8#BFF
4?4A684G868@58E A8GB9G4K
"AD57HC:8CDH=CBC:,.'C
(H<9F7CADF9<9BG=J9=B7CA9@CGG 69:CF9H5L
ACIBHG69:CF9F97@5GG=:=75H=CBG
ACIBHGF97@5GG=:=98CIH
-CH5@CH<9F7CADF9<9BG=J9=B7CA9@CGG 69:CF9H5L
-5L9::97H
-CH5@CH<9F7CADF9<9BG=J9=B7CA9@CGG B9HC:H5L
4?4A684G868@58E A8GB9G4K
(H<9F7CADF9<9BG=J9=B7CA9@CGG 69:CF9H5L
ACIBHG69:CF9F97@5GG=:=75H=CBG
ACIBHGF97@5GG=:=98CIH T
-CH5@CH<9F7CADF9<9BG=J9=B7CA9@CGG 69:CF9H5L
-5L9::97H
-CH5@CH<9F7CADF9<9BG=J9=B7CA9@CGG B9HC:H5L
4?4A684G868@58E A8GB9G4K
(H<9F7CADF9<9BG=J9=B7CA9@CGG 69:CF9H5L
ACIBHG69:CF9F97@5GG=:=75H=CBG
ACIBHGF97@5GG=:=98CIH N
-CH5@CH<9F7CADF9<9BG=J9=B7CA9@CGG 69:CF9H5L
-5L9::97H
-CH5@CH<9F7CADF9<9BG=J9=B7CA9@CGG B9HC:H5L
4?4A684G868@58E A8GB9G4K
"B7CA9H5L9G5F9BCHDFCJ=898:CF:CF9=;BHF5BG@5H=CBF9@5H=B;HCD9FA5B9BH=BJ9GHA9BHG=B=BH9FB5H=CB5@GI6G=8=5F=9G 6IHH5L
9::97HGK=H<=B7IAI@5H=J9HF5BG@5H=CB8C9G=B7@I89=AD57HG:FCA=H9AGGI7<5GB9H=BJ9GHA9BH<98;9HF5BG57H=CBG
+97@5GG=:=75H=CB58>IGHA9BHG5F9A589HC5JC=88CI6@97CIBH=B;=B7CADF9<9BG=J9=B7CA9=H9AGH<5H5F9GI6G9EI9BH@MF97CF898
5GD5FHC:B9H=B7CA9
-- 78 of 142 --
)86?4FF<9<64G<BAFBHGB966H@H?4G87&G;8EB@CE8;8AF<I8 A6B@8GGE<5HG45?8GB$
8G4<?F45BHG66H@H?4G87&G;8EB@CE8;8AF<I8 A6B@8
B@CBA8AGF$<??<BAF
@BHAGF)86?4FF<9<879EB@
66H@H?4G87&G;8EB@CE8;8AF<I8 A6B@8
#B64G<BABA
A6B@8*G4G8@8AG
084E8A787868@58E
IAI@5H=J9HF5BG@5H=CB58>IGHA9BH
97CBGC@=85H=CBC:/9B9NI9@5BGI6G=8=5FM N T (H<9F9LD9BG9=B7CA9 B9H
-CH5@69:CF9H5L N T
-5L9::97H N T T )FCJ=G=CB:CF=B7CA9H5L9G
'9HC:H5L N T
9:=B9869B9:=HD9BG=CB5B8DCGHF9H=F9A9BHD@5BG
58>IGHA9BHG
5=BG@CGG9G5GGC7=5H98K=H<89:=B9869B9:=H
D9BG=CB5B8DCGHF9H=F9A9BHD@5BG5ACFH=N5H=CB
-F5BG=H=CB5GG9H T (H<9F9LD9BG9=B7CA9 B9H
)F=CFG9FJ=7969B9:=H (H<9F9LD9BG9=B7CA9 B9H
'9H57HI5F=5@@CGG (H<9F9LD9BG9=B7CA9 B9H
IFH5=@A9BHG ,9HH@9A9BHG (H<9F9LD9BG9=B7CA9 B9H
97CBGC@=85H=CBC:/9B9NI9@5BGI6G=8=5FM N T (H<9F9LD9BG9=B7CA9 B9H
-CH5@69:CF9H5L
-5L9::97H )FCJ=G=CB:CF=B7CA9H5L9G
'9HC:H5L
5G<:@CK<98;=B;=BGHFIA9BHG;5=BG@CGG9G
CF9=;B7IFF9B7M:CFK5F8 CDH=CB7CBHF57HG CGHC:G5@9G
"BH9F9GHF5H97CBHF57HG "BH9F9GH9LD9BG9
-CH5@69:CF9H5L
-5L9::97H )FCJ=G=CB:CF=B7CA9H5L9G
'9HC:H5L
-CH5@F97@5GG=:=75H=CBG:CFH<9D9F=C8 B9HC:H5L
%&+ *HCC?8@8AG4?4F;?BJ A9BE@4G<BA
$<??<BAF
5G<=B7CA9H5LD5MA9BHG B9HC:F9:IB8G
5G<=BH9F9GHD5MA9BHG
5G<=BH9F9GHD5MA9BHG=B7@I89=BH9F9GHD5=8CB896H5B8:=B5B79@95G965@5B79G 5G<=BH9F9GHD5MA9BHG9L7@I89H<975G<D5=8
:CF95F@M896H9LH=B;I=G<A9BH7CGHG 88=H=CB5@89H5=@G5F989G7F=698=B'CH9
"B8=J=8I5@5ACIBHG=BH<9CBGC@=85H98,H5H9A9BHC:5G<@CKG9L7@I89H<9=AD57HGC:57EI=G=H=CBG 8=J9GH=HIF9G5B89L7<5B;9
F5H9=AD57HG K<=7<5F9DF9G9BH98G9D5F5H9@M
%&+ A6B@8+4K8F
A6B@889BE8 A6B@8+4K8F
$<??<BAF
.B=H98,H5H9G
"BH9FB5H=CB5@
-CH5@
-- 79 of 142 --
'EBI<F<BA9BE A6B@8+4K8F
$<??<BAF
IFF9BH@MD5M56@9
989F5@
,H5H9
"BH9FB5H=CB5@
9:9FF98
989F5@
,H5H9
"BH9FB5H=CB5@
-CH5@
B@CBA8AGFB9898EE87+4KFF8GF4A7#<45<?<G<8F
$<??<BAF
9:9FF98H5L5GG9HG
77FI5@GBCH7IFF9BH@M898I7H=6@9
AD@CM9969B9:=H7CGHG
)FC8I7H5B8CH<9F7@5=AG
&=G79@@5B9CIG577FI5@G
)9BG=CB7CGHG
,HC7? 65G987CAD9BG5H=CB
8J5B798D5MA9BHG T
'9HCD9F5H=B; 75D=H5@@CGG GH5H9H5L7F98=H75FFM:CFK5F8G
CF9=;BH5L7F98=HG
IFF9B7MHF5BG@5H=CB N
%95G9@=56=@=H=9G
)FC8I7H5B8CH<9F=BGIF5B79F979=J56@9G N
"BJ9BHCFM
(H<9F
FCGG89:9FF98H5L5GG9HG
/5@I5H=CB5@@CK5B79
-CH5@89:9FF98H5L5GG9HG
9:9FF98H5L@=56=@=H=9G
)FC8I7H5B8CH<9F=BGIF5B79F979=J56@9G N
779@9F5H9889DF97=5H=CB
"BH5B;=6@95ACFH=N5H=CB
+=;<H C: IG95GG9H
-CH5@89:9FF98H5L@=56=@=H=9G
'9H89:9FF98H5L5GG9HG
-<9B9H89:9FF98H5L5GG9HG5F9=B7@I8985G7CADCB9BHGC:(H<9FGG9HG5B8(H<9F%=56=@=H=9GK=H<=BH<9CBGC@=85H985@5B79
,<99H ,99'CH9U,IDD@9A9BH5@5@5B79,<99H"B:CFA5H=CBV:CF:IFH<9F89H5=@G
GC:979A69F H<9CAD5BM<58H5L9::97H98CD9F5H=B;@CGG9G 75D=H5@@CGG9G 5B8H5L7F98=H75FFMCJ9FG:CF:989F5@
5DDFCL=A5H9@MA=@@=CB GH5H95DDFCL=A5H9@MA=@@=CB 5B8=BH9FB5H=CB5@5DDFCL=A5H9@MA=@@=CB K=H<5@@
5ACIBHG69:CF9@=A=H5H=CB=AD57HG5B8J5@I5H=CB5@@CK5B79G 989F5@H5L5HHF=6IH975FFMCJ9FGK=@@9LD=F95:H9FCB9HCM95FG
H<9GH5H95:H9FCB9HCM95FG 5B8H<9=BH9FB5H=CB5@5:H9FCB9M95FHC5B=B89:=B=H975FFMCJ9FD9F=C8 GC:979A69F
H<9CAD5BM<5GDFCJ=898A=@@=CBC:J5@I5H=CB5@@CK5B795;5=BGH79FH5=BC:H<9G989:9FF98H5L5GG9HG65G98CB
A5B5;9A9BHWG89H9FA=B5H=CBH<5H=H=GACF9 @=?9@M H<5B BCHH<5HH<9H5L69B9:=HGF9@5H98HCH<9G95GG9HGK=@@BCH69F95@=N98
-- 80 of 142 --
)86BA6<?<4G<BAB99986G<I8 A6B@8+4K)4G8
,H5HIHCFM. , H5LF5H9
,H5H9=B7CA9H5L9G B9HC::989F5@69B9:=H
"BH9FB5H=CB5@=B7CA9H5L9G B9H
@C65@"BH5B;=6@9%CK-5L98"B7CA9 "%-"
CF9=;B9F=J98"BH5B;=6@9"B7CA9""
. , F9G95F7<5B889J9@CDA9BH7F98=H
+9G9FJ9G:CFH5L7CBH=B;9B7=9G
AD@CM99G<5F9 65G98D5MA9BHG
@@CH<9F B9H
::97H=J9KCF@8K=89H5LF5H9
-<99::97H=J9H5LF5H9:CF 5B8K9F9 D9F79BH D9F79BH 5B8 D9F79BH F9GD97H=J9@M -<9G9F9:@97H5
897F95G9C: D9F79BH5;9DC=BHG:FCAHC5B85:@5H7CAD5F=GCB:FCAHC -<9DF=A5FM:57HCFGH<5H
897F95G98H<99::97H=J9H5LF5H9:CFK9F9;9C;F5D<=75@=B7CA9A=L5B8:5JCF56@958>IGHA9BHG=BF9@5H98HC=AD57HGC:
. , =BH9FB5H=CB5@H5LDFCJ=G=CBG
-<9-5LIHG5B8#C6G7H-#=BJC@J985HF5BG=H=CBH5LH<5H=GD5M56@9CJ9F9=;<HM95FG69;=BB=B;=B GC:
979A69F 5B8979A69F &F9:@97H98A=@@=CB5B8A=@@=CB F9GD97H=J9@M =B@CB;H9FA=B7CA9
H5L9GD5M56@9 GC:979A69F 5B8979A69F &F9:@97H98A=@@=CB5B8A=@@=CB F9GD97H=J9@M
D5M56@9K=H<=BCB9M95F5GGC7=5H98K=H<H<9HF5BG=H=CBH5L
-<9"+,<5G7CAD@9H98=HG:=9@89L5A=B5H=CBC:H<9CAD5BMWG. , :989F5@=B7CA9H5LF9HIFBGH<FCI;< 6IHH<9M95FG
H<FCI;<<5J9BCH7@CG985GH<9CAD5BM=G=BH<9DFC79GGC:F9GC@J=B;=GGI9G=89BH=:=988IF=B;H<CG99L5A=B5H=CBG
"B588=H=CBHCH<9. , :989F5@9L5A=B5H=CB H<9F9=G5@GC5I8=H57H=J=HM=BG9J9F5@. , GH5H95B8:CF9=;B>IF=G8=7H=CBGK<9F9H<9
CAD5BM=GGI6>97HHCCB;C=B;H5L9L5A=B5H=CBG5B8;CJ9FBA9BH5@5GG9GGA9BHG K<=7<7CI@869=AD57H986M9JC@J=B;DC@=H=75@
9BJ=FCBA9BHG=BH<CG9>IF=G8=7H=CBG GC:979A69F BCH5L=B;5IH<CF=HMDFCDCG98G=;B=:=75BH58>IGHA9BHGHCH<9
CAD5BMWGH5LDCG=H=CBG:CFK<=7<H<9CAD5BM=GBCH589EI5H9@MF9G9FJ98
"H=GF95GCB56@MDCGG=6@9H<5HH<95ACIBHC:IBF97C;B=N98H5L69B9:=HG7CI@8G=;B=:=75BH@M7<5B;9K=H<=BH<9B9LHACBH<G -<9
CAD5BM<5GCB;C=B;:989F5@ GH5H95B8=BH9FB5H=CB5@=B7CA9H5L5I8=HG=BJ5F=CIG>IF=G8=7H=CBG5B89J5@I5H9GIB79FH5=BH5L
DCG=H=CBGH<5HA5M697<5@@9B;986M@C75@H5L5IH<CF=H=9G5B8BCH:I@@MGIGH5=B98 -<9G9IB79FH5=BH5LDCG=H=CBG5F9F9J=9K98CB
5BCB;C=B;65G=G5B858>IGH98=B@=;<HC::57HG5B87=F7IAGH5B79G=B7@I8=B;DFC;F9GG=CBC:H5L5I8=HG 89J9@CDA9BHG=B75G9@5K
5B87@CG=B;GH5HIH9GC:@=A=H5H=CB HH<=GH=A9 H<9CAD5BM=GBCH56@9HC9GH=A5H9H<9F5B;96MK<=7<H<9G9DCH9BH=5@9J9BHG
7CI@8=AD57H&WGIBF97C;B=N98H5L69B9:=HGK=H<=BH<9B9LHACBH<G
-<9CAD5BMF97C;B=N9GH<95ACIBHC:H5L69B9:=HH<5H<5G5;F95H9FH<5BD9F79BH@=?9@=<CC8C:69=B;I@H=A5H9@MF95@=N98
IDCBG9HH@9A9BH F97CB7=@=5H=CBC:H<969;=BB=B;5B89B8=B;5ACIBHC:;FCGGIBF97C;B=N98H5L69B9:=HG.-=G5G:C@@CKG
-- 81 of 142 --
878E4? *G4G84A7BE8<:A+4K
$<??<BAF
FCGG.-5@5B795H#5BI5FM
88=H=CBG65G98CBH5LDCG=H=CBGF9@5H98HCH<97IFF9BHM95F
88=H=CBG:CFH5LDCG=H=CBGC:DF=CFM95FG
88=H=CBGF9@5H98HCF979BH57EI=G=H=CBG N T
+98I7H=CBG:CFH5LDCG=H=CBGC:DF=CFM95FG
,9HH@9A9BHG
+98I7H=CBG8I9HC@5DG9C:5DD@=756@9GH5HIH9C:@=A=H5H=CBG
FCGG.-5@5B795H979A69F
'9H.-H<5HKCI@8=AD57HH<99::97H=J9H5LF5H95H979A69F
-<9HCH5@5ACIBHC:.- =:F97C;B=N98 KCI@85::97HH<99::97H=J9H5LF5H96M A=@@=CB5GC:979A69F
A=@@=CB5GC:979A69F 5B8 A=@@=CB5GC:979A69F -<99B8=B;B9H.-F9GI@HG:FCA58>IGH=B;H<9
;FCGG65@5B79:CF89:9FF98=H9AG =BH9F9GH5B8D9B5@H=9G 5B8898I7H=6@9H5L9G -<9B9H.-=G=B7@I8985G7CADCB9BHGC:(H<9F
GG9HG 77FI98"B7CA9-5L9G 5B8(H<9F%=56=@=H=9GK=H<=BH<9CBGC@=85H985@5B79,<99H
-<9CAD5BMF97C;B=N9G=BH9F9GH5B8D9B5@H=9G577FI98F9@5H98HCIBF97C;B=N98H5L69B9:=HG=BH5L9LD9BG9 -<9CAD5BM
F97C;B=N98=BH<97CBGC@=85H98GH5H9A9BHC:=B7CA9CB5;FCGG65G=G5DDFCL=A5H9@MA=@@=CBC:9LD9BG9 A=@@=CBC:
9LD9BG9 5B8A=@@=CBC:9LD9BG9=B 5B8 F9GD97H=J9@M -<95ACIBHC:=BH9F9GH5B8D9B5@H=9GF97C;B=N98
A5M695B9LD9BG9CF69B9:=H8I9HCB9KCFF9A95GIF98IBF97C;B=N98H5L69B9:=H577FI5@G H979A69F 5B8
979A69F 577FI98=BH9F9GH5B8D9B5@H=9G=BH<97CBGC@=85H9865@5B79G<99HCB5;FCGG65G=GK9F9A=@@=CB5B8
A=@@=CB F9GD97H=J9@M "B7@I898=BH<9G9=BH9F9GH5B8D9B5@HM5ACIBHG5F9=BH9F9GH5B8D9B5@H=9GF9@5H98HCH5LDCG=H=CBG:CF
K<=7<H<9I@H=A5H9898I7H=6=@=HM=G<=;<@M79FH5=B6IH:CFK<=7<H<9F9=GIB79FH5=BHM56CIHH<9H=A=B;C:GI7<898I7H=6=@=HM
G5F9GI@HC:79FH5=B9AD@CMA9BH7CAA=HA9BHG5B875D=H5@=BJ9GHA9BHGA5896M& =B7CA9:FCA79FH5=B:CF9=;BCD9F5H=CBG
=BH<9:C@@CK=B;7CIBHF=9G=GGI6>97HHCF98I798H5LF5H9GCF =BGCA975G9G =G9L9ADH:FCAH5L:CFM95FGH<FCI;<H<9:C@@CK=B;
<=B5 ,K=HN9F@5B8 F5N=@5B8,=B;5DCF9 -<9=B7CA9H5L69B9:=HG5HHF=6IH56@9HCH<9H5LGH5HIGC:
H<9G9GI6G=8=5F=9G5F99GH=A5H98HC69A=@@=CB79BHGD9F8=@IH98G<5F9=B A=@@=CB79BHGD9F8=@IH98
G<5F9=B 5B8A=@@=CB79BHGD9F8=@IH98G<5F9=B
GC:979A69F H<9CAD5BM<5G5DDFCL=A5H9@M 6=@@=CBC:IB8=GHF=6IH9895FB=B;G=B=HG:CF9=;BGI6G=8=5F=9G
DDFCL=A5H9@M 6=@@=CBC:H<9G995FB=B;G5F9BC@CB;9F7CBG=89F98D9FA5B9BH@MF9=BJ9GH98 -<9=B7F9A9BH5@H5L7CGHHC
F9D5HF=5H9H<9G995FB=B;GHCH<9.,=G=AA5H9F=5@ -<9CAD5BM<5GBCHDFCJ=89889:9FF98H5L9GCB5DDFCL=A5H9@M 6=@@=CB
C:IB8=GHF=6IH9895FB=B;G:FCABCB . , GI6G=8=5F=9G5GC:979A69F K<=7<5F9=B89:=B=H9@MF9=BJ9GH98=BCD9F5H=CBG
975IG9C:H<9AI@H=D@95J9BI9G6MK<=7<HCF9D5HF=5H9H<995FB=B;GHCA=B=A=N9H5L7CGH 5B86975IG95@5F;9DCFH=CBC:H<9G9
95FB=B;G5F9BCH@=EI=8 =H=GBCHDF57H=75@HC89H9FA=B9H<9=B7CA9H5L@=56=@=HMH<5HKCI@869D5M56@9=:GI7<95FB=B;GK9F9BCH
F9=BJ9GH98=B89:=B=H9@M
-- 82 of 142 --
%&+ $4E>8G45?8*86HE<G<8F
$4E>8G45?8*86HE<G<8F
-<9CAD5BM=BJ9GHG=B5GG9H 657?98G97IF=H=9G 79FH=:=75H9GC:89DCG=H H=A989DCG=HG 7CAA9F7=5@D5D9F 5B8CH<9FG97IF=H=9G
-<9:C@@CK=B;=G5GIAA5FMC:5ACIBHGF97CF898CBH<9CBGC@=85H985@5B79,<99H:CFA5F?9H56@9G97IF=H=9G7IFF9BH5B8BCB
7IFF9BH
$<??<BAF
CFDCF5H9896HG97IF=H=9G N
CAA9F7=5@D5D9F
9FH=:=75H9GC:89DCG=H H=A989DCG=HG
. , HF95GIFMG97IF=H=9G
. , AIB=7=D5@G97IF=H=9G
HEE8AG@4E>8G45?8F86HE<G<8F
. , AIB=7=D5@G97IF=H=9G
%BA 6HEE8AG@4E>8G45?8F86HE<G<8F
+BG4?@4E>8G45?8F86HE<G<8F
H979A69F 5B8 ;FCGGIBF95@=N98 ;FCGGF95@=N98 5B8B9HF95@=N98;5=BG5B8 CF@CGG9GDF9 H5LK9F9BCH
A5H9F=5@
-<965@5B795H979A69F :CFA5F?9H56@9G97IF=H=9G6M7CBHF57HI5@A5HIF=HM5F9G<CKB69@CK 7HI5@A5HIF=H=9GA5M
8=::9F:FCA7CBHF57HI5@A5HIF=H=9G6975IG9H<9=GGI9FGC:H<9G97IF=H=9GA5M<5J9H<9F=;<HHCDF9D5MC6@=;5H=CBGK=H<CIH
DF9D5MA9BHD9B5@H=9G
$<??<BAF
I9=BCB9M95FCF@9GG
I95:H9FCB9M95FH<FCI;<:=J9M95FG
I95:H9F:=J9M95FGH<FCI;<H9BM95FG
-CH5@A5F?9H56@9G97IF=H=9G
%&+ #BA: +8E@85G4A7*;BEG +8E@BEEBJ<A:F
-<9:C@@CK=B;896HH56@9GF9:@97H9::97H=J9=BH9F9GHF5H9G K<=7<=B7@I89H<9=AD57HC:=BH9F9GHF5H9GK5DG 5GC:979A69F
":H<9896HK5G=GGI98CB57CA6=B9865G=G H<9896H<5G699BG9D5F5H98HCG<CKH<9=AD57HC:H<9:=L98J9FGIG:@C5H=B;
9::97H=J9=BH9F9GHF5H9G 5FFM=B;J5@I9=B7@I89GH<9=AD57HC:896H=GGI5B797CGHG5B8:5=FJ5@I9<98;=B;57H=J=HM %CB; H9FA
896H5B8G<CFH H9FA6CFFCK=B;G5GC:979A69F7CBG=GH98C:H<9:C@@CK=B;
-- 83 of 142 --
#BA: +8E@85G
$<??<BAF HEE8A6L
<K87IF ?B4G<A: 9986G<I8
AG8E8FG)4G8 <A4?
$4GHE<GL4G8
4EEL<A:-4?H8
8F6E<CG<BA 'E<A6<C4?@BHAG
IFC6CB8F9D5=8=B .+=L98 T N
IFC6CB8F9D5=8=B .+@C5H=B; T N
&98=IA H9FABCH9F9D5=8=B .,=L98 T N
&98=IA H9FABCH9XA=@@=CB .+=L98
&98=IA H9FABCH9A=@@=CB .,=L98
&98=IA H9FABCH9XA=@@=CB .+=L98
+9;=GH9F98BCH9A=@@=CB .,=L98
&98=IA H9FABCH9A=@@=CB .,=L98
&98=IA H9FABCH9A=@@=CB .,=L98
&98=IA H9FABCH9A=@@=CB .,=L98
&98=IA H9FABCH9A=@@=CB .,@C5H=B;
&98=IA H9FABCH9A=@@=CB .,=L98
+9;=GH9F98BCH9A=@@=CB .,=L98
+9;=GH9F98BCH9A=@@=CB .,=L98
&98=IA H9FABCH9XA=@@=CB .+=L98
&98=IA H9FABCH9A=@@=CB .,=L98
&98=IA H9FABCH9A=@@=CB .,=L98
@C5H=B;F5H9BCH9A=@@=CB .,@C5H=B; T
M95F8969BHIF9A=@@=CB .,=L98
@C5H=B;F5H9BCH9A=@@=CB .,@C5H=B; T
@C5H=B;F5H9BCH9A=@@=CB .,@C5H=B; T
@C5H=B;F5H9BCH9A=@@=CB .,@C5H=B; T
&98=IA H9FABCH9A=@@=CB .,=L98
@C5H=B;F5H9BCH9A=@@=CB .,@C5H=B; T
@C5H=B;F5H9BCH9A=@@=CB .,@C5H=B; T
+9;=GH9F98BCH96=@@=CB .,=L98
&98=IA H9FABCH9A=@@=CB .,=L98
&98=IA H9FABCH9XA=@@=CB .+=L98
+9;=GH9F98BCH9A=@@=CB .,=L98
&98=IA H9FABCH9XA=@@=CB .+=L98
M95F6CB8A=@@=CB .,=L98
@C5H=B;F5H9BCH9A=@@=CB .,@C5H=B; T
@C5H=B;F5H9BCH9A=@@=CB .,@C5H=B; T
&98=IA H9FABCH9A=@@=CB .,=L98
@C5H=B;F5H9BCH9A=@@=CB .,@C5H=B; T
&98=IA H9FABCH9A=@@=CB .,=L98
&98=IA H9FABCH9A=@@=CB .,=L98
&98=IA H9FABCH9A=@@=CB .,=L98
&98=IA H9FABCH9A=@@=CB .,=L98
+9;=GH9F98BCH9A=@@=CB .,=L98
+9;=GH9F98BCH9A=@@=CB .,=L98
(H<9F6CFFCK=B;G /5F=CIG
-CH5@@CB; H9FA896H
%9GG7IFF9BHDCFH=CBC:@CB; H9FA896H
%CB; H9FA896H9L7@I8=B;7IFF9BHDCFH=CB
-- 84 of 142 --
'BFG *J4CBEEBJ<A:#BA: +8E@85G A6?H7<A:HEE8AG'BEG<BA
$<??<BAF 4EEL<A:
-4?H8
9986G<I8
AG8E8FG)4G8
4EEL<A:
-4?H8
9986G<I8
AG8E8FG)4G8
=L98 F5H9896H
@C5H=B; F5H9896H
-CH5@@CB; H9FA896H =B7@I8=B;7IFF9BHDCFH=CB
*;BEG +8E@BEEBJ<A:F4A7HEE8AG'BEG<BAB9#BA: +8E@85G
9986G<I8
AG8E8FG)4G8
4EEL<A:-4?H8
$<??<BAF
IFF9BHDCFH=CBC:@CB; H9FA896H
. , 8C@@5F7CAA9F7=5@D5D9F N N T
(H<9F6CFFCK=B;G
-CH5@G<CFH H9FA6CFFCK=B;G5B87IFF9BHDCFH=CBC:@CB; H9FA896H
(H<9FG<CFH H9FA6CFFCK=B;GDF=A5F=@M7CBG=GH98C:65B?6CFFCK=B;G6M=BH9FB5H=CB5@GI6G=8=5F=9G
HGHE8$4GHE<G<8FB9#BA: G8E@85G
&5HIF=H=9GC:@CB; H9FA896H=BH<9H56@969@CKF9:@97HH<9=AD57HC:DIHDFCJ=G=CBG5GGC7=5H98K=H<79FH5=B896H=BGHFIA9BHG5B8
5F9B9HC:H<9IB577F9H98896H=GGI97CGHGGI7<H<5HHCH5@A5HIF=H=9G9EI5@H<975FFM=B;J5@I9C:@CB; H9FA896H5GC:
979A69F -<9A5HIF=H=9GC:@CB; H9FA896H:CFH<9D9F=C8GGI6G9EI9BHHC979A69F 5F95G:C@@CKG=B
A=@@=CBG
9G8E +BG4?
G5F9GI@HC:DIHDFCJ=G=CBG5GGC7=5H98K=H<79FH5=B896H=BGHFIA9BHG @CB; H9FA896HD5MA9BHG8I9=B=B7@I89:@C5H=B;F5H9
BCH9GHCH5@=B;A=@@=CB7@5GG=:=985G7IFF9BHDCFH=CBC:@CB; H9FA896H5B8A=@@=CB8I9=B
E87<G46<?<G<8F
&<5G5B5A9B8985B8F9GH5H98 6=@@=CB:=J9 M95FF9JC@J=B;7F98=H:57=@=HM9LD=F=B;=B'CJ9A69F -<9F9JC@J=B;
7F98=H5;F99A9BH=B7@I89G5DFCJ=G=CBIB89FK<=7<&A5MF9EI9GH5B=B7F95G9C:IDHC 6=@@=CB5H@9B89FWG8=G7F9H=CB
6F=B;=B;H<9HCH5@:57=@=HMIDHC 6=@@=CB "B588=H=CB &9BH9F98=BHC5 6=@@=CB 85M7F98=H:57=@=HM K<=7<K5G
F9B9K98=B'CJ9A69FK=H<5B9LD=F5H=CB85H9C:'CJ9A69F -<9 85M7F98=H5;F99A9BH=B7@I89G5DFCJ=G=CB
IB89FK<=7<&A5M7CBJ9FH5BM58J5B79GCIHGH5B8=B;CBH<9A5HIF=HM85H9=BHCH9FA@C5BG<5J=B;5A5HIF=HM85H9CB9M95F
@5H9F -<9G97F98=H:57=@=H=9GK9F9IB8F5KB5H979A69F .B89F6CH<H<9 6=@@=CB5B8 6=@@=CB7F98=H
5;F99A9BHG H<9CAD5BM=GF9EI=F98HCA5=BH5=B=HG"-HC"BH9F9GH+5H=C5GC:H<99B8C:957<:=G75@EI5FH9F5HBCH@9GG
H<5B HC -<=G=G75@7I@5H985G89:=B98=BH<95;F99A9BH5GH<9F5H=CC:7CBGC@=85H98HCH5@"-:CFH<9:CIF7CBG97IH=J9
EI5FH9FGH<9B9B898HCHCH5@=BH9F9GH9LD9BG9CB5@@:IB898896H:CFH<9G5A9D9F=C8 H979A69F H<=GF5H=CK5G
5DDFCL=A5H9@MHC 96H7CJ9B5BHG8CBCHF9GHF=7HH<9D5MA9BHC:8=J=89B8G
"B979A69F &9BH9F98=BHC56=@@=CB896H:=B5B7=B;7CAA=HA9BHF9@5H98HCH<9=BH9B898CC8,5:9HM=J=G=CBGD=B
C::CFGD@=H C::HF5BG57H=CB8=G7IGG98=B'CH9 -<=G7CAA=HA9BHDFCJ=89GDCH9BH=5@6F=8;9:=B5B7=B;:CFH<9CC8,5:9HM
6IG=B9GGGD5MA9BHC:5DDFCL=A5H9@M6=@@=CBC:7CBG=89F5H=CB GI6>97HHC7@CG=B;5B8CH<9F58>IGHA9BHG HC&IB89FH<9
H9FAGC:H<9HF5BG57H=CB ACIBHGCIHGH5B8=B;IB89FH<=G:57=@=HM<5J95H9FAC:85MG:C@@CK=B;H<96CFFCK=B;85H95B85F9
F9EI=F98HC69F9D5=8K<9B79FH5=B7CB8=H=CBG5F9A9H =B7@I8=B;IDCB7CAD@9H=CBC:D9FA5B9BH:=B5B7=B; -<=G7CAA=HA9BH
K5GIB8F5KB5H979A69F .DCBH<97@CG9C:H<9GD=B C::CFGD@=H C::HF5BG57H=CB CIHGH5B8=B;C6@=;5H=CBGIB89FH<9
7CAA=HA9BHHF5BG:9FK=H<H<9CC8,5:9HM6IG=B9GG5B8697CA9H<CG9C:H<9G9D5F5H9B9K@M7CA6=B987CAD5BM
&G;8EE87<G46<?<G<8F
D5FH:FCAH<97CAA=HH987F98=H:57=@=H=9G89G7F=69856CJ9 =B,9DH9A69F &9BH9F98=BHC57F98=H:57=@=HM=B=H=5@@M
9LD=F=B;=B#I@MH<5HK5G:IFH<9F9LH9B898HCI;IGH=BH<95ACIBHC:6=@@=CB#5D5B9G9M9B "B'CJ9A69F
-- 85 of 142 --
3M entered into a credit facility expiring in November 2020 in the amount of 150 million euros. During the third quarter of
2020, the Company paid the outstanding balances and closed these credit facilities.
The Company also had an additional $266 million in stand-alone letters of credit and bank guarantees issued and outstanding at
December 31, 2021. These instruments are utilized in connection with normal business activities.
Long-Term Debt Issuances and Fixed-to-Floating Interest Rate Swaps
The principal amounts, interest rates and maturity dates of individual long-term debt issuances can be found in the long-term
debt table found at the beginning of this note.
During the second and third quarters of 2021, 3M entered into interest rate swaps with an aggregate notional amount of
$800 million. These swaps converted $500 million and $300 million of 3M’s $1.0 billion and $650 million principal amount of
fixed rate notes due 2049 and 2050, respectively, into floating rate debt for the portion of their terms through mid-2028 with an
interest rate based on a three-month LIBOR index.
In March 2020, 3M issued $1.75 billion aggregate principal amount of fixed rate registered notes. These were comprised of
$500 million of 5-year notes due 2025 with a coupon rate of 2.65%, $600 million of 10-year notes due 2030 with a coupon rate
of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%.
In February 2019, 3M issued $2.25 billion aggregate principal amount of fixed rate medium-term notes. These were comprised
of $450 million of 3-year notes due 2022 with a coupon rate of 2.75%, $500 million of remaining 5-year notes due 2024 with a
coupon rate of 3.25%, $800 million of 10-year notes due 2029 with a coupon rate of 3.375%, and $500 million of remaining
29.5-year notes due 2048 with a coupon rate of 4.00%. Issuances of the 5-year and 29.5-year notes were pursuant to a
reopening of existing securities issued in September 2018.
In August 2019, 3M issued $3.25 billion aggregate principal amount of fixed rate registered notes. These were comprised of
$500 million of 3.5-year notes due 2023 with a coupon rate of 1.75%, $750 million of 5.5-year notes due 2025 with a coupon
rate of 2.00%, $1.0 billion of 10-year notes due 2029 with a coupon rate of 2.375%, and $1.0 billion of 30-year notes due 2049
with a coupon rate of 3.25%.
Long-Term Debt Maturities and Extinguishments
In November 2021, 3M repaid 600 million euros aggregate principal amount of Eurobonds that matured.
In March 2021, 3M, via a make-whole-call offer, redeemed $450 million principal amount of 2.75% notes due 2022. The
Company recorded an early debt extinguishment pre-tax charge of approximately $11 million within interest expense. This
charge reflected the differential between the carrying value and the amount paid to reacquire the notes and related expenses.
In December 2020, 3M, via make-whole-call offers, repaid $1 billion aggregate principal amount of its outstanding notes. This
included $400 million aggregate principal amount of 3.00% notes and $600 million aggregate principal amount of 1.625%
notes, both of which were due to mature in 2021. The Company recorded an early debt extinguishment pre-tax charge of
approximately $10 million within interest expense. This charge reflected the differential between the carrying value and the
amount paid to reacquire the notes and related expenses.
In May 2020, 3M repaid 650 million euros aggregate principal amount of floating-rate medium-term notes that matured. In
August 2020, 3M repaid $500 aggregate principal amount of floating rate medium-term notes that matured.
In June 2019, 3M repaid $625 million aggregate principal amount of fixed-rate medium-term notes that matured.
In 2019, 3M also assumed approximately $2.6 billion of debt in connection with the acquisitions of Acelity and M*Modal (See
Note 3) of which $2.1 billion was immediately redeemed or paid at close.
In-Substance Defeasance
In conjunction with the October 2019 acquisition of Acelity (see Note 3), 3M assumed outstanding debt of the business, of
which $445 million in principal amount of third lien senior secured notes (Third Lien Notes) maturing in 2021 with a coupon
rate of 12.5% was not immediately redeemed at closing. Instead, at closing, 3M satisfied and discharged the Third Lien Notes
via an in-substance defeasance, whereby 3M transferred cash equivalents and marketable securities to a trust with irrevocable
78
-- 86 of 142 --
instructions to redeem the Third Lien Notes on May 1, 2020. The trust assets were restricted from use in 3M’s operations and
were only used for the redemption of the Third Lien Notes that occurred in May 2020.
Floating Rate Notes
At various times, 3M has issued floating rate notes containing put provisions. 3M would be required to repurchase these
securities at various prices ranging from 99 percent to 100 percent of par value according to the reduction schedules for each
security. In December 2004, 3M issued a forty-year $60 million floating rate note, with a rate based on a floating LIBOR index.
Under the terms of this floating rate note due in 2044, holders have an annual put feature at 100 percent of par value from 2014
and every anniversary thereafter until final maturity. Under the terms of the floating rate notes due in 2027, 2040 and 2041,
holders have put options that commence ten years from the date of issuance and each third anniversary thereafter until final
maturity at prices ranging from 99 percent to 100 percent of par value. For the periods presented, 3M was required to
repurchase an immaterial amount of principal on the aforementioned floating rate notes.
NOTE 13. Pension and Postretirement Benefit Plans
As discussed in Note 1, effective in the first quarter of 2021, 3M made a change in accounting principle for net periodic pension
and postretirement plan cost. This impacted the expected return on plan assets and the amortization of net unamortized actuarial
gains or losses expense components of net periodic benefit cost. This change was applied retrospectively to all periods
presented within 3M’s financial statements.
3M has company-sponsored retirement plans covering substantially all U.S. employees and many employees outside the United
States. In total, 3M has over 75 defined benefit plans in 28 countries. Pension benefits associated with these plans generally are
based on each participant’s years of service, compensation, and age at retirement or termination. The primary U.S. defined-
benefit pension plan was closed to new participants effective January 1, 2009. The Company also provides certain
postretirement health care and life insurance benefits for its U.S. employees who reach retirement age while employed by the
Company and were employed by the Company prior to January 1, 2016. Most international employees and retirees are covered
by government health care programs. The cost of company-provided postretirement health care plans for international
employees is not material and is combined with U.S. amounts in the tables that follow.
The Company has made deposits for its defined benefit plans with independent trustees. Trust funds and deposits with
insurance companies are maintained to provide pension benefits to plan participants and their beneficiaries. There are no plan
assets in the non-qualified plan due to its nature. For its U.S. postretirement health care and life insurance benefit plans, the
Company has set aside amounts at least equal to annual benefit payments with an independent trustee.
The Company also sponsors employee savings plans under Section 401(k) of the Internal Revenue Code. These plans are
offered to substantially all regular U.S. employees. For eligible employees hired prior to January 1, 2009, employee
401(k) contributions of up to 5% of eligible compensation matched in cash at rates of 45% or 60%, depending on the plan in
which the employee participates. Employees hired on or after January 1, 2009, receive a cash match of 100% for employee
401(k) contributions of up to 5% of eligible compensation and receive an employer retirement income account cash
contribution of 3% of the participant’s total eligible compensation. All contributions are invested in a number of investment
funds pursuant to the employees’ elections. Employer contributions to the U.S. defined contribution plans were $231 million,
$201 million and $186 million for 2021, 2020 and 2019, respectively. 3M subsidiaries in various international countries also
participate in defined contribution plans. Employer contributions to the international defined contribution plans were $117
million, $103 million and $96 million for 2021, 2020 and 2019, respectively.
In May 2019 (as part of the 2019 restructuring actions discussed in Note 5), the Company began offering a voluntary early
retirement incentive program to certain eligible participants of its U.S. pension plans who met age and years of pension service
requirements. The eligible participants who accepted the offer and retired by July 1, 2019 received an enhanced pension benefit.
Pension benefits were enhanced by adding one additional year of pension service and one additional year of age for certain
benefit calculations. Approximately 800 participants accepted the offer and retired before July 1, 2019. As a result, the
Company incurred a $35 million charge related to these special termination benefits in the second quarter of 2019.
In the fourth quarter of 2019, the Company recognized a non-operating $32 million settlement expense in its U.S. non-qualified
pension plan. The charge is related to lump sum payments made to employees at retirement. The settlement expense is an
accelerated recognition of past actuarial losses.
In the second quarter of 2020, as a result of the divestiture of the drug delivery business, the Company recognized a curtailment
in its United Kingdom Pension Plan. The resulting re-measurement of the pension plan funded status reduced long-term prepaid
79
-- 87 of 142 --
D9BG=CB5B8DCGHF9H=F9A9BH5GG9HG@C75H98K=H<=BUCH<9F5GG9HGVC:H<9CAD5BMWG65@5B79G<99H6M5DDFCL=A5H9@M
A=@@=CB K<=7<K5GC::G9HK=H<=B577IAI@5H98CH<9F7CADF9<9BG=J9=B7CA9@C75H98K=H<=BH<99EI=HMG97H=CBC:H<9CAD5BMWG
65@5B79G<99H -<99LD9BG9=AD57HC:H<=GF9 A95GIF9A9BHK5G=AA5H9F=5@:CFH<9G97CB8EI5FH9FC:5B8GI6G9EI9BH
D9F=C8G
-<9:C@@CK=B;H56@9G=B7@I895F97CB7=@=5H=CBC:H<969;=BB=B;5B89B8=B;65@5B79GC:H<969B9:=HC6@=;5H=CB5B8H<9:5=FJ5@I9C:
D@5B5GG9HG5GK9@@5G5GIAA5FMC:H<9F9@5H985ACIBHGF97C;B=N98=BH<9CAD5BMWG7CBGC@=85H9865@5B79G<99H5GC:
979A69FC:H<9F9GD97H=J9M95FG &5@GC<5G79FH5=BBCB EI5@=:=98IB:IB898D9BG=CB5B8DCGHF9H=F9A9BH69B9:=HD@5BG
=B7@IG=J9C:D@5BGF9@5H98HCGIDD@9A9BH 9L79GG69B9:=HG:CF9AD@CM99G=AD57H986MD5FH=7I@5FF9@C75H=CBG5B8CH<9FA5HH9FG H<5H
=B8=J=8I5@@M5B8=BH<95;;F9;5H95F9BCHG=;B=:=75BH5B8K<=7<5F9BCH=B7@I898=BH<9H56@9GH<5H:C@@CK -<9C6@=;5H=CBG:CF
H<9G9D@5BG5F9=B7@I898K=H<=BCH<9F@=56=@=H=9G=BH<9CAD5BMWG7CBGC@=85H9865@5B79G<99H5B85;;F9;5H98HC@9GGH<5B
A=@@=CB5GC:979A69F 5B8
(H4?<9<874A7%BA '8AF<BA8A89<GF 'BFGE8G<E8@8AG
8A89<GF ,A<G87*G4G8F AG8EA4G<BA4?
$<??<BAF
;4A:8<A58A89<GB5?<:4G<BA
9B9:=HC6@=;5H=CB5H69;=BB=B;C:M95F
7EI=G=H=CBG -F5BG:9FG N T N N T
,9FJ=797CGH
"BH9F9GH7CGH
)5FH=7=D5BH7CBHF=6IH=CBG N T N T
CF9=;B9L7<5B;9F5H97<5B;9G N T
)@5B5A9B8A9BHG N T T N T
7HI5F=5@;5=B@CGG
9B9:=HD5MA9BHG
,9HH@9A9BHG 7IFH5=@A9BHG GD97=5@H9FA=B5H=CB
69B9:=HG5B8CH<9F N T
9B9:=HC6@=;5H=CB5H9B8C:M95F
;4A:8<AC?4A4FF8GF
5=FJ5@I9C:D@5B5GG9HG5H69;=BB=B;C:M95F
7EI=G=H=CBG -F5BG:9FG N T N T N T
7HI5@F9HIFBCBD@5B5GG9HG
CAD5BM7CBHF=6IH=CBG
)5FH=7=D5BH7CBHF=6IH=CBG N T N T
CF9=;B9L7<5B;9F5H97<5B;9G N T N T
9B9:=HD5MA9BHG
,9HH@9A9BHG 7IFH5=@A9BHG GD97=5@H9FA=B5H=CB
69B9:=HG5B8CH<9F N T
5=FJ5@I9C:D@5B5GG9HG5H9B8C:M95F
IB898GH5HIG5H9B8C:M95F
@BHAGFE86B:A<M87<AG;8BAFB?<74G874?4A68*;88G4FB9
868@58E $<??<BAF
(H4?<9<874A7%BA DH4?<9<87'8AF<BA8A89<GF 'BFGE8G<E8@8AG
8A89<GF ,A<G87*G4G8F AG8EA4G<BA4?
'CB 7IFF9BH5GG9HG N T N T
77FI9869B9:=H7CGH
IFF9BH@=56=@=H=9G
'CB 7IFF9BH@=56=@=H=9G
B8=B;65@5B79
-- 88 of 142 --
@BHAGFE86B:A<M87<A466H@H?4G87BG;8E6B@CE8;8AF<I8
<A6B@84FB9868@58E $<??<BAF
(H4?<9<874A7%BA DH4?<9<87'8AF<BA8A89<GF 'BFGE8G<E8@8AG
8A89<GF ,A<G87*G4G8F AG8EA4G<BA4?
'9HHF5BG=H=CBC6@=;5H=CB5GG9H N T N T
'9H57HI5F=5@@CGG;5=B
)F=CFG9FJ=797CGH7F98=H
B8=B;65@5B79
-<965@5B79C:5ACIBHGF97C;B=N98:CF=BH9FB5H=CB5@D@5BG=B577IAI@5H98CH<9F7CADF9<9BG=J9=B7CA95GC:979A69F=B
H<9DF9798=B;H56@95F9DF9G9BH9865G98CBH<9:CF9=;B7IFF9B7M9L7<5B;9F5H9CBH<5H85H9
-<9D9BG=CB577IAI@5H9869B9:=HC6@=;5H=CBF9DF9G9BHGH<957HI5F=5@DF9G9BHJ5@I9C:69B9:=HG65G98CB9AD@CM99G9FJ=795B8
7CAD9BG5H=CB5GC:H<9A95GIF9A9BH85H95B88C9GBCH=B7@I895B5GGIADH=CB56CIH:IHIF97CAD9BG5H=CB@9J9@G -<9:C@@CK=B;
H56@9GIAA5F=N9GH<9HCH5@577IAI@5H9869B9:=HC6@=;5H=CBG H<9577IAI@5H9869B9:=HC6@=;5H=CBG5B8:5=FJ5@I9C:D@5B5GG9HG:CF
89:=B9869B9:=HD9BG=CBD@5BGK=H<577IAI@5H9869B9:=HC6@=;5H=CBG=B9L79GGC:D@5B5GG9HG 5B8H<9DFC>97H9869B9:=HC6@=;5H=CB
5B8:5=FJ5@I9C:D@5B5GG9HG:CF89:=B9869B9:=HD9BG=CBD@5BGK=H<DFC>97H9869B9:=HC6@=;5H=CB=B9L79GGC:D@5B5GG9HG5GC:
979A69F
(H4?<9<874A7%BA DH4?<9<87'8AF<BA'?4AF
,A<G87*G4G8F AG8EA4G<BA4?
$<??<BAF
77IAI@5H9869B9:=HC6@=;5H=CB
'?4AFJ<G;466H@H?4G8758A89<GB5?<:4G<BA<A8K68FFB9C?4A4FF8GF
77IAI@5H9869B9:=HC6@=;5H=CB
5=FJ5@I9C:D@5B5GG9HG N
'?4AFJ<G;CEB=86G8758A89<GB5?<:4G<BA<A8K68FFB9C?4A4FF8GF
)FC>97H9869B9:=HC6@=;5H=CB
5=FJ5@I9C:D@5B5GG9HG
-- 89 of 142 --
B@CBA8AGFB9A8GC8E<B7<66BFG4A7BG;8E4@BHAGFE86B:A<M87<ABG;8E6B@CE8;8AF<I8<A6B@8
-<9G9FJ=797CGH7CADCB9BHC:89:=B9869B9:=HB9HD9F=C8=769B9:=H7CGH=GF97CF898=B7CGHC:G5@9G G9@@=B; ;9B9F5@5B8
58A=B=GHF5H=J99LD9BG9G 5B8F9G95F7< 89J9@CDA9BH5B8F9@5H989LD9BG9G G8=G7IGG98=B'CH9 H<9CH<9F7CADCB9BHGC:B9H
D9F=C8=769B9:=H7CGH5F9F9:@97H98=BCH<9F9LD9BG9=B7CA9 B9H CADCB9BHGC:B9HD9F=C8=769B9:=H7CGH5B8CH<9F
GIDD@9A9BH5@=B:CFA5H=CB:CFH<9M95FG9B898979A69F:C@@CK
(H4?<9<874A7%BA DH4?<9<87'8AF<BA8A89<GF 'BFGE8G<E8@8AG
8A89<GF ,A<G87*G4G8F AG8EA4G<BA4?
$<??<BAF
%8GC8E<B7<658A89<G6BFG58A89<G
&C8E4G<A:8KC8AF8
,9FJ=797CGH
%BA BC8E4G<A:8KC8AF8
"BH9F9GH7CGH
LD97H98F9HIFBCBD@5B5GG9HG
ACFH=N5H=CBC:HF5BG=H=CB5GG9H N T T T N T T
ACFH=N5H=CBC:DF=CFG9FJ=7969B9:=H
ACFH=N5H=CBC:B9H57HI5F=5@@CGG
,9HH@9A9BHG 7IFH5=@A9BHG GD97=5@
H9FA=B5H=CB69B9:=HG5B8CH<9F
-CH5@BCB CD9F5H=B;9LD9BG969B9:=H
-CH5@B9HD9F=C8=769B9:=H7CGH69B9:=H
&G;8E6;4A:8F<AC?4A4FF8GF4A758A89<G
B5?<:4G<BAFE86B:A<M87<ABG;8E
6B@CE8;8AF<I8<A6B@8?BFF
ACFH=N5H=CBC:HF5BG=H=CB5GG9H N T T T N T T
)F=CFG9FJ=797CGH69B9:=H N T T T N T
ACFH=N5H=CBC:DF=CFG9FJ=7969B9:=H
'9H57HI5F=5@;5=B@CGG
ACFH=N5H=CBC:B9H57HI5F=5@@CGG
CF9=;B7IFF9B7M N T T
,9HH@9A9BHG 7IFH5=@A9BHG GD97=5@
H9FA=B5H=CB69B9:=HG5B8CH<9F
-CH5@F97C;B=N98=BCH<9F
7CADF9<9BG=J9=B7CA9@CGG
-CH5@F97C;B=N98=BB9HD9F=C8=769B9:=H
7CGH69B9:=H5B8CH<9F7CADF9<9BG=J9
=B7CA9@CGG
.8<:;G87 4I8E4:84FFH@CG<BAFHF87GB78G8E@<A858A89<GB5?<:4G<BAF4FB9868@58E
(H4?<9<874A7%BA DH4?<9<87'8AF<BA8A89<GF 'BFGE8G<E8@8AG
8A89<GF ,A<G87*G4G8F AG8EA4G<BA4?
=G7CIBHF5H9
CAD9BG5H=CBF5H9=B7F95G9 % ' '
-- 90 of 142 --
.8<:;G87 4I8E4:84FFH@CG<BAFHF87GB78G8E@<A8A8G6BFG9BEL84EF8A787868@58E
(H4?<9<874A7%BA DH4?<9<87'8AF<BA8A89<GF 'BFGE8G<E8@8AG
8A89<GF ,A<G87*G4G8F AG8EA4G<BA4?
=G7CIBHF5H9 G9FJ=797CGH
=G7CIBHF5H9 =BH9F9GH7CGH
LD97H98F9HIFBCB5GG9HG
CAD9BG5H=CBF5H9=B7F95G9 % ' '
-<9CAD5BMDFCJ=89G9@=;=6@9F9H=F99G=BH<9. , DCGHF9H=F9A9BH<95@H<75F969B9:=HD@5BGHC5G5J=B;G577CIBH69B9:=HG 65G98
D@5B -<97CBHF=6IH=CBGDFCJ=8986MH<9CAD5BMHCH<9<95@H<G5J=B;G577CIBHG=B7F95G9D9F79BHD9FM95F:CF9AD@CM99GK<C
F9H=F98DF=CFHC#5BI5FM 5B8=B7F95G9 D9F79BH:CF9AD@CM99GK<CF9H=F9CBCF5:H9F#5BI5FM -<9F9:CF9 H<9
CAD5BMBC@CB;9F<5GA5H9F=5@9LDCGIF9HC<95@H<75F97CGH=B:@5H=CB
-<9CAD5BM89H9FA=B9GH<98=G7CIBHF5H9IG98HCA95GIF9D@5B@=56=@=H=9G5GC:H<9979A69FA95GIF9A9BH85H9:CFH<9
D9BG=CB5B8DCGHF9H=F9A9BH69B9:=HD@5BG K<=7<=G5@GCH<985H9IG98:CFH<9F9@5H985BBI5@A95GIF9A9BH5GGIADH=CBG -<9
8=G7CIBHF5H9F9:@97HGH<97IFF9BHF5H95HK<=7<H<95GGC7=5H98@=56=@=H=9G7CI@8699::97H=J9@MG9HH@985HH<99B8C:H<9M95F -<9
CAD5BMG9HG=HGF5H9HCF9:@97HH<9M=9@8C:5DCFH:C@=CC:<=;<EI5@=HM :=L98 =B7CA9896H=BGHFIA9BHGH<5HKCI@8DFC8I7975G<
:@CKGGI::=7=9BH=BH=A=B;5B85ACIBHHCG9HH@9DFC>97H98:IHIF969B9:=HG .G=B;H<=GA9H<C8C@C;M H<9CAD5BM89H9FA=B985
8=G7CIBHF5H9C: :CFH<9. , D9BG=CBD@5BG5B8 :CFH<9DCGHF9H=F9A9BH69B9:=HD@5BG5GC:979A69F
K<=7<=G5B=B7F95G9C: D9F79BH5;9DC=BHG5B8 D9F79BH5;9DC=BHG F9GD97H=J9@M :FCAH<9F5H9GIG985GC:979A69F
B=B7F95G9=BH<98=G7CIBHF5H9897F95G9GH<9)FC>97H989B9:=H(6@=;5H=CB)( H<9=B7F95G9=BH<98=G7CIBHF5H95GC:
979A69F F9GI@H98=B5B5DDFCL=A5H9@M 6=@@=CB@CK9F69B9:=HC6@=;5H=CB:CFH<9. , D9BG=CB5B8DCGHF9H=F9A9BH
D@5BG
-<9CAD5BMA95GIF9GG9FJ=797CGH5B8=BH9F9GH7CGHG9D5F5H9@MIG=B;H<9GDCHM=9@87IFJ95DDFC57<5DD@=98HC957<
7CFF9GDCB8=B;C6@=;5H=CB ,9FJ=797CGHG5F989H9FA=B9865G98CB8IF5H=CB GD97=:=7GDCHF5H9G5DD@=98HCH<9G9FJ=797CGH75G<
:@CKG -<9=BH9F9GH7CGH75@7I@5H=CB=G89H9FA=B986M5DD@M=B;8IF5H=CB GD97=:=7GDCHF5H9GHCH<9M95F 6M M95FDFC>97H9869B9:=H
D5MA9BHG -<9GDCHM=9@87IFJ95DDFC57<8C9GBCH5::97HH<9A95GIF9A9BHC:H<9HCH5@69B9:=HC6@=;5H=CBG5GH<97<5B;9=B
G9FJ=795B8=BH9F9GH7CGHGC::G9H=BH<957HI5F=5@;5=BG5B8@CGG9GF97CF898=BCH<9F7CADF9<9BG=J9=B7CA9
CFH<9DF=A5FM. , EI5@=:=98D9BG=CBD@5B H<9CAD5BMWG5GGIADH=CB:CFH<99LD97H98F9HIFBCBD@5B5GG9HGK5G =B
)FC>97H98F9HIFBG5F965G98DF=A5F=@MCB6FC58 DI6@=7@MHF58989EI=HM5B8:=L98 =B7CA9=B8=79G5B8:CFK5F8 @CC?=B;
9GH=A5H9GC:57H=J9DCFH:C@=C5B8=BJ9GHA9BHA5B5;9A9BH GC:979A69F H<9CAD5BMWG9LD97H98@CB; H9FA
F5H9C:F9HIFBCB. , D@5B5GG9HG=G -<99LD97H98F9HIFB5GGIADH=CB=G65G98CBH<9GHF5H9;=75GG9H5@@C75H=CBC:H<9D@5B
@CB;H9FA75D=H5@A5F?9HF9HIFB9LD97H5H=CBG5B89LD97H98D9F:CFA5B79:FCA57H=J9=BJ9GHA9BHA5B5;9A9BH -<9
9LD97H98@CB; H9FAF5H9C:F9HIFB=G65G98CB5B5GG9H5@@C75H=CB5GGIADH=CBC:;@C65@9EI=H=9G DF=J5H99EI=H=9G
:=L98 =B7CA9G97IF=H=9G 5B856GC@IH9F9HIFB=BJ9GHA9BHG=B89D9B89BHC:HF58=H=CB5@D9F:CFA5B7969B7<A5F?G 5@CB;K=H<
DCG=H=J9F9HIFBG:FCA57H=J9=BJ9GHA9BHA5B5;9A9BH -<957HI5@B9HF5H9C:F9HIFBCBD@5B5GG9HG=BK5G "BH<9
D@5B95FB985F5H9C:F9HIFBC: 5B8=B95FB985F9HIFBC: -<95J9F5;95BBI5@57HI5@F9HIFBCBH<9D@5B5GG9HG
CJ9FH<9D5GH5B8M95FG<5G699B 5B8 F9GD97H=J9@M +9HIFBCB5GG9HG5GGIADH=CBG:CF=BH9FB5H=CB5@D9BG=CB5B8
CH<9FDCGH F9H=F9A9BH69B9:=HD@5BG5F975@7I@5H98CB5D@5B 6M D@5B65G=GIG=B;D@5B5GG9H5@@C75H=CBG5B89LD97H98@CB; H9FA
F5H9C:F9HIFB5GGIADH=CBG
GC:979A69F H<9CAD5BM7CBJ9FH98HCH<9U)F= ;;F9;5H9&CFH5@=HM-56@9V "BH<9CAD5BMID85H98
H<9ACFH5@=HM=ADFCJ9A9BHG75@9GHCH<9,C7=9HMC:7HI5F=9G,75@9&) -<9979A69F ID85H9F9GI@H98=B5B
=AA5H9F=5@=B7F95G9HCH<9. , D9BG=CB)(5B8. , 577IAI@5H98DCGHF9H=F9A9BH69B9:=HC6@=;5H=CBG
IF=B; H<9CAD5BM7CBHF=6IH98A=@@=CBHC=HG. , 5B8=BH9FB5H=CB5@D9BG=CBD@5BG5B8A=@@=CBHC=HG
DCGHF9H=F9A9BHD@5BG IF=B; H<9CAD5BM7CBHF=6IH98A=@@=CBHC=HG. , 5B8=BH9FB5H=CB5@D9BG=CBD@5BG5B8
A=@@=CBHC=HGDCGHF9H=F9A9BHD@5BG "B H<9CAD5BM9LD97HGHC7CBHF=6IH95B5ACIBH=BH<9F5B;9C:A=@@=CBHC
A=@@=CBC:75G<HC=HG. , 5B8=BH9FB5H=CB5@F9H=F9A9BHD@5BG -<9CAD5BM8C9GBCH<5J95F9EI=F98A=B=AIA75G<D9BG=CB
7CBHF=6IH=CBC6@=;5H=CB:CF=HG. , D@5BG=B IHIF97CBHF=6IH=CBGK=@@89D9B8CBA5F?9H7CB8=H=CBG =BH9F9GHF5H9G5B8CH<9F
:57HCFG
-- 91 of 142 --
HGHE8'8AF<BA4A7'BFGE8G<E8@8AG8A89<G'4L@8AGF
-<9:C@@CK=B;H56@9DFCJ=89GH<99GH=A5H98D9BG=CB5B8DCGHF9H=F9A9BH69B9:=HD5MA9BHGH<5H5F9D5M56@9:FCAH<9D@5BGHC
D5FH=7=D5BHG
(H4?<9<874A7%BA DH4?<9<87
'8AF<BA8A89<GF 'BFGE8G<E8@8AG
8A89<GF $<??<BAF ,A<G87*G4G8F AG8EA4G<BA4?
9B9:=H)5MA9BHG
9B9:=H)5MA9BHG
9B9:=H)5MA9BHG
9B9:=H)5MA9BHG
9B9:=H)5MA9BHG
'9LH:=J9M95FG
'?4AFF8G$4A4:8@8AG
&WG=BJ9GHA9BHGHF5H9;M:CF=HGD9BG=CB5B8DCGHF9H=F9A9BHD@5BG=GHCA5B5;9H<9:IB8GCB5;C=B; 7CB79FB65G=G -<9DF=A5FM
;C5@C:H<9HFIGH:IB8G=GHCA99HH<9C6@=;5H=CBG5GF9EI=F98 -<9G97CB85FM;C5@=GHC95FBH<9<=;<9GHF5H9C:F9HIFBDCGG=6@9
K=H<CIH>9CD5F8=N=B;=HGDF=A5FM;C5@ 5B8K=H<CIHGI6>97H=B;H<9CAD5BMHC5BIB8I95ACIBHC:7CBHF=6IH=CBF=G? IB8
F9HIFBG5F9IG98HC<9@D:=B5B79DF9G9BH5B8:IHIF9C6@=;5H=CBGHCH<99LH9BHDCGG=6@9K=H<=B57HI5F=5@@M89H9FA=B98:IB8=B;@=A=HG
5B8H5L 89H9FA=B985GG9H@=A=HG H<IGF98I7=B;H<9DCH9BH=5@B998:CF588=H=CB5@7CBHF=6IH=CBG:FCA& -<9=BJ9GHA9BHGHF5H9;M
<5GIG98@CB;8IF5H=CB75G<6CB8G5B889F=J5H=J9=BGHFIA9BHGHCC::G9H5G=;B=:=75BHDCFH=CBC:H<9=BH9F9GHF5H9G9BG=H=J=HMC:
. , D9BG=CB@=56=@=H=9G
'CFA5@@M &8C9GBCH6IMCFG9@@5BMC:=HGCKBG97IF=H=9G5G58=F97H=BJ9GHA9BH:CF=HGD9BG=CB5B8CH<9FDCGHF9H=F9A9BH
69B9:=H:IB8G !CK9J9F 8I9HC9LH9FB5@=BJ9GHA9BHA5B5;9A9BHC:H<9:IB8G H<9D@5BGA5M=B8=F97H@M6IM G9@@CF<C@8&
G97IF=H=9G -<95;;F9;5H95ACIBHC:&G97IF=H=9G5F9BCH7CBG=89F98HC69A5H9F=5@F9@5H=J9HCH<95;;F9;5H9:IB8D9F79BH5;9G
-<98=G7IGG=CBH<5H:C@@CKGF9:9F9B79GH<9:5=FJ5@I9A95GIF9A9BHGC:79FH5=B5GG9HG=BH9FAGC:@9J9@G 5B8 ,99'CH9
:CF89G7F=DH=CBGC:H<9G9@9J9@G 0<=@9H<97CAD5BM69@=9J9GH<9J5@I5H=CBA9H<C8G5F95DDFCDF=5H95B87CBG=GH9BHK=H<CH<9F
A5F?9HD5FH=7=D5BHG H<9IG9C:8=::9F9BHA9H<C8C@C;=9GCF5GGIADH=CBGHC89H9FA=B9H<9:5=FJ5@I9C:79FH5=B:=B5B7=5@
=BGHFIA9BHG7CI@8F9GI@H=B58=::9F9BH9GH=A5H9C::5=FJ5@I95HH<9F9DCFH=B;85H9
%#!-6;176!4)6;)6,!7;<:-<1:-5-6<-6-.1<!4)6;;-<;
"BCF89FHC57<=9J9H<9=BJ9GHA9BHC6>97H=J9G=BH<9. , D9BG=CBD@5BG5B8. , DCGHF9H=F9A9BH69B9:=HD@5BG H<9=BJ9GHA9BH
DC@=7=9G=B7@I895H5F;9HGHF5H9;=75GG9H5@@C75H=CB -<9=BJ9GHA9BHDC@=7=9G5@@CKGCA9HC@9F5B795FCIB8H<9H5F;9H=BF97C;B=H=CB
H<5HA5F?9H:@I7HI5H=CBG5B8=@@=EI=8=HMC:GCA9=BJ9GHA9BHGA5M75IG9H<95@@C75H=CBHC5GD97=:=75GG9H7@5GGHCJ5FM:FCAH<9
H5F;9H5@@C75H=CB DCH9BH=5@@M:CF@CB;D9F=C8GC:H=A9 779DH56@9F5B;9G<5J9699B89G=;B98HC5@@CK:CF89J=5H=CB:FCA
GHF5H9;=7H5F;9HG5B8HC5@@CK:CFH<9CDDCFHIB=HM:CFH57H=75@CJ9F 5B8IB89F K9=;<HG -<9DCFH:C@=CGK=@@BCFA5@@M69
F965@5B798K<9BH<9EI5FH9F 9B85GG9H5@@C75H=CB89J=5H9G:FCA5779DH56@9F5B;9G -<95@@C75H=CB=GF9J=9K98F9;I@5F@M6MH<9
B5A98:=8I7=5FMC:H<9D@5BG DDFCL=A5H9@MC:H<9DCGHF9H=F9A9BH69B9:=HD@5B5GG9HG5F9=B5<577CIBH -<9<
577CIBH5GG9HG5F9=BH<9G5A9HFIGH5GH<9DF=A5FM. , D9BG=CBD@5B5B8=BJ9GH98K=H<H<9G5A9=BJ9GHA9BHC6>97H=J9G5GH<9
DF=A5FM. , D9BG=CBD@5B
-- 92 of 142 --
-<9:5=FJ5@I9GC:H<95GG9HG<9@86MH<9. , D9BG=CBD@5BG6M5GG9H7@5GG5F95G:C@@CKG
4<E-4?H8$84FHE8@8AGF,F<A: ACHGFBAF<78E874F 4<E-4?H84G
868@58E #8I8? #8I8? #8I8?
FF8G?4FF$<??<BAF
EI=H=9G
. , 9EI=H=9G N T N T
'CB . , 9EI=H=9G N T N T
"B89L5B8@CB; G<CFH9EI=HM:IB8G
-CH5@EI=H=9G N T N T
=L98"B7CA9
. , ;CJ9FBA9BHG97IF=H=9G N T
'CB . , ;CJ9FBA9BHG97IF=H=9G N T N T
)F9:9FF985B87CBJ9FH=6@9G97IF=H=9G N T N T
. , 7CFDCF5H96CB8G N T
'CB . , 7CFDCF5H96CB8G N T N T
9F=J5H=J9=BGHFIA9BHG N T
(H<9F
-CH5@=L98"B7CA9 N T
)F=J5H9EI=HM
FCKH<9EI=HM N T N T
)5FHB9FG<=D=BJ9GHA9BHG
-CH5@)F=J5H9EI=HM N T N T
6GC@IH9+9HIFB
=L98=B7CA95B8CH<9F T N T
!98;9:IB8 :IB8C::IB8G
)5FHB9FG<=D=BJ9GHA9BHG
-CH5@6GC@IH9+9HIFB T N T
5G<5B85G<EI=J5@9BHG
5G<5B875G<9EI=J5@9BHG N T
+9DIF7<5G95;F99A9BHG5B889F=J5H=J9
A5F;=B57H=J=HM N T N N T N
5G<5B875G<9EI=J5@9BHG J5@I985H
B9H5GG9HJ5@I9
-CH5@5G<5B85G<EI=J5@9BHG N T
-CH5@ N T
(H<9F=H9AGHCF97CB7=@9HC:5=FJ5@I9C:D@5B5GG9HG
5=FJ5@I9C:D@5B5GG9HG
"B577CF85B79K=H<, 79FH5=B=BJ9GHA9BHGH<5H5F9A95GIF985H:5=FJ5@I9IG=B;H<9B9H5GG9HJ5@I9'/D9FG<5F9
CF=HG9EI=J5@9BH5G5DF57H=75@9LD98=9BH<5J9BCH699B7@5GG=:=98=BH<9:5=FJ5@I9<=9F5F7<M -<9'/=G65G98CBH<9:5=F
J5@I9C:H<9IB89F@M=B;5GG9HGCKB986MH<9:IB8 A=BIG=HG@=56=@=H=9GH<9B8=J=8986MH<9BIA69FC:IB=HGCIHGH5B8=B;5B8=G
89H9FA=B986MH<9=BJ9GHA9BHA5B5;9FCF7IGHC8=5BC:H<9:IB8 -<9:5=FJ5@I95ACIBHGDF9G9BH98=BH<=GH56@95F9=BH9B898HC
D9FA=HF97CB7=@=5H=CBC:H<9:5=FJ5@I9<=9F5F7<MHCH<95ACIBHGDF9G9BH98=BH<9:5=FJ5@I9C:D@5B5GG9HG
-- 93 of 142 --
-<9:5=FJ5@I9GC:H<95GG9HG<9@86MH<9DCGHF9H=F9A9BH69B9:=HD@5BG6M5GG9H7@5GG5F95G:C@@CKG
4<E-4?H8$84FHE8@8AGF,F<A: ACHGFBAF<78E874F 4<E-4?H84G
868@58E #8I8? #8I8? #8I8?
FF8G?4FF$<??<BAF
EI=H=9G
. , 9EI=H=9G N T N T
'CB . , 9EI=H=9G N T N T
"B89L5B8@CB; G<CFH9EI=HM:IB8G
-CH5@EI=H=9G N T N T
=L98"B7CA9
. , ;CJ9FBA9BHG97IF=H=9G N T
'CB . , ;CJ9FBA9BHG97IF=H=9G N T N T
. , 7CFDCF5H96CB8G N T
'CB . , 7CFDCF5H96CB8G N T N T
9F=J5H=J9=BGHFIA9BHG N T N T N T N T
(H<9F
-CH5@=L98"B7CA9 N T
)F=J5H9EI=HM
FCKH<9EI=HM N T N T
)5FHB9FG<=D=BJ9GHA9BHG
-CH5@)F=J5H9EI=HM N T N T
6GC@IH9+9HIFB
=L98=B7CA95B8CH<9F N T N T
!98;9:IB8 :IB8C::IB8G
)5FHB9FG<=D=BJ9GHA9BHG
-CH5@6GC@IH9+9HIFB N T N T
5G<5B85G<EI=J5@9BHG
5G<5B875G<9EI=J5@9BHG N N T
5G<5B875G<9EI=J5@9BHG J5@I985H
B9H5GG9HJ5@I9
-CH5@5G<5B85G<EI=J5@9BHG N N T
-CH5@ N T
(H<9F=H9AGHCF97CB7=@9HC:5=FJ5@I9C:D@5B5GG9HG
5=FJ5@I9C:D@5B5GG9HG
"B577CF85B79K=H<, 79FH5=B=BJ9GHA9BHGH<5H5F9A95GIF985H:5=FJ5@I9IG=B;H<9'/D9FG<5F9CF=HG
9EI=J5@9BH5G5DF57H=75@9LD98=9BH<5J9BCH699B7@5GG=:=98=BH<9:5=FJ5@I9<=9F5F7<M -<9'/=G65G98CBH<9:5=FJ5@I9C:
H<9IB89F@M=B;5GG9HGCKB986MH<9:IB8 A=BIG=HG@=56=@=H=9GH<9B8=J=8986MH<9BIA69FC:IB=HGCIHGH5B8=B;5B8=G89H9FA=B98
6MH<9=BJ9GHA9BHA5B5;9FCF7IGHC8=5BC:H<9:IB8 -<9:5=FJ5@I95ACIBHGDF9G9BH98=BH<=GH56@95F9=BH9B898HCD9FA=H
F97CB7=@=5H=CBC:H<9:5=FJ5@I9<=9F5F7<MHCH<95ACIBHGDF9G9BH98=BH<9:5=FJ5@I9C:D@5B5GG9HG
)I6@=7@MHF58989EI=H=9G5F9J5@I985HH<97@CG=B;DF=79F9DCFH98=BH<957H=J9A5F?9H=BK<=7<H<9=B8=J=8I5@G97IF=H=9G5F9
HF5898
=L98=B7CA9=B7@I89G89F=J5H=J9=BGHFIA9BHGGI7<5G7F98=H89:5I@HGK5DG =BH9F9GHF5H9GK5DG5B8:IHIF9G7CBHF57HG CFDCF5H9
896H=B7@I89G6CB8G5B8BCH9G 5GG9H657?98G97IF=H=9G 7C@@5H9F5@=N98ACFH;5;9C6@=;5H=CBG5B8DF=J5H9D@579A9BHG ,K5DG5B8
89F=J5H=J9=BGHFIA9BHG5F9J5@I986MH<97IGHC8=5BIG=B;7@CG=B;A5F?9HGK5D7IFJ9G5B8A5F?9H89F=J98=BDIHG . ,
;CJ9FBA9BH5B8;CJ9FBA9BH5;9B7M6CB8G5B8BCH9G5F9J5@I985HH<97@CG=B;DF=79F9DCFH98=BH<957H=J9A5F?9H=BK<=7<H<9
=B8=J=8I5@G97IF=HM=GHF5898 CFDCF5H96CB8G5B8BCH9G 5GG9H657?98G97IF=H=9G5B87C@@5H9F5@=N98ACFH;5;9C6@=;5H=CBG5F9
J5@I985H9=H<9FH<9M=9@8G7IFF9BH@M5J5=@56@9CB7CAD5F56@9G97IF=H=9GC:=GGI9FGK=H<G=A=@5F7F98=HF5H=B;GCFJ5@I98IB89F5
8=G7CIBH9875G<:@CK5DDFC57<H<5HIH=@=N9GC6G9FJ56@9=BDIHG GI7<5G7IFF9BHM=9@8GC:G=A=@5F=BGHFIA9BHG 6IH=B7@I89G
-- 94 of 142 --
adjustments for certain risks that may not be observable such as credit and liquidity risks. Private placements are valued by the
custodian using recognized pricing services and sources.
The private equity portfolio is a diversified mix of derivative instruments, growth equity and partnership interests. Growth
equity investments are valued at the closing price reported in the active market in which the individual securities are traded.
Absolute return consists primarily of partnership interests in hedge funds, hedge fund of funds or other private fund vehicles.
Corporate debt instruments are valued at either the yields currently available on comparable securities of issuers with similar
credit ratings or valued under a discounted cash flow approach that utilizes observable inputs, such as current yields of similar
instruments, but includes adjustments for certain risks that may not be observable such as credit and liquidity risk ratings.
Other items to reconcile to fair value of plan assets include, interest receivables, amounts due for securities sold, amounts
payable for securities purchased and interest payable.
There were no level 3 assets in the fair values of the U.S. pension and postretirement plans assets for the periods ended
December 31, 2021 and 2020.
International Pension Plans Assets
Outside the U.S., pension plan assets are typically managed by decentralized fiduciary committees. The disclosure below of
asset categories is presented in aggregate for over 70 defined benefit plans in 25 countries; however, there is significant
variation in asset allocation policy from country to country. Local regulations, local funding rules, and local financial and tax
considerations are part of the funding and investment allocation process in each country. The Company provides standard
funding and investment guidance to all international plans with more focused guidance to the larger plans.
Each plan has its own strategic asset allocation. The asset allocations are reviewed periodically and rebalanced when necessary.
87
-- 95 of 142 --
-<9:5=FJ5@I9GC:H<95GG9HG<9@86MH<9=BH9FB5H=CB5@D9BG=CBD@5BG6M5GG9H7@5GG5F95G:C@@CKG
4<E-4?H8$84FHE8@8AGF,F<A: ACHGFBAF<78E874F 4<E-4?H84G
868@58E #8I8? #8I8? #8I8?
FF8G?4FF$<??<BAF
EI=H=9G
FCKH<9EI=H=9G N T
/5@I99EI=H=9G N T
CF99EI=H=9G
EI=H=9G J5@I985HB9H5GG9HJ5@I9
-CH5@EI=H=9G
=L98"B7CA9
CA9GH=7;CJ9FBA9BH
CF9=;B;CJ9FBA9BH N T
CFDCF5H9896HG97IF=H=9G
=L98=B7CA9G97IF=H=9G J5@I985HB9H
5GG9HJ5@I9
-CH5@=L98"B7CA9
)F=J5H9EI=HM
+95@9GH5H9
+95@9GH5H9 J5@I985HB9H5GG9HJ5@I9
)5FHB9FG<=D=BJ9GHA9BHG
-CH5@)F=J5H9EI=HM
6GC@IH9+9HIFB
9F=J5H=J9G N T N T
"BGIF5B79 N T N T
(H<9F N T
(H<9F J5@I985HB9H5GG9HJ5@I9 N
!98;9:IB8G
-CH5@6GC@IH9+9HIFB
5G<5B85G<EI=J5@9BHG
5G<5B875G<9EI=J5@9BHG N T
5G<5B875G<9EI=J5@9BHG J5@I985H
B9H5GG9HJ5@I9
-CH5@5G<5B85G<EI=J5@9BHG N T
-CH5@
(H<9F=H9AGHCF97CB7=@9HC:5=FJ5@I9C:D@5B5GG9HG
5=FJ5@I9C:D@5B5GG9HG
"B577CF85B79K=H<, 79FH5=B=BJ9GHA9BHGH<5H5F9A95GIF985H:5=FJ5@I9IG=B;H<9'/D9FG<5F9CF=HG
9EI=J5@9BH5G5DF57H=75@9LD98=9BH<5J9BCH699B7@5GG=:=98=BH<9:5=FJ5@I9<=9F5F7<M -<9'/=G65G98CBH<9:5=FJ5@I9C:
H<9IB89F@M=B;5GG9HGCKB986MH<9:IB8 A=BIG=HG@=56=@=H=9GH<9B8=J=8986MH<9BIA69FC:IB=HGCIHGH5B8=B;5B8=G89H9FA=B98
6MH<9=BJ9GHA9BHA5B5;9FCF7IGHC8=5BC:H<9:IB8 -<9:5=FJ5@I95ACIBHGDF9G9BH98=BH<=GH56@95F9=BH9B898HCD9FA=H
F97CB7=@=5H=CBC:H<9:5=FJ5@I9<=9F5F7<MHCH<95ACIBHGDF9G9BH98=BH<9:5=FJ5@I9C:D@5B5GG9HG
EI=H=9G7CBG=GHDF=A5F=@MC:A5B85H9G=BDI6@=79EI=HMG97IF=H=9GA5B5;98HCJ5F=CIGDI6@=79EI=HM=B8=79G )I6@=7@MHF5898
9EI=H=9G5F9J5@I985HH<97@CG=B;DF=79F9DCFH98=BH<957H=J9A5F?9H=BK<=7<H<9=B8=J=8I5@G97IF=H=9G5F9HF5898
=L98"B7CA9=BJ9GHA9BHG=B7@I898CA9GH=75B8:CF9=;B;CJ9FBA9BH 5B87CFDCF5H9 =B7@I8=B;ACFH;5;9657?985B8CH<9F
896HG97IF=H=9G CJ9FBA9BHG 7CFDCF5H96CB8G5B8BCH9G5B8ACFH;5;9657?98G97IF=H=9G5F9J5@I985HH<97@CG=B;DF=79
F9DCFH98=:HF5898CB5B57H=J9A5F?9HCF5HM=9@8G7IFF9BH@M5J5=@56@9CB7CAD5F56@9G97IF=H=9GC:=GGI9FGK=H<G=A=@5F7F98=H
-- 96 of 142 --
ratings or valued under a discounted cash flow approach that utilizes observable inputs, such as current yields of similar
instruments, but includes adjustments for certain risks that may not be observable such as credit and liquidity risks.
Private equity funds consist of partnership interests in a variety of funds. Real estate consists of property funds and REITS
(Real Estate Investment Trusts). REITS are valued at the closing price reported in the active market in which it is traded.
Absolute return consists of private partnership interests in hedge funds, insurance contracts, derivative instruments, hedge fund
of funds, and other alternative investments. Insurance consists of insurance contracts, which are valued using cash surrender
values which is the amount the plan would receive if the contract was cashed out at year end. Derivative instruments consist of
various swaps and bond futures that are used to help manage risks.
Other items to reconcile to fair value of plan assets include the net of interest receivables, amounts due for securities sold,
amounts payable for securities purchased and interest payable.
The balances of and changes in the fair values of the international pension plans’ level 3 assets consist primarily of insurance
contracts under the absolute return asset class. In 2021 the aggregate of net purchases and net unrealized gains and losses
decreased this balance by $7 million and the change in currency exchange rates decreased this balance by $44 million for a net
decrease of $51 million. In 2020 the aggregate net purchases and net unrealized gains decreased this balance by $1 million and
the change in currency exchange rates increased the balance by $44 million for a net increase to this balance of $43 million.
NOTE 14. Derivatives
The Company uses interest rate swaps, currency swaps, and forward and option contracts to manage risks generally associated
with foreign exchange rate, interest rate and commodity price fluctuations. The information that follows explains the various
types of derivatives and financial instruments used by 3M, how and why 3M uses such instruments, how such instruments are
accounted for, and how such instruments impact 3M’s financial position and performance.
Additional information with respect to derivatives is included elsewhere as follows:
• Impact on other comprehensive income of nonderivative hedging and derivative instruments is included in Note 8.
• Fair value of derivative instruments is included in Note 15.
• Derivatives and/or hedging instruments associated with the Company’s long-term debt are also described in Note 12.
Refer to the section below titled Statement of Income Location and Impact of Cash Flow and Fair Value Derivative Instruments
and Derivatives Not Designated as Hedging Instruments for details on the location within the consolidated statements of
income for amounts of gains and losses related to derivative instruments designated as cash flow or fair value hedges (along
with similar information relative to the hedged items) and derivatives not designated as hedging instruments. Additional
information relative to cash flow hedges, fair value hedges, net investment hedges and derivatives not designated as hedging
instruments is included below as applicable.
Cash Flow Hedges:
For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative is reported as a
component of other comprehensive income and reclassified into earnings in the same period during which the hedged
transaction affects earnings. Gains and losses on the derivative representing hedge components excluded from the assessment of
effectiveness are recognized in current earnings.
Cash Flow Hedging - Foreign Currency Forward and Option Contracts: The Company enters into foreign exchange forward
and option contracts to hedge against the effect of exchange rate fluctuations on cash flows denominated in foreign currencies.
These transactions are designated as cash flow hedges. The settlement or extension of these derivatives will result in
reclassifications (from accumulated other comprehensive income) to earnings in the period during which the hedged
transactions affect earnings. 3M may de-designate these cash flow hedge relationships in advance of the occurrence of the
forecasted transaction. The portion of gains or losses on the derivative instrument previously included in accumulated other
comprehensive income for de-designated hedges remains in accumulated other comprehensive income until the forecasted
transaction occurs or becomes probable of not occurring. Changes in the value of derivative instruments after de-designation are
recorded in earnings and are included in the Derivatives Not Designated as Hedging Instruments section below. The maximum
length of time over which 3M hedges its exposure to the variability in future cash flows of the forecasted transactions is 36
months.
89
-- 97 of 142 --
+=269A/.1381F8>/</=>$+>/98><+->=-<9CAD5BMA5MIG9:CFK5F8GH5FH=B;=BH9F9GHF5H97CBHF57HG5B8HF95GIFMF5H9
@C7?7CBHF57HGHC<98;99LDCGIF9HCJ5F=56=@=HM=B75G<:@CKG:FCA=BH9F9GHD5MA9BHGCB:CF975GH98896H=GGI5B79G
IF=B; H<9CAD5BM9BH9F98=BHC588=H=CB5@:CFK5F8GH5FH=B;=BH9F9GHF5H9GK5DGK=H<5BCH=CB5@5ACIBHC:A=@@=CB
-<9G9GK5DG 5GK9@@5GA=@@=CBC:BCH=CB5@5ACIBH=B9L=GH=B;CIHGH5B8=B;GK5DG<58699B89G=;B5H985G<98;9G5;5=BGH
=BH9F9GHF5H9JC@5H=@=HM5GGC7=5H98K=H<:CF975GH98=GGI5B79GC::=L98F5H9896H CB7IFF9BHK=H<H<9=GGI5B79C:H<9A98=IA H9FA
BCH9G=B96FI5FM5B8H<9588=H=CB5@=GGI5B79C:F9;=GH9F98BCH9G=BI;IGH &H9FA=B5H985@@CIHGH5B8=B;=BH9F9GH
F5H9GK5DGF9@5H98HC:CF975GH98=GGI5B79GC:896H -<9G9H9FA=B5H=CBGF9GI@H98=B5B9H@CGGC:A=@@=CBK=H<=B577IAI@5H98
CH<9F7CADF9<9BG=J9=B7CA9H<5HK=@@695ACFH=N98CJ9FH<9F9GD97H=J9@=J9GC:H<9896H
"B&5F7< H<9CAD5BM9BH9F98=BHCHF95GIFMF5H9@C7?7CBHF57HGK=H<5BCH=CB5@5ACIBHC:A=@@=CBH<5HK9F9
H9FA=B5H987CB7IFF9BH@MK=H<H<9&5F7<=GGI5B79C:F9;=GH9F98BCH9G5G8=G7IGG98=B'CH9 -<9H9FA=B5H=CBF9GI@H98=B
5B=AA5H9F=5@B9H@CGGK=H<=B577IAI@5H98CH<9F7CADF9<9BG=J9=B7CA9H<5HK=@@695ACFH=N98:CFH<9F9GD97H=J9@=J9GC:H<9
896H
-<95ACFH=N5H=CBC:;5=BG5B8@CGG9GCB:CFK5F8GH5FH=B;=BH9F9GHF5H9GK5DG=G=B7@I898=BH<9H56@9G69@CK5GD5FHC:H<9;5=B
@CGGF97@5GG=:=98:FCA577IAI@5H98CH<9F7CADF9<9BG=J9=B7CA9=BHC=B7CA9
GC:979A69F H<9CAD5BM<58565@5B79C:A=@@=CB5GGC7=5H98K=H<H<95:H9F H5LB9HIBF95@=N98@CGG
5GGC7=5H98K=H<75G<:@CK<98;=B;=BGHFIA9BHGF97CF898=B577IAI@5H98CH<9F7CADF9<9BG=J9=B7CA9 -<=G=B7@I89G5
F9A5=B=B;65@5B79C:A=@@=CB5:H9F H5L@CGGF9@5H98HCH<9:CFK5F8GH5FH=B;=BH9F9GHF5H9GK5D5B8HF95GIFMF5H9@C7?
7CBH57HG K<=7<K=@@695ACFH=N98CJ9FH<9F9GD97H=J9@=J9GC:H<9BCH9G 5G98CB9L7<5B;9F5H9G5GC:979A69F C:
H<9HCH5@5:H9F H5LB9HIBF95@=N9865@5B795GC:979A69F &9LD97HGHCF97@5GG=:M5DDFCL=A5H9@MA=@@=CB5:H9F H5L
B9HIBF95@=N98;5=BCJ9FH<9B9LHACBH<GK=H<H<9=AD57HC::G9H6M95FB=B;G @CGG9G:FCAIB89F@M=B;<98;98=H9AG
-<95ACIBHC:DF9H5L;5=B@CGGF97C;B=N98=BCH<9F7CADF9<9BG=J9=B7CA9F9@5H98HC89F=J5H=J9=BGHFIA9BHG89G=;B5H985G75G<
:@CK<98;9G=GDFCJ=898=BH<9:C@@CK=B;H56@9
'E8G4K4<A#BFF)86B:A<M87<A&G;8E
B@CE8;8AF<I8 A6B@8BA8E<I4G<I8
$<??<BAF
CF9=;B7IFF9B7M:CFK5F8 CDH=CB7CBHF57HG
"BH9F9GHF5H97CBHF57HG T
-CH5@
5=F/5@I9!98;9G
CF89F=J5H=J9=BGHFIA9BHGH<5H5F989G=;B5H985B8EI5@=:M5G:5=FJ5@I9<98;9G H<9;5=BCF@CGGCBH<989F=J5H=J9G5GK9@@5GH<9
C::G9HH=B;@CGGCF;5=BCBH<9<98;98=H9A5HHF=6IH56@9HCH<9<98;98F=G?5F9F97C;B=N98=B7IFF9BH95FB=B;G
+3<(+6?//.13818>/</=>$+>/%A+:=-<9CAD5BMA5B5;9G=BH9F9GH9LD9BG9IG=B;5A=LC::=L985B8:@C5H=B;F5H9896H
-C<9@DA5B5;96CFFCK=B;7CGHG H<9CAD5BMA5M9BH9F=BHC=BH9F9GHF5H9GK5DG .B89FH<9G95FF5B;9A9BHG H<9CAD5BM
5;F99GHC9L7<5B;9 5HGD97=:=98=BH9FJ5@G H<98=::9F9B7969HK99B:=L985B8:@C5H=B;=BH9F9GH5ACIBHG75@7I@5H986MF9:9F9B79HC
5B5;F998 IDCBBCH=CB5@DF=B7=D5@5ACIBH -<9A5F? HC A5F?9HC:H<9G9:5=FJ5@I9<98;9G=GF97CF8985G;5=BGCF@CGG9G=B
=BH9F9GH9LD9BG95B8=GC::G9H6MH<9;5=BCF@CGGC:H<9IB89F@M=B;896H=BGHFIA9BH K<=7<5@GC=GF97CF898=B=BH9F9GH9LD9BG9
"B'CJ9A69F &=GGI985IFC6CB8K<=7<K5G8I9=B:CF5:5795ACIBHC:A=@@=CB9IFCG .DCB896H=GGI5B79
&7CAD@9H985:=L98 HC :@C5H=B;=BH9F9GHF5H9GK5DCB5BCH=CB5@5ACIBHC:A=@@=CB9IFCG5G5:5=FJ5@I9<98;9C:5DCFH=CB
C:H<9:=L98=BH9F9GHF5H9IFC6CB8C6@=;5H=CB -<=G=BH9F9GHF5H9GK5DA5HIF98=B7CB>IB7H=CBK=H<H<9F9D5MA9BHC:H<9
IFC6CB8=B'CJ9A69F
"B#IB9 &=GGI98A=@@=CB5;;F9;5H9DF=B7=D5@5ACIBHC:A98=IA H9FABCH9G .DCB896H=GGI5B79 H<9CAD5BM
9BH9F98=BHC5B=BH9F9GHF5H9GK5DHC7CBJ9FHA=@@=CBC:5A=@@=CBBCH9H<5HK5G8I9=B =B7@I898=BH<=G=GGI5B79
HC5B=BH9F9GHF5H965G98CB5:@C5H=B;H<F99 ACBH<%"(+=B89L5G5:5=FJ5@I9<98;9C:5DCFH=CBC:H<9:=L98=BH9F9GHF5H9
A98=IA H9FABCH9C6@=;5H=CB -<=G=BH9F9GHF5H9GK5DA5HIF98=B7CB>IB7H=CBK=H<H<9F9D5MA9BHC:H<9A=@@=CB5;;F9;5H9
DF=B7=D5@5ACIBHC::=L98 F5H9A98=IABCH9GH<5HA5HIF98=B#IB9
-- 98 of 142 --
"BI;IGH &=GGI98 6=@@=CB5;;F9;5H9DF=B7=D5@5ACIBHC:A98=IA H9FABCH9G .DCB896H=GGI5B79 H<9CAD5BM
9BH9F98=BHCHKC=BH9F9GHF5H9GK5DG5G:5=FJ5@I9<98;9GC:5DCFH=CBC:H<9:=L98=BH9F9GHF5H9A98=IA H9FABCH9C6@=;5H=CB -<9
:=FGH7CBJ9FH985A=@@=CBH<F99 M95F:=L98F5H9BCH9H<5HA5HIF98=BI;IGH5HK<=7<H=A9H<95GGC7=5H98=BH9F9GHF5H9
GK5D5@GCA5HIF98 5B8H<9G97CB87CBJ9FH98A=@@=CBC:5:=J9 M95F:=L98F5H9BCH9H<5HA5HIF98=BI;IGH5HK<=7<
H=A9H<95GGC7=5H98=BH9F9GHF5H9GK5D5@GCA5HIF98
"BH<9:CIFH<EI5FH9FC: H<9CAD5BM9BH9F98=BHC5B=BH9F9GHF5H9GK5D5G5:5=FJ5@I9<98;9K=H<5BCH=CB5@5ACIBHC:
A=@@=CBH<5H7CBJ9FH98H<97CAD5BMWG:=L98 F5H9A98=IA H9FABCH9H<5HA5HIF98=BI;IGH5HK<=7<H=A9H<9
5GGC7=5H98=BH9F9GHF5H9GK5D5@GCA5HIF98
"B,9DH9A69F H<9CAD5BM9BH9F98=BHC5B=BH9F9GHF5H9GK5DK=H<5BCH=CB5@5ACIBHC:A=@@=CBH<5H7CBJ9FH985
DCFH=CBC:H<9CAD5BMWGA=@@=CB5;;F9;5H9DF=B7=D5@5ACIBHC::=L98F5H9A98=IA H9FABCH9G8I9=BHC5:@C5H=B;
F5H9BCH9K=H<5B=BH9F9GHF5H965G98CB5H<F99 ACBH<%"(+=B89L5G5<98;9C:=HG9LDCGIF9HC7<5B;9G=B:5=FJ5@I9H<5H5F9
5HHF=6IH56@9HC=BH9F9GHF5H9F=G? -<9CAD5BMH9FA=B5H98H<=G=BH9F9GHF5H9GK5D=B7CB>IB7H=CBK=H<H<995F@M896HF9D5MA9BH=B
979A69FC:A=@@=CB5;;F9;5H9DF=B7=D5@5ACIBHC::=L98 F5H9A98=IABCH9G:IFH<9F89G7F=698=B'CH9
IF=B;H<9G97CB85B8H<=F8EI5FH9FGC: &9BH9F98=BHC=BH9F9GHF5H9GK5DGK=H<5B5;;F9;5H9BCH=CB5@5ACIBHC:
A=@@=CB -<9G9GK5DG7CBJ9FH98A=@@=CB5B8A=@@=CBC:&WG 6=@@=CB5B8A=@@=CBDF=B7=D5@5ACIBHC:
:=L98F5H9BCH9G8I95B8 F9GD97H=J9@M =BHC:@C5H=B;F5H9896H:CFH<9DCFH=CBC:H<9=FH9FAGH<FCI;<A=8 K=H<5B
=BH9F9GHF5H965G98CB5H<F99 ACBH<%"(+=B89L
-<9:C@@CK=B;5ACIBHGK9F9F97CF898CBH<97CBGC@=85H9865@5B79G<99HF9@5H98HC7IAI@5H=J965G=G58>IGHA9BHG:CF:5=FJ5@I9
<98;9G
4EEL<A:-4?H8B9G;8
87:87#<45<?<G<8F
H@H?4G<I8@BHAGB94<E-4?H8
87:<A:7=HFG@8AG A6?H787<A
G;84EEL<A:-4?H8B9G;887:87
#<45<?<G<8F
#B64G<BABAG;8BAFB?<74G874?4A68*;88G$<??<BAF
,<CFH H9FA6CFFCK=B;G5B87IFF9BHDCFH=CBC:@CB; H9FA896H T T
%CB; H9FA896H
-CH5@
'9H"BJ9GHA9BH!98;9G
-<9CAD5BMA5MIG9BCB 89F=J5H=J9:CF9=;B7IFF9B7M89BCA=B5H98896H5B889F=J5H=J9:CF9=;B9L7<5B;9:CFK5F87CBHF57HG
=BGHFIA9BHGHC<98;9DCFH=CBGC:H<9CAD5BMWG=BJ9GHA9BH=B:CF9=;BGI6G=8=5F=9G5B8A5B5;9:CF9=;B9L7<5B;9F=G? CF
=BGHFIA9BHGH<5H5F989G=;B5H985B8EI5@=:M5G<98;9GC:B9H=BJ9GHA9BHG=B:CF9=;BCD9F5H=CBG5B8H<5HA99HH<99::97H=J9B9GG
F9EI=F9A9BHG H<9B9H;5=BGCF@CGG9G5HHF=6IH56@9HC7<5B;9G=BGDCH9L7<5B;9F5H9G5F9F97CF898=B7IAI@5H=J9HF5BG@5H=CBK=H<=B
CH<9F7CADF9<9BG=J9=B7CA9 -<9F9A5=B89FC:H<97<5B;9=BJ5@I9C:GI7<=BGHFIA9BHG=GF97CF898=B95FB=B;G +97C;B=H=CB=B
95FB=B;GC:5ACIBHGDF9J=CIG@MF97CF898=B7IAI@5H=J9HF5BG@5H=CB=G@=A=H98HC7=F7IAGH5B79GGI7<5G7CAD@9H9CFGI6GH5BH=5@@M
7CAD@9H9@=EI=85H=CBC:H<9B9H=BJ9GHA9BH=BH<9<98;98:CF9=;BCD9F5H=CB -CH<99LH9BH:CF9=;B7IFF9B7M89BCA=B5H98896H=G
BCH89G=;B5H98=BCF=G89 89G=;B5H98:FCA5B9H=BJ9GHA9BH<98;9F9@5H=CBG<=D 7<5B;9G=BJ5@I9C:H<5HDCFH=CBC::CF9=;B
7IFF9B7M89BCA=B5H98896H8I9HC9L7<5B;9F5H97<5B;9G5F9F97CF898=B95FB=B;GH<FCI;<H<9=FA5HIF=HM85H9
&WGIG9C::CF9=;B9L7<5B;9:CFK5F87CBHF57HG89G=;B5H98=B<98;9GC:H<9CAD5BMWGB9H=BJ9GHA9BH=B:CF9=;BGI6G=8=5F=9G
75BJ5FM6MH=A9D9F=C889D9B8=B;CBK<9B:CF9=;B7IFF9B7M89BCA=B5H98896H65@5B79G89G=;B5H98=BGI7<F9@5H=CBG<=DG5F9
89 89G=;B5H98 A5HIF98 CF5F9B9K@M=GGI985B889G=;B5H98 88=H=CB5@@M J5F=5H=CB75BC77IF=B7CBB97H=CBK=H<H<99LH9BHC:
H<9CAD5BMWG89G=F98:CF9=;B9L7<5B;9F=G?7CJ9F5;9
H979A69F H<9HCH5@BCH=CB5@5ACIBHC::CF9=;B9L7<5B;9:CFK5F87CBHF57HG89G=;B5H98=BB9H=BJ9GHA9BH<98;9G
K5G5DDFCL=A5H9@MA=@@=CB9IFCG 5@CB;K=H<5DF=B7=D5@5ACIBHC:@CB; H9FA896H=BGHFIA9BHG89G=;B5H98=BB9H=BJ9GHA9BH
<98;9GHCH5@=B; 6=@@=CB9IFCG -<9A5HIF=HM85H9GC:H<9G989F=J5H=J95B8BCB89F=J5H=J9=BGHFIA9BHG89G=;B5H98=BB9H
=BJ9GHA9BH<98;9GF5B;9:FCAHC
-- 99 of 142 --
-<95ACIBHC:;5=B@CGG9L7@I898:FCA9::97H=J9B9GGH9GH=B;F97C;B=N98=B=B7CA9F9@5H=J9HC=BGHFIA9BHG89G=;B5H98=BB9H
=BJ9GHA9BH<98;9F9@5H=CBG<=DG=GBCHA5H9F=5@ -<95ACIBHC:DF9H5L;5=B@CGGF97C;B=N98=BCH<9F7CADF9<9BG=J9=B7CA9
F9@5H98HC89F=J5H=J95B8BCB89F=J5H=J9=BGHFIA9BHG89G=;B5H985GB9H=BJ9GHA9BH<98;9G5F95G:C@@CKG
'E8G4K4<A#BFF)86B:A<M874F
H@H?4G<I8+E4AF?4G<BAJ<G;<A&G;8E
B@CE8;8AF<I8 A6B@8
$<??<BAF
CF9=;B7IFF9B7M89BCA=B5H98896H
CF9=;B7IFF9B7M:CFK5F87CBHF57HG
-CH5@
9F=J5H=J9G'CH9G=;B5H985G!98;=B;"BGHFIA9BHG
9F=J5H=J9GBCH89G=;B5H985G<98;=B;=BGHFIA9BHG=B7@I8989 89G=;B5H98:CF9=;B7IFF9B7M:CFK5F85B8CDH=CB7CBHF57HGH<5H
:CFA9F@MK9F989G=;B5H98=B75G<:@CK<98;=B;F9@5H=CBG<=DG5GF9:9F9B798=BH<95G<@CK!98;9GG97H=CB56CJ9 "B
588=H=CB &9BH9FG=BHC:CF9=;B7IFF9B7M7CBHF57HGH<5H5F9BCH89G=;B5H98=B<98;=B;F9@5H=CBG<=DGHCC::G9H =BD5FH H<9=AD57HG
C:7<5B;9G=BJ5@I9C:J5F=CIGBCB :IB7H=CB5@7IFF9B7M89BCA=B5H98=H9AG=B7@I8=B;79FH5=B=BH9F7CAD5BM:=B5B7=B;65@5B79G
-<9G989F=J5H=J9=BGHFIA9BHG5F9BCH89G=;B5H98=B<98;=B;F9@5H=CBG<=DGH<9F9:CF9 :5=FJ5@I9;5=BG5B8@CGG9GCBH<9G9
7CBHF57HG5F9F97CF898=B95FB=B;G -<9CAD5BM8C9GBCH<C@8CF=GGI989F=J5H=J9:=B5B7=5@=BGHFIA9BHG:CFHF58=B;DIFDCG9G
%>+>/7/8>908-97/9-+>398+8.7:+->90+=269A+8.+3<(+6?//<3@+>3@/8=><?7/8>=+8./<3@+>3@/= 9>/=318+>/.
+=/.13818=><?7/8>=
-<9@C75H=CB=BH<97CBGC@=85H98GH5H9A9BHC:=B7CA95B8DF9 H5L5ACIBHGF97C;B=N98=B=B7CA9F9@5H98HC89F=J5H=J9
=BGHFIA9BHG89G=;B5H98=B575G<:@CKCF:5=FJ5@I9<98;=B;F9@5H=CBG<=D5B8:CF89F=J5H=J9GBCH89G=;B5H985G<98;=B;
=BGHFIA9BHG5F95G:C@@CKG
#B64G<BA4A7@BHAGB94<A#BFF)86B:A<M87<A A6B@8
BFGB9F4?8F &G;8E8KC8AF8<A6B@8 A8G
$<??<BAF
A9BE@4G<BAE8:4E7<A:64F;9?BJ4A794<EI4?H8;87:<A:
E8?4G<BAF;<CF
-CH5@5ACIBHGC:=B7CA95B89LD9BG9@=B9=H9AGDF9G9BH98=B
H<97CBGC@=85H98GH5H9A9BHC:=B7CA9=BK<=7<H<99::97HGC:
75G<:@CKCF:5=FJ5@I9<98;9G5F9F97CF898
4<ABE?BFFBA64F;9?BJ;87:<A:E8?4G<BAF;<CF
BE8<:A6HEE8A6L9BEJ4E7 BCG<BA6BAGE46GF
ACIBHC:;5=BCF@CGGF97@5GG=:=98:FCA577IAI@5H98
CH<9F7CADF9<9BG=J9=B7CA9=BHC=B7CA9 T T T
AG8E8FGE4G86BAGE46GF
ACIBHC:;5=BCF@CGGF97@5GG=:=98:FCA577IAI@5H98
CH<9F7CADF9<9BG=J9=B7CA9=BHC=B7CA9 T T T
4<ABE?BFFBA94<EI4?H8;87:<A:E8?4G<BAF;<CF
AG8E8FGE4G86BAGE46GF
!98;98=H9AG T T T
9F=J5H=J9G89G=;B5H985G<98;=B;=BGHFIA9BHG T T T
A9BE@4G<BAE8:4E7<A:78E<I4G<I8FABG78F<:A4G874F
;87:<A:<AFGEH@8AGF
4<ABE?BFFBA78E<I4G<I8FABG78F<:A4G874F
<AFGEH@8AGF
CF9=;B7IFF9B7M:CFK5F8 CDH=CB7CBHF57HG
-- 100 of 142 --
9-+>398+3<(+6?/+8.<9== 9>398+679?8>=90/<3@+>3@/8=><?7/8>=
-<9:C@@CK=B;H56@9GGIAA5F=N9H<9:5=FJ5@I9C:&WG89F=J5H=J9=BGHFIA9BHG 9L7@I8=B;BCB89F=J5H=J9=BGHFIA9BHGIG985G
<98;=B;=BGHFIA9BHG 5B8H<9=F@C75H=CB=BH<97CBGC@=85H9865@5B79G<99H 'CH=CB5@5ACIBHG69@CK5F9DF9G9BH985HD9F=C89B8
:CF9=;B9L7<5B;9F5H9G 9L79DH:CF79FH5=B=BH9F9GHF5H9GK5DG K<=7<5F9DF9G9BH98IG=B;H<9=B79DH=CB85H9WG:CF9=;B9L7<5B;9
F5H9
EBFF%BG<BA4?
@BHAG
FF8GF #<45<?<G<8F
#B64G<BA
4<E-4?H8@BHAG
#B64G<BA
4<E-4?H8@BHAG
$<??<BAF
8E<I4G<I8F78F<:A4G874F
;87:<A:<AFGEH@8AGF
CF9=;B7IFF9B7M:CFK5F8
CDH=CB7CBHF57HG
(H<9F7IFF9BH
5GG9HG
(H<9F7IFF9BH
@=56=@=H=9G
CF9=;B7IFF9B7M:CFK5F8
CDH=CB7CBHF57HG
(H<9F5GG9HG (H<9F@=56=@=H=9G
"BH9F9GHF5H97CBHF57HG N (H<9F7IFF9BH
5GG9HG
N (H<9F7IFF9BH
@=56=@=H=9G
N T
"BH9F9GHF5H97CBHF57HG T (H<9FGG9HG N T (H<9F@=56=@=H=9G T
+BG4?78E<I4G<I8F78F<:A4G87
4F;87:<A:<AFGEH@8AGF
8E<I4G<I8FABG78F<:A4G874F
;87:<A:<AFGEH@8AGF
CF9=;B7IFF9B7M:CFK5F8
CDH=CB7CBHF57HG
(H<9F7IFF9BH
5GG9HG
(H<9F7IFF9BH
@=56=@=H=9G
+BG4?78E<I4G<I8FABG
78F<:A4G874F;87:<A:
<AFGEH@8AGF
+BG4?78E<I4G<I8<AFGEH@8AGF
</.3>$3=5+8.!00=/>>38190==/>=+8.3+,363>3/=90/<3@+>3@/8=><?7/8>=
-<9CAD5BM=G9LDCG98HC7F98=H@CGG=BH<99J9BHC:BCBD9F:CFA5B796M7CIBH9FD5FH=9G=B=BH9F9GHF5H9GK5DG 7IFF9B7MGK5DG
5B8:CFK5F85B8CDH=CB7CBHF57HG !CK9J9F H<9CAD5BMWGF=G?=G@=A=H98HCH<9:5=FJ5@I9C:H<9=BGHFIA9BHG -<9CAD5BM
57H=J9@MACB=HCFG=HG9LDCGIF9HC7F98=HF=G?H<FCI;<H<9IG9C:7F98=H5DDFCJ5@G5B87F98=H@=A=HG 5B86MG9@97H=B;A5>CF
=BH9FB5H=CB5@65B?G5B8:=B5B7=5@=BGH=HIH=CBG5G7CIBH9FD5FH=9G &9BH9FG=BHCA5GH9FB9HH=B;5FF5B;9A9BHGK=H<7CIBH9FD5FH=9G
K<9BDCGG=6@9HCA=H=;5H97F98=HF=G?=B89F=J5H=J9HF5BG57H=CBG A5GH9FB9HH=B;5FF5B;9A9BHA5M5@@CK957<7CIBH9FD5FHMHC
B9HG9HH@95ACIBHGCK9869HK99B5&9BH=HM5B8H<97CIBH9FD5FHM5G5F9GI@HC:AI@H=D@9 G9D5F5H989F=J5H=J9HF5BG57H=CBG -<9
CAD5BM8C9GBCH5BH=7=D5H9BCBD9F:CFA5B796M5BMC:H<9G97CIBH9FD5FH=9G
&<5G9@97H98HCDF9G9BHH<9:5=FJ5@I9C:89F=J5H=J95GG9HG5B8@=56=@=H=9GK=H<=BH<9CAD5BMWG7CBGC@=85H9865@5B79G<99HCB5
;FCGG65G=G9J9BK<9B89F=J5H=J9HF5BG57H=CBG5F9GI6>97HHCA5GH9FB9HH=B;5FF5B;9A9BHG5B8A5MCH<9FK=G9EI5@=:M:CFB9H
DF9G9BH5H=CB !CK9J9F H<9:C@@CK=B;H56@9GDFCJ=89=B:CFA5H=CB5G=:H<9CAD5BM<589@97H98HCC::G9HH<95GG9H5B8@=56=@=HM
65@5B79GC:89F=J5H=J9=BGHFIA9BHG B9HH98=B577CF85B79K=H<J5F=CIG7F=H9F=5=BH<99J9BHC:89:5I@HCFH9FA=B5H=CB5GGH=DI@5H98
6MH<9H9FAGC:B9HH=B;5FF5B;9A9BHGK=H<957<C:H<97CIBH9FD5FH=9G CF957<7CIBH9FD5FHM =:B9HH98 H<9CAD5BMKCI@8
C::G9HH<95GG9H5B8@=56=@=HM65@5B79GC:5@@89F=J5H=J9G5HH<99B8C:H<9F9DCFH=B;D9F=C865G98CBH<9&9BH=HMH<5H=G5D5FHMHC
H<9HF5BG57H=CBG 9F=J5H=J9GBCHGI6>97HHCA5GH9FB9HH=B;5;F99A9BHG5F9BCH9@=;=6@9:CFB9HDF9G9BH5H=CB
-- 101 of 142 --
&99F8GG<A:B9<A4A6<4?FF8GFHA78E$4FG8E%8GG<A::E88@8AGFJ<G;8E<I4G<I8BHAG8EC4EG<8F
EBFF@BHAGB9
8E<I4G<I8FF8GF
'E8F8AG87<AG;8
BAFB?<74G87
4?4A68*;88G
EBFF@BHAGFABG&99F8G<AG;8
BAFB?<74G874?4A68*;88GG;4G4E8*H5=86G
GB$4FG8E%8GG<A::E88@8AGF
%8G@BHAGB9
8E<I4G<I8FF8GF
EBFF@BHAGB9
?<:<5?8&99F8GG<A:
)86B:A<M87
8E<I4G<I8#<45<?<G<8F 4F;B??4G8E4?)868<I87
$<??<BAF
9F=J5H=J9GGI6>97HHCA5GH9F
B9HH=B;5;F99A9BHG T T
9F=J5H=J9GBCHGI6>97HHC
A5GH9FB9HH=B;5;F99A9BHG T T T T
-CH5@
&99F8GG<A:B9<A4A6<4?#<45<?<G<8FHA78E$4FG8E%8GG<A::E88@8AGFJ<G;8E<I4G<I8BHAG8EC4EG<8F
EBFF@BHAGB9
8E<I4G<I8#<45<?<G<8F
'E8F8AG87<AG;8
BAFB?<74G87
4?4A68*;88G
EBFF@BHAGFABG&99F8G<AG;8
BAFB?<74G874?4A68*;88GG;4G4E8*H5=86G
GB$4FG8E%8GG<A::E88@8AGF
%8G@BHAGB9
8E<I4G<I8#<45<?<G<8F
EBFF@BHAGB9
?<:<5?8&99F8GG<A:
)86B:A<M87
8E<I4G<I8FF8GF 4F;B??4G8E4?)868<I87
$<??<BAF
9F=J5H=J9GGI6>97HHCA5GH9F
B9HH=B;5;F99A9BHG T T
9F=J5H=J9GBCHGI6>97HHC
A5GH9FB9HH=B;5;F99A9BHG T T T T
-CH5@
9</318?<</8-C00/->=
&9GH=A5H9GH<5HM95F CB M95F:CF9=;B7IFF9B7MHF5BG57H=CB9::97HG =B7@I8=B;<98;=B;=AD57HG 897F95G98DF9 H5L=B7CA96M
5DDFCL=A5H9@MA=@@=CB=B 897F95G98DF9 H5L=B7CA96M5DDFCL=A5H9@MA=@@=CB=B 5B8=B7F95G98DF9 H5L
=B7CA96M5DDFCL=A5H9@MA=@@=CB=B -<9G99GH=A5H9G=B7@I89HF5BG57H=CB;5=BG5B8@CGG9G =B7@I8=B;89F=J5H=J9
=BGHFIA9BHG89G=;B98HCF98I79:CF9=;B7IFF9B7M9L7<5B;9F5H9F=G?G
%&+ 4<E-4?H8$84FHE8@8AGF
==/>=+8.3+,363>3/=>2+>+<//+=?</.+>+3<(+6?/98+$/-?<<381+=3=
CF& 5GG9HG5B8@=56=@=H=9GH<5H5F9A95GIF985H:5=FJ5@I9CB5F97IFF=B;65G=GDF=A5F=@MF9@5H9HC5J5=@56@9 :CF G5@9
A5F?9H56@9G97IF=H=9G5B879FH5=B89F=J5H=J9=BGHFIA9BHG 9F=J5H=J9G=B7@I8975G<:@CK<98;9G =BH9F9GHF5H9GK5DG5B8B9H
=BJ9GHA9BH<98;9G -<9=B:CFA5H=CB=BH<9:C@@CK=B;D5F5;F5D<G5B8H56@9GDF=A5F=@M588F9GG9GA5HH9FGF9@5H=J9HCH<9G9
:=B5B7=5@5GG9HG5B8@=56=@=H=9G ,9D5F5H9@M H<9F9K9F9BCA5H9F=5@:5=FJ5@I9A95GIF9A9BHGK=H<F9GD97HHCBCB:=B5B7=5@5GG9HGCF
@=56=@=H=9GH<5H5F9F97C;B=N98CF8=G7@CG985H:5=FJ5@I9=BH<9CAD5BMWG:=B5B7=5@GH5H9A9BHGCB5F97IFF=B;65G=G:CF5B8
&IG9GJ5F=CIGJ5@I5H=CBH97<B=EI9G K<=7<5F9DF=A5F=@M65G98IDCBH<9A5F?9H5B8=B7CA95DDFC57<9G K=H<F9GD97HHC
:=B5B7=5@5GG9HG5B8@=56=@=H=9G C@@CK=B;=G589G7F=DH=CBC:H<9J5@I5H=CBA9H<C8C@C;=9GIG98:CFH<9F9GD97H=J9:=B5B7=5@5GG9HG
5B8@=56=@=H=9GA95GIF985H:5=FJ5@I9
J5=@56@9 :CF G5@9A5F?9H56@9G97IF=H=9GT9L79DH79FH5=B. , AIB=7=D5@G97IF=H=9G
&5F?9H56@9G97IF=H=9G 9L79DH79FH5=B. , AIB=7=D5@G97IF=H=9G 5F9J5@I98IH=@=N=B;AI@H=D@9GCIF79G K9=;<H985J9F5;9DF=79
=GIG98:CFH<9G9G97IF=H=9G &5F?9HDF=79G5F9C6H5=B98:CFH<9G9G97IF=H=9G:FCA5J5F=9HMC:=B8IGHFMGH5B85F885H5DFCJ=89FG
G97IF=HMA5GH9F:=@9G:FCA@5F;9:=B5B7=5@=BGH=HIH=CBG 5B8CH<9FH<=F8 D5FHMGCIF79G -<9G9AI@H=D@9DF=79G5F9IG985G=BDIHG=BHC
58=GHF=6IH=CB 7IFJ9 65G985@;CF=H<AHC89H9FA=B9H<985=@M:5=FJ5@I9HC69IG98 &7@5GG=:=9G. , HF95GIFMG97IF=H=9G5G@9J9@
-- 102 of 142 --
K<=@95@@CH<9FA5F?9H56@9G97IF=H=9G9L7@I8=B;79FH5=B. , AIB=7=D5@G97IF=H=9G5F97@5GG=:=985G@9J9@ &5F?9H56@9
G97IF=H=9G5F98=G7IGG98:IFH<9F=B'CH9
J5=@56@9 :CF G5@9A5F?9H56@9G97IF=H=9GT79FH5=B. , AIB=7=D5@G97IF=H=9GCB@M
&<C@8GAIB=7=D5@G97IF=H=9GK=H<G9J9F5@7=H=9G=BH<9.B=H98,H5H9G5GC:979A69F I9HCH<9B5HIF9C:H<9G9
G97IF=H=9G H<9J5@I5H=CBA9H<C8F9:9F9B79GH<975FFM=B;J5@I9C:H<97CFF9GDCB8=B;:=B5B79@95G9C6@=;5H=CB 5B85GGI7< K=@@69
7@5GG=:=985G@9J9@G97IF=H=9GG9D5F5H9@M
9F=J5H=J9=BGHFIA9BHG
-<9CAD5BMWG89F=J5H=J95GG9HG5B8@=56=@=H=9GK=H<=BH<9G7CD9C:, /<3@+>3@/=+8./.1381 5F9F9EI=F98HC69
F97CF8985H:5=FJ5@I9 -<9CAD5BMWG89F=J5H=J9GH<5H5F9F97CF8985H:5=FJ5@I9=B7@I89:CF9=;B7IFF9B7M:CFK5F85B8CDH=CB
7CBHF57HG =BH9F9GHF5H9GK5DG 5B8B9H=BJ9GHA9BH<98;9GK<9F9H<9<98;=B;=BGHFIA9BH=GF97CF8985H:5=FJ5@I9 '9H=BJ9GHA9BH
<98;9GH<5HIG9:CF9=;B7IFF9B7M89BCA=B5H98896HHC<98;9&WGB9H=BJ9GHA9BH5F9BCH=AD57H986MH<9:5=FJ5@I9
A95GIF9A9BHGH5B85F8IB89F, 5GH<9896HIG985GH<9<98;=B;=BGHFIA9BH=GA5F?98HC5J5@I9K=H<F9GD97HHC7<5B;9G
=BGDCH:CF9=;B7IFF9B7M9L7<5B;9F5H9G5B8BCHK=H<F9GD97HHCCH<9F:57HCFGH<5HA5M=AD57H:5=FJ5@I9
&<5G89H9FA=B98H<5H:CF9=;B7IFF9B7M:CFK5F8G 7IFF9B7MGK5DG :CF9=;B7IFF9B7MCDH=CBG =BH9F9GHF5H9GK5DG5B87FCGG
7IFF9B7MGK5DGK=@@697CBG=89F98@9J9@A95GIF9A9BHG &IG9G=BDIHGCH<9FH<5BEICH98DF=79GH<5H5F9C6G9FJ56@9:CFH<9
5GG9H -<9G9=BDIHG=B7@I89:CF9=;B7IFF9B7M9L7<5B;9F5H9G JC@5H=@=H=9G 5B8=BH9F9GHF5H9G 9F=J5H=J9DCG=H=CBG5F9DF=A5F=@M
J5@I98IG=B;GH5B85F875@7I@5H=CBG AC89@GH<5HIG95GH<9=F65G=GF958=@MC6G9FJ56@9A5F?9HD5F5A9H9FG "B8IGHFMGH5B85F885H5
DFCJ=89FG5F9&WGDF=A5FMGCIF79:CF:CFK5F85B8GDCHF5H9=B:CFA5H=CB:CF6CH<=BH9F9GHF5H9G5B87IFF9B7MF5H9G K=H<
F9GI@H=B;J5@I5H=CBGD9F=C8=75@@MJ5@=85H98H<FCI;<H<=F8 D5FHMCF7CIBH9FD5FHMEICH9G5B85B9HDF9G9BHJ5@I9GHF95AC:75G<
:@CKGAC89@
-<9:C@@CK=B;H56@9GDFCJ=89=B:CFA5H=CB6M@9J9@:CF5GG9HG5B8@=56=@=H=9GH<5H5F9A95GIF985H:5=FJ5@I9CB5F97IFF=B;65G=G
4<E-4?H8$84FHE8@8AGF,F<A: ACHGFBAF<78E874F
8F6E<CG<BA 4<E-4?H8 #8I8? #8I8? #8I8?
G868@58E $<??<BAF
GG9HG
J5=@56@9 :CF G5@9
&5F?9H56@9G97IF=H=9G
CFDCF5H9896HG97IF=H=9G N N T N N T
CAA9F7=5@D5D9F N T N T
9FH=:=75H9GC:89DCG=H H=A989DCG=HG N T N T
. , HF95GIFMG97IF=H=9G N T N T
. , AIB=7=D5@G97IF=H=9G N T N T
9F=J5H=J9=BGHFIA9BHGT5GG9HG
CF9=;B7IFF9B7M:CFK5F8 CDH=CB7CBHF57HG N T N T
"BH9F9GHF5H97CBHF57HG N N T N N T
%=56=@=H=9G
9F=J5H=J9=BGHFIA9BHGT@=56=@=H=9G
CF9=;B7IFF9B7M:CFK5F8 CDH=CB7CBHF57HG N T N T
"BH9F9GHF5H97CBHF57HG T N T T N T
-- 103 of 142 --
-<9:C@@CK=B;H56@9DFCJ=89G5F97CB7=@=5H=CBC:H<969;=BB=B;5B89B8=B;65@5B79GC:=H9AGA95GIF985H:5=FJ5@I9CB5
F97IFF=B;65G=G=BH<9H56@956CJ9H<5HIG98G=;B=:=75BHIBC6G9FJ56@9=BDIHG@9J9@
$4E>8G45?8F86HE<G<8FN68EG4<A, * @HA<6<C4?F86HE<G<8FBA?L
$<??<BAF
9;=BB=B;65@5B79
-CH5@;5=BGCF@CGG9G
"B7@I898=B95FB=B;G N T T
"B7@I898=BCH<9F7CADF9<9BG=J9=B7CA9 N T T
)IF7<5G9G5B8=GGI5B79G N
,5@9G5B8G9HH@9A9BHG
-F5BG:9FG=B5B8 CFCIHC:@9J9@ N T T
B8=B;65@5B79
<5B;9=BIBF95@=N98;5=BGCF@CGG9G:CFH<9D9F=C8=B7@I898=B95FB=B;G:CF
G97IF=H=9G<9@85HH<99B8C:H<9F9DCFH=B;D9F=C8 N T T
"B588=H=CB H<9D@5B5GG9HGC:&WGD9BG=CB5B8DCGHF9H=F9A9BH69B9:=HD@5BG5F9A95GIF985H:5=FJ5@I9CB5F97IFF=B;65G=G5H
@95GH5BBI5@@M +9:9FHC'CH9
==/>=+8.3+,363>3/=>2+>+<//+=?</.+>+3<(+6?/98+ 98</-?<<381+=3=
=G7@CGIF9G5F9F9EI=F98:CF79FH5=B5GG9HG5B8@=56=@=H=9GH<5H5F9A95GIF985H:5=FJ5@I9 6IH5F9F97C;B=N985B88=G7@CG985H:5=F
J5@I9CB5BCBF97IFF=B;65G=G=BD9F=C8GGI6G9EI9BHHC=B=H=5@F97C;B=H=CB CF& GI7<A95GIF9A9BHGC::5=FJ5@I9DF=A5F=@M
F9@5H9HC=B89:=B=H9 @=J985B8@CB; @=J985GG9H=AD5=FA9BHG ;CC8K=@@=AD5=FA9BHG 5B858>IGHA9BH=B75FFM=B;J5@I9C:9EI=HM
G97IF=H=9G:CFK<=7<H<9A95GIF9A9BH5@H9FB5H=J9C:7CGH@9GG=AD5=FA9BHD@IGCFA=BIGC6G9FJ56@9DF=797<5B;9G=GIG98 -<9F9
K9F9BCA5H9F=5@@CB; @=J985GG9H=AD5=FA9BHG:CF5B8 -<9F9K9F9BCA5H9F=5@58>IGHA9BHGHC9EI=HMG97IF=H=9GIG=B;
H<9A95GIF9A9BH5@H9FB5H=J9:CF5B8 &F9:@97H985B=AA5H9F=5@7<5F;9F9@5H98HC=AD5=FA9BHC:79FH5=B=B89:=B=H9
@=J985GG9HG5B85B9H7<5F;9C:A=@@=CBF9@5H98HC58>IGHA9BHHCH<975FFM=B;J5@I9C:9EI=HMG97IF=H=9GIG=B;H<9
A95GIF9A9BH5@H9FB5H=J98IF=B;H<9:=FGHEI5FH9FC:
+3<(+6?/9038+8-3+68=><?7/8>=
-<9CAD5BMWG:=B5B7=5@=BGHFIA9BHG=B7@I8975G<5B875G<9EI=J5@9BHG A5F?9H56@9G97IF=H=9G <9@8 HC A5HIF=HM896HG97IF=H=9G
577CIBHGF979=J56@9 79FH5=B=BJ9GHA9BHG 577CIBHGD5M56@9 6CFFCK=B;G 5B889F=J5H=J97CBHF57HG -<9:5=FJ5@I9GC:75G<
9EI=J5@9BHG 577CIBHGF979=J56@9 <9@8 HC A5HIF=HM896HG97IF=H=9G 577CIBHGD5M56@9 5B8G<CFH H9FA6CFFCK=B;G5B87IFF9BH
DCFH=CBC:@CB; H9FA896H5DDFCL=A5H9875FFM=B;J5@I9G6975IG9C:H<9G<CFH H9FAB5HIF9C:H<9G9=BGHFIA9BHG J5=@56@9 :CF
G5@9A5F?9H56@9G97IF=H=9G =B588=H=CBHC79FH5=B89F=J5H=J9=BGHFIA9BHG 5F9F97CF8985H:5=FJ5@I9G5G=B8=75H98=BH<9DF9798=B;
8=G7@CGIF9G -C9GH=A5H9:5=FJ5@I9G7@5GG=:=985G@9J9@:CF=HG@CB; H9FA896H H<9CAD5BMIH=@=N98H<=F8 D5FHMEICH9G K<=7<
5F989F=J985@@CF=BD5FH:FCAAC89@DF=79G 9LH9FB5@GCIF79G A5F?9HDF=79G CFH<9H<=F8 D5FHMWG=BH9FB5@F97CF8G "B:CFA5H=CB
K=H<F9GD97HHCH<975FFM=B;5ACIBHG5B89GH=A5H98:5=FJ5@I9GC:H<9G9:=B5B7=5@=BGHFIA9BHG:C@@CK
868@58E 868@58E
$<??<BAF 4EEL<A:-4?H8 4<E-4?H8 4EEL<A:-4?H8 4<E-4?H8
%CB; H9FA896H 9L7@I8=B;7IFF9BHDCFH=CB
-<9:5=FJ5@I9GF9:@97H9856CJ97CBG=89FH<9H9FAGC:H<9F9@5H98896H56G9BHH<9=AD57HGC:89F=J5H=J9 <98;=B;57H=J=HM -<9
75FFM=B;5ACIBHC:@CB; H9FA896HF9:9F9B79856CJ9=G=AD57H986M79FH5=B:=L98 HC :@C5H=B;=BH9F9GHF5H9GK5DGH<5H5F9
89G=;B5H985G:5=FJ5@I9<98;9G5B86MH<989G=;B5H=CBC:79FH5=B:=L98F5H9IFC6CB8G97IF=H=9G=GGI986MH<9CAD5BM5G
<98;=B;=BGHFIA9BHGC:H<9CAD5BMWGB9H=BJ9GHA9BH=B=HGIFCD95BGI6G=8=5F=9G BIA69FC:&WG:=L98 F5H96CB8GK9F9
HF58=B;5H5DF9A=IA5H979A69F 5B88I9HCH<9@CK9F=BH9F9GHF5H9G5B8H=;<H9F7F98=HGDF958G7CAD5F98HC
=GGI5B79@9J9@G
-- 104 of 142 --
NOTE 16. Commitments and Contingencies
Warranties/Guarantees:
3M’s accrued product warranty liabilities, recorded on the Consolidated Balance Sheet as part of current and long-term
liabilities, are estimated at approximately $48 million at December 31, 2021, and $46 million at December 31, 2020. Further
information on product warranties is not disclosed, as the Company considers the balance immaterial to its consolidated results
of operations and financial condition. 3M guarantees of loans with third parties and other guarantee arrangements are not
material.
Legal Proceedings:
The Company and some of its subsidiaries are involved in numerous claims and lawsuits, principally in the United States, and
regulatory proceedings worldwide. These claims, lawsuits and proceedings include, but are not limited to, products liability
(involving products that the Company now or formerly manufactured and sold), intellectual property, commercial, antitrust,
federal healthcare program related laws and regulations, such as the False Claims Act and anti-kickback laws, securities, and
environmental laws in the United States and other jurisdictions. Unless otherwise stated, the Company is vigorously defending
all such litigation and proceedings. From time to time, the Company also receives subpoenas, investigative demands or requests
for information from various government agencies. The Company generally responds in a cooperative, thorough and timely
manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the
Company. Such requests can also lead to the assertion of claims or the commencement of administrative, civil or criminal legal
proceedings against the Company and others, as well as to settlements. The outcomes of legal proceedings and regulatory
matters are often difficult to predict. Any determination that the Company’s operations or activities are not, or were not, in
compliance with applicable laws or regulations could result in the imposition of fines, civil or criminal penalties, and equitable
remedies, including disgorgement, suspension or debarment or injunctive relief.
Process for Disclosure and Recording of Liabilities Related to Legal Proceedings
Many lawsuits and claims involve highly complex issues relating to causation, scientific evidence, and alleged actual damages,
all of which are otherwise subject to substantial uncertainties. Assessments of lawsuits and claims can involve a series of
complex judgments about future events and can rely heavily on estimates and assumptions. When making determinations about
recording liabilities related to legal proceedings, the Company complies with the requirements of ASC 450, Contingencies, and
related guidance, and records liabilities in those instances where it can reasonably estimate the amount of the loss and when the
loss is probable. Where the reasonable estimate of the probable loss is a range, the Company records as an accrual in its
financial statements the most likely estimate of the loss, or the low end of the range if there is no one best estimate. The
Company either discloses the amount of a possible loss or range of loss in excess of established accruals if estimable, or states
that such an estimate cannot be made. The Company discloses significant legal proceedings even where liability is not probable
or the amount of the liability is not estimable, or both, if the Company believes there is at least a reasonable possibility that a
loss may be incurred.
Because litigation is subject to inherent uncertainties, and unfavorable rulings or developments could occur, there can be no
certainty that the Company may not ultimately incur charges in excess of presently recorded liabilities. Many of the matters
described are at preliminary stages or seek an indeterminate amount of damages. It is not uncommon for claims to be resolved
over many years. A future adverse ruling, settlement, unfavorable development, or increase in accruals for one or more of these
matters could result in future charges that could have a material adverse effect on the Company’s results of operations or cash
flows in the period in which they are recorded. Based on experience and developments, the Company reexamines its estimates
of probable liabilities and associated expenses and receivables each period, and whether it is able to estimate a liability
previously determined to be not estimable and/or not probable. Where appropriate, the Company makes additions to or
adjustments of its estimated liabilities. As a result, the current estimates of the potential impact on the Company’s consolidated
financial position, results of operations and cash flows for the legal proceedings and claims pending against the Company could
change in the future.
Process for Disclosure and Recording of Insurance Receivables Related to Legal Proceedings
The Company estimates insurance receivables based on an analysis of the terms of its numerous policies, including their
exclusions, pertinent case law interpreting comparable policies, its experience with similar claims, and assessment of the nature
of the claim and remaining coverage, and records an amount it has concluded is recognizable and expects to receive in light of
the loss recovery and/or gain contingency models under ASC 450, ASC 610-30, and related guidance. For those insured legal
proceedings where the Company has recorded an accrued liability in its financial statements, the Company also records
97
-- 105 of 142 --
receivables for the amount of insurance that it concludes as recognizable from the Company’s insurance program. For those
insured matters where the Company has not recorded an accrued liability because the liability is not probable or the amount of
the liability is not estimable, or both, but where the Company has incurred an expense in defending itself, the Company records
receivables for the amount of insurance that it concludes as recognizable for the expense incurred.
The following sections first describe the significant legal proceedings in which the Company is involved, and then describe the
liabilities and associated insurance receivables the Company has accrued relating to its significant legal proceedings.
Respirator Mask/Asbestos Litigation
As of December 31, 2021, the Company is a named defendant, with multiple co-defendants, in numerous lawsuits in various
courts that purport to represent approximately 3,876 individual claimants, compared to approximately 2,075 individual
claimants with actions pending on December 31, 2020.
The vast majority of the lawsuits and claims resolved by and currently pending against the Company allege use of some of the
Company’s mask and respirator products and seek damages from the Company and other defendants for alleged personal injury
from workplace exposures to asbestos, silica, coal mine dust or other occupational dusts found in products manufactured by
other defendants or generally in the workplace. A minority of the lawsuits and claims resolved by and currently pending against
the Company generally allege personal injury from occupational exposure to asbestos from products previously manufactured
by the Company, which are often unspecified, as well as products manufactured by other defendants, or occasionally at
Company premises.
The Company’s current volume of new and pending matters is substantially lower than it experienced at the peak of filings in
2003. The Company expects that filing of claims by unimpaired claimants in the future will continue to be at much lower levels
than in the past. Accordingly, the number of claims alleging more serious injuries, including mesothelioma, other malignancies,
and black lung disease, will represent a greater percentage of total claims than in the past. Over the past twenty plus years, the
Company has prevailed in fifteen of the sixteen cases tried to a jury (including the lawsuits in 2018 described below). In 2018,
3M received a jury verdict in its favor in two lawsuits – one in California state court in February and the other in Massachusetts
state court in December – both involving allegations that 3M respirators were defective and failed to protect the plaintiffs
against asbestos fibers. In April 2018, a jury in state court in Kentucky found 3M’s 8710 respirators failed to protect two coal
miners from coal mine dust and awarded compensatory damages of approximately $2 million and punitive damages totaling
$63 million. In August 2018, the trial court entered judgment and the Company appealed. During March and April 2019, the
Company agreed in principle to settle a substantial majority of the then-pending coal mine dust lawsuits in Kentucky and West
Virginia for $340 million, including the jury verdict in April 2018 in the Kentucky case mentioned above. That settlement was
completed in 2019, and the appeal has been dismissed. In October 2020, 3M defended a respirator case before a jury in King
County, Washington, involving a former shipyard worker who alleged 3M’s 8710 respirator was defective and that 3M acted
negligently in failing to protect him against asbestos fibers. The jury delivered a complete defense verdict in favor of 3M,
concluding that the 8710 respirator was not defective in design or warnings and any conduct by 3M was not a cause of
plaintiff’s mesothelioma. The plaintiff’s appeal is pending. A ruling is expected during the first quarter of 2022.
The Company has demonstrated in these past trial proceedings that its respiratory protection products are effective as claimed
when used in the intended manner and in the intended circumstances. Consequently, the Company believes that claimants are
unable to establish that their medical conditions, even if significant, are attributable to the Company’s respiratory protection
products. Nonetheless, the Company’s litigation experience indicates that claims of persons alleging more serious injuries,
including mesothelioma, other malignancies, and black lung disease, are costlier to resolve than the claims of unimpaired
persons, and it therefore believes the average cost of resolving pending and future claims on a per-claim basis will continue to
be higher than it experienced in prior periods when the vast majority of claims were asserted by medically unimpaired
claimants. Since the second half of 2020, the Company has experienced an increase in the number of cases filed that allege
injuries from exposures to coal mine dust; that increase represents the substantial majority of the growth in case numbers
referred to above.
As previously reported, the State of West Virginia, through its Attorney General, filed a complaint in 2003 against the
Company and two other manufacturers of respiratory protection products in the Circuit Court of Lincoln County, West
Virginia, and amended its complaint in 2005. The amended complaint seeks substantial, but unspecified, compensatory
damages primarily for reimbursement of the costs allegedly incurred by the State for worker’s compensation and healthcare
benefits provided to all workers with occupational pneumoconiosis and unspecified punitive damages. In October 2019, the
court granted the State’s motion to sever its unfair trade practices claim. In January 2020, the manufacturers filed a petition with
the West Virginia Supreme Court, challenging the trial court’s rulings; that petition was denied in November 2020. Trial for the
unfair trade practices claims has been set for August 2022. No liability has been recorded for this matter because the Company
believes that liability is not probable and reasonably estimable at this time. In addition, the Company is not able to estimate a
possible loss or range of loss given the lack of any meaningful discovery responses by the State of West Virginia, the otherwise
98
-- 106 of 142 --
minimal activity in this case, and the assertions of claims against two other manufacturers where a defendant’s share of liability
may turn on the law of joint and several liability and by the amount of fault, if any, a jury may allocate to each defendant if the
case were ultimately tried.
Respirator Mask/Asbestos Liabilities and Insurance Receivables
The Company regularly conducts a comprehensive legal review of its respirator mask/asbestos liabilities. The Company
reviews recent and historical claims data, including without limitation, (i) the number of pending claims filed against the
Company, (ii) the nature and mix of those claims (i.e., the proportion of claims asserting usage of the Company’s mask or
respirator products and alleging exposure to each of asbestos, silica, coal or other occupational dusts, and claims pleading use of
asbestos-containing products allegedly manufactured by the Company), (iii) the costs to defend and resolve pending claims, and
(iv) trends in filing rates and in costs to defend and resolve claims, (collectively, the “Claims Data”). As part of its
comprehensive legal review, the Company regularly provides the Claims Data to a third party with expertise in determining the
impact of Claims Data on future filing trends and costs. The third party assists the Company in estimating the costs to defend
and resolve pending and future claims. The Company uses these estimates to develop its best estimate of probable liability.
Developments may occur that could affect the Company’s estimate of its liabilities. These developments include, but are not
limited to, significant changes in (i) the key assumptions underlying the Company’s accrual, including the number of future
claims, the nature and mix of those claims, the average cost of defending and resolving claims, and in maintaining trial
readiness, (ii) trial and appellate outcomes, (iii) the law and procedure applicable to these claims, and (iv) the financial viability
of other co-defendants and insurers.
As a result of its review of its respirator mask/asbestos liabilities, of pending and expected lawsuits and of the cost of resolving
claims of persons who claim more serious injuries, including mesothelioma, other malignancies, and black lung disease, the
Company increased its accruals in 2021 for respirator mask/asbestos liabilities by $74 million. In 2021, the Company made
payments for legal defense costs and settlements of $96 million related to the respirator mask/asbestos litigation. As previously
disclosed, during the first quarter of 2019, the Company recorded a pre-tax charge of $313 million in conjunction with an
increase in the accrual as a result of the March and April 2019 settlements-in-principle of the coal mine dust lawsuits mentioned
above and the Company’s assessment of other then current and expected coal mine dust lawsuits (including the costs to resolve
all then current and expected coal mine dust lawsuits in Kentucky and West Virginia at the time of the charge). As of December
31, 2021, the Company had an accrual for respirator mask/asbestos liabilities (excluding Aearo accruals) of $640 million. This
accrual represents the Company’s best estimate of probable loss and reflects an estimation period for future claims that may be
filed against the Company approaching the year 2050. The Company cannot estimate the amount or upper end of the range of
amounts by which the liability may exceed the accrual the Company has established because of the (i) inherent difficulty in
projecting the number of claims that have not yet been asserted or the time period in which future claims may be asserted, (ii)
the complaints nearly always assert claims against multiple defendants where the damages alleged are typically not attributed to
individual defendants so that a defendant’s share of liability may turn on the law of joint and several liability, which can vary
by state, (iii) the multiple factors described above that the Company considers in estimating its liabilities, and (iv) the several
possible developments described above that may occur that could affect the Company’s estimate of liabilities.
As of December 31, 2021, the Company’s receivable for insurance recoveries related to the respirator mask/asbestos litigation
was $4 million. The Company continues to seek coverage under the policies of certain insolvent and other insurers. Once those
claims for coverage are resolved, the Company will have collected substantially all of its remaining insurance coverage for
respirator mask/asbestos claims.
Respirator Mask/Asbestos Litigation — Aearo Technologies
On April 1, 2008, a subsidiary of the Company acquired the stock of Aearo Holding Corp., the parent of Aearo Technologies
(“Aearo”). Aearo manufactured and sold various products, including personal protection equipment, such as eye, ear, head,
face, fall and certain respiratory protection products.
As of December 31, 2021, Aearo and/or other companies that previously owned and operated Aearo’s respirator business
(American Optical Corporation, Warner-Lambert LLC, AO Corp. and Cabot Corporation (“Cabot”)) are named defendants,
with multiple co-defendants, including the Company, in numerous lawsuits in various courts in which plaintiffs allege use of
mask and respirator products and seek damages from Aearo and other defendants for alleged personal injury from workplace
exposures to asbestos, silica-related, coal mine dust, or other occupational dusts found in products manufactured by other
defendants or generally in the workplace.
99
-- 107 of 142 --
As of December 31, 2021, the Company, through its Aearo subsidiary, had accruals of $46 million for product liabilities and
defense costs related to current and future Aearo-related asbestos, silica-related and coal mine dust claims. This accrual
represents the Company’s best estimate of Aearo’s probable loss and reflects an estimation period for future claims that may be
filed against Aearo approaching the year 2050. The accrual reflects the Company’s assessment of pending and expected
lawsuits, its review of its respirator mask/asbestos liabilities, and the cost of resolving claims of persons who claim more
serious injuries. Responsibility for legal costs, as well as for settlements and judgments, is currently shared in an informal
arrangement among Aearo, Cabot, American Optical Corporation and a subsidiary of Warner Lambert and their respective
insurers (the “Payor Group”). Liability is allocated among the parties based on the number of years each company sold
respiratory products under the “AO Safety” brand and/or owned the AO Safety Division of American Optical Corporation and
the alleged years of exposure of the individual plaintiff.
Aearo’s share of the contingent liability is further limited by an agreement entered into between Aearo and Cabot on July 11,
1995. This agreement provides that, so long as Aearo pays to Cabot a quarterly fee of $100,000, Cabot will retain responsibility
and liability for, and indemnify Aearo against, any product liability claims involving exposure to asbestos, silica, or silica
products for respirators sold prior to July 11, 1995. Because of the difficulty in determining how long a particular respirator
remains in the stream of commerce after being sold, Aearo and Cabot have applied the agreement to claims arising out of the
alleged use of respirators involving exposure to asbestos, silica or silica products prior to January 1, 1997. With these
arrangements in place, Aearo’s potential liability is limited to exposures alleged to have arisen from the use of respirators
involving exposure to asbestos, silica, or silica products on or after January 1, 1997. To date, Aearo has elected to pay the
quarterly fee. Aearo could potentially be exposed to additional claims for some part of the pre-July 11, 1995 period covered by
its agreement with Cabot if Aearo elects to discontinue its participation in this arrangement, or if Cabot is no longer able to
meet its obligations in these matters.
Developments may occur that could affect the estimate of Aearo’s liabilities. These developments include, but are not limited
to: (i) significant changes in the number of future claims, (ii) significant changes in the average cost of resolving claims, (iii)
significant changes in the legal costs of defending these claims, (iv) significant changes in the mix and nature of claims
received, (v) trial and appellate outcomes, (vi) significant changes in the law and procedure applicable to these claims, (vii)
significant changes in the liability allocation among the co-defendants, (viii) the financial viability of members of the Payor
Group including exhaustion of available insurance coverage limits, and/or (ix) a determination that the interpretation of the
contractual obligations on which Aearo has estimated its share of liability is inaccurate. The Company cannot determine the
impact of these potential developments on its current estimate of Aearo’s share of liability for these existing and future claims.
If any of the developments described above were to occur, the actual amount of these liabilities for existing and future claims
could be significantly larger than the amount accrued.
Because of the inherent difficulty in projecting the number of claims that have not yet been asserted, the complexity of
allocating responsibility for future claims among the Payor Group, and the several possible developments that may occur that
could affect the estimate of Aearo’s liabilities, the Company cannot estimate the amount or range of amounts by which Aearo’s
liability may exceed the accrual the Company has established.
Environmental Matters and Litigation
The Company’s operations are subject to environmental laws and regulations including those pertaining to air emissions,
wastewater discharges, toxic substances, and the handling and disposal of solid and hazardous wastes enforceable by national,
state, and local authorities around the world, and private parties in the United States and abroad. These laws and regulations
provide, under certain circumstances, a basis for the remediation of contamination, for capital investment in pollution control
equipment, for restoration of or compensation for damages to natural resources, and for personal injury and property damage
claims. The Company has incurred, and will continue to incur, costs and capital expenditures in complying with these laws and
regulations, defending personal injury and property damage claims, and modifying its business operations in light of its
environmental responsibilities. In its effort to satisfy its environmental responsibilities and comply with environmental laws and
regulations, the Company has established, and periodically updates, policies relating to environmental standards of performance
for its operations worldwide.
Under certain environmental laws, including the United States Comprehensive Environmental Response, Compensation and
Liability Act of 1980 (CERCLA) and similar state laws, the Company may be jointly and severally liable, typically with other
companies, for the costs of remediation of environmental contamination at current or former facilities and at off-site locations.
The Company has identified numerous locations, most of which are in the United States, at which it may have some liability.
Please refer to the section entitled “Environmental Liabilities and Insurance Receivables” that follows for information on the
amount of the accrual for such liabilities.
100
-- 108 of 142 --
Environmental Matters
As previously reported, the Company has been voluntarily cooperating with ongoing reviews by local, state, federal (primarily
the U.S. Environmental Protection Agency (EPA)), and international agencies of possible environmental and health effects of
various perfluorinated compounds, including perfluorooctanoate (PFOA), perfluorooctane sulfonate (PFOS), perfluorohexane
sulfonate (PFHxS), or other per- and polyfluoroalkyl substances (collectively PFAS). As a result of its phase-out decision in
May 2000, the Company no longer manufactures certain PFAS compounds including PFOA, PFOS, PFHxS, and their pre-
cursor compounds. The Company ceased manufacturing and using the vast majority of these compounds within approximately
two years of the phase-out announcement and ceased all manufacturing and the last significant use of this chemistry by the end
of 2008. The Company continues to manufacture a variety of shorter chain length PFAS compounds, including, but not limited
to, pre-cursor compounds to perfluorobutane sulfonate (PFBS). These compounds are used as input materials to a variety of
products, including engineered fluorinated fluids, fluoropolymers and fluorelastomers, as well as surfactants, additives, and
coatings. Through its ongoing life cycle management and its raw material composition identification processes associated with
the Company’s policies covering the use of all persistent and bio-accumulative materials, the Company continues to review,
control or eliminate the presence of certain PFAS in purchased materials or as byproducts in some of 3M’s current
fluorochemical manufacturing processes, products, and waste streams.
PFAS Regulatory Activity
Regulatory activities concerning PFAS continue in the United States, Europe and elsewhere, and before certain international
bodies. These activities include gathering of exposure and use information, risk assessment, and consideration of regulatory
approaches. In the European Union, where 3M has manufacturing facilities in countries such as Germany and Belgium, recent
regulatory activities have included both preliminary and on-going work on various restrictions under the Regulation concerning
the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), including the restriction of PFAS in certain
usages and a broader restriction of PFAS as a class. As of the second half of 2020, PFOA is subject to broad restrictions under
the EU’s Persistent Organic Pollutants (POPs) Regulation. Dyneon, a 3M subsidiary that operates a facility at Gendorf,
Germany, has a recycling process for a critical emulsifier from which small amounts of PFOA are present after recycling, as an
unintended and unavoidable byproduct of certain earlier process steps. The recycling process removes and concentrates the
PFOA for incineration in accordance with applicable waste law. With respect to the applicability of the recently enacted POPs,
Dyneon proactively consulted with the relevant German regulatory authority regarding process improvements underway that
are designed to ensure compliance with the PFOA limits in the recycled material. In October 2021, Dyneon also discussed with
the authority technical complexities it had recently discovered in achieving PFOA reductions. The engagement is ongoing.
In addition, as previously disclosed, 3M Belgium, a subsidiary of the Company, has been working with the Public Flemish
Waste Agency (OVAM) for several years to investigate and remediate historical PFOA contaminations at and near the 3M
Belgium facility in Zwijndrecht, Antwerp, Belgium. In connection with a ring road construction project (the Oosterweel
Project) in Antwerp that has involved extensive soil work, an investigative committee with judicial investigatory powers was
formed in June 2021 by the Flemish Parliament to investigate PFAS found in the soil and groundwater near the Zwijndrecht
facility. The Company testified at Flemish parliamentary committee hearings in June and September 2021 on PFAS-related
matters. The Flemish Parliament, the Minister of the Environment, and regulatory authorities have initiated investigations and
demands for information related to the release of PFAS from the Zwijndrecht facility. The Company is cooperating with the
authorities in the investigations and information requests. Separately, as previously disclosed, the Company is aware that certain
residents of Zwijndrecht have filed a criminal complaint with an Antwerp investigatory judge against 3M Belgium, alleging it
had unlawfully abandoned waste in violation of its environmental care obligations. 3M Belgium has not been served with any
such complaint.
Safety measures – wastewater discharge. In August 2021, the Flemish Government served 3M Belgium with a notice of intent
to impose a safety measure (wastewater discharge stoppage) and issued an infraction report alleging permit and/or legal
violations in connection with the discharge of certain specific PFAS compounds for alleged lack of specific authorization.
Following discussions with the government officials, 3M Belgium implemented a focused safety measure that would allow
continued production activities and plans to contest through appeal the underlying legal and factual basis for the safety measure.
Separately, the permitting authority has initiated a process to tighten the wastewater discharge limits immediately. In October
2021, the Province of Antwerp adopted lower discharge limits for the nine PFAS compounds specifically identified in the water
discharge permit and added a special condition that essentially prohibits discharge of any PFAS chemistry without a specific
limit in the permit. The action by the Province was timely appealed and a hearing on the appeal was held in January 2022. The
Flemish Regional Environmental Permit Commission subsequently issued a recommendation that the appeal be denied and that
lower limits on PFAS compounds be imposed immediately. A decision on the appeal is pending. An adverse ruling on the
appeal would restrict the discharge of wastewater under the special condition noted above, which would materially and
adversely impact the facility’s operations including the possibility of causing the facility to cease operations. While the
101
-- 109 of 142 --
Company is exploring multiple options to mitigate the impact of an adverse ruling, a prolonged suspension or interruption of
the facility's operations could have a significant adverse impact on the Company's businesses that receive products and other
materials from the facility, some of which may not be available in similar quantities from other 3M facilities.
Safety measure – emissions. As previously disclosed, in October 2021, the Flemish environmental agency issued a new safety
measure that prohibits all emissions of all forms of PFAS from the facility unless and until specifically approved on a process-
by-process basis. 3M Belgium thereupon commenced an immediate appeal process to the Council of States, seeking, among
other things, urgent suspension of the safety measure during the pendency of the appeal process. At the same time, 3M Belgium
initiated efforts to comply with the safety measure by temporarily idling the affected production at the facility. The Council of
States declined to grant urgent suspension of the safety measure. An unsuccessful appeal of the safety measure would extend
the period the affected production is idled and could have a material negative impact on the Zwijndrecht facility’s operations.
3M Belgium has established a regular cadence of meetings with the relevant authorities in connection with the requests to
restart specific production processes that may result in emissions to air. The authorities have accepted the third-party experts
proposed by 3M Belgium who are required by the safety measure to review and opine on proposals necessary for process
restart. Although some limited requests have been approved for testing purposes, and the facility is taking actions to remedy
emission issues, a prolonged suspension and idling of the facility's operations could have a significant adverse impact on the
Company's businesses that receive products and other materials from the facility, some of which may not be available in similar
quantities from other 3M facilities, which could in turn impact these businesses’ ability to fulfill supply obligations to their
customers.
Administrative measure – soil piles. In September 2021, the Flemish Government served 3M Belgium with a notice of intent to
impose an administrative measure related to the removal and potential remediation of soil piles on the Zwijndrecht site. 3M
Belgium continues to have discussions with the relevant authorities to explain the timing constraints for certain actions.
Notice of default – environmental law compliance. Also in September 2021, the Flemish Region issued a notice of default
alleging violations of environmental laws and seeking PFAS-related information, indemnity and a remediation plan for soil and
water impacts due to PFAS originating from the Zwijndrecht facility. In September 2021, 3M responded to the notice of default
and announced a plan to invest up to 125 million euros in the next three years in actions related to the Zwijndrecht community,
including support for local commercial farmers impacted by restrictions on sale of agricultural products, and enhancements to
site discharge control technologies. 3M is also committed to payment for ongoing off-site descriptive soil investigation and
appropriate soil remediation.
In the United States, the EPA has developed human health effects documents summarizing the available data studies of both
PFOA and PFOS. In May 2016, the EPA announced lifetime health advisory levels for PFOA and PFOS at 70 parts per trillion
(ppt) (superseding the provisional levels established by the EPA in 2009 of 400 ppt for PFOA and 200 ppt for PFOS). Where
PFOA and PFOS are found together, EPA’s lifetime health advisory for PFOA and PFOS combined is also 70 ppt. Lifetime
health advisories, which are non-enforceable and non-regulatory, provide information about concentrations of drinking water
contaminants at which adverse health effects are not expected to occur over the specified exposure duration.
The U.S. Agency for Toxic Substances and Disease Registry (ATSDR) within the Department of Health and Human Services
released a draft Toxicological Profile for PFAS for public review and comment in June 2018. In the draft report, ATSDR
proposed draft minimal risk levels (MRLs) for PFOS, PFOA and several other PFAS. An MRL is an estimate of the daily
human exposure to a hazardous substance that is likely to be without appreciable risk of adverse non-cancer health effects over
a specified duration of exposure. MRLs establish a screening level and are not intended to define cleanup or action levels for
ATSDR or other agencies. In May 2021, ATSDR released a final toxicological profile for certain PFAS that preserved the draft
MRLs. Earlier, in April 2021, EPA released a final toxicity assessment for PFBS.
As periodically required under the Safe Drinking Water Act (SDWA), the EPA published in May 2012 a list of unregulated
substances, including six PFAS chemicals, required to be monitored during the period 2013-2015 by public water system
suppliers to determine the extent of their occurrence. Through January 2017, the EPA reported results for 4,920 public water
supplies nationwide. Based on the 2016 lifetime health advisory, 13 public water supplies exceeded the level for PFOA and 46
exceeded the level for PFOS (unchanged from the July 2016 EPA summary). These results are based on one or more samples
collected during the period 2012-2015 and do not necessarily reflect current conditions of these public water supplies. EPA
reporting does not identify the sources of the PFOA and PFOS in the public water supplies. In December 2021, EPA published
the fifth version of the unregulated contaminant monitoring rule, which requires monitoring for 29 PFAS compounds between
2023 and 2025.
With respect to PFOA and PFOS in groundwater, EPA issued interim recommendations in December 2019, providing guidance
for screening levels and preliminary remediation goals for groundwater that is a current or potential drinking water source, to
inform final clean-up levels of contaminated sites.
102
-- 110 of 142 --
In October 2021, EPA released its “PFAS Strategic Roadmap: EPA's Commitments to Action 2021-2024,” which presents
EPA’s approach to PFAS, including investing in research to increase an understanding of PFAS, pursuing a comprehensive
approach to proactively control PFAS exposures to humans and the environment, and broadening and accelerating the scope of
clean-up of PFAS in the environment. The 2021-2024 Roadmap sets timelines by which EPA plans to take specific actions,
including, among other items, publishing a national PFAS testing strategy, proposing to designate PFOA and PFOS as
CERCLA hazardous substances, restricting PFAS discharges from industrial sources through Effluent Limitations Guidelines,
publishing the final toxicity assessment for five additional PFAS compounds, requiring water systems to test for 29 PFAS
compounds under the SDWA, and publishing improved analytical methods in eight different environmental matrices to monitor
40 PFAS compounds present in wastewater and stormwater discharges.
EPA previously published its intention to initiate a process to develop a national primary drinking water regulation for PFOA
and PFOS; the process is expected to take several years and will include further analyses, scientific review and opportunities for
public comment. EPA initiated the first step in the process in November 2021 by referring its proposed approach to developing
a Maximum Contaminant Level Goal to the Science Advisory Board and soliciting public comment. The Company submitted
initial comments in December 2021. In October 2021, in response to a petition by New Mexico, EPA announced it will initiate
a rulemaking to designate four PFAS compounds as hazardous constituents under the Resource Conservation and Recovery Act
(RCRA). Further, in January 2022, EPA formally submitted to the Office of Management and Budget (OMB) its plan to
designate PFOA and PFOS as hazardous substances under CERCLA.
EPA has also taken several actions to increase reporting and restrictions regarding PFAS under the Toxic Substances Control
Act (TSCA) and the Toxics Release Inventory (TRI), which is a part of the Emergency Planning and Community Right-to-
Know Act. EPA has added more than 170 PFAS compounds to the list of substances that must be included in TRI reports as of
July 2021. In June 2021, EPA published a proposed rule under TSCA that, if adopted, would require certain persons that
manufacture (including import) or have manufactured PFAS in any year since 2011 to report information regarding PFAS uses,
production volumes, disposal, exposures, and hazards. The Company submitted comments on the proposed rule during the
public comment period, which ended in September 2021.
Several state legislatures and state agencies have been evaluating or have taken actions related to cleanup standards,
groundwater values or drinking water values for PFOS, PFOA, and other PFAS, and 3M has submitted various responsive
comments. Those states include the following:
• Minnesota Department of Health in May 2017 stated that Health Based Values (HBVs) “are designed to reduce long-
term health risks across the population and are based on multiple safety factors to protect the most vulnerable citizens,
which makes them overprotective for most of the residents in our state.” As of 2021, the current HBVs are 35 ppt for
PFOA, 15 ppt for PFOS, 47 ppt for PFHxS and 2 ppb for PFBS. In February 2018, the MDH published reports finding
no unusual rates of certain cancers or adverse birth outcomes (low birth rates or premature births) among residents of
Washington and Dakota Counties in Minnesota.
• Minnesota Pollution Control Agency (MPCA) and three other state agencies published “Minnesota’s PFAS Blueprint”
in February 2021. The Blueprint outlines the State’s plans to manage, investigate, monitor, research and regulate PFAS
discharges or releases in Minnesota. In November 2021, MPCA published for public notice its “Draft PFAS
Monitoring Plan,” which proposes a system for voluntary PFAS monitoring at solid waste, wastewater and stormwater
facilities, facilities with air emissions, and sites in the Superfund or the state’s Brownfield programs.
• California finalized drinking water response levels for PFOA and PFOS in February 2020.
• Vermont finalized drinking water standards for a combination of PFOA, PFOS and three other PFAS compounds in
March 2020.
• New Jersey finalized drinking water standards and designated PFOA and PFOS as hazardous substances in June 2020.
• New York established drinking water standards for PFOA and PFOS in July 2020.
• New Hampshire established drinking water standards by legislation for certain PFAS compounds, including PFOS and
PFOA, in July 2020.
• Michigan implemented final drinking water standards for certain PFAS compounds, including PFOS and PFOA, in
August 2020.
• Massachusetts published final regulations establishing a drinking water standard relating to six combined PFAS
compounds in October 2020.
Some other states have also been evaluating or have taken actions relating to PFOA, PFOS and other PFAS compounds in
products such as food packaging, carpets and other products. For example, in October 2021, two bills were signed into law in
California that prohibit the use of PFAS in children’s products and in food packaging. Additionally, in December 2021,
California finalized its listing of PFOS as a carcinogen, and PFNA as a reproductive toxicant under its Proposition 65 law.
California has also proposed listing PFOA as a carcinogen and PFDA, PFHxS, and PFUNDA as reproductive toxicants under
Proposition 65. In August 2021, Maine became the first state to ban all PFAS compounds in all products, except where use is
unavoidable. The ban becomes effective in 2030.
103
-- 111 of 142 --
In October 2020, 3M and several other parties filed notices of appeal in the appellate division of the Superior Court of New
Jersey to challenge the validity of the New Jersey PFOS and PFOA regulations. In January 2021, the appellate division of the
court denied the group’s motion to stay the regulations. The parties completed briefing on the merits in October 2021. In March
2021, 3M filed a lawsuit against the New York State Department of Health, on the grounds that drinking water levels set by the
agency for PFOS and PFOA should be vacated because they are arbitrary and did not comply with statutorily required
processes. An oral argument on the merits was held in December 2021. In April 2021, 3M also filed a lawsuit against the
Michigan Department of Environment, Great Lakes, and Energy (EGLE) to invalidate the drinking water standards EGLE
promulgated under an accelerated timeline. EGLE moved to dismiss that lawsuit. In September 2021, the court denied EGLE’s
motion in part, and the parties are proceeding to litigation on the merits of the remaining claims.
The Company cannot predict what additional regulatory actions in the United States, Europe and elsewhere arising from the
foregoing or other proceedings and activities, if any, may be taken regarding such compounds or the consequences of any such
actions to the Company.
Litigation Related to Historical PFAS Manufacturing Operations in Alabama
As previously reported, a former employee filed a putative class action lawsuit against 3M, BFI Waste Management Systems of
Alabama, and others in the Circuit Court of Morgan County, Alabama (the “St. John” case), seeking property damage from
exposure to certain perfluorochemicals at or near the Company’s Decatur, Alabama, manufacturing facility. The parties have
agreed to repeated stays of the St. John case, to permit ongoing mediation between the parties involved in this case and another
case discussed below. Two additional putative class actions filed in the same court by certain residents in the vicinity of the
Decatur plant seeking relief on similar grounds (the Chandler case and the Stover case, respectively) are stayed pending the
resolution of class certification issues in the St. John case.
In June 2016, the Tennessee Riverkeeper, Inc. (Riverkeeper), a non-profit corporation, filed a lawsuit in the U.S. District Court
for the Northern District of Alabama against 3M; BFI Waste Systems of Alabama; the City of Decatur, Alabama; and the
Municipal Utilities Board of Decatur, Morgan County, Alabama. The complaint alleges that the defendants violated the
Resource Conservation and Recovery Act in connection with the disposal of certain PFAS compounds through their ownership
and operation of their respective sites. The complaint further alleges such practices may present an imminent and substantial
endangerment to health and/or the environment and that Riverkeeper has suffered and will continue to suffer irreparable harm
caused by defendants’ failure to abate the endangerment unless the court grants the requested relief, including declaratory and
injunctive relief. This case was also stayed pending ongoing mediation and discussions between the parties in conjunction with
the St. John case.
In October 2021, 3M reached agreements in principle to resolve litigation with the Tennessee Riverkeeper organization, as well
as the plaintiffs in the St. John (including Stover, Owens and Chandler) matters. The agreements, if finalized and approved by
the court, will complement the Interim Consent Order that 3M entered with the Alabama Department of Environmental
Management (ADEM) in 2020, as described below. Key provisions of these agreements include 3M’s continued environmental
characterization, including sampling of environmental media, such as soil, ground water, and sediment, regarding the potential
presence of PFAS at the 3M Decatur facility and legacy disposal sites, as well as supporting the execution of appropriate
remedial actions. In December 2021, the court in the St. John action granted preliminary approval of the class settlement, and a
hearing for final approval is scheduled for April 2022. Also in December 2021, the court handling the Tennessee Riverkeeper
action administratively closed that case in light of the settlement between the parties.
In October 2015, West Morgan-East Lawrence Water & Sewer Authority (Water Authority) filed a complaint against 3M
Company, Dyneon, L.L.C, and Daikin America, Inc., in the U.S. District Court for the Northern District of Alabama. The
complaint also includes representative plaintiffs who brought the complaint on behalf of themselves, and a class of all owners
and possessors of property who use water provided by the Water Authority and five local water works to which the Water
Authority supplies water. The complaint seeks compensatory and punitive damages and injunctive relief based on allegations
that the defendants’ chemicals, including PFOA and PFOS from their manufacturing processes in Decatur, have contaminated
the water in the Tennessee River at the water intake, and that the chemicals cannot be removed by the water treatment processes
utilized by the Water Authority. In April 2019, 3M and the Water Authority settled the lawsuit for $35 million, which will fund
a new water filtration system, with 3M indemnifying the Water Authority from liability resulting from the resolution of the
currently pending and future lawsuits against the Water Authority alleging liability or damages related to 3M PFAS. In October
2021, with respect to the putative class claims brought by the representative plaintiffs who were supplied drinking water by the
Water Authority (the “Lindsey” case), the parties reached an agreement in principle, subject to court approval, to resolve the
claims for an immaterial amount. In November 2021, the court entered an order of preliminary approval of the class settlement.
A hearing on final approval of the settlement is scheduled for March 2022.
In August 2016, a group of over 200 plaintiffs filed a putative class action against West Morgan-East Lawrence Water and
Sewer Authority (Water Authority), 3M, Dyneon, Daikin, BFI, and the City of Decatur in state court in Lawrence County,
104
-- 112 of 142 --
Alabama (the “Billings” case). Plaintiffs are residents of Lawrence, Morgan and other counties who are or have been customers
of the Water Authority. They contend defendants have released PFAS that contaminate the Tennessee River and, in turn, their
drinking water, causing damage to their health and properties. In January 2017, the court in the St. John case, discussed above,
stayed this litigation pending resolution of the St. John case. Plaintiffs in the Billings case have amended their complaint
numerous times to add additional plaintiffs. There are now approximately 4,500 named plaintiffs. The parties have reached an
agreement in principle to resolve the litigation.
In January 2017, several hundred plaintiffs sued 3M, Dyneon and Daikin America in Lawrence and Morgan Counties, Alabama
(the “Owens” case). The plaintiffs are owners of property, residents, and holders of property interests who receive their water
from the West Morgan-East Lawrence Water and Sewer Authority (Water Authority). They assert common law claims for
negligence, nuisance, trespass, wantonness, and battery, and they seek injunctive relief and punitive damages. The plaintiffs
contend that the defendants own and operate manufacturing and disposal facilities in Decatur that have released and continue to
release PFOA, PFOS and related chemicals into the groundwater and surface water of their sites, resulting in discharges into the
Tennessee River. The plaintiffs contend that, as a result of the alleged discharges, the water supplied by the Water Authority to
the plaintiffs was, and is, contaminated with PFOA, PFOS and related chemicals at a level dangerous to humans. The court
denied a motion by co-defendant Daikin to stay this case pending resolution of the St. John case. The parties have reached an
agreement in principle to resolve the litigation.
In November 2017, a putative class action (the “King” case) was filed against 3M, Dyneon, Daikin America and the West
Morgan-East Lawrence Water and Sewer Authority (Water Authority) in the U.S. District Court for the Northern District of
Alabama. The plaintiffs are residents of Lawrence and Morgan County, Alabama who receive their water from the Water
Authority and seek injunctive relief, attorneys’ fees, compensatory and punitive damages for their alleged personal injuries. The
plaintiffs contend that the defendants own and operate manufacturing and disposal facilities in Decatur, Alabama that have
released and continue to release PFOA, PFOS and related chemicals into the groundwater and surface water of their sites,
resulting in discharges into the Tennessee River. The plaintiffs contend that, as a result of the alleged discharges, the water
supplied by the Water Authority to the plaintiffs was, and is, contaminated with PFOA, PFOS and related chemicals at a level
dangerous to humans. In November 2019, the King plaintiffs amended their complaint to withdraw all class allegations. Since
then, the complaint has been amended several times to add or dismiss plaintiffs, and the case currently involves 42 plaintiffs.
The case is scheduled for trial in July 2023. Discovery in this case is proceeding.
In July 2019, 3M announced that it had initiated an investigation into the possible presence of PFAS in three closed municipal
landfills in Decatur that accepted waste from 3M’s Decatur plant and other companies in the 1960s through the 1980s. 3M has
worked with the City of Decatur and other local and state entities such as Morgan County and Decatur Utilities as it conducted
its investigation. In November 2021, 3M and the City of Decatur, Decatur Utilities and Morgan County executed a
collaborative agreement under which the Company agreed to contribute approximately $99 million and also to continue to
address certain PFAS-related matters in the area. The contribution relates to initiatives to improve the quality of life and overall
environment in Decatur, including community redevelopment and recreation projects by the City, County and Decatur Utilities.
It also includes addressing PFAS matters at the Morgan County landfill and reimbursement of costs previously incurred related
to PFAS remediation. In addition to the contribution, 3M will continue to address PFAS at certain other closed municipal sites
at which the Company historically disposed waste and continue environmental characterization in the area. This work will
complement the Interim Consent Order that 3M entered with ADEM in 2020 and includes sampling of environmental media,
such as ground water, regarding the potential presence of PFAS at the 3M Decatur facility and legacy disposal sites, as well as
supporting the execution of any appropriate remedial actions.
3M is also defending or has received notice of potential lawsuits in state and federal court brought by individual property
owners who claim damages related to historical PFAS disposal at former area landfills near their Decatur-area properties. 3M
continues to negotiate with property owners and has resolved for an immaterial amount some of the claims brought by them.
In September 2020, the City of Guin Water Works and Sewer Board (Guin WWSB) brought a lawsuit against 3M in Alabama
state court alleging that PFAS contamination in the Guin water system stems from manufacturing operations at 3M’s Guin
facility and disposal activity at a nearby landfill. In this same month, Guin WWSB dismissed its lawsuit without prejudice and
has been working with 3M to further investigate the presence of chemicals in the area. In December 2021, the parties reached a
settlement under which 3M agreed to contribute $30 million that will be used on a new treatment system for Guin’s drinking
water and a new wastewater treatment facility.
Litigation Related to Historical PFAS Manufacturing Operations in Minnesota
In July 2016, the City of Lake Elmo filed a lawsuit in the U.S. District Court for the District of Minnesota against 3M alleging
that the City suffered damages from drinking water supplies contaminated with PFAS, including costs to construct alternative
sources of drinking water. In April 2019, 3M and the City of Lake Elmo agreed to settle the lawsuit for less than $5 million.
105
-- 113 of 142 --
State Attorneys General Litigation related to PFAS
Minnesota. In December 2010, the State of Minnesota, by its Attorney General, filed a lawsuit in Hennepin County District
Court against 3M seeking damages and injunctive relief with respect to the presence of PFAS in the groundwater, surface
water, fish or other aquatic life, and sediments in the state of Minnesota (the “NRD Lawsuit”). In February 2018, 3M and the
State of Minnesota reached a resolution of the NRD Lawsuit. Under the terms of the settlement, 3M agreed to provide an $850
million grant to the State for a special “3M Water Quality and Sustainability Fund.” This Fund, which is administered by the
State, will enable projects that support water sustainability in the Twin Cities East Metro region, such as continued delivery of
water to residents and enhancing groundwater recharge to support sustainable growth. Other purposes of the grant include
habitat and recreation improvements, such as fishing piers, trails, and open space preservation. 3M recorded a pre-tax charge of
$897 million, inclusive of legal fees and other related obligations, in the first quarter of 2018 associated with the resolution of
this matter.
In connection with the above referenced settlement, the Minnesota Pollution Control Agency and the Department of Natural
Resources, as co-trustees of the Fund, released in September 2020 a conceptual drinking water supply plan for the communities
in the East Metro area, seeking public comment on three recommended options for utilizing the Fund. In December 2020, 3M
submitted preliminary comments on the co-trustees’ draft conceptual drinking water supply plan to address legal and technical
aspects of the draft plan. The Company and the State continue to discuss those aspects of the draft plan.
New York. The State of New York, by its Attorney General, has filed four lawsuits (in June 2018, February 2019, July 2019,
and November 2019) against 3M and other defendants seeking to recover the costs incurred in responding to PFAS
contamination allegedly caused by Aqueous Film Forming Foam (AFFF) manufactured by 3M and others. Each of the four
suits was filed in Albany County Supreme Court before being removed to federal court, and each has been transferred to the
multi-district litigation (MDL) proceeding for AFFF cases, which is discussed further below. The state is seeking compensatory
and punitive damages, and injunctive and equitable relief in the form of a monetary fund for the State’s reasonably expected
future damages, and/or requiring defendants to perform investigative and remedial work.
Ohio. In December 2018, the State of Ohio, by its Attorney General, filed a lawsuit in the Common Pleas Court of Lucas
County, Ohio against 3M, Tyco Fire Products LP, Chemguard, Inc., Buckeye Fire Equipment Co., National Foam, Inc., and
Angus Fire Armour Corp., seeking injunctive relief and compensatory and punitive damages for remediation costs and alleged
injury to Ohio natural resources from AFFF manufacturers. This case was removed to federal court and transferred to the MDL.
New Jersey. In March 2019, the New Jersey Attorney General filed two actions against 3M, DuPont, and Chemours on behalf
of the New Jersey Department of Environmental Protection (NJDEP), the NJDEP’s commissioner, and the New Jersey Spill
Compensation Fund regarding alleged discharges at two DuPont facilities in Pennsville, New Jersey (Salem County) and Parlin,
New Jersey (Middlesex County). 3M is included as a defendant in both cases because it allegedly supplied PFOA to DuPont for
use at the facilities at issue. Both cases expressly seek to have the defendants pay all costs necessary to investigate, remediate,
assess, and restore the affected natural resources of New Jersey. DuPont removed these cases to federal court. In June 2020, the
court consolidated the two actions, along with two others brought by the NJDEP relating to the DuPont facilities, for case
management and pretrial purposes. In December 2021, the court denied various motions to dismiss that the defendants had
filed, including 3M's motions. The parties are conducting discovery.
In May 2019, the New Jersey Attorney General and NJDEP filed a lawsuit against 3M, DuPont, and six other companies,
alleging natural resource damages from AFFF products and seeking damages, including punitive damages, and associated fees.
This case was removed to federal court and transferred to the AFFF MDL.
New Hampshire. In May 2019, the New Hampshire Attorney General filed two lawsuits alleging contamination of the state’s
drinking water supplies and other natural resources by PFAS chemicals. The first lawsuit was filed against 3M and seven co-
defendants, alleging PFAS contamination resulting from the use of AFFF products at several sites around the state. This case
was removed to federal court and transferred to the AFFF MDL. The second suit asserts PFAS contamination from non-AFFF
sources and names 3M, DuPont, and Chemours as defendants. In its June 2020 ruling on defendants’ motions to dismiss, the
court dismissed the state’s trespass claim, but allowed several claims to proceed. In October 2020, the state amended its
complaint to add a state commission as plaintiff and make a claim related to the state’s drinking water and groundwater trust
fund statute. In July 2021, the court granted defendants’ motions to dismiss these amendments. In September 2021 the state
filed its second amended complaint, which 3M answered in October 2021. A hearing on case scheduling has been set for March
2022, and the case remains in early stages of litigation.
Vermont. In June 2019, the Vermont Attorney General filed two lawsuits alleging contamination of the state’s drinking water
supplies and other natural resources by PFAS chemicals. The first lawsuit was filed against 3M and ten co-defendants, alleging
PFAS contamination resulting from the use of AFFF products at several sites around the state. This case was removed to federal
106
-- 114 of 142 --
court and transferred to the AFFF MDL. The second suit asserts PFAS contamination from non-AFFF sources and names 3M
and several entities related to DuPont and Chemours as defendants. This suit is proceeding in state court. In May 2020, the
court denied the defendants’ motion to dismiss, but dismissed the state’s trespass claim as to property the state does not own.
The parties are now engaged in discovery and the court has set a trial-ready date in October 2023.
Michigan. In January 2020, the Michigan Attorney General filed a lawsuit in state court against 3M, Dyneon, DuPont,
Chemours and others seeking injunctive and equitable relief and damages for alleged injury to Michigan public natural
resources and its residents related to PFAS, excluding AFFF. The case was removed to federal court in March 2021 and
subsequently transferred to the AFFF MDL. The state has filed a motion to remand the case to state court. In addition, in
August 2020, the Michigan Attorney General filed two lawsuits against numerous AFFF manufacturers and distributors, and
suppliers of PFAS to AFFF manufacturers. 3M is named a defendant in one of the lawsuits, filed in federal court, and the case
has been transferred to the AFFF MDL, where it remains in early stages of litigation.
Guam. In September 2019, the Attorney General of Guam filed a lawsuit against 3M and other defendants relating to
contamination of the territory’s drinking water supplies and other natural resources by PFAS, allegedly resulting from the use
of AFFF products at several sites around the island. This lawsuit has been removed to federal court and transferred to the AFFF
MDL.
Commonwealth of Northern Mariana Islands. In December 2019, the Attorney General of the Commonwealth of Northern
Mariana Islands, a U.S. territory, filed a lawsuit against 3M and other defendants relating to contamination of the territory’s
drinking water supplies and other natural resources by PFAS, allegedly resulting from the use of AFFF products. This lawsuit
has been removed to federal court and transferred to the AFFF MDL.
Mississippi. In December 2020, the Mississippi Attorney General filed an AFFF-related PFAS lawsuit against 3M and other
defendants directly with the AFFF MDL court in South Carolina. The lawsuit alleges injuries to the State’s property and natural
resources purportedly caused by PFAS contamination from AFFF use and seeks both compensatory and punitive damages.
Alaska. In April 2021, the State of Alaska filed a lawsuit against 3M and other defendants, alleging damages from the release of
PFAS into the environment from a variety of products, including AFFF. This lawsuit was removed to federal court and
transferred to the AFFF MDL in August 2021.In addition, in July 2021, the State of Alaska named 3M as a third-party
defendant in two cases originally brought against the state by plaintiffs alleging property damage from AFFF use. Both of these
cases were also removed to federal court and transferred to the AFFF MDL.
North Carolina. In November 2021, the State of North Carolina filed four lawsuits against 3M and other defendants, alleging
damages from the release of PFAS into the environment from AFFF use at certain air force bases and a fire training academy.
These cases have been removed to federal court and have been transferred to the AFFF MDL.
In addition to the above state attorneys general actions, several other states and the District of Columbia, through their attorneys
general, have announced selection processes to retain outside law firms to bring PFAS-related lawsuits against certain
manufacturers including the Company. In addition, the Company is in discussions with several state attorneys general and
agencies, responding to information and other requests relating to PFAS matters and exploring potential resolution of some of
the matters raised.
Aqueous Film Forming Foam (AFFF) Environmental Litigation
3M manufactured and marketed AFFF for use in firefighting at airports and military bases from approximately 1963 to 2002.
As of December 31, 2021, 2,043 lawsuits (including 32 putative class actions) alleging injuries or damages by AFFF use have
been filed against 3M (along with other defendants) in various state and federal courts. As further described below, a vast
majority of these pending cases are in a federal Multi-District Litigation (MDL) court in South Carolina. Additional AFFF
cases continue to be filed in or transferred to the MDL. The Company also continues to defend certain AFFF cases that remain
in state court and is in discussions with pre-suit claimants for possible resolutions where appropriate.
In December 2018, the U.S. Judicial Panel on Multidistrict Litigation (JPML) granted motions to transfer and consolidate all
AFFF cases pending in federal courts to the U.S. District Court for the District of South Carolina to be managed in an MDL
proceeding to centralize pre-trial proceedings. The parties in the MDL are currently in the process of conducting discovery. An
initial pool of ten water supplier cases was selected in February 2021 for case-specific fact discovery as potential bellwether
cases. In October 2021, the parties and the MDL court selected three of these cases for additional fact and expert discovery and
for potential trial as bellwether cases. The MDL court in August 2021 issued a scheduling order and set the first bellwether
cases to begin trial on or after January 1, 2023. The MDL court has encouraged the parties to negotiate to resolve cases in the
107
-- 115 of 142 --
MDL. In November 2021, the defendants filed an omnibus motion regarding their government contractor defense. In December
2021, the plaintiffs filed a response.
In June 2019, several subsidiaries of Valero Energy Corporation, an independent petroleum refiner, filed eight AFFF cases
against 3M and other defendants, including DuPont/Chemours, National Foam, Buckeye Fire Equipment, and Kidde-Fenwal, in
various state courts. Plaintiffs seek damages that allegedly have been or will be incurred in investigating and remediating PFAS
contamination at their properties and replacing or disposing of AFFF products containing long-chain PFAS compounds. Two of
these cases have been removed to federal court and transferred to the AFFF MDL. Five cases remain pending in state courts
where they are in early stages of litigation, after Valero dismissed its Ohio state court action without prejudice in October 2019.
The parties in the state court cases have agreed to stay all five cases until March 2022.
As of December 31, 2021, the Company is aware of 15 other AFFF suits originally filed in various state courts in which the
Company has been named a defendant. Seven of these cases have been removed to federal court, where defendants have sought
transfer to the AFFF MDL.
Two subsidiaries of Husky Energy filed suit in April 2020 against 3M and other AFFF manufacturers in Wisconsin state court
relating to alleged PFAS contamination from AFFF use at Husky facilities in Superior, Wisconsin and Lima, Ohio. The parties
have entered into a tolling agreement deferring further action on the plaintiffs’ claims. The plaintiffs filed a notice of dismissal
without prejudice in September 2020.
Separately, the Company is aware of pre-suit claims or demands by other parties related to the use and disposal of AFFF, one of
which purports to represent a large group of firefighters. The Company had discussions with certain potential pre-suit claimants
and, as a result of such discussions, reached a negotiated resolution for an immaterial amount with the City of Bemidji in March
2021.
Other PFAS-related Product and Environmental Litigation
3M manufactured and sold various products containing PFOA and PFOS, including Scotchgard, for several decades. Starting in
2017, 3M has been served with individual and putative class action complaints in various state and federal courts alleging,
among other things, that 3M’s customers’ improper disposal of PFOA and PFOS resulted in the contamination of groundwater
or surface water. The plaintiffs in these cases generally allege that 3M failed to warn its customers about the hazards of
improper disposal of the product. They also generally allege that contaminated groundwater has caused various injuries,
including personal injury, loss of use and enjoyment of their properties, diminished property values, investigation costs, and
remediation costs. Several companies have been sued along with 3M, including Saint-Gobain Performance Plastics Corp.,
Honeywell International Inc. f/k/a Allied-Signal Inc. and/or AlliedSignal Laminate Systems, Inc., Wolverine World Wide Inc.,
Georgia-Pacific LLC, E.I. DuPont De Nemours and Co., Chemours Co., and various carpet manufacturers.
In New York, 3M is defending 40 individual cases and one putative class action filed in the U.S. District Court for the Northern
District of New York and four additional individual cases filed in New York state court against 3M, Saint-Gobain Performance
Plastics Corp. (Saint-Gobain), Honeywell International Inc. and E.I. DuPont De Nemours and Co. (DuPont). Tonaga, Inc.
(Taconic) is also a defendant in the state court actions. Plaintiffs allege that PFOA discharged from fabric coating facilities
operated by non-3M entities (that allegedly had used PFOA-containing materials from 3M, among others) contaminated the
drinking water in the Village of Hoosick Falls, the Town of Hoosick and Petersburg, New York. They assert various tort claims
for personal injury and property damage and in some cases request medical monitoring. 3M has answered the complaints in
these individual cases, which are now proceeding through discovery. In the federal court individual cases, the parties selected
24 claimants in May 2021 for a pool from which eight plaintiffs will be chosen for expert discovery and dispositive motions. At
the conclusion of these motions, the court will determine which case(s) will continue toward trial. In the putative class action,
certain parties, including 3M, reached an agreement to resolve litigation among the settling parties. In February 2022, the
district court issued an order granting final approval of the settlement. Under the agreement, 3M, Saint-Gobain and Honeywell
will collectively contribute to a fixed total amount of approximately $65 million to resolve the plaintiffs’ claims and those of
the proposed classes. 3M’s contribution is not considered material. 3M is also defending 13 cases in the U.S. District Court for
the Eastern District of New York filed by various drinking water providers. The plaintiffs in these cases allege that products
manufactured by 3M, DuPont, and additional unnamed defendants contaminated plaintiffs’ water supply sources with various
PFAS compounds. DuPont’s motion to transfer these cases to the AFFF MDL was denied in March 2020. 3M has filed answers
in these cases and discovery is ongoing.
In Michigan, one consolidated putative class action is pending in the U.S. District Court for the Western District of Michigan
against 3M and Wolverine World Wide (Wolverine). The action arises from Wolverine’s allegedly improper disposal of
materials and wastes, including 3M Scotchgard, related to Wolverine’s shoe manufacturing operations. Plaintiffs allege
Wolverine used 3M Scotchgard in its manufacturing process and that chemicals from 3M’s product contaminated the
108
-- 116 of 142 --
environment and drinking water sources after disposal. In June 2021, the court partially denied the defendants' motions to
dismiss, by granting the motions to dismiss the negligence claim only insofar as the plaintiffs seek damages for personal
injuries, as opposed to property damage. In September 2021, the plaintiffs filed a motion to amend the complaint, including to
add four new named plaintiffs and putative class representatives. 3M and Wolverine filed a motion to strike the plaintiffs’
motion for class certification and opposed plaintiffs’ motion to amend the complaint. The parties also filed several dispositive
and expert witness-related Daubert motions in November 2021, and the parties have had ongoing mediation discussions. The
court has set a trial date in June 2022. In addition to the consolidated federal court putative class action, as of December 31,
2021, 3M is a defendant in approximately 275 private individual actions in Michigan state court based on similar allegations.
These cases are coordinated for pre-trial purposes. Five of these cases were selected over time for bellwether trials. In January
2020, the court issued the first round of dispositive motion rulings related to the first two bellwether cases, including dismissing
the second bellwether case entirely and dismissing certain plaintiffs’ medical monitoring and risk of future disease claims, and
granting summary judgment to the defendants on one plaintiff’s cholesterol injury claims. The parties settled the first bellwether
case in early 2020 for an immaterial amount. In June 2020, the court denied the plaintiffs’ motion to reconsider the dismissal of
the second bellwether case, and the plaintiffs have appealed the decision to the state appellate court. In January 2021, the court
granted summary judgment in favor of the defendants in one of three remaining bellwether cases. The plaintiffs in this
dismissed bellwether case have also appealed the dismissal to the state appellate court. The Company settled both remaining
bellwether cases for an immaterial amount. Following mediation, in October 2021, 3M and Wolverine reached a settlement in
principle with counsel representing all but three of the remaining private individual actions. At a further mediation in December
2021, 3M and Wolverine reached a settlement in principle to resolve two more of the remaining cases (on behalf of seven
plaintiff families). Upon completion of these settlements, only one private individual action will remain pending in Michigan
state court.
3M was also a defendant, together with Georgia-Pacific as co-defendant, in a putative class action in federal court in Michigan
brought by residents of Parchment, who allege that the municipal drinking water was contaminated from waste generated by a
paper mill owned by Georgia-Pacific’s corporate predecessor. The defendants’ motion to dismiss certain claims in the
complaint was denied in January 2021. The parties engaged in mediation and in April 2021 reached a preliminary settlement
agreement, subject to court approval, under which 3M and Georgia-Pacific would jointly pay an amount and be released from
plaintiffs’ putative class action claims. 3M’s portion is not considered material. The court approved the settlement in September
2021.
In Alabama and Georgia, 3M, together with multiple co-defendants, is defending three state court cases brought by municipal
water utilities, relating to 3M’s sale of PFAS-containing products to carpet manufacturers in Georgia. The plaintiffs in these
cases allege that the carpet manufacturers improperly discharged PFAS into the surface water and groundwater, contaminating
drinking water supplies of cities located downstream along the Coosa River, including Rome, Georgia and Centre and Gadsden,
Alabama. The three water utility cases are proceeding through discovery. Another case originally filed in Georgia state court
was brought by individuals asserting PFAS contamination by the Georgia carpet manufacturers and seeking economic damages
and injunctive relief on behalf of a putative class of Rome and Floyd County water subscribers. This case has been removed to
federal court, where 3M filed a motion to dismiss a series of amended complaints, resulting in the dismissal of plaintiffs’
negligence claim against 3M. This case is proceeding through discovery. 3M, together with co-defendants, is also defending
another putative class action in federal court in Georgia, in which plaintiffs seek relief on behalf of a class of individual
ratepayers in Summerville, Georgia who allege their water supply was contaminated by PFAS discharged from a textile mill. In
May 2021, the City of Summerville filed a motion to intervene in the lawsuit, which remains pending. 3M has moved to dismiss
this case. This case remains in early stages of litigation.
In California, 3M and other defendants were named as defendants in an action brought in federal court by Golden State Water
Company, alleging PFAS contamination of certain wells located in its water systems. 3M filed a motion to dismiss in
November 2020 and in January 2021, the court granted defendants’ motion to dismiss the case for lack of personal jurisdiction.
In February 2021, the plaintiffs voluntarily dismissed their action without prejudice and filed a new case in the AFFF MDL
court. Separately, in December 2020, the Orange County Water District and ten additional local water providers sued 3M,
Decra Roofing and certain DuPont-related entities in California state court, alleging PFAS contamination of the plaintiffs’ water
sources and also referring to 3M's industrial minerals facility in Corona, California as a potential source of contamination. The
plaintiffs filed an amended complaint, and 3M filed a demurrer to the amended complaint in March 2021. In April 2021, the
court denied 3M’s demurrer, and the case remains in early stages of litigation. In May 2021, the Orange County plaintiffs filed
a second amended complaint. In June 2021, the case was removed to the U.S. District Court for the Central District of
California where the plaintiffs moved to remand the case back to state court. The court granted plaintiffs’ motion to remand.
3M has appealed the remand decision to the U.S. Court of Appeals for the Ninth Circuit, which is hearing the appeal on an
expedited basis, with oral argument scheduled in February 2022. Pending that appeal, in September 2021, the state court
ordered that discovery can proceed against 3M. In February 2021, the City of Corona and a local utility authority filed a lawsuit
in California state court against 3M and other defendants, alleging PFAS contamination from 3M products generally as well as
from 3M’s Corona facility and roofing granules products. Plaintiffs filed an amended complaint in June 2021. In July 2021, the
case was removed to the U.S. District Court for the Central District of California. The federal court granted plaintiffs’ motion to
remand the action to state court. In October 2021, 3M filed a demurrer to the amended complaint in state court. In October
2021, a lawsuit was filed against 3M in California state court in San Luis Obispo County by the Atascadero Mutual Water
109
-- 117 of 142 --
Company, a local water supplier. The complaint alleges PFAS contamination from 3M products generally. In November 2021,
the case was removed to the U.S. District Court for the Central District of California. The plaintiffs have indicated they intend
to amend their complaint.
In Delaware, 3M, together with several co-defendants, is defending one putative class action brought by individuals alleging
PFAS contamination of their water supply resulting from the operations of local metal plating facilities. Plaintiffs allege that
3M supplied PFAS to the metal plating facilities. DuPont, Chemours, and the metal platers have also been named as defendants.
This case has been removed from state court to federal court, and plaintiffs have withdrawn its motion to remand to state court
and filed an amended complaint. 3M has filed a motion to dismiss the amended complaint. In February 2021, the court raised
the question whether subject matter jurisdiction under the Class Action Fairness Act was proper, issued an order requiring the
parties to brief the issue and denied defendants’ motions to dismiss with leave to renew pending the court’s ruling on
jurisdiction. An oral argument was held in September 2021. In December 2021, the court issued an order retaining jurisdiction
over the case and 3M renewed its previous motion to dismiss.
In New Jersey, 3M is a defendant in an action brought in federal court by Middlesex Water Company, alleging PFAS
contamination of its water wells. 3M’s motion to transfer the case to the AFFF MDL was denied. 3M has moved to dismiss the
complaint, and discovery closed in September 2021. The parties are engaged in mediation. In September 2020, 3M was named
a defendant in a similar lawsuit brought by the Borough of Hopatcong. In December 2020, 3M filed a motion to dismiss the
Hopatcong matter. In January 2021, 3M was named a defendant in another similar lawsuit brought by the Pequannock
Township. In March 2021, 3M filed a motion to dismiss the Pequannock matter. Discovery is ongoing in both Hopatcong and
Pequannock matters. 3M, together with several co-defendants, is also defending fourteen cases in New Jersey federal court
brought by individuals with private drinking water wells near certain DuPont and Solvay facilities that were allegedly supplied
with PFAS by 3M. These cases have all been coordinated for discovery, which is ongoing. Plaintiffs in eight of these cases seek
medical monitoring and property damages. 3M’s motion to dismiss the earliest filed of these cases was largely denied in
February 2021, and 3M has since filed answers in all eight cases. Plaintiffs in the six remaining individual cases in federal court
allege personal injuries to themselves or their disabled adult children. 3M has moved to dismiss five of these cases, and it has
not yet been served in the sixth. In February 2022, 3M's motion to dismiss was largely denied. In December 2021, plaintiffs
filed four additional cases in New Jersey state court similar to the personal injury actions filed in federal court. 3M has not yet
been served in these cases. Finally, 3M is also defending a putative class action filed in New Jersey federal court in November
2021 by individuals who received drinking water from Middlesex Water Company that was allegedly contaminated with PFAS
in excess of state regulatory levels. Middlesex Water Company is also named as a defendant in this action. With respect to 3M,
the suit asserts claims for negligence, nuisance, and trespass. Plaintiffs seek an injunction to include bottled water and home
treatment systems and alleged damages for diminution-in-property value, among other relief. 3M plans to respond to the
complaints. This case remains in early stages of litigation.
In October 2018, 3M and other defendants, including DuPont and Chemours, were named in a putative class action in the U.S.
District Court for the Southern District of Ohio brought by the named plaintiff, a firefighter allegedly exposed to PFAS
chemicals through his use of firefighting foam, purporting to represent a putative class of all U.S. individuals with detectable
levels of PFAS in their blood. The plaintiff brings claims for negligence, battery, and conspiracy and seeks injunctive relief,
including an order “establishing an independent panel of scientists” to evaluate PFAS. 3M and other entities jointly filed a
motion to dismiss in February 2019. In September 2019, the court denied the defendants’ motion to dismiss. In February 2020,
the court denied 3M’s motion to transfer the case to the AFFF MDL. Briefing on plaintiff’s class certification motion is
complete, and the court’s ruling on class certification is pending.
Other PFAS-related Matters
In July 2019, the Company received a written request from the Subcommittee on Environment of the Committee on Oversight
and Reform, U.S. House of Representatives, seeking certain documents and information relating to the Company’s
manufacturing and distribution of PFAS products. In September 2019, a 3M representative testified before and responded to
questions from the Subcommittee on Environment with respect to PFAS and the Company’s environmental stewardship
initiatives. The Company continues to cooperate with the Subcommittee.
The Company continues to make progress in its work, under the supervision of state regulators, to remediate historic disposal of
PFAS-containing waste associated with manufacturing operations at its Decatur, Alabama; Cottage Grove, Minnesota; and
Cordova, Illinois plants.
As previously reported, the Illinois EPA in August 2014 approved a request by the Company to establish a groundwater
management zone at its manufacturing facility in Cordova, Illinois, which includes ongoing pumping of impacted site
groundwater, groundwater monitoring and routine reporting of results.
110
-- 118 of 142 --
In Minnesota, the Company continues to work with the Minnesota Pollution Control Agency (MPCA) pursuant to the terms of
the previously disclosed May 2007 Settlement Agreement and Consent Order to address the presence of certain PFAS
compounds in the soil and groundwater at former disposal sites in Washington County, Minnesota (Oakdale and Woodbury)
and at the Company’s manufacturing facility at Cottage Grove, Minnesota. Under this agreement, the Company’s principal
obligations include (i) evaluating releases of certain PFAS compounds from these sites and proposing response actions; (ii)
providing treatment or alternative drinking water upon identifying any level exceeding a HBV or Health Risk Limit (HRL) (i.e.,
the amount of a chemical in drinking water determined by the Minnesota Department of Health (MDH) to be safe for human
consumption over a lifetime) for certain PFAS compounds for which a HBV and/or HRL exists as a result of contamination
from these sites; (iii) remediating identified sources of other PFAS compounds at these sites that are not controlled by actions to
remediate PFOA and PFOS; and (iv) sharing information with the MPCA about certain perfluorinated compounds. During
2008, the MPCA issued formal decisions adopting remedial options for the former disposal sites in Washington County,
Minnesota (Oakdale and Woodbury). In August 2009, the MPCA issued a formal decision adopting remedial options for the
Company’s Cottage Grove manufacturing facility. During the spring and summer of 2010, 3M began implementing the agreed
upon remedial options at the Cottage Grove and Woodbury sites. 3M commenced the remedial option at the Oakdale site in late
2010. At each location the remedial options were recommended by the Company and approved by the MPCA. The Company
has completed remediation work and continues with operational and maintenance activities at the Oakdale and Woodbury sites.
Remediation work has been substantially completed at the Cottage Grove site, with operational and maintenance activities
ongoing.
In Alabama, as previously reported, the Company entered into a voluntary remedial action agreement with ADEM to remediate
the presence of PFAS in the soil and groundwater at the Company’s manufacturing facility in Decatur, Alabama associated with
the historic (1978-1998) incorporation of wastewater treatment plant sludge. With ADEM’s agreement, 3M substantially
completed installation of a multilayer cap on the former sludge incorporation areas. Further remediation activities, including
certain on-site and off-site investigations and studies, will be conducted in accordance with the July 2020 Interim Consent
Order described below.
The Company operates under a 2009 consent order issued under the federal Toxic Substances Control Act (TSCA) (the “2009
TSCA consent order”) for the manufacture and use of two perfluorinated materials (FBSA and FBSEE) at its Decatur, Alabama
site that does not permit release of these materials into “the waters of the United States.” In March 2019, the Company halted
the manufacture, processing, and use of these materials at the site upon learning that these materials may have been released
from certain specified processes at the Decatur site into the Tennessee River. In April 2019, the Company voluntarily disclosed
the releases to the U.S. EPA and ADEM. During June and July 2019, the Company took steps to fully control the
aforementioned processes by capturing all wastewater produced by the processes and by treating all air emissions. These
processes have been back on-line and in operation since July 2019. The Company continues to cooperate with the EPA and
ADEM in their investigations and will work with the regulatory authorities to demonstrate compliance with the release
restrictions.
The Company is authorized to discharge wastewater from its Decatur plant pursuant to the terms of a Clean Water Act National
Pollutant Discharge Elimination System (NPDES) permit issued by ADEM. The NPDES permit requires the Company to report
on a monthly and quarterly basis the quality and quantity of pollutants discharged to the Tennessee River. In June 2019, as
previously reported, the Company voluntarily disclosed to the EPA and ADEM that it had included incorrect values in certain
of its monthly and quarterly reports. The Company has submitted the corrected values to both the EPA and ADEM.
As previously reported, as part of ongoing work with the EPA and ADEM to address compliance matters at the Decatur facility,
the Company discovered it had not fully characterized its PFAS discharge in its NPDES permit. In September 2019, the
Company disclosed the matter to the EPA and ADEM and announced that it had elected to temporarily idle certain other
manufacturing processes at 3M Decatur. The Company is reviewing its operations at the plant, has installed wastewater
treatment controls and has restarted idled processes.
As a result of the Company’s discussions with ADEM to address these and other related matters in the state of Alabama, as
previously reported, 3M and ADEM agreed to the terms of an interim Consent Order in July 2020 to cover all PFAS-related
wastewater discharges and air emissions from the Company’s Decatur facility. Under the interim Consent Order, the
Company’s principal obligations include commitments related to (i) future ongoing site operations such as (a) providing certain
notices or reports and performing various analytical and characterization studies and (b) future capital improvements; and (ii)
remediation activities, including certain on-site and off-site investigations and studies. Obligations related to ongoing future site
operations under the Consent Order will involve additional operating costs and capital expenditures over multiple years. As
offsite investigation activities continue, additional remediation amounts may become probable and reasonably estimable in the
future.
111
-- 119 of 142 --
As previously reported, in December 2019, the Company received a grand jury subpoena from the U.S. Attorney’s Office for
the Northern District of Alabama for documents related to, among other matters, the Company’s compliance with the 2009
TSCA consent order and unpermitted discharges to the Tennessee River. The Company is cooperating with this and other
inquiries and requests regarding its manufacturing facilities and is producing documents in response to the inquiries.
In addition, as previously reported, as part of its ongoing evaluation of regulatory compliance at its Cordova, Illinois facility,
the Company discovered it had not fully characterized its PFAS discharge in its NPDES permit for the Cordova facility. In
November 2019, the Company disclosed this matter to the EPA, and in January 2020 disclosed this matter to the Illinois
Environmental Protection Agency (IEPA). The Company continues to work with the EPA and IEPA to address these issues
from the Cordova facility, including a draft EPA SDWA Administrative Consent Order received in December 2021 proposing
that the Company survey and sample proposed private and public drinking water wells within the vicinity of the Cordova
facility.
The Company is also reviewing operations at its other plants with similar manufacturing processes, such as the plant in Cottage
Grove, Minnesota, to ensure those operations are in compliance with applicable environmental regulatory requirements and
Company policies and procedures. As a result of these reviews, as previously reported, the Company discovered it had not fully
characterized its PFAS discharge in its NPDES permit for the Cottage Grove facility. In March 2020, the Company disclosed
this matter to the Minnesota Pollution Control Agency (MPCA) and the EPA. In July 2020, the Company received an
information request from MPCA for documents and information related to, among other matters, the Company’s compliance
with the Clean Water Act at its Cottage Grove facility. The Company is cooperating with this inquiry and is producing
documents and information in response to the request for information. The Company continues to work with the MPCA and
EPA to address the discharges from the Cottage Grove facility.
Separately, as previously reported, in June 2020, the Company reported to EPA and MPCA that it had not fully complied with
elements of the inspection, characterization and waste stream profile verification process of the Waste and Feedstream Analysis
Plan (WAP/FAP) of its Resource Conservation and Recovery Act (RCRA) permit for its Cottage Grove incinerator. In July
2020, the Company received an information request from MPCA related to the June 2020 disclosure, to which the Company
responded in September 2020. The Company continues to work with the MPCA to address WAP/FAP implementation issues
disclosed in June 2020. In January 2021, the Company received a notice of violation (NOV) from MPCA related to, among
other matters, the above-described Clean Water Act and RCRA issues. The Company is cooperating with MPCA to address the
issues that are the subject of the NOV and is in discussions with MPCA regarding an assessed penalty. In October 2021, the
Company received information requests from MPCA seeking additional toxicological and other information related to certain
PFAS compounds. The Company is cooperating with these inquires and is producing documents and information in response to
the requests.
In February 2020, as previously reported, the Company received an information request from EPA for documents and
information related to, among other matters, the Company’s compliance with the Clean Water Act at its facilities that
manufacture, process and use PFAS, including the Decatur, Cordova and Cottage Grove facilities. The Company is cooperating
with this inquiry and is producing documents and information in response to the request for information.
The Company continues to work with relevant federal and state agencies (including EPA, the U.S. Department of Justice, state
environmental agencies and state attorneys general) as it conducts these reviews and responds to information, inspection and
other requests from the agencies. The Company cannot predict at this time the outcomes of resolving these compliance matters,
what actions may be taken by the regulatory agencies or the potential consequences to the Company.
Other Environmental Litigation
In July 2018, the Company, along with more than 120 other companies, was served with a complaint seeking cost recovery and
contribution towards the cleaning up of approximately eight miles of the Lower Passaic River in New Jersey. The plaintiff,
Occidental Chemical Corporation, alleges that it agreed to design and pay the estimated $165 million cost to remove and cap
sediment containing eight chemicals of concern, including PCBs and dioxins. The complaint seeks to spread those costs among
the defendants, including the Company. The Company’s involvement in the case relates to its past use of two commercial drum
conditioning facilities in New Jersey. Whether, and to what extent, the Company may be required to contribute to the costs at
issue in the case remains to be determined.
For environmental matters and litigation described above, unless otherwise described below, no liability has been recorded as
the Company believes liability in those matters is not probable and reasonably estimable and the Company is not able to
estimate a possible loss or range of possible loss at this time. The Company’s environmental liabilities and insurance
receivables are described below.
112
-- 120 of 142 --
Environmental Liabilities and Insurance Receivables
The Company periodically examines whether the contingent liabilities related to the environmental matters and litigation
described above are probable and reasonably estimable based on experience and ongoing developments in those matters,
including discussions regarding negotiated resolutions. During 2021, as a result of recent developments in ongoing
environmental matters and litigation, the Company increased its accrual for PFAS-related other environmental liabilities by
$138 million since December 31, 2020 and made related payments of $142 million. As previously disclosed, in the first and
fourth quarters of 2019, in conjunction with other adjustments as a result of developments in then ongoing environmental
matters and litigation, 3M recorded pre-tax charges aggregating to $449 million. These pre-tax charges were in light of the EPA
issuance of its PFAS Action Plan; the Company’s settlement of litigation with the Water Authority; updates to evaluation of
certain customer-related litigation based on continued, productive settlement discussions with multiple parties; completion of
and then ongoing updates to a comprehensive review with the assistance of environmental consultants and other experts
regarding environmental matters and litigation related to historical PFAS manufacturing operations; and expanded evaluation of
other 3M sites that may have used certain PFAS-containing materials and locations at which they were disposed. As of
December 31, 2021, the Company had recorded liabilities of $412 million for “other environmental liabilities.” The accruals
represent the Company’s best estimate of the probable loss in connection with the environmental matters and PFAS-related
litigation described above. The Company is not able to estimate a possible loss or range of possible loss in excess of the
established accruals at this time.
As of December 31, 2021, the Company had recorded liabilities of $29 million for estimated non-PFAS related “environmental
remediation” costs to clean up, treat, or remove hazardous substances at current or former 3M manufacturing or third-party
sites. The Company evaluates available facts with respect to each individual site each quarter and records liabilities for
remediation costs on an undiscounted basis when they are probable and reasonably estimable, generally no later than the
completion of feasibility studies or the Company’s commitment to a plan of action. Liabilities for estimated costs of
environmental remediation, depending on the site, are based primarily upon internal or third-party environmental studies, and
estimates as to the number, participation level and financial viability of any other potentially responsible parties, the extent of
the contamination and the nature of required remedial actions. The Company adjusts recorded liabilities as further information
develops or circumstances change. The Company expects that it will pay the amounts recorded over the periods of remediation
for the applicable sites, currently ranging up to 20 years.
It is difficult to estimate the cost of environmental compliance and remediation given the uncertainties regarding the
interpretation and enforcement of applicable environmental laws and regulations, the extent of environmental contamination
and the existence of alternative cleanup methods. Developments may occur that could affect the Company’s current assessment,
including, but not limited to: (i) changes in the information available regarding the environmental impact of the Company’s
operations and products; (ii) changes in environmental regulations, changes in permissible levels of specific compounds in
drinking water sources, or changes in enforcement theories and policies, including efforts to recover natural resource damages;
(iii) new and evolving analytical and remediation techniques; (iv) success in allocating liability to other potentially responsible
parties; and (v) the financial viability of other potentially responsible parties and third-party indemnitors. For sites included in
both “environmental remediation liabilities” and “other environmental liabilities,” at which remediation activity is largely
complete and remaining activity relates primarily to operation and maintenance of the remedy, including required post-
remediation monitoring, the Company believes the exposure to loss in excess of the amount accrued would not be material to
the Company’s consolidated results of operations or financial condition. However, for locations at which remediation activity is
largely ongoing, the Company cannot estimate a possible loss or range of possible loss in excess of the associated established
accruals for the reasons described above.
The Company has both pre-1986 general and product liability occurrence coverage and post-1985 occurrence reported product
liability and other environmental coverage for environmental matters and litigation. As of December 31, 2021, the Company’s
receivable for insurance recoveries related to the environmental matters and litigation was $8 million. Various factors could
affect the timing and amount of recovery of this and future expected increases in the receivable, including (i) delays in or
avoidance of payment by insurers; (ii) the extent to which insurers may become insolvent in the future, (iii) the outcome of
negotiations with insurers, and (iv) the scope of the insurers’ purported defenses and exclusions to avoid coverage.
Product Liability Litigation
Aearo Technologies sold Dual-Ended Combat Arms – Version 2 earplugs starting in about 2003. 3M acquired Aearo
Technologies in 2008 and sold these earplugs from 2008 through 2015, when the product was discontinued. In December 2018,
a military veteran filed an individual lawsuit against 3M in the San Bernardino Superior Court in California alleging that he
sustained personal injuries while serving in the military caused by 3M’s Dual-Ended Combat Arms earplugs – Version 2. The
plaintiff asserts claims of product liability and fraudulent misrepresentation and concealment. The plaintiff seeks various
damages, including medical and related expenses, loss of income, and punitive damages.
113
-- 121 of 142 --
As of December 31, 2021, the Company is a named defendant in approximately 3,616 lawsuits (including 14 putative class
actions) in various state and federal courts that purport to represent approximately 13,531 individual claimants making similar
allegations. In April 2019, the U.S. Judicial Panel on Multidistrict Litigation granted motions to transfer and consolidate all
cases pending in federal courts to the U.S. District Court for the Northern District of Florida to be managed in a multi-district
litigation (MDL) proceeding to centralize pre-trial proceedings. The plaintiffs and 3M filed preliminary summary judgment
motions on the government contractor defense. In July 2020, the MDL court granted the plaintiffs’ summary judgment motion
and denied the defendants’ summary judgment motion, ruling that plaintiffs’ claims are not barred by the government
contractor defense. The court denied the Company’s request to immediately certify the summary judgment ruling for appeal to
the U.S. Court of Appeals for the Eleventh Circuit. In December 2020, the court granted the plaintiffs’ motion to consolidate
three plaintiffs for the first bellwether trial, which began in March 2021.
In April 2021, 3M received an adverse jury verdict in the first bellwether trial. The jury awarded the three plaintiffs less than $1
million in compensatory damages and $6 million in punitive damages for a total of $7 million. 3M has appealed the verdicts,
challenging, among other rulings, the MDL court's denial of 3M’s motion to assert the government contractor defense. The next
two bellwether trials occurred in May and June of 2021. In May 2021, 3M received a verdict in its favor in the second
bellwether trial, in which a jury rejected claims that 3M knowingly sold earplugs with design defects. In June 2021, 3M
received an adverse verdict in the third bellwether trial. The jury found 3M liable for strict liability failure to warn, but found
3M not liable for design defect or fraud. The jury apportioned fault 62 percent to 3M and 38 percent to the plaintiff for a total
damage award of approximately $1 million. 3M has appealed the verdict. In October 2021, 3M received an adverse verdict in
the fourth bellwether trial, in which a jury awarded $8 million to the plaintiff. 3M plans to appeal the verdict. 3M received
verdicts in its favor in the fifth and sixth bellwether trials. 3M received an adverse verdict in the seventh and eighth bellwether
trials, in which the juries awarded the plaintiffs $13 million and $23 million, respectively. 3M plans to appeal these verdicts.
3M prevailed in the ninth and tenth bellwether cases but received adverse verdicts in the eleventh bellwether case in which the
jury awarded each of the two plaintiffs $15 million in compensatory and $40 million in punitive damages. 3M plans to appeal
these verdicts. The next five bellwether cases are scheduled for trial in March, April and May 2022. These trials will not include
several bellwether cases that plaintiffs' counsel dismissed with prejudice either during discovery or after being set for trial. An
administrative docket of approximately 240,000 unfiled and unverified claims (after factoring in approximately 50,000 claims
in a transitional process as described below) has also been maintained at the MDL court. The MDL court in August 2021
provided notice of an intent to issue forthcoming transition orders requiring all claims be moved off the administrative docket to
the active docket on a rolling basis over 12 months. The orders will provide that any case not moved to the active docket will be
dismissed without prejudice, and the administrative docket will then be closed. To date approximately 50,000 claims are in the
process of being transitioned to the active docket or dismissed. The MDL court also ordered the parties to prepare for trial 1,500
cases in three waves of 500 cases over the next 14 months. After the preparation of these cases is completed, the cases will be
remanded to the federal district courts where the cases were originally filed. In November 2021, the judge issued the first wave
order of the first 500 cases over the next eight months.
3M is also defending lawsuits brought primarily by non-military plaintiffs in state court in Hennepin County, Minnesota. 3M
removed these actions to federal court, and the federal court remanded them to state court in March 2020. On appeal, the U.S.
Court of Appeals for the Eighth Circuit ruled in October 2021 that the cases brought by non-military plaintiffs were properly
remanded to state court, whereas the cases brought by military contractor plaintiffs who had received the Combat Arms
Earplugs from the military should have remained in federal court. In November 2021, the Eighth Circuit granted 3M's
unopposed motion to vacate the remand orders in the remaining appeals of military service member cases. The military service
member cases are expected to be remanded to federal court and transferred to the MDL. There are approximately 65 lawsuits
involving approximately 1,100 plaintiffs pending in the state court, but the number of plaintiffs is expected to decline as cases
are remanded to federal court. The cases remaining in state court are subject to a bellwether case selection process. The first
trial in Hennepin County is scheduled for no earlier than April 2022.
No liability has been recorded for these matters because the Company believes that any such liability is not probable and
reasonably estimable at this time.
As of December 31, 2021, the Company was a named defendant in approximately 5,266 lawsuits in the United States and one
Canadian putative class action with a single named plaintiff, alleging that the Bair Hugger™ patient warming system caused a
surgical site infection.
As previously disclosed, 3M is a named defendant in lawsuits in federal courts involving over 5,000 plaintiffs alleging that they
underwent various joint arthroplasty, cardiovascular, and other surgeries and later developed surgical site infections due to the
use of the Bair Hugger™ patient warming system. The plaintiffs seek damages and other relief based on theories of strict
liability, negligence, breach of express and implied warranties, failure to warn, design and manufacturing defect, fraudulent
and/or negligent misrepresentation/concealment, unjust enrichment, and violations of various state consumer fraud, deceptive or
unlawful trade practices and/or false advertising acts.
114
-- 122 of 142 --
The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all cases pending in federal courts to the U.S. District
Court for the District of Minnesota to be managed in a multi-district litigation (MDL) proceeding. In July 2019, the court
excluded several of the plaintiffs’ causation experts, and granted summary judgment for 3M in all cases pending at that time in
the MDL. Plaintiffs appealed that decision to the U.S. Court of Appeals for the Eighth Circuit. Plaintiffs also appealed a 2018
jury verdict in favor of 3M in the first bellwether trial in the MDL and appealed the dismissal of another bellwether case. The
Eighth Circuit court heard oral argument on all pending appeals in March 2021. A panel of the appellate court in August 2021
reversed the district court’s exclusion of the plaintiffs’ causation experts and the grant of summary judgment for 3M. The
Company sought further appellate en banc review by the full Eighth Circuit court. In November 2021, the Eighth Circuit court
denied 3M’s petition for rehearing en banc. In February 2022, the Company filed a petition for a writ of certiorari in the U.S.
Supreme Court. The MDL court has not yet issued a new case management order. In February 2022, the MDL court ordered the
parties to engage in any mediation sessions that a court-appointed mediator deems appropriate. Also, in August 2021, the
Eighth Circuit court separately affirmed the 2018 jury verdict in 3M’s favor in the only bellwether trial in the MDL.
In addition to the federal cases, there are four state court cases. Three are pending in Missouri state court and combine Bair
Hugger product liability claims with medical malpractice claims. Two of the Missouri cases are set for trial; one in September
2022 and one in April 2023. There is also one case in Hidalgo County, Texas that combines Bair Hugger product liability
claims with medical malpractice claims. In August 2019, the MDL court enjoined the individual plaintiff from pursuing his
claims in Texas state court because he had previously filed and dismissed a claim in the MDL. That plaintiff has appealed the
order to the U.S. Court of Appeals for the Eighth Circuit, which heard oral argument on this appeal in March 2021. In May
2021, the Court of Appeals lifted the MDL court’s injunction that barred plaintiff from litigating the Texas state court case. The
court has set a trial date in December 2022.
As previously disclosed, 3M had been named a defendant in 61 cases in Minnesota state court. In January 2018, the Minnesota
state court excluded plaintiffs’ experts and granted 3M’s motion for summary judgment on general causation. The Minnesota
Court of Appeals affirmed the state court orders in their entirety and the Minnesota Supreme Court denied plaintiffs’ petition
for review and entered the finial dismissal in 2019, effectively ending the Minnesota state court cases.
In June 2016, the Company was served with a putative class action filed in the Ontario Superior Court of Justice for all
Canadian residents who underwent various joint arthroplasty, cardiovascular, and other surgeries and later developed surgical
site infections that the representative plaintiff claims was due to the use of the Bair Hugger™ patient warming system. The
representative plaintiff seeks relief (including punitive damages) under Canadian law based on theories similar to those asserted
in the MDL.
No liability has been recorded for the Bair Hugger™ litigation because the Company believes that any such liability is not
probable and reasonably estimable at this time.
For product liability litigation matters described in this section for which a liability has been recorded, the amount recorded is
not material to the Company’s consolidated results of operations or financial condition. In addition, the Company is not able to
estimate a possible loss or range of possible loss in excess of the established accruals at this time.
Securities and Shareholder Litigation
In July 2019, Heavy & General Laborers’ Locals 472 & 172 Welfare Fund filed a putative securities class action against 3M
Company, its former Chairman and CEO, current Chairman and CEO, and former CFO in the U.S. District Court for the
District of New Jersey. In August 2019, an individual plaintiff filed a similar putative securities class action in the same district.
Plaintiffs allege that defendants made false and misleading statements regarding 3M's exposure to liability associated with
PFAS and bring claims for damages under Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 against
all defendants, and under Section 20(a) of the Securities and Exchange Act of 1934 against the individual defendants. In
October 2019, the court consolidated the securities class actions and appointed a group of lead plaintiffs. In January 2020, the
defendants filed a motion to transfer venue to the U.S. District Court for the District of Minnesota. In August 2020, the court
denied the motion to transfer venue, and in September 2020, the defendants filed a petition for writ of mandamus to the U.S.
Court of Appeals for the Third Circuit. In November 2020, the federal Court of Appeals granted 3M’s petition for a writ of
mandamus and directed the New Jersey federal court to transfer the action to the Minnesota federal court. The defendants filed
a motion to dismiss the action in January 2021, and in September 2021, the Minnesota federal court granted 3M’s motion to
dismiss the securities class action, which judgment is now final.
In October 2019, a stockholder derivative lawsuit was filed in the U.S. District Court for the District of New Jersey against 3M
and several of its current and former executives and directors. In November and December 2019, two additional derivative
lawsuits were filed in a Minnesota state court. The derivative lawsuits rely on similar factual allegations as the putative
securities class action discussed above. The state court cases were consolidated and stayed pending a decision on the motion to
dismiss in the securities class action, and the Minnesota state plaintiffs are likely to have until March 2022 to file an amended
115
-- 123 of 142 --
complaint. In October 2020, the derivative action pending in the U.S. District Court for the District of New Jersey was
dismissed, without prejudice, for failure to serve the complaint within the required time period.
In August 2020, a stockholder who had previously submitted a books and records demand filed an additional follow-on
derivative lawsuit in the U.S. District Court for the District of New Jersey against 3M and several of its current and former
executives and directors. This derivative lawsuit, having been transferred to Minnesota federal court, also relies on similar
factual allegations as the putative securities class action discussed above. In February 2021, an additional stockholder derivative
lawsuit was filed in the District of Minnesota, making similar factual allegations as the putative securities class action discussed
above. The Minnesota federal court consolidated these federal derivative suits and stayed them pending and through any appeal
of the securities class action dismissal. The Minnesota federal plaintiffs have until February 16, 2022 to file an amended
complaint.
Federal False Claims Act / Qui Tam Litigation
In October 2019, 3M acquired Acelity, Inc. and its KCI subsidiaries, including Kinetic Concepts, Inc. and KCI USA, Inc. As
previously disclosed in the SEC filings by the KCI entities, in 2009, Kinetic Concepts, Inc. received a subpoena from the U.S.
Department of Health and Human Services Office of Inspector General. In 2011, following the completion of the government’s
review and its decision declining to intervene in two qui tam actions described further below, the qui tam relator-plaintiffs’
pleadings were unsealed.
The government inquiry followed two qui tam actions filed in 2008 by two former employees against Kinetic Concepts, Inc.
and KCI USA, Inc. (collectively, the “KCI defendants”) under seal in the U.S. District Court for the Central District of
California. The complaints contain allegations that the KCI Defendants violated the federal False Claims Act by submitting
false or fraudulent claims to federal healthcare programs by billing for V.A.C.® Therapy in a manner that was not consistent
with the Local Coverage Determinations issued by the Durable Medical Equipment Medicare Administrative Contractors and
seek monetary damages. One complaint (the “Godecke case”) also contains allegations that the KCI Defendants retaliated
against the relator-plaintiff for alleged whistle-blowing behavior.
In October 2016, the KCI Defendants filed counterclaims in the Godecke case, asserting breach of contract and conversion. In
August 2017, the relator-plaintiff’s fraud claim in the Godecke case was dismissed in favor of the KCI defendants. In January
2018, the district court stayed the retaliation claim and the KCI Defendants' counterclaims pending the relator-plaintiff’s appeal.
In September 2019, the U.S. Court of Appeals for the Ninth Circuit reversed and remanded the case to the district court for
further proceedings. In August 2021, the district court entered a discovery and pretrial schedule with an April 2022 trial date.
Relator-plaintiff Godecke and the KCI Defendants reached a settlement, which includes a settlement payment by the KCI
Defendants to relator-plaintiff of an agreed amount and a complete dismissal of all claims with prejudice by both parties and
without prejudice to the United States. In January 2022, the district court entered an order dismissing the case with prejudice as
to the relator-plaintiff and the KCI Defendants and without prejudice to the United States.
Separately, in June 2019, the district court in the second case (the “Hartpence case”) entered summary judgment in the KCI
Defendants’ favor on all of the relator-plaintiff’s claims. The relator-plaintiff then filed an appeal in the U.S. Court of Appeals
for the Ninth Circuit. Oral argument in the Hartpence case was held in July 2020. The appellate court’s opinion remains
pending.
For the matters described in this section for which a liability has been recorded, the amount recorded is not material to the
Company’s consolidated results of operations or financial condition.
Compliance Matter
The Company, through its internal processes, discovered certain travel activities and related funding and record keeping issues
raising concerns, arising from marketing efforts by certain business groups based in China. The Company initiated an internal
investigation to determine whether the expenditures may have violated the U.S. Foreign Corrupt Practices Act (FCPA) or other
potentially applicable anti-corruption laws. The Company has retained outside counsel and a forensic accounting firm to assist
with the investigation. In July 2019, the Company voluntarily disclosed this investigation to both the Department of Justice and
Securities and Exchange Commission and is cooperating with both agencies. The Company cannot predict at this time the
outcome of its investigation or what potential actions may be taken by the Department of Justice or Securities and Exchange
Commission.
116
-- 124 of 142 --
%&+ #84F8F
-<97CADCB9BHGC:@95G99LD9BG95F95G:C@@CKG
$<??<BAF
(D9F5H=B;@95G97CGH
=B5B79@95G97CGH
ACFH=N5H=CBC:5GG9HG
"BH9F9GHCB@95G9@=56=@=H=9G
/5F=56@9@95G97CGH
-CH5@B9H@95G97CGH
,<CFH H9FA@95G97CGH5B8=B7CA9F9@5H98HCGI6 @95G957H=J=HM=G=AA5H9F=5@:CFH<9CAD5BM
,IDD@9A9BH5@65@5B79G<99H=B:CFA5H=CBF9@5H98HC@95G9G=G5G:C@@CKG
$<??<BAFHA?8FFABG87 #B64G<BABA9468B94?4A68*;88G
(D9F5H=B;@95G9G
(D9F5H=B;@95G9F=;<HC:IG95GG9HG (D9F5H=B;@95G9F=;<HC:IG95GG9HG
IFF9BHCD9F5H=B;@95G9@=56=@=H=9G (D9F5H=B;@95G9@=56=@=H=9G 7IFF9BH
'CB7IFF9BHCD9F5H=B;@95G9@=56=@=H=9G (D9F5H=B;@95G9@=56=@=H=9G
-CH5@CD9F5H=B;@95G9@=56=@=H=9G
=B5B79@95G9G
)FCD9FHM5B89EI=DA9BH 5H7CGH )FCD9FHM D@5BH5B89EI=DA9BH
77IAI@5H985ACFH=N5H=CB )FCD9FHM D@5BH5B89EI=DA9BH577IAI@5H98
89DF97=5H=CB
)FCD9FHM5B89EI=DA9BH B9H
IFF9BHC6@=;5H=CBGC::=B5B79@95G9G (H<9F7IFF9BH@=56=@=H=9G
=B5B79@95G9G B9HC:7IFF9BHC6@=;5H=CBG (H<9F@=56=@=H=9G
-CH5@:=B5B79@95G9@=56=@=H=9G
09=;<H985J9F5;9F9A5=B=B;@95G9H9FA=BM95FG
(D9F5H=B;@95G9G
=B5B79@95G9G
09=;<H985J9F5;98=G7CIBHF5H9
(D9F5H=B;@95G9G
=B5B79@95G9G
-- 125 of 142 --
,IDD@9A9BH5@75G<:@CK5B8CH<9F=B:CFA5H=CBF9@5H98HC@95G9G=G5G:C@@CKG
$<??<BAF
5G<D5=8:CF5ACIBHG=B7@I898=BH<9A95GIF9A9BHC:@95G9@=56=@=H=9G
(D9F5H=B;75G<:@CKG:FCACD9F5H=B;@95G9G
(D9F5H=B;75G<:@CKG:FCA:=B5B79@95G9G
=B5B7=B;75G<:@CKG:FCA:=B5B79@95G9G
+=;<HC:IG95GG9HGC6H5=B98=B9L7<5B;9:CF@95G9@=56=@=H=9G
(D9F5H=B;@95G9G
=B5B79@95G9G
,5@9@95G98 657?57H=J=HM=BK5GBCHA5H9F=5@ "BH<9:=FGHEI5FH9FC: &GC@85B8@95G98 657?79FH5=BF979BH@M
7CBGHFI7H98A57<=B9FM5B89EI=DA9BH=BF9HIFB:CFAIB=7=D5@G97IF=H=9G K<=7<=B5;;F9;5H9 K9F9F97CF8985G5:=B5B79@95G9
5GG9H5B8C6@=;5H=CBC:5DDFCL=A5H9@MA=@@=CB "BH<9:=FGHEI5FH9FC: &GC@85B8@95G98 657?79FH5=BF979BH@M
7CBGHFI7H98A57<=B9FM5B89EI=DA9BH=BF9HIFB:CFAIB=7=D5@G97IF=H=9G K<=7<=B5;;F9;5H9 K9F9F97CF8985G5:=B5B79@95G9
5GG9H5B8C6@=;5H=CBC:5DDFCL=A5H9@MA=@@=CB IF=B; H<9CAD5BMGC@85B8@95G98 657?5BC::=79@C75H=CB5B85
A5BI:57HIF=B;G=H9F9GI@H=B;=B57CA6=B98;5=BC:A=@@=CB
&5HIF=H=9GC:@95G9@=56=@=H=9GK9F95G:C@@CKG
868@58E
$<??<BAF <A4A68#84F8F
&C8E4G<A:
#84F8F
:H9F
-CH5@
%9GGACIBHGF9DF9G9BH=B;=BH9F9GH
)F9G9BHJ5@I9C::IHIF9A=B=AIA@95G9D5MA9BHG
%9GGIFF9BHC6@=;5H=CBG
%CB; H9FAC6@=;5H=CBG
GC:979A69F H<9CAD5BM<5G588=H=CB5@CD9F5H=B;@95G97CAA=HA9BHGH<5H<5J9BCHM9H7CAA9B798C:
5DDFCL=A5H9@MA=@@=CB -<9G97CAA=HA9BHGD9FH5=BHC&WGF=;<HC:IG9C:79FH5=B6I=@8=B;G
%&+ *GB6> 4F87B@C8AF4G<BA
HH<9&5MBBI5@&99H=B; H<9G<5F9<C@89FG5DDFCJ98H<9A9B8985B8+9GH5H98&CAD5BM%CB; -9FA
"B79BH=J9)@5B%-") K<=7<=B7@I8985B=B7F95G9C: =BH<9BIA69FC:G<5F9G5J5=@56@9:CF=GGI5B79 K5F8GA5M69
=GGI98=BH<9:CFAC:=B79BH=J9GHC7?CDH=CBG BCBEI5@=:=98GHC7?CDH=CBG GHC7?5DDF97=5H=CBF=;<HG F9GHF=7H98GHC7? F9GHF=7H98
GHC7?IB=HG CH<9FGHC7?5K5F8G 5B8D9F:CFA5B79IB=HG5B8D9F:CFA5B79G<5F9G GC:979A69F H<9F9A5=B=B;G<5F9G
5J5=@56@9:CF;F5BHIB89FH<9%-"))FC;F5A5F9A=@@=CB5B8H<9F9K9F95DDFCL=A5H9@M D5FH=7=D5BHGK=H<CIHGH5B8=B;
CDH=CBG F9GHF=7H98GHC7? CFF9GHF=7H98GHC7?IB=HG
-<9CAD5BMWG5BBI5@GHC7?CDH=CB5B8F9GHF=7H98GHC7?IB=H;F5BH=GA589=B96FI5FMHCDFCJ=895GHFCB;5B8=AA98=5H9@=B?
69HK99BH<9D9F:CFA5B79C:=B8=J=8I5@G8IF=B;H<9DF9798=B;M95F5B8H<9G=N9C:H<9=F5BBI5@GHC7?7CAD9BG5H=CB;F5BHG -<9
;F5BHHC9@=;=6@99AD@CM99GIG9GH<97@CG=B;GHC7?DF=79CBH<9;F5BH85H9 77CIBH=B;FI@9GF9EI=F9F97C;B=H=CBC:9LD9BG9IB89F
5BCB GI6GH5BH=J9J9GH=B;D9F=C85DDFC57< F9EI=F=B;7CAD9BG5H=CB9LD9BG9F97C;B=H=CBK<9B5B9AD@CM99=G9@=;=6@9HCF9H=F9
AD@CM99G5F97CBG=89F989@=;=6@9HCF9H=F95H5;95B85:H9F<5J=B;7CAD@9H98H9BM95FGC:G9FJ=79 -<=GF9H=F99 9@=;=6@9
-- 126 of 142 --
DCDI@5H=CBF9DF9G9BHGD9F79BHC:H<95BBI5@;F5BHWGGHC7? 65G987CAD9BG5H=CB9LD9BG9H<9F9:CF9 <=;<9FGHC7? 65G98
7CAD9BG5H=CB9LD9BG9=GF97C;B=N98=BH<9:=FGHEI5FH9F
"B588=H=CBHCH<95BBI5@;F5BHG H<9CAD5BMA5?9GCH<9FA=BCF;F5BHGC:GHC7?CDH=CBG F9GHF=7H98GHC7?IB=HG5B8CH<9FGHC7?
65G98;F5BHG -<9CAD5BM=GGI9G75G<G9HH@98F9GHF=7H98GHC7?IB=HG5B8GHC7?5DDF97=5H=CBF=;<HG=B79FH5=B7CIBHF=9G -<9G9
;F5BHG8CBCHF9GI@H=BH<9=GGI5B79C:7CAACBGHC7?5B85F97CBG=89F98=AA5H9F=5@6MH<9CAD5BM
ACIBHGF97C;B=N98=BH<9:=B5B7=5@GH5H9A9BHGK=H<F9GD97HHCGHC7? 65G987CAD9BG5H=CBDFC;F5AG K<=7<=B7@I89GHC7?
CDH=CBG F9GHF=7H98GHC7? F9GHF=7H98GHC7?IB=HG D9F:CFA5B79G<5F9G5B8H<9 9B9F5@AD@CM99GW,HC7?)IF7<5G9)@5B ,))
5F9DFCJ=898=BH<9:C@@CK=B;H56@9 5D=H5@=N98GHC7? 65G987CAD9BG5H=CB5ACIBHGK9F9BCHA5H9F=5@
*GB6> 4F87B@C8AF4G<BAKC8AF8
$<??<BAF
CGHC:G5@9G
,9@@=B; ;9B9F5@5B858A=B=GHF5H=J99LD9BG9G
+9G95F7< 89J9@CDA9BH5B8F9@5H989LD9BG9G
,HC7? 65G987CAD9BG5H=CB9LD9BG9G
"B7CA9H5L69B9:=HG
,HC7? 65G987CAD9BG5H=CB9LD9BG9G69B9:=HG B9HC:H5L
*GB6>&CG<BA'EB:E4@
-<9:C@@CK=B;H56@9GIAA5F=N9GGHC7?CDH=CB57H=J=HM:CFH<9M95FG9B898979A69F
&CG<BAF<AG;BHF4A7F
%H@58EB9
&CG<BAF
.8<:;G87
I8E4:8
K8E6<F8'E<68
%H@58EB9
&CG<BAF
.8<:;G87
I8E4:8
K8E6<F8'E<68
%H@58EB9
&CG<BAF
.8<:;G87
I8E4:8
K8E6<F8'E<68
.B89FCDH=CBT
#5BI5FM
F5BH98
L9F7=G98
CF:9=H98
979A69F
(DH=CBG9L9F7=G56@9
979A69F
,HC7?CDH=CBG;9B9F5@@MJ9GHCJ9F5D9F=C8:FCACB9HCH<F99M95FGK=H<H<99LD=F5H=CB85H95HM95FG:FCA85H9C:;F5BH GC:
979A69F H<9F9K5GA=@@=CBC:7CAD9BG5H=CB9LD9BG9H<5H<5GM9HHC69F97C;B=N98F9@5H98HCBCB J9GH98GHC7?
CDH=CB65G985K5F8G -<=G9LD9BG9=G9LD97H98HC69F97C;B=N98CJ9FH<9F9A5=B=B;K9=;<H98 5J9F5;9J9GH=B;D9F=C8C:
ACBH<G CFCDH=CBGCIHGH5B8=B;5H979A69F H<9K9=;<H98 5J9F5;9F9A5=B=B;7CBHF57HI5@@=:9K5GACBH<G5B8H<9
5;;F9;5H9=BHF=BG=7J5@I9K5GA=@@=CB CFCDH=CBG9L9F7=G56@95H979A69F H<9K9=;<H98 5J9F5;9F9A5=B=B;
7CBHF57HI5@@=:9K5GACBH<G5B8H<95;;F9;5H9=BHF=BG=7J5@I9K5GA=@@=CB
-<9HCH5@=BHF=BG=7J5@I9GC:GHC7?CDH=CBG9L9F7=G988IF=B; 5B8K5GA=@@=CB A=@@=CB5B8
A=@@=CB F9GD97H=J9@M 5G<F979=J98:FCACDH=CBG9L9F7=G988IF=B; 5B8K5GA=@@=CB A=@@=CB5B8
A=@@=CB F9GD97H=J9@M -<9CAD5BMWG57HI5@H5L69B9:=HGF95@=N98:CFH<9H5L898I7H=CBGF9@5H98HCH<99L9F7=G9C:
9AD@CM99GHC7?CDH=CBG:CF 5B8K5GA=@@=CB A=@@=CB5B8A=@@=CB F9GD97H=J9@M
CFH<9DF=A5FM5BBI5@GHC7?CDH=CB;F5BH H<9K9=;<H985J9F5;9:5=FJ5@I95HH<985H9C:;F5BHK5G75@7I@5H98IG=B;H<9@57?
,7<C@9GCDH=CB DF=7=B;AC89@5B8H<95GGIADH=CBGH<5H:C@@CK
-- 127 of 142 --
*GB6>&CG<BAFFH@CG<BAF
AAH4?
L9F7=G9DF=79
+=G? :F99=BH9F9GHF5H9
=J=89B8M=9@8
LD97H98JC@5H=@=HM
LD97H98@=:9ACBH<G
@57? ,7<C@9G:5=FJ5@I9
LD97H98JC@5H=@=HM=G5GH5H=GH=75@A95GIF9C:H<95ACIBH6MK<=7<5GHC7?DF=79=G9LD97H98HC:@I7HI5H98IF=B;5D9F=C8 CFH<9
5BBI5@;F5BH85H9 H<9CAD5BM9GH=A5H98H<99LD97H98JC@5H=@=HM65G98IDCBH<9:C@@CK=B;H<F99JC@5H=@=H=9GC:&GHC7?
H<9A98=5BC:H<9H9FAC:H<99LD97H98@=:9FC@@=B;JC@5H=@=HMH<9A98=5BC:H<9ACGHF979BHH9FAC:H<99LD97H98@=:9JC@5H=@=HM
5B8H<9=AD@=98JC@5H=@=HMCBH<9;F5BH85H9 -<99LD97H98H9FA5GGIADH=CB=G65G98CBH<9K9=;<H985J9F5;9C:<=GHCF=75@;F5BHG
)8FGE<6G87*GB6>4A7)8FGE<6G87*GB6>,A<GF
-<9:C@@CK=B;H56@9GIAA5F=N9GF9GHF=7H98GHC7?5B8F9GHF=7H98GHC7?IB=H57H=J=HM:CFH<9M95FG9B898979A69F
*;4E8F<AG;BHF4A7F
%H@58EB9
*;4E8F
.8<:;G87
I8E4:8
E4AG4G8
4<E-4?H8
%H@58EB9
*;4E8F
.8<:;G87
I8E4:8
E4AG4G8
4<E-4?H8
%H@58EB9
*;4E8F
.8<:;G87
I8E4:8
E4AG4G8
4<E-4?H8
'CBJ9GH9865@5B79T
GC:#5BI5FM
F5BH98
BBI5@
(H<9F N N
/9GH98
CF:9=H98
GC:979A69F
GC:979A69F H<9F9K5GA=@@=CBC:7CAD9BG5H=CB9LD9BG9H<5H<5GM9HHC69F97C;B=N98F9@5H98HCBCB J9GH98
F9GHF=7H98GHC7?5B8F9GHF=7H98GHC7?IB=HG -<=G9LD9BG9=G9LD97H98HC69F97C;B=N98CJ9FH<9F9A5=B=B;K9=;<H98 5J9F5;9
J9GH=B;D9F=C8C:ACBH<G -<9HCH5@:5=FJ5@I9C:F9GHF=7H98GHC7?5B8F9GHF=7H98GHC7?IB=HGH<5HJ9GH988IF=B;979A69F
5B8K5GA=@@=CB A=@@=CB5B8A=@@=CB F9GD97H=J9@M -<9CAD5BMWG57HI5@H5L69B9:=HGF95@=N98
:CFH<9H5L898I7H=CBGF9@5H98HCH<9J9GH=B;C:F9GHF=7H98GHC7?5B8F9GHF=7H98GHC7?IB=HG:CF 5B8K5G
A=@@=CB A=@@=CB5B8A=@@=CB F9GD97H=J9@M
+9GHF=7H98GHC7?IB=HG;F5BH98;9B9F5@@MJ9GHH<F99M95FG:C@@CK=B;H<9;F5BH85H95GGIA=B;7CBH=BI989AD@CMA9BH =J=89B8
9EI=J5@9BHG9EI5@HCH<98=J=89B8GD5M56@9CBH<9G5A9BIA69FC:G<5F9GC:&7CAACBGHC7?577FI9CBH<9G9F9GHF=7H98GHC7?
IB=HG8IF=B;H<9J9GH=B;D9F=C8 5@H<CI;<BC8=J=89B89EI=J5@9BHG5F9D5=8CB5BMC:H<9G9F9GHF=7H98GHC7?IB=HGH<5H5F9:CF:9=H98
DF=CFHCH<9J9GH=B;85H9 =J=89B8G5F9D5=8CIH=B75G<5HH<9J9GH85H9CBF9GHF=7H98GHC7?IB=HG ,=B79H<9F=;<HGHC8=J=89B8G
5F9:CF:9=H56@9 H<9F9=GBC=AD57HCB65G=795FB=B;GD9FG<5F975@7I@5H=CBG 09=;<H985J9F5;9F9GHF=7H98GHC7?IB=HG<5F9G
CIHGH5B8=B;5F9=B7@I898=BH<97CADIH5H=CBC:8=@IH9895FB=B;GD9FG<5F9
'8E9BE@4A68*;4E8F
"BGH958C:F9GHF=7H98GHC7?IB=HG H<9CAD5BMA5?9G5BBI5@;F5BHGC:D9F:CFA5B79G<5F9GHCA9A69FGC:=HG9L97IH=J9
A5B5;9A9BH -<9D9F:CFA5B797F=H9F=5:CFH<9G9D9F:CFA5B79G<5F9GCF;5B=7JC@IA9;FCKH< F9HIFBCB=BJ9GH9875D=H5@
:F9975G<:@CK7CBJ9FG=CB 5B895FB=B;GD9FG<5F9;FCKH<K9F9G9@97H986975IG9H<9CAD5BM69@=9J9GH<5HH<9M5F9=ADCFH5BH
8F=J9FGC:@CB; H9FAGHC7?<C@89FJ5@I9 -<9BIA69FC:G<5F9GC:&7CAACBGHC7?H<5H7CI@857HI5@@M6989@=J9F985HH<99B8
C:H<9H<F99M95FD9F:CFA5B79D9F=C8A5M695BMK<9F9:FCAHCC:957<D9F:CFA5B79G<5F9;F5BH98 89D9B8=B;CBH<9
D9F:CFA5B79C:H<9CAD5BM8IF=B;GI7<D9F:CFA5B79D9F=C8 0<9B;F5BH98 H<9G9D9F:CFA5B79G<5F9G5F95K5F8985HC:
-- 128 of 142 --
H<99GH=A5H98BIA69FC:G<5F9G5HH<99B8C:H<9H<F99 M95FD9F:CFA5B79D9F=C85B85F9F9:@97H98IB89FU F5BH98V=BH<9H56@9
69@CK 'CB GI6GH5BH=J9J9GH=B;F9EI=F9GH<5H9LD9BG9:CFH<9D9F:CFA5B79G<5F9G69F97C;B=N98CJ9FCB9CFH<F99M95FG
89D9B8=B;CBK<9B957<=B8=J=8I5@6975A95&9L97IH=J9 -<9D9F:CFA5B79G<5F9;F5BHG577FI98=J=89B8GH<9F9:CF9 H<9
;F5BH85H9:5=FJ5@I9=G9EI5@HCH<97@CG=B;GHC7?DF=79CBH<985H9C:;F5BH ,=B79H<9F=;<HGHC8=J=89B8G5F9:CF:9=H56@9 H<9F9=G
BC=AD57HCB65G=795FB=B;GD9FG<5F975@7I@5H=CBG 09=;<H985J9F5;9D9F:CFA5B79G<5F9GK<CG9D9F:CFA5B79D9F=C8=G
7CAD@9H95F9=B7@I898=B7CADIH5H=CBC:8=@IH9895FB=B;GD9FG<5F9
-<9:C@@CK=B;H56@9GIAA5F=N9GD9F:CFA5B79G<5F957H=J=HM:CFH<9M95FG9B898979A69F
*;4E8F<AG;BHF4A7F %H@58EB9
*;4E8F
.8<:;G87
I8E4:8
E4AG4G8
4<E-4?H8 %H@58EB9
*;4E8F
.8<:;G87
I8E4:8
E4AG4G8
4<E-4?H8 %H@58EB9
*;4E8F
.8<:;G87
I8E4:8
E4AG4G8
4<E-4?H8
.B8=GHF=6IH9865@5B79T
GC:#5BI5FM
F5BH98
=GHF=6IH98
)9F:CFA5B797<5B;9
CF:9=H98
GC:979A69F
GC:979A69F H<9F9K5GA=@@=CBC:7CAD9BG5H=CB9LD9BG9H<5H<5GM9HHC69F97C;B=N98F9@5H98HCD9F:CFA5B79
G<5F9G -<=G9LD9BG9=G9LD97H98HC69F97C;B=N98CJ9FH<9F9A5=B=B;K9=;<H98 5J9F5;995FB=B;GD9F=C8C:ACBH<G -<9HCH5@
:5=FJ5@I9C:D9F:CFA5B79G<5F9GH<5HK9F98=GHF=6IH98K9F9A=@@=CB A=@@=CB 5B8A=@@=CB:CF 5B8
F9GD97H=J9@M -<9CAD5BMWG57HI5@H5L69B9:=HGF95@=N98:CFH<9H5L898I7H=CBGF9@5H98HCH<98=GHF=6IH=CBC:D9F:CFA5B79G<5F9G
K9F9A=@@=CB A=@@=CB 5B8A=@@=CBD9FM95F:CF 5B8 F9GD97H=J9@M
-6-:)45847A--;C#<7+3!=:+0);-!4)6#!!
GC:979A69F G<5F9<C@89FG<5J95DDFCJ98A=@@=CBG<5F9G:CF=GGI5B79IB89FH<9CAD5BMWG ,))
,I6GH5BH=5@@M5@@9AD@CM99G5F99@=;=6@9HCD5FH=7=D5H9=BH<9D@5B )5FH=7=D5BHG5F9;F5BH98CDH=CBG5HC:A5F?9HJ5@I95HH<9
85H9C:;F5BH -<9F95F9BC ,))G<5F9GIB89FCDH=CB5HH<969;=BB=B;CF9B8C:957<M95F6975IG9CDH=CBG5F9;F5BH98CBH<9
:=FGH6IG=B9GG85M5B89L9F7=G98CBH<9@5GH6IG=B9GG85MC:H<9G5A9ACBH<
-<9K9=;<H98 5J9F5;9:5=FJ5@I9D9FCDH=CB;F5BH988IF=B; 5B8K5G 5B8 F9GD97H=J9@M
-<9:5=FJ5@I9C: ,))CDH=CBGK5G65G98CBH<9DIF7<5G9DF=798=G7CIBH -<9CAD5BMF97C;B=N987CAD9BG5H=CB
9LD9BG9:CF ,,)CDH=CBGC:A=@@=CB=B A=@@=CB=B 5B8A=@@=CB=B
%&+ HF<A8FF*8:@8AGF4A78B:E4C;<6 A9BE@4G<BA
&WG6IG=B9GG9G5F9CF;5B=N98 A5B5;985B8=BH9FB5@@M;FCID98=BHCG9;A9BHG65G98CB8=::9F9B79G=BA5F?9HG DFC8I7HG
H97<BC@C;=9G5B8G9FJ=79G &A5B5;9G=HGCD9F5H=CBG=B:CIF6IG=B9GGG9;A9BHG,5:9HM5B8"B8IGHF=5@-F5BGDCFH5H=CB5B8
@97HFCB=7G!95@H<5F95B8CBGIA9F &WG:CIF6IG=B9GGG9;A9BHG6F=B;HC;9H<9F7CAACBCFF9@5H98&H97<BC@C;=9G
9B<5B7=B;H<989J9@CDA9BHC:=BBCJ5H=J9DFC8I7HG5B8G9FJ=79G5B8DFCJ=8=B;:CF9::=7=9BHG<5F=B;C:6IG=B9GGF9GCIF79G
-F5BG57H=CBG5ACB;F9DCFH56@9G9;A9BHG5F9F97CF8985H7CGH &=G5B=BH9;F5H989BH9FDF=G97<5F57H9F=N986MGI6GH5BH=5@
=BH9FG9;A9BH7CCD9F5H=CB 7CGH5@@C75H=CBG5B8=BJ9BHCFMHF5BG:9FG -<9F9:CF9 A5B5;9A9BH8C9GBCHF9DF9G9BHH<5HH<9G9
G9;A9BHG =:CD9F5H98=B89D9B89BH@M KCI@8F9DCFHH<9CD9F5H=B;=B7CA9=B:CFA5H=CBG<CKB
&8=G7@CG9G6IG=B9GGG9;A9BHCD9F5H=B;=B7CA95G=HGA95GIF9C:G9;A9BHDFC:=H @CGG F97CB7=@98HC6CH<HCH5@&CD9F5H=B;
=B7CA95B8=B7CA969:CF9H5L9G IG=B9GGG9;A9BHCD9F5H=B;=B7CA9=B7@I89G8I5@7F98=H:CF79FH5=BF9@5H98CD9F5H=B;=B7CA9
5G89G7F=69869@CK=BU@=A=B5H=CBC:I5@F98=HV IG=B9GGG9;A9BHCD9F5H=B;=B7CA99L7@I89G79FH5=B9LD9BG9G5B8
=B7CA9H<5H5F9BCH5@@C75H98HC6IG=B9GGG9;A9BHG5G89G7F=69869@CK=BUCFDCF5H95B8.B5@@C75H98V 88=H=CB5@@M H<9
:C@@CK=B;GD97=5@=H9AG5F99L7@I898:FCA6IG=B9GGG9;A9BHCD9F5H=B;=B7CA95B8 =BGH958 5F9=B7@I898K=H<=BCFDCF5H95B8
.B5@@C75H98G=;B=:=75BH@=H=;5H=CB F9@5H987<5F;9G 69B9:=HG ;5=B @CGGCBG5@9C:6IG=B9GG9GG99'CH9 5B88=J9GH=HIF9 F9@5H98
F9GHFI7HIF=B;57H=CBGG99'CH9
-- 129 of 142 --
::97H=J9=BH<9:=FGHEI5FH9FC: H<9A95GIF9C:G9;A9BHCD9F5H=B;D9F:CFA5B79IG986M&WG(&7<5B;985B8 5G5
F9GI@H &WG8=G7@CG98A95GIF9C:G9;A9BHDFC:=H @CGG6IG=B9GGG9;A9BHCD9F5H=B;=B7CA9K5GID85H98 -<97<5B;9HC
6IG=B9GGG9;A9BHCD9F5H=B;=B7CA95@=;BGK=H<H<9ID85H9HC<CKH<9(&5GG9GG9GD9F:CFA5B795B85@@C75H9GF9GCIF79G:CF
H<9CAD5BMWG6IG=B9GGG9;A9BHG -<97<5B;9=B7@I898H<9:C@@CK=B;
2+81/=38-9=>+>><3,?>398
-<99LH9BHC:5@@C75H=CB5B8A9H<C8C:5HHF=6IH=CBC:79FH5=BB9H7CGHGK9F9ID85H98HCF9GI@H=B:9K9F=H9AGF9A5=B=B;=B
CFDCF5H95B8.B5@@C75H985B8 =BGH958 =B7@I8=B;H<9A=B&WG6IG=B9GGG9;A9BHGWCD9F5H=B;D9F:CFA5B79 ,99H<9
ID85H9889G7F=DH=CBC:CFDCF5H95B8.B5@@C75H9869@CK )F9J=CIG@M 5@5F;9FDCFH=CBC:CB;C=B;7CFDCF5H9GH5::7CGHG5B8
7CGHG5GGC7=5H98K=H<79BHF5@@MA5B5;98A5H9F=5@F9GCIF7979BH9FGK5GF9H5=B98=BCFDCF5H95B8.B5@@C75H98 "B588=H=CB
DCFH=CBGC:D9BG=CB7CGHG5B87CGHG5GGC7=5H98K=H<79FH5=B79BHF5@@MA5B5;986IHCB;C=B;6IG=B9GG F9@5H98@9;5@A5HH9FG
5@CB;K=H<79FH5=B=BGIF5B79 F9@5H987CGHG K9F9F9H5=B98=BCFDCF5H95B8.B5@@C75H98
98>38?/.+63187/8>90-?=>97/<+--9?8>+->3@3>C
GD5FHC:&WGF9;I@5F7IGHCA9F :C7IG=B=H=5H=J9G H<9CAD5BMF95@=;B9879FH5=B7IGHCA9F577CIBH57H=J=HMUG5@9G
8=GHF=7HVHC7CFF9@5H9K=H<H<9DF=A5FM8=J=G=CB5@DFC8I7HC::9F=B;G=BJ5F=CIG7CIBHF=9G5B8F98I797CAD@9L=HM:CF
7IGHCA9FGK<9B=BH9F57H=B;K=H<AI@H=D@9&6IG=B9GG9G -<=G=AD57H98H<95ACIBHC:8I5@7F98=H79FH5=B6IG=B9GG
G9;A9BHGF979=J95G5F9GI@HC:G5@9G8=GHF=7H5HHF=6IH=CB
@GC9::97H=J9=BH<9:=FGHEI5FH9FC: K=H<=B&WGCBGIA9F6IG=B9GGG9;A9BH 79FH5=BG5:9HMDFC8I7HG:CFA9F@MK=H<=BH<9
CBGHFI7H=CB5B8!CA9"ADFCJ9A9BH=J=G=CB5B8H<9,H5H=CB9FM5B8(::=79=J=G=CBK9F9ACJ98HCH<9B9K@MB5A98
CBGIA9F!95@H<5B8,5:9HM=J=G=CB:CFA9F@MH<9CBGIA9F!95@H<5F9=J=G=CB
-<9:=B5B7=5@=B:CFA5H=CBDF9G9BH98<9F9=BF9:@97HGH<9=AD57HC:H<9DF9798=B;6IG=B9GGG9;A9BHF9DCFH=B;7<5B;9G:CF5@@
D9F=C8GDF9G9BH98
HF<A8FF*8:@8AG'EB7H6GF
HF<A8FF*8:@8AG )8CE8F8AG4G<I8E8I8AH8 :8A8E4G<A:46G<I<G<8F CEB7H6GFBEF8EI<68F
,5:9HM5B8"B8IGHF=5@ Z "B8IGHF=5@56F5G=J9G5B8:=B=G<=B;:CFA9H5@KCF?=B;5DD@=75H=CBG
Z IHC6C8MF9D5=FGC@IH=CBG
Z @CGIF9GMGH9AG:CFD9FGCB5@<M;=9B9DFC8I7HG A5G?=B; 5B8D57?5;=B;A5H9F=5@G
Z @97HF=75@DFC8I7HG5B8A5H9F=5@G:CF7CBGHFI7H=CB5B8A5=BH9B5B79 DCK9F8=GHF=6IH=CB5B8
9@97HF=75@(&G
Z ,HFI7HIF5@58<9G=J9G5B8H5D9G
Z +9GD=F5HCFM <95F=B; 9M95B8:5@@DFCH97H=CBGC@IH=CBG
Z '5HIF5@5B87C@CF 7C5H98A=B9F5@;F5BI@9G:CFG<=B;@9G
-F5BGDCFH5H=CB5B8
@97HFCB=7G Z 8J5B79879F5A=7GC@IH=CBG
Z HH57<A9BHH5D9G :=@AG GCIB85B8H9AD9F5HIF9A5B5;9A9BH:CFHF5BGDCFH5H=CBJ9<=7@9G
Z )F9A=IA@5F;9:CFA5H;F5D<=7:=@AG:CF58J9FH=G=B;5B8:@99HG=;B5;9
Z %=;<HA5B5;9A9BH:=@AG5B89@97HFCB=7G5GG9A6@MGC@IH=CBG
Z )57?5;=B;5B8=BH9F7CBB97H=CBGC@IH=CBG
Z +9:@97H=J9G=;B5;9:CF<=;<K5M 5B8J9<=7@9G5:9HM
!95@H<5F9 Z CC8G5:9HM=B8=75HCFGC@IH=CBG
Z !95@H<75F9DFC798IF97C8=B;5B8F9=A6IFG9A9BHGC:HK5F9
Z ,?=B KCIB875F9 5B8=B:97H=CBDF9J9BH=CBDFC8I7HG5B8GC@IH=CBG
Z 9BH=GHFM5B8CFH<C8CBH=5GC@IH=CBG
Z =@HF5H=CB5B8DIF=:=75H=CBGMGH9AG
CBGIA9F Z CBGIA9F65B85;9G 6F579G GIDDCFHG5B87CBGIA9FF9GD=F5HCFG
Z @95B=B;DFC8I7HG:CFH<9<CA9
Z +9H5=@56F5G=J9G D5=BH5779GGCF=9G 75F75F9"2DFC8I7HG D=7HIF9<5B;=B;5B87CBGIA9F5=F
EI5@=HMGC@IH=CBG
Z ,H5H=CB9FMDFC8I7HG
-- 130 of 142 --
HF<A8FF*8:@8AG A9BE@4G<BA
%8G*4?8F$<??<BAF
,5:9HM5B8"B8IGHF=5@
-F5BGDCFH5H=CB5B8@97HFCB=7G
!95@H<5F9
CBGIA9F
CFDCF5H95B8.B5@@C75H98
@=A=B5H=CBC:I5@F98=H
-CH5@CAD5BM
&C8E4G<A:'8E9BE@4A68$<??<BAF
,5:9HM5B8"B8IGHF=5@
-F5BGDCFH5H=CB5B8@97HFCB=7G
!95@H<5F9
CBGIA9F
@=A=B5H=CBC:I5@F98=H
+BG4?5HF<A8FFF8:@8AGBC8E4G<A:<A6B@8
CFDCF5H95B8.B5@@C75H98
,D97=5@=H9AG
,=;B=:=75BH@=H=;5H=CB F9@5H987<5F;9G 69B9:=HG N
5=B @CGGCBG5@9C:6IG=B9GG9G N
=J9GH=HIF9 F9@5H98F9GHFI7HIF=B;57H=CBG N T
(H<9F7CFDCF5H99LD9BG9 B9H
-CH5@CFDCF5H95B8.B5@@C75H98
+BG4?B@C4ALBC8E4G<A:<A6B@8
(H<9F9LD9BG9 =B7CA9 B9H
A6B@8589BE8<A6B@8G4K8F
FF8GF 8CE86<4G<BA@BEG<M4G<BA 4C<G4?KC8A7<GHE8F
$<??<BAF
,5:9HM5B8"B8IGHF=5@
-F5BGDCFH5H=CB5B8@97HFCB=7G
!95@H<5F9
CBGIA9F
CFDCF5H95B8.B5@@C75H98
-CH5@CAD5BM
GG9HGGI6>97HHC5HHF=6IH=CBHC6IG=B9GGG9;A9BHG@5F;9@M=B7@I89577CIBHGF979=J56@9=BJ9BHCF=9GDFCD9FHM D@5BH5B8
9EI=DA9BH;CC8K=@@=BH5B;=6@95GG9HG5B879FH5=B@=A=H98CH<9F5GG9HG @@CH<9F=H9AG5F9F9:@97H98=BCFDCF5H95B8
.B5@@C75H98 77CIBHGF979=J56@95B8=BJ9BHCFM5F95HHF=6IH9865G98CBIB89F@M=B;G5@9GCF57H=J=HM )FCD9FHM D@5BH5B8
9EI=DA9BH5F95HHF=6IH98HC5D5FH=7I@5F6IG=B9GGG9;A9BH65G98CBH<5H=H9AWGDF=A5FMIG9FK<=@979FH5=B=H9AGGI7<5G
7CFDCF5H9 G<5F98<958EI5FH9FG 58A=B=GHF5H=J979BH9FG @56CF5HCF=9G 8=GHF=6IH=CB79BH9FG5B89BH9FDF=G9GC:HK5F9GMGH9AG5F9
F9:@97H98=BCFDCF5H95B8.B5@@C75H98 "BH5B;=6@95GG9HG5B8;CC8K=@@5F9@5F;9@M8=F97H@M5GGC7=5H98K=H<5D5FH=7I@5FF9DCFH=B;
IB=H5B85HHF=6IH98CBH<5H65G=G IG=B9GGG9;A9BH89DF97=5H=CBF9:@97H9856CJ9=G65G98CBH<9IB89F@M=B;IG5;9C:5GG9HG
K<=@9H<9D5FH=7I@5F5GG9H=HG9@:A5M699BH=F9@MF9:@97H98K=H<=B58=::9F9BH6IG=B9GGG9;A9BHWG5GG9H65@5B795G=HGDF=A5FM
IG9F -<=G89DF97=5H=CB5@GC=B7@I89G5@@C75H9889DF97=5H=CB5GGC7=5H98K=H<5BIA69FC:H<95GG9HGF9:@97H98=BCFDCF5H95B8
.B5@@C75H985G89G7F=69856CJ9
-- 131 of 142 --
9<:9<+>/+8.'8+669-+>/.
CFDCF5H95B8.B5@@C75H98CD9F5H=B;=B7CA9=B7@I89GUGD97=5@=H9AGV5B8UCH<9F7CFDCF5H99LD9BG9 B9HV ,D97=5@=H9AG=B7@I89
G=;B=:=75BH@=H=;5H=CB F9@5H987<5F;9G 69B9:=HG ;5=B @CGGCBG5@9C:6IG=B9GG9G 5B88=J9GH=HIF9 F9@5H98F9GHFI7HIF=B;7CGHG (H<9F
7CFDCF5H99LD9BG9 B9H=B7@I89G=H9AGGI7<5GB9H7CGHGF9@5H98HC@=A=H98IB5@@C75H987CFDCF5H9GH5::5B879BHF5@@MA5B5;98
A5H9F=5@F9GCIF7979BH9FGC:9LD9FH=G97CGHG 79FH5=B@=H=;5H=CB5B89BJ=FCBA9BH5@9LD9BG9G@5F;9@MF9@5H98HC@9;57MDFC8I7HG
6IG=B9GG9GBCH5@@C75H98HC6IG=B9GGG9;A9BHG 7CFDCF5H9D<=@5BH<FCD=757H=J=HM 5B8CH<9FB9H7CGHGH<5H&A5M7<CCG9BCHHC
5@@C75H98=F97H@MHC=HG6IG=B9GGG9;A9BHG (H<9F7CFDCF5H99LD9BG9 B9H5@GC=B7@I89G7CGHG5B8=B7CA9:FCA7CBHF57H
A5BI:57HIF=B; HF5BG=H=CBG9FJ=79G5B8CH<9F5FF5B;9A9BHGK=H<H<957EI=F9FC:H<9CAAIB=75H=CB&5F?9HG=J=G=CB:C@@CK=B;
=HG8=J9GH=HIF9H<FCI;<5B8H<957EI=F9FC:H<9:CFA9FFI;9@=J9FM6IG=B9GG:C@@CK=B;=HG8=J9GH=HIF9 "H9AG
7@5GG=:=985GF9J9BI9:FCAH<=G57H=J=HM5F9=B7@I898=BCFDCF5H95B8.B5@@C75H98B9HG5@9G 975IG9CFDCF5H95B8.B5@@C75H98
=B7@I89G5J5F=9HMC:A=G79@@5B9CIG=H9AG =H=GGI6>97HHC:@I7HI5H=CBCB5EI5FH9F@M5B85BBI5@65G=G
63738+>39890?+6</.3>
&6IG=B9GGG9;A9BHF9DCFH=B;A95GIF9G=B7@I898I5@7F98=HHC6IG=B9GGG9;A9BHG:CF79FH5=BG5@9G5B8F9@5H98CD9F5H=B;
=B7CA9 &5B5;9A9BH9J5@I5H9G957<C:=HG:CIF6IG=B9GGG9;A9BHG65G98CBB9HG5@9G5B8CD9F5H=B;=B7CA9D9F:CFA5B79
=B7@I8=B;8I5@7F98=HF9DCFH=B;HC:IFH<9F=B79BH=J=N9G5@9G;FCKH< G5F9GI@H &F9:@97HG588=H=CB5@U8I5@V7F98=HHC5BCH<9F
6IG=B9GGG9;A9BHK<9BH<97IGHCA9F577CIBH57H=J=HMUG5@9G8=GHF=7HVK=H<F9GD97HHCH<9D5FH=7I@5FDFC8I7HGC@8HCH<99LH9FB5@
7IGHCA9F=GDFCJ=8986M58=::9F9BH6IG=B9GGG9;A9BH -<=G588=H=CB5@8I5@7F98=H=G@5F;9@MF9:@97H985HH<98=J=G=CB@9J9@ CF
9L5AD@9 DF=J57MG7F99BDFCH97H=CBDFC8I7HG5F9DF=A5F=@MGC@86MH<9=GD@5M&5H9F=5@G5B8,MGH9AG=J=G=CBK=H<=BH<9
-F5BGDCFH5H=CB5B8@97HFCB=7G6IG=B9GGG9;A9BH<CK9J9F 79FH5=BG5@9G8=GHF=7HGK=H<=BH<9CBGIA9F6IG=B9GGG9;A9BH
DFCJ=89H<97IGHCA9F577CIBH57H=J=HM:CFG5@9GC:H<9DFC8I7HHCD5FH=7I@5F7IGHCA9FG "BH<=G9L5AD@9 H<9BCB DF=A5FMG9@@=B;
G9;A9BHCBGIA9FKCI@85@GCF979=J97F98=H:CFH<95GGC7=5H98B9HG5@9G=B=H=5H98H<FCI;<=HGG5@9G8=GHF=7H5B8H<9F9@5H98
5DDFCL=A5H9CD9F5H=B;=B7CA9 -<95GG=;B98CD9F5H=B;=B7CA9F9@5H98HC8I5@7F98=H57H=J=HMA5M8=::9F:FCACD9F5H=B;=B7CA9
H<5HKCI@8F9GI@H:FCA57HI5@7CGHG5GGC7=5H98K=H<GI7<G5@9G -<9C::G9HHCH<98I5@7F98=H6IG=B9GGG9;A9BHF9DCFH=B;=G
F9:@97H985G5F97CB7=@=B;=H9A9BH=H@98U@=A=B5H=CBC:I5@F98=H VGI7<H<5HG5@9G5B8CD9F5H=B;=B7CA9=BHCH5@5F9
IB7<5B;98
8B:E4C;<6 A9BE@4G<BA
9C;F5D<=75F95=B:CFA5H=CB=GIG986MH<9CAD5BM5G5G97CB85FMD9F:CFA5B79A95GIF9HCA5B5;9=HG6IG=B9GG9G LDCFH
G5@9G5B879FH5=B=B7CA95B89LD9BG9=H9AG5F9;9B9F5@@MF9DCFH98K=H<=BH<9;9C;F5D<=75F95K<9F9H<9:=B5@G5@9GHC&
7IGHCA9FG5F9A589 +9:9FHC'CH9:CF;9C;F5D<=7B9HG5@9G
'EBC8EGL '?4AG4A7
DH<C@8AG A8G
$<??<BAF
A9F=75G
G=5)57=:=7
IFCD9 &=88@95GH5B8:F=75
-CH5@CAD5BM
.B=H98,H5H9GB9HDFCD9FHM D@5BH5B89EI=DA9BH))K5G A=@@=CB5B8 A=@@=CB5H979A69F 5B8
F9GD97H=J9@M <=B5 !CB;$CB;B9HDFCD9FHM D@5BH5B89EI=DA9BH))K5GA=@@=CB5B8A=@@=CB5H
979A69F 5B8 F9GD97H=J9@M
-- 132 of 142 --
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.
None.
Item 9A. Controls and Procedures.
a. The Company carried out an evaluation, under the supervision and with the participation of its management, including
the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s
“disclosure controls and procedures” (as defined in the Exchange Act Rule 13a-15(e)) as of the end of the period covered by
this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s
disclosure controls and procedures are effective.
b. The Company’s management is responsible for establishing and maintaining an adequate system of internal control
over financial reporting, as defined in the Exchange Act Rule 13a-15(f). Management conducted an assessment of the
Company’s internal control over financial reporting based on the framework established by the Committee of Sponsoring
Organizations of the Treadway Commission in Internal Control — Integrated Framework (2013). Based on the assessment,
management concluded that, as of December 31, 2021, the Company’s internal control over financial reporting is effective. The
Company’s internal control over financial reporting as of December 31, 2021 has been audited by PricewaterhouseCoopers
LLP, an independent registered public accounting firm, as stated in their report which is included herein, which expresses an
unqualified opinion on the effectiveness of the Company’s internal control over financial reporting as of December 31, 2021.
c. There was no change in the Company’s internal control over financial reporting that occurred during the Company’s
most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s
internal control over financial reporting.
The Company is implementing an enterprise resource planning (“ERP”) system on a worldwide basis, which is expected to
improve the efficiency of certain financial and related transaction processes. The gradual implementation is expected to occur in
phases over the next several years. The implementation of a worldwide ERP system will likely affect the processes that
constitute our internal control over financial reporting and will require testing for effectiveness.
The Company completed implementation with respect to various processes/sub-processes in certain subsidiaries/locations,
including aspects relative to the United States, and will continue to roll out the ERP system over the next several years. As with
any new information technology application we implement, this application, along with the internal controls over financial
reporting included in this process, was appropriately considered within the testing for effectiveness with respect to the
implementation in these instances. We concluded, as part of its evaluation described in the above paragraphs, that the
implementation of the ERP system in these circumstances has not materially affected our internal control over financial
reporting.
Item 9B. Other Information.
Disclosure Under Iran Threat Reduction and Syria Human Rights Act of 2012
The Company is making the following disclosure under Section 13(r) of the Exchange Act:
Protection of Intellectual Property Rights in Iran Pursuant to Specific License
As part of its intellectual property (“IP”) protection efforts, 3M has obtained and maintains patents and trademarks in Iran.
Periodically, 3M pays renewal fees, through IP service providers/counsel located in Germany, Dubai and Iran, to the Iran
Intellectual Property Office (“IIPO”) for these patents and trademarks and has sought to prosecute and defend such trademarks.
On January 15, 2020, OFAC granted 3M a specific license to make payments to IIPO at its account in Bank Melli, which was
designated on November 5, 2018 by OFAC under its counter terrorism authority pursuant to Executive Order 13224. As
authorized by OFAC’s specific license, in the period ended December 31, 2021, 3M paid $307 to IIPO as part of its intellectual
property protection efforts in Iran. 3M plans to continue these activities, as authorized under the specific license.
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Not applicable
125
-- 133 of 142 --
PART III
Documents Incorporated by Reference
In response to Part III, Items 10, 11, 12, 13 and 14, parts of the Company’s definitive proxy statement (to be filed pursuant to
Regulation 14A within 120 days after Registrant’s fiscal year-end of December 31, 2021) for its annual meeting to be held on
May 10, 2022, are incorporated by reference in this Form 10-K.
Item 10. Directors, Executive Officers and Corporate Governance.
The information relating to directors and nominees of 3M is set forth under the caption “Proposal No. 1” in 3M’s proxy
statement for its annual meeting of stockholders to be held on May 10, 2022 (“3M Proxy Statement”) and is incorporated by
reference herein. Information about executive officers is included in Item 1 of this Annual Report on Form 10-K. The
information required by Items 405, 407(c)(3), (d)(4) and (d)(5) of Regulation S-K is contained under the captions “Corporate
Governance At 3M — Board Membership Criteria — Identification, Evaluation, and Selection of Nominees,” “—Shareholder
Nominations,” “—Shareholder Nominations – Advance Notice Bylaw”, and “—Proxy Access Nominations” and “Corporate
Governance At 3M -- Board Committees – Audit Committee” of the 3M Proxy Statement and such information is incorporated
by reference herein.
Code of Ethics. All of our employees, including our Chief Executive Officer, Chief Financial Officer and Chief Accounting
Officer and Controller, are required to abide by 3M’s long-standing business conduct policies to ensure that our business is
conducted in a consistently legal and ethical manner. 3M has posted the text of such code of ethics on its website (https://
www.3M.com/3M/en_US/ethics-compliance). At the same website, any future amendments to the code of ethics will also be
posted. Any person may request a copy of the code of ethics, at no cost, by writing to us at the following address:
3M Company
3M Center, Building 220-11W-09
St. Paul, MN 55144-1000
Attention: Senior Vice President, 3M Ethics &
Compliance
Item 11. Executive Compensation.
The information required by Item 402 of Regulation S-K is contained under the captions “Executive Compensation” (excluding
the information under the caption “— Compensation Committee Report”) and “Director Compensation” and “Stock Retention
Requirement” of the 3M Proxy Statement. Such information is incorporated by reference.
The information required by Items 407(e)(4) and (e)(5) of Regulation S-K is contained in the “Executive Compensation”
section under the captions “Compensation Committee Report” and “Compensation Committee Interlocks and Insider
Participation” of the 3M Proxy Statement. Such information (other than the Compensation Committee Report, which shall not
be deemed to be “filed”) is incorporated by reference.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
The information relating to security ownership of certain beneficial owners and management is set forth under the designation
“Security Ownership of Management” and “Security Ownership of Certain Beneficial Owners” in the 3M Proxy Statement and
such information is incorporated by reference herein.
126
-- 134 of 142 --
EI=HM7CAD9BG5H=CBD@5BG=B:CFA5H=CB5GC:979A69F :C@@CKG
DH<GLB@C8AF4G<BA'?4AF A9BE@4G<BA
'?4A4G8:BELBCG<BAF4A7F;4E8F<AG;BHF4A7F
%H@58EB9
F86HE<G<8FGB58
<FFH87HCBA
8K8E6<F8B9
BHGFG4A7<A:
BCG<BAF J4EE4AGF
4A7E<:;GF
.8<:;G87
4I8E4:88K8E6<F8
CE<68B9
BHGFG4A7<A:
BCG<BAF
J4EE4AGF4A7
E<:;GF
%H@58E
B9F86HE<G<8F
E8@4<A<A:4I4<?45?8
9BE9HGHE8<FFH4A68
HA78E8DH<GL
6B@C8AF4G<BA
C?4AF8K6?H7<A:
F86HE<G<8F
E89?86G87<A
6B?H@A
EI=HM7CAD9BG5H=CBD@5BG5DDFCJ986MG97IF=HM<C@89FG
,HC7?CDH=CBG N
+9GHF=7H98GHC7?IB=HG N
)9F:CFA5B79G<5F9G N
'CB 9AD@CM998=F97HCF89:9FF98GHC7?IB=HG N
-CH5@
AD@CM99GHC7?DIF7<5G9D@5B N
,I6HCH5@
-CH5@
3333333333333333333333333333333333
"B7C@IAB H<9K9=;<H98 5J9F5;99L9F7=G9DF=79=GCB@M5DD@=756@9HCGHC7?CDH=CBG "B7C@IAB H<9BIA69FC:G97IF=H=9G
F9A5=B=B;5J5=@56@9:CF:IHIF9=GGI5B79:CFGHC7?CDH=CBG F9GHF=7H98GHC7?IB=HG 5B8GHC7?5K5F8G:CFBCB 9AD@CM99
8=F97HCFG=G5DDFCJ98=BHCH5@5B8BCH=B8=J=8I5@@MK=H<F9GD97HHCH<9G9=H9AG
G8@ 8EG4<A)8?4G<BAF;<CF4A7)8?4G87+E4AF46G<BAF 4A7<E86GBE A78C8A78A68
0=H<F9GD97HHC79FH5=BF9@5H=CBG<=DG5B8F9@5H98HF5BG57H=CBG5GG9H:CFH<=B"H9AC:+9;I@5H=CB, $ BCA5HH9FGF9EI=F9
8=G7@CGIF9K=H<F9GD97HHCHF5BG57H=CBGK=H<F9@5H98D9FGCBG -<9=B:CFA5H=CBF9EI=F986M"H9A65B8"H9A5C:
+9;I@5H=CB, $=G7CBH5=B98IB89FH<9G97H=CBUCFDCF5H9 CJ9FB5B795H&VIB89FH<975DH=CBGU=F97HCF"B89D9B89B79V5B8
U+9@5H98)9FGCB-F5BG57H=CB)C@=7M5B8)FC798IF9GVC:H<9&)FCLM,H5H9A9BH5B8GI7<=B:CFA5H=CB=G=B7CFDCF5H986M
F9:9F9B79<9F9=B
G8@ 'E<A6<C4?66BHAG<A:88F4A7*8EI<68F
-<9=B:CFA5H=CBF9@5H=B;HCDF=B7=D5@577CIBH=B;:99G5B8G9FJ=79G=GG9H:CFH<=BH<9G97H=CB9BH=H@98UI8=HCAA=HH99&5HH9FGV
IB89FH<989G=;B5H=CBUI8=HCAA=HH99)C@=7MCB)F9 DDFCJ5@C:I8=H5B8)9FA=GG=6@9'CB I8=H,9FJ=79GC:H<9
"B89D9B89BH77CIBH=B;=FAV5B8U99GC:H<9"B89D9B89BH77CIBH=B;=FAV=BH<9&)FCLM,H5H9A9BH5B8GI7<
=B:CFA5H=CB=G=B7CFDCF5H986MF9:9F9B79<9F9=B
-- 135 of 142 --
128
PART IV
Item 15. Exhibits, Financial Statement Schedules.
(a) (1) Financial Statements. The consolidated financial statements filed as part of this report are listed in the index to financial
statements at the beginning of this document.
(a) (2) Financial Statement Schedules. Financial statement schedules are omitted because of the absence of the conditions under
which they are required or because the required information is included in the Consolidated Financial Statements or the notes
thereto. The financial statements of unconsolidated subsidiaries are omitted because, considered in the aggregate, they would
not constitute a significant subsidiary.
(a) (3) Exhibits. The exhibits are either filed with this report or incorporated by reference into this report. See (b) Exhibits,
which follow.
(b) Exhibits.
(3) Articles of Incorporation and bylaws
(3.1) Certificate of incorporation, as amended as of December 4, 2017, is incorporated by reference from our Form 8-
K dated December 7, 2017.
(3.2) Amended and Restated Bylaws, as adopted as of February 2, 2021, are incorporated by reference from our
Form 8-K dated February 3, 2021.
(4) Instruments defining the rights of security holders, including indentures
(4.1) Indenture, dated as of November 17, 2000, between 3M and The Bank of New York Mellon Trust Company,
N.A., as successor trustee, with respect to 3M’s senior debt securities, is incorporated by reference from our
Form 8-K dated December 7, 2000.
(4.2) First Supplemental Indenture, dated as of July 29, 2011, to Indenture dated as of November 17, 2000, between
3M and The Bank of New York Mellon Trust Company, N.A., as successor trustee, with respect to 3M’s senior
debt securities, is incorporated by reference from our Form 10-Q for the quarter ended June 30, 2011.
(4.3) Description of Securities is incorporated by reference from our Form 10-K for the year ended December 31,
2019.
(10) Material contracts and management compensation plans and arrangements:
(10.1)* 3M Company 2016 Long-Term Incentive Plan, as amended and restated effective May 11, 2021, is incorporated
by reference from our Form 8-K dated May 13, 2021.
(10.2)* Form of Stock Option Award Agreement under the 3M Company 2016 Long-Term Incentive Plan is
incorporated by reference from our Form 8-K dated May 12, 2016.
(10.3)* Form of Stock Appreciation Right Award Agreement under the 3M Company 2016 Long-Term Incentive Plan is
incorporated by reference from our Form 8-K dated May 12, 2016.
(10.4)* Form of Restricted Stock Unit Award Agreement under the 3M Company 2016 Long-Term Incentive Plan is
incorporated by reference from our Form 8-K dated May 12, 2016.
(10.5)* Form of Performance Share Award Agreement for performance share awards granted under the 3M Company
2016 Long-Term Incentive Plan on or after February 5, 2018 is incorporated by reference from our Form 10-K
for the year ended December 31, 2017.
(10.6)* Form of Performance Share Award Agreement for performance share awards granted under the 3M Company
2016 Long-Term Incentive Plan on or after February 1, 2021 is incorporated by reference from our Form 10-K
for the year ended December 31, 2020.
(10.7)* Form of Stock Issuance Award Agreement for stock issuances on or after January 1, 2019 to Non-Employee
Directors under the 3M Company 2016 Long-Term Incentive Plan is incorporated by reference from our Form
10-K for the year ended December 31, 2018.
(10.8)* Form of Deferred Stock Unit Award Agreement for deferred stock units granted on or after January 1, 2019 to
Non-Employee Directors under the 3M Company 2016 Long-Term Incentive Plan is incorporated by reference
from our Form 10-K for the year ended December 31, 2018.
-- 136 of 142 --
129
(10.9)* 3M 2008 Long-Term Incentive Plan (including amendments through February 2, 2016) is incorporated by
reference from our Form 10-K for the year ended December 31, 2015.
(10.10)* Form of Stock Option Agreement for options granted to Executive Officers under the 3M 2008 Long-Term
Incentive Plan, commencing February 9, 2010, is incorporated by reference from our Form 10-K for the year
ended December 31, 2009.
(10.11)* Form of Stock Option Agreement for U.S. Employees under 3M 2008 Long-Term Incentive Plan is incorporated
by reference from our Form 10-K for the year ended December 31, 2008.
(10.12)* Amended and Restated 3M VIP Excess Plan, as amended and restated effective December 1, 2021, is filed
herewith.
(10.13)* Amended and Restated 3M VIP (Voluntary Investment Plan) Plus Plan is incorporated by reference from our
Form 10-K for the year ended December 31, 2016.
(10.14)* Amended and Restated 3M Deferred Compensation Excess Plan, as amended and restated effective December 1,
2021, is filed herewith.
(10.15)* 3M Performance Awards Deferred Compensation Plan is incorporated by reference from our Form 10-K for the
year ended December 31, 2009.
(10.16)* 3M Annual Incentive Plan (including amendments through February 3, 2020) is incorporated by reference from
our Form 10-K for the year ended December 31, 2019.
(10.17)* 3M Annual Incentive Plan, as amended and restated effective January 1, 2022, is incorporated by reference from
our Form 8-K dated November 12, 2021.
(10.18)* 3M Executive Severance Plan is incorporated by reference from our Form 10-K for the year ended December 31,
2019.
(10.19)* 3M Compensation Plan for Non-Employee Directors, as amended, through November 8, 2004, is incorporated
by reference from our Form 10-K for the year ended December 31, 2004.
(10.20)* Amendment of 3M Compensation Plan for Non-Employee Directors is incorporated by reference from our Form
8-K dated November 14, 2008.
(10.21)* Amendment of 3M Compensation Plan for Non-Employee Directors as of August 12, 2013, is incorporated by
reference from our Form 10-Q for the quarter ended September 30, 2013.
(10.22)* Amendment and Restatement of 3M Compensation Plan for Non-Employee Directors as of January 1, 2019, is
incorporated by reference from our Form 10-K for the year ended December 31, 2018.
(10.23)* 3M Executive Life Insurance Plan, as amended, is incorporated by reference from our Form 10-K for the year
ended December 31, 2017.
(10.24)* Policy on Reimbursement of Incentive Payments is incorporated by reference from our Form 10-Q for the
quarter ended June 30, 2018.
(10.25)* Amended and Restated 3M Nonqualified Pension Plan I is incorporated by reference from our Form 10-K for the
year ended December 31, 2016.
(10.26)* Amended and Restated 3M Nonqualified Pension Plan II is incorporated by reference from our Form 10-K for
the year ended December 31, 2016.
(10.27)* Amended and Restated 3M Nonqualified Pension Plan III is incorporated by reference from our Form 10-K for
the year ended December 31, 2016.
(10.28)* Offer letter of Employment of Monish Patolawala, dated May 19, 2020 is incorporated by reference from our
Form 8-K dated June 3, 2020.
(10.29) Amended and restated five-year credit agreement as of November 15, 2019, is incorporated by reference from
our Form 8-K dated November 19, 2019.
(10.30) 364-day credit agreement as of November 12, 2021, is incorporated by reference from our Form 8-K dated
November 15, 2021.
(10.31) Registration Rights Agreement as of August 4, 2009, between 3M Company and State Street Bank and Trust
Company as Independent Fiduciary of the 3M Employee Retirement Income Plan, is incorporated by reference
from our Form 8-K dated August 5, 2009.
-- 137 of 142 --
130
Filed herewith, in addition to items, if any, specifically identified above:
(21) Subsidiaries of the Registrant.
(23) Consent of independent registered public accounting firm.
(24) Power of attorney.
(31.1) Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, 18
U.S.C. Section 1350.
(31.2) Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, 18
U.S.C. Section 1350.
(32.1) Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18
U.S.C. Section 1350.
(32.2) Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18
U.S.C. Section 1350.
(95) Mine Safety Disclosures.
(101.INS) Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its
XBRL tags are embedded within the Inline XBRL document)
(101.SCH) Inline XBRL Taxonomy Extension Schema Document
(101.CAL) Inline XBRL Taxonomy Extension Calculation Linkbase Document
(101.DEF) Inline XBRL Taxonomy Extension Definition Linkbase Document
(101.LAB) Inline XBRL Taxonomy Extension Label Linkbase Document
(101.PRE)
(104)
Inline XBRL Taxonomy Extension Presentation Linkbase Document
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
* Management contract or compensatory plan or arrangement required to be filed as an exhibit pursuant to Item 15 of Form 10-
K.
Item 16. Form 10-K Summary.
A Form 10-K summary is provided at the beginning of this document, with hyperlinked cross-references. This allows users to
easily locate the corresponding items in Form 10-K, where the disclosure is fully presented. The summary does not include
certain Part III information that is incorporated by reference from a future proxy statement filing.
-- 138 of 142 --
* %+,)*
)IFGI5BHHCH<9F9EI=F9A9BHGC:,97H=CBCF8C:H<9,97IF=H=9GL7<5B;97HC: H<9+9;=GHF5BH<5G8I@M75IG98H<=G
F9DCFHHC69G=;B98CB=HG69<5@:6MH<9IB89FG=;B98 H<9F9IBHC8I@M5IH<CF=N98
&(&)'2
M G &CB=G<)5HC@5K5@5
&CB=G<)5HC@5K5@5
L97IH=J9/=79)F9G=89BH5B8<=9:=B5B7=5@5B8
-F5BG:CFA5H=CB(::=79F
)F=B7=D5@=B5B7=5@(::=79F
96FI5FM
)IFGI5BHHCH<9F9EI=F9A9BHGC:H<9,97IF=H=9GL7<5B;97HC: H<=GF9DCFH<5G699BG=;B9869@CK6MH<9:C@@CK=B;
D9FGCBGCB69<5@:C:H<9+9;=GHF5BH5B8=BH<975D57=H=9G=B8=75H98CB96FI5FM
*<:A4GHE8 +<G?8
G &=7<59@ +CA5B <5=FA5BC:H<9C5F85B8<=9:L97IH=J9(::=79F)F=B7=D5@L97IH=J9(::=79F5B8=F97HCF
G -<9F9G5 +9=BG9H< ,9B=CF/=79)F9G=89BH CFDCF5H9CBHFC@@9F5B8<=9:77CIBH=B;(::=79F
)F=B7=D5@77CIBH=B;(::=79F
-<CA5G$ FCKB =F97HCF
)5A9@5# F5=; =F97HCF
5J=8 =@@CB =F97HCF
&=7<59@% G?9K =F97HCF
#5A9G+ =HH9F@=B; =F97HCF
!9F69FH% !9B?9@ =F97HCF
AM !CC8 =F97HCF
&I<H5F$9BH =F97HCF
5A6=G5 &CMC =F97HCF
F9;CFM+ )5;9 =F97HCF
)5HF=7=5 0C9FHN =F97HCF
&CB=G<)5HC@5K5@5 6MG=;B=B;<=GB5A9<9F9HC 8C9G<9F96MG=;BH<=G8C7IA9BHDIFGI5BHHCDCK9FGC:5HHCFB9M8I@M9L97IH98
6MH<9CH<9FD9FGCBGB5A98 :=@98K=H<H<9,97IF=H=9G5B8L7<5B;9CAA=GG=CBCB69<5@:C:GI7<CH<9FD9FGCBG 5@@=BH<9
75D57=H=9G5B8CBH<985H9GH5H98 GI7<D9FGCBG7CBGH=HIH=B;5A5>CF=HMC:H<98=F97HCFGC:H<9CAD5BM
M G &CB=G<)5HC@5K5@5
&CB=G<)5HC@5K5@5 >>9<8/C38+->
-- 139 of 142 --
This page is left intentionally blank.
132
-- 140 of 142 --
Account Information
Registered 3M shareholders can access account
information and get answers to frequently asked
questions in several ways:
Internet: www.shareowneronline.com
Telephone: (651) 450-4064 or 1-800-401-1952
E-mail: Go to www.shareowneronline.com
and select Contact Us.
Mail: EQ Shareowner Services
P.O. Box 64854
St. Paul, MN 55164-08540
Shareholder information
Dividends
Quarterly dividends on 3M common stock typically are
paid on or about the 12th of March, June, September and
December. 3M has paid dividends since 1916. Shareholders
can reinvest dividends and make additional cash contributions
through the Automatic Dividend Reinvestment Plan or have
dividend payments automatically deposited into checking
or savings accounts through the Electronic Dividend
Deposit Service.
Stock Listings
3M’s common stock trades on the New York and Chicago
stock exchanges, and is also traded on the SIX Swiss
Exchange. Our symbol is MMM. 3M is one of 30 companies
in the Dow Jones Industrial Average and is also a component
of the Standard & Poor’s 500 Index.
3M Stock Performance (With Dividend Reinvestment)
The graph above compares the five-year cumulative total
shareholder return for 3M common stock with that of the
Standard & Poor’s 500 Stock Index (S&P 500) and the
Dow Jones Industrial Average (DJIA). The comparison
assumes that $100 was invested in 3M stock and the two
indexes on Dec. 31, 2016, and that all quarterly dividends
were reinvested.
2021 Annual Report
Annual Shareholders’ Meeting
3M’s annual meeting of shareholders will be held virtually
on Tuesday, May 10, 2022, at 8:30 a.m. (Central Daylight
Time). Shareholders of record may vote proxies via the
Internet at www.proxyvote.com, by calling 1-800-690-6903,
or by mail. If a broker holds your shares, please contact the
broker to determine your voting options.
Investor Inquiries
Securities analysts, portfolio managers and
representatives of financial institutions should contact:
3M Investor Relations
3M Center, Building 224-1W-02
St. Paul, MN 55144-1000
Phone: (651) 737-8503
Corporate News and Reports
Corporate news releases, 3M’s Annual Report,
and Forms 10-K and 10-Q are available online at:
investors.3M.com
Product Information
Information about 3M products and services is available at:
Internet: www.3M.com/product
Telephone: 1-800-3M HELPS (1-800-364-3577)
Forward-Looking Statements
This Annual Report contains forward-looking statements
that involve risks and uncertainties that could cause
results to differ materially from those projected. Please
refer to the section titled “Cautionary Note Concerning
Factors That May Affect Future Results” in Item 1 and
“Risk Factors” in Item 1A of the Annual Report on Form
10-K for a discussion of these risks and uncertainties.
Visit us on the Web
www.3M.com
2021
240.0
220.0
200.0
180.0
160.0
140.0
120.0
100.0
2017 2016 2018 2020 2019
3M
DJIA
S&P
500
-- 141 of 142 --
On the cover:
Loading 3M™ Polisher ST capsules as part of the biopharmaceutical
manufacturing process.
Corporate Headquarters
3M Center
St. Paul, MN 55144-1000
USA
(651) 733-1110
www.3M.com
Please recycle
Printed in U.S.A.
© 3M 2022. All rights reserved.
-- 142 of 142 --